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Abstract
Over 30 different mutations in p62 UBA have been identified in patients with
Paget's disease of bone (PDB). The mechanisms which underlie PDB are poorly
understood, although impaired ubiquitin binding has been identified as a
mechanism in the onset of disease. However, the decrease in affinity is subtle for
many PDB mutants. The p62 UBA is unique amongst UBAs since it exists as a
highly stable dimer but binds to ubiquitin as a monomer. The dimerisation
interface partially occludes the ubiquitin binding interface resulting in competing
equilibria. The factors which regulate the affinity of p62 UBA were examined in
this thesis.
In isolated p62 UBA the monomer-dimer equilibrium and the effects of
phosphorylation were investigated. By mutating residues at the dimerisation
interface, weaker dimers which had a higher affinity for ubiquitin were produced.
The weak dimers had an increased population of monomer at equilibrium. A
phosphorylation site at Ser403 in p62 UBA was recently identified.
Phosphomimetic mutants which showed subtle increases in affinity for ubiquitin
were generated. The increase was attributed to the close proximity of Ser403 to
the ubiquitin binding interface.
Factors outside the UBA also have a role in regulating UBA affinity. Binding by
p62 UBA was therefore probed in longer p62 constructs. A fragment of p62
encoding residues 300-440 was used to investigate p62 binding to multiple
proteins. A ternary complex was formed, but an allosteric relationship was not
observed by ubiquitin and MAP-Le3 in binding to the p62 fragment. A model of
full length oligomeric p62 was generated to probe avid binding to polyubiquitin'
chains. The model showed higher affinity for linear diubiquitin than
monoubiquitin suggesting avidity effects are influential in oligomeric p62
binding. Since the effects of PDB mutations and phosphorylation are subtle, they
are likely to be amplified by avidity in vivo.
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1.0 Introduction
1.1 Cell signaling pathways
There are an estimated 1 billion individual protein molecules in a typical
mammalian cell'. Each protein performs a specific function within the cell. With
such a diverse range of functions performed by a vast network of molecules, a
communication mechanism enabling each protein to reach its correct binding
partner is required. Thus, complex signalling pathways which utilise a relatively
low number of proteins whilst maintaining a high degree of specificity have
evolved. Over the past twenty years theories have emerged about proteins which
belong to certain signalling pathways achieving their specificity by being
sequestered to certain compartments to form a spacially organised cell2,3. This
organisation can be achieved using subcellular organelles, co localisation to the
cell membrane or scaffold proteins", Cell signalling pathways are activated by
various stimuli often resulting in changes in gene expression or gene splicing.
This enables the signalling pathway to regulate the levels of the different proteins
involved in that pathway to generate the desired response. In addition to cellular
organisation, the proteins themselves, are spacially organised keeping their
catalytic domains separate from other domains which might be involved in
targeting them to specific cellular compartments. Overall the evolution of these
pathways to convey molecular signals with such high specificity is remarkable.
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1.2 Post translational modifications
Post translational modifications (PTMs) are chemical modifications of proteins
which occur after protein translation. Nearly every protein that is synthesized by
the cell undergoes a form of PTM in its lifespan. Examples of chemical
modifications include acetylation and methylation, which alter the charge of
amino acids, and lipidation, which enable proteins to be anchored to cell
membranes. More complex PTMs include phosphorylation and ubiquitination,
both of which are reversible covalent attachments. In phosphorylation proteins are
modified by phosphate groups, whereas ubiquitination involves the addition of the
small protein ubiquitin to act as a molecular signal. Protein phosphorylation is a
vital regulatory mechanism as many proteins become activated or deactivated by
the modification. Both phosphorylation and ubiquitination processes have evolved
families of enzymes for the attachment or the removal of the chemical
modification. In the case of phosphorylation protein kinases attach phosphate
groups to amino acids and phosphatases remove phosphate groups. Ubiquitination
involves a cascade of enzymes for its attachment and deubiquitinases (DUBs) for
its removal, both of which are discussed in detail later in this thesis. However
there are two vast differences between ubiquitination and phosphorylation: the
size of the attachment and the ability of ubi quit in to form long polymers', It is the
added complexity of protein ubiquitination which has left the ubiquitin system
with the greatest challenges to fully understand.
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1.3 Ubiquitination
Ubiquitin was discovered in 1975 by Aaron Cienhanover, Avram Hershko and
Irwin Rose. Their discovery was revealed to be so monumental that the trio were
awarded the Nobel Prize in Chemistry in 20046• Uhiquitin is a small protein with
a molecular weight of just 8.5 kilo daltons (kDa) and a surface area of 4800 A2. It
consists of 76 amino acids that adopt a p-grasp globular fold composed of a 5
stranded p-sheet flanked by a single a-helix 7,8. The backbone of ubiquitin is rigid
but conformational flexibility has been shown in the Pl-P2 loop (residues 8-11)
and the C-terminal (residues 72-76t This protein is expressed ubiquitously in
eukaryotes, hence it's name. Ubiquitin has a highly conserved protein fold
maintained by the exceptionally high percentage sequence identity found amongst
various orthologues'", This is demonstrated well by yeast and human orthologues,
which differ by just 3 residues, suggesting a high evoluntionary pressure to
conserve the structure of ubiquitin. The ubiquitin fold has also been adopted by
domains referred to as ubiquitin-like (UhL) domains. Prokaryotes lack a
functionally equivalent protein; however, proteins containing the ubiquitin fold
exist highlighting the evolutionary precursors to ubiquitin in these cells.
Uhiquitin is covalently attached to proteins as a PTM to act as a molecular signal
to determine the fate of the target protein. In protein ubiquitination Lys residues in
the target protein become linked to the C-terminal diglycine motif of ubiquitin.
The resultant isopeptide bond is formed between the carboxy-terminus of
ubiquitin and the e-amino group of a Lys residue in a target protein. Ubiquitin
itself can also be ubiquitinated permitting the formation of long polyubiquitin
chains via anyone of its seven Lys residues which serve as additional points of
attachment I I. Linear polyubiquitin chains can also be formed with a peptide bond
being formed by the carboxy-terminus and amino-terminus of two ubiquitin
molecules. Ubiquitin was initially discovered for its ability to mark proteins for
degradation by the proteasome in a system termed the ubiquitin-proteasome
system (UPS)12. However extensive study since the discovery of the UPS has
revealed a complicated system which exploits polymerisation to modulate various
molecular signals". The complexity of this system has led to thoughts on the level
of protein ubiquitination and chain linkage becoming the key to cracking the
ubiquitin code.
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Unlike most proteins ubiquitin has a remarkable ability to bind with high
specificity and sufficient affinity to a diverse array of binding partners. Most
residues in ubiquitin are rigid; however, the C-terminal tail exhibits some
conformational flexibility". Recently residues in the ~1I~2 loop, which contains
Leu8, were shown to be flexible13. The study used relaxation dispersion nuclear
magnetic resonance (NMR), refined by residual dipolar couplings (RDC's), to
investigate the full dynamic behaviour of ubi quit in in solution. The study revealed
a pincer-like motion of ubiquitin contributing to the molecular recognition of
binding partners 13.
Ubiquitin has several binding interfaces, the most common of them being centred
on Leu8, Ile44 and Va17014.However non canonical binding sites have also been
identified on the surface of ubiquitin ". The presence of multiple binding sites
permits the formation of ubiquitin-mediated ternary complexes, in which ubiquitin
can be transferred between proteins using a 'hand off' mechanism 16. Other
binding surfaces centred on His68, Glu58 and C-terminal tail have been
identified, although the binding site of His58 is often combined with the canonical
I1e44 patch as they are located in such close proximity. Nearly all of the binding
sites identified on ubiquitin are located n the same face of the molecule (figure
1.1). Both conformational selection and induced fit mechanisms have been
implicated in the binding of ubiquitin to other proteins 13,17.
c
N N
Figure 1.1- The different binding surfaces identified on ubiquitin (PDB ID
1UBQ). The known patches are coloured and labelled. Nearly all of the binding
sites are located on one face of ubiquitin, with only the Asp58 patch located on
the other face.
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1.3.1 Ubiquitination enzymes
The covalent attachment of ubiquitin to target proteins is completed usmg
different classes of enzymes (figure 1.2). First a ubiquitin-conjugating enzyme,
known as an E I enzyme, adenylates the C-terminal glycine to form an
intermediate which is then transferred to a cysteine residue in the El. The
resultant ubiquitin-EI thiol ester is termed activated ubiquitin and its formation is
ATP dependent I I, 12. There are only 2 El enzymes encoded in the human genome
which have been identified to date, UBE I and UBE IL2. It had been previously
assumed that a single El, UBEI, performed the initial step in the cascade alone,
until the discovery of UBEIL2 in recent yearsl8,19, The two enzymes share 40 %
sequence identity. Other El enzymes exist for the attachment of UbL proteins but
are not able to activate ubiquitin itselfo.
The next step involves a ubiquitin-conjugating enzyme, known as an E2, to
catalyse the transfer of the activated ubiquitin from the cysteine of the El to the
active site cysteine in the E2. The reaction is a transthioesterification reaction.
There are significantly more E2 enzymes than El enzymes. The human genome
encodes around thirty seven different E2's21, A study using E2 enzymes indicated
that the E2's have the most influence on which of the seven Lys residues in
ubiquitin is targeted by polyubiquitination. It highlighted how E2 enzymes can
only produce polyubiquitin chains targeting either a subset of Lys residues or an
explicit Lys residue. Further experiments which included the E3 ubiquitin ligase,
the final enzyme involved in the ubiquitination process, showed that the E2's
capability to polymerise through a specific Lys residue is not altered by the
presence of the E322,
As briefly mentioned, the final step in the attachment of ubiquitin to the target
molecule is for a ubiquitin ligase known as an E3, to facilitate isopeptide bond
formation between the two proteins. The mechanism of action of E3s is poorly
understood. However it is believed the E3 binds to the E2 ubiquitin thioester and
activates release of ubiquitirr". There are an extraordinary number of E3s, in fact
more than 600 have been identified to date23, This exceptional number reflects the
large array of substrates targeted for ubiquitination. These enzymes can be divided
into 3 different families of proteins, Really Interesting New Protein (RING),
Homologous to E6AP Carboxy Terminus (HECT) and UFD2 homology (U-box)
5
proteins. RING E3s contain 2 co-ordinated zinc ions which are surrounded by
histidine and cysteine residues to form a zinc finger motif'".
(0 _8 E3 HEa
@-k-0-L0 ~
@ @
Ubiquitin Ubiquitin
activation conjugation
Ubiquitin-protein
ligation
Ubiquitinated
protein
Figure 1.2- A schematic diagram of the ubiquitination cascade. The El, E2 and
E3 enzymes attach the ubiquitin moiety to the substrate via a Lys residue in the
ubiquitin.
More recently a group of enzymes termed E4's were discovered in 199925. Not all
ubiquitinations are catalysed by an E4 but they do represent a separate protein
family in their own right. E4 enzymes propagate chain extension for proteins
already primed for degradation, leading to the formation of long polyubiquitin
chains". Much of the focus on E4 enzymes is linked to the first E4 to be
identified, a protein known as UFD225, 27, 28.
1.3.2 Types of ubiquitination
The complexity associated with the ubiquitin system is caused by the ability of
ubiquitin to polymerise". As discussed, the polymerisation can occur through any
on the seven Lys residues found in ubiquitin or via the Nand C terminals of
consecutive ubiquitin molecules. The ubiquitin modification can be a
monoubiquitination, a multi-monoubiquitination or a polyubiquitination.
Polyubiquitin chains can be either homotypic (i.e. linked via the same Lys residue
in adjacent ubiquitin molecules or linear polyubiquitin) or heterotypic (i.e. linked
via different Lys residues to form chains of mixed linkage). Heterotypic chains
can also contain certain ubiquitin molecules which have become
multiubiqutinated to form forked chains. The exploration of homotypic chains has
been underway for the past few decades since the first structure of a diubiquitin
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chain was reported". However, heterotypic chains present a bigger challenge and
research into these chains is rather limited.
Monoubiquitin is the simplest form of ubiquitination, but like polyubiquitination
it has been implicated in a variety of cellular processes including DNA repair and
viral budding30,31. Multi-monoubiquitination is also a common modification to
proteins. The p53 protein which has been implicated in several cancers is
regulated by the E3 mdm2 which has been shown to favour multi-
monoubiquitination over polyubiquitination ", Although the simplest form of
ubiquitination the enzymes which catalyse monubiquitination have been shown to
exert a high degree of specificity. These enzymes have to recognise substrate Lys
residues whilst sparing those on ubiquitin from modification.
The Lys residues on ubiquitin are all surface exposed. They are located all around
the ubiquitin molecule and are not confined to a specific patch (figure 1.3).
Consequently, when polymerised the ubiquitin chain can adopt diverse structures
with differing conformational flexibilities. The topologies of the different chains
cause different interaction surfaces to be presented to other proteins and different
flexibilities of the linker between the two moieties. The hydrophobic patch
centred on Ile44 can be fully or partially buried or exposed in different
orientations to enable high affinity binding to certain linkages. These residual
differences account for the specific molecular recognition of the chain as a distinct
molecular signal. The surfaces are recognised by different ubiquitin binding
domains (UBDs) and DUBs with certain linkages preferentially bound. Many
structural investigations using both X-ray crystallography and solution NMR have
led to multiple conformations of diubiquitin chains formed by the same
linkage33,34,35,36.This has lead to speculation about ubiquitin chains being viewed
as flexible units which can be shaped by their binding partner.
The diversity of polyubiquitin chains has attracted the interest of synthetic
chemists in recent years. The synthesis of all possible diubiquitin chains as
synthetic analogues has now been completed by various groups37,38,39.The ability
to probe the selectivity of various UBDs, including DUBs, can be achieved using
such synthetic analogues. This approach could provide substantial advances in the
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field as ubiquitination enzymes for the synthesis of Lys48, Lys63, Lys 11 and
linear chains are only currently known.
N
K6
K63 c
N
c
Figure 1.3 - Ubiquitin surface plot (PDB ID 1UBQ) which shows the locations of
the seven Lys residues (highlighted in red). The Lys residues are used as points of
attachment in the formation of polyubiquitin chains. An isopeptide bond is formed
between the carboxy-terminal of ubiquitin and the s-amino group of the Lys
residues on another ubiquitin molecule. The Nand C terminals (also indicated) in
consecutive ubiquitin molecules can also form peptide bonds to form linear
polyubiquitin chains.
1.3.3 Ubiquitin chain linkage
A recent study using S. Cerevisiae profiled the yeast proteome and found
evidence for all seven Lys linked polyubiquitin chains and linear chains 40. This
observation had previously not been confirmed in vivo and also highlighted some
intriguing results. The most abundant linkage was unsurprisingly found to be
Lys48 at 29% with the unconventional Lysll linakge highlighted as the second
most frequent linkage at 28 %. The third most common linkage was found to be
Lys63 at 17%. The roles of both Lys48 and Lys63 linked polyubiquitin chains
have now been clearly established''Y"; however, the revelation of the abundance
of Lysll chains in vivo has provoked extensive research into the role of these
chains33. The structures of many of diubiquitins are now known, revealing
differences in the overall structure, the flexibilities of the linkers and the
orientations of the binding interfaces (figure 1.5).
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1.3.3.1 Lys48 linkages
Lys48 chains are the most extensively studied chains because they were the first
linkage to be discovered. The ubiquitination reaction for the formation of Lys48
linked chains in vitro has been published allowing chains of this linkage to be
commercially available. Such chains are constructed by the E2 enzymes UBE2RI,
UBE2G2 and UBE2K43,44. Lys48 linked tetraubiquitin is the minimum
requirement for degradation by the 26S proteasome'". The canonical Leu8, Ile44,
Val70 hydrophobic patch on ubiquitin is recognised by the proteasome'f:". The
tag marks the target protein for degradation thus allowing the amino acid
components to be recycled by the cell during protein synthesis. Ubiquitin itself is
also recycled but it is not degraded by the proteasome. The proteasome regulates
the cellular concentrations of proteins and therefore represents a vital degradation
pathway. The crystal and solution NMR structures of Lys48 linked diubiquitin29,47
and tetraubiquitin'f' 46, 48,49 have provided great insight to the specific
conformation of this linkage. The 2-fold symmetry in each of the ubiquitin pairs
in Lys48 tetraubiquitin is quite different from the 2-fold symmetry observed in the
structure of Lys48 linked diubiquitin. There are multiple hydrophobic contacts in
Lys48 tetraubiquitin causing the formation of a buried hydrophobic core (figure
1.4). This hydrophobic surface is located centrally to the diubiquitin structure and
is more open than in Lys48 tetraubiquitin. The hydrophobic interface is therefore
liberated in Lys48 linked diubiquitin, freeing it to interact with various chain-
recognition factors, including the proteasome50-52•
Solution NMR studies aimed at probing discrepancies between different crystal
structures have highlighted that Lys48 chains are inheritantly flexible, with a pH
dependent equilibrium between open and closed conformations existingr'. The
compact conformation is dominant at physiological pH (pH 7), with the subunits
forming stabilising hydrophobic contacts with one another burying the canonical
binding site. During an interaction, the closed conformation opens due to the
weakness of the interaction between the subunits, presenting the hydrophobic
patches. In Lys48 diubiquitin the proximal ubiquitin (the subunit which carries the
free Gly76 residue) binds more strongly than the distal molecule enabling the
UBD to position itself between the two subunits forming a sandwich-like
complex". In the open conformation, which is more populated at low pH (pH
9
4.5), there are no hydrophobic contacts between the two subunits exposing the
patch for interaction with UBDs and the proteasome'". More recently, this
conformation has been shown to interact with UBDs in the same manner and with
comparable affinity as the closed conformations, highlighting a conserved binding
mechanism amongst Lys48 linked chains".
Hydrophobic
core
K48
K48
Ubi
Figure 1.4 - The structure of Lys48 linked tetraubiquitin (POB 10 206V).The
Lys48 residues are highlighted as dark grey spheres. The structure folds back on
itself forming contacts between the individual subunits to adopt a compact overall
structure with a buried hydrophobic core.
1.3.3.2 Lys63 linkages
Lys63 linked polyubiquitin chains are assembled by UBE2N and UBE2VI E2 and
E3 enzmyes55,56. These chains, unlike Lys48 chains, form open and extended
conformations in which there are no contacts formed between the ubiquitin
subunits. The hydrophobic binding patch centred on Ile44 is surface exposed in
this open conformation, even in chains with more than two ubiquitin
moieties57,58,35,59. These chains can rotate without restraints but can also form
more compact structures due to the flexibility of the linker region between the
ubiquitin moieties. Not only is the structure of Lys63 chains completely different
to Lys48 chains but so is the function. Lys63 linked polyubiquitin chains are not
linked to proteasomal degradation'Y". Lys63 linked chains have been linked to
several diverse functions ranging from DNA repair to cell signalling and
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trafficking and most importantly to this study, nuclear factor-ill (NF-ill)
activation42•61• Lys63 linked chains have been shown to exhibit structural
flexibility depending on binding partner. When bound to the associated molecule
with the Src homology 3 (AMSH) domain Lys63 linked diubiquitin is stretched'";
whereas, in complex with an antibody a more compact structure with contacts
between the subunits is utilised'".
1.3.3.3 Lys11 linkages
A recent advancement in the ubiquitin field is the discovery of the high abundance
of Lys 11 linked chains in the yeast proteome'", Although similar studies in higher
order eukaryotes did not yield similar results". The anaphase-promoting complex
(APC/C) has been identified as an E3 which assembles Lys 11 linked chains in
combination with the E2 enzymes UBE2S and UbcH1 065,66,67. In 2010 two
different crystal structures of compact Lysll linked diubiquitin were reported.
One of the structures showed Leu8 and Val70 at the interface of the two ubiquitin
moieties and the two hydrophobic patches merging to form a larger surface33• The
other structure identified a previously unreported interface on the ubiquitin
helix34• It is now believed that Lys 11 chains are able to adopt an ensemble of
structures, including the two reported crystal structures; highlighting, the dynamic
nature of this linkage".
Initial research into the function of these chains highlights a role in the
degradation of mitotic regulators, with the abundance of the chains markedly
increasing when cells exit mitosis33,69. The change in abundance is linked directly
to the activation of the APC/C during the cell cycle. The APC/C is responsible for
the progression through the cell cycle by targeting cell cycle regulators for
degradation as well as the assembly of Lysll chains. The ubiquitination of APC
substrates with Lysl1 chains was shown to be strongly influenced by two motifs
known as the D box and TEK box within the substrate70,71. For chain assembly
both motifs have been suggested to work together, the D box holds the ubiquitin
in place while the TEK box in the substrate is replaced by the ubiquitin TEK box.
Proteins modified with Lys 11 chains have been shown to be rapidly degraded by
the proteasome during cell cycle progression6S,67,71,72.
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1.3.3.4 Linear ubiquitin linkages
The N-tenninal methionine can be conjugated to the C terminal glycine of the
adjoining ubiquitin in a head to tail manner to form linear polyubiquitin chains.
Linear chains are also assembled by the E3 linear ubiquitin chain assembly
complex (LUBAC)73. Linear diubiquitin was originally shown to be structurally
equivalent to Lys63 linked diubiquitin, adopting an open conformation with no
contacts between the ubiquitin subunits. The main difference to Lys63 chains is
the distinctive peptide linkage". The flexibility of the linker in Lys63 linked
chains is not seen in linear chains as it is restrained by the N-tenninal Met residue
allowing the two chains to be recognised by different UBDs such as NEMO (NF-
KB essential modifier) also known as IKKy74,75.NEMO binds linear diubiquitin
with a different topology and about 100-fold higher affinity than it does Lys63
linked diubiquitin. Linear chains, like Lys63 chains, have been shown to be
essential for NF-KB signalling74,76,77.NEMO is a subunit of LUBAC and is
required to phosphorylate the inhibitor of NF-KB (IKB), thereby inducing its
degradation and releasing NF-KB to relocate to the nucleus and regulate the
expression of immune genes, a role which is shared by Lys63 chains. However, a
recent structure showed linear diubiquitin in a compact but not completely closed
conformatiorr". It would appear that like Lys 11 chains, an ensemble of structures
are utilized by linear chains dependent on the binding partner.
1.3.3.5 Non conventional linkages
Very little is known about the other linkages of polyubiquitin chains and their
roles have not been elucidated in vivo. The structures of diubiquitin molecules
connected by these linkages have yet to be solved, with the exception of Lys6
diubiquitin, which was solved in 201078. Lys6 diubiquitin was assembled using a
chemical approach rather than using ubiquitination enzymes. The structure
revealed an asymmetric compact structure distinct from previously observed
structures. The proximal ubiquitin binds to the distal ubiquitin via the canonical
hydrophobic surface and a second hydrophobic patch centred on Leu71 and Ile36
acts as the hydrophobic counterpart in the distal ubiquitin" . Despite the recent
insights into the structure of Lys6 diubiquitin, much more research needs to be
conducted on the structure, function and assembly of the remaining polyubiquitin
chain linkages.
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lys48 (lAAR)
lys6 (2XKS)
lysll (3NOB)
linear (3AXC)
lys48 (3AUl)
lys63 (2FJS)
lysll (2XEW)
linear (2W9N)
Figure 1.5 - Comparison of the structures of the different diubiquitin molecules.
The PDB ID's are indicated in brackets next to each structure. The proximal
ubiquitin is coloured in pink and the distal ubiquitin is coloured in blue. The
hydrophobic patches (Leu8, I1e44 and Va170) from each subunit are highlighted in
dark grey. From these structures it is clear that the hydrophobic patches are
presented in different orientations for binding to UBDs. In the case of Lys48
(lAAR) the hydrophobic patches are not available for binding as they buried in a
hydrophobic core.
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1.4 Ubiqutin binding domains (URDs)
UBDs are domains which interpret the ubiquitin code by binding non-covalently
to ubiquitin. More than 20 families of UBDs have been identified to date79,8o,81.
The large number of proteins known to interact with ubiquitin strongly reflects the
functional importance of ubiquitin in vivo. The human genome encodes over 200
proteins which contain one or more form of UBD. There are many structural
differences found between the different families of UDB. Many UBDs utilize a
helices for binding to the hydrophobic patch in the p-sheet of ubiquitin; however,
some UBDs utilize p sheets to bind to ubiquitin and in some cases UBDs bind to
other recognition sites on ubiquitin, such as Asp58. Ubiquitin-interacting motifs
(UIMs), ubiquitin-associated (UBA) domains and coupling of ubiquitin
conjugation to endoplasmic reticulum degradation (CUE) domains all possess a
helical structures in order to bind to ubiquitin'". Zinc fingers are also used by
UBDs but these domains tend to have roles in regulating the response to DNA
damage'r'. Whilst the structure of the UBD clearly has a role in determining which
type ubiquitin chains is preferentially bound, an exclusive relationship between
UBD family and linkage is not observed. In a number of cases it is the spatial
arrangement or the presence of multiple ubiquitin interacting sites which
determines the specificity.
Structural investigations probing ubiquitin binding by different UBDs has
contributed significantly to the world of structural biology. As a result, a
multitude of different structures with different binding specificities have been
deposited into the Protein databank (figure 1.6). For example, the Rabex-5 protein
binds to monoubiquitin using the Ile44 and Asp58 binding sites using an inverted
UIM and an A20 zinc finger83, the NZF in the TAB2 protein inserts itself between
the extended conformation of Lys63 linked diubiquitin'" and the Hrs-UIM binds
to two ubiquitin molecules, one on either side, both using the Ile44 surface with
equal binding affinities8s• The UBAN domain ofNEMO forms a coiled coil which
is capable of binding to two linear diubiquitins. Multiple contacts are made with
both ubiquitins, thus conveying the specificity for linear chains74,77. The ZnF4
A20 binds to three ubiquitins or Lys63 linked triubiquitin. The interaction site on
ubiquitin is different for each ubiquitin, with the hydrophobic patch only utilized
in binding to one ubiquitin'".
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NEMO
UBAN
ZnF4
A20
Ub3
hHR23A UBA2
Linear
DiUB
Linear
DiUB
DS8
RabexS A20 ZnF and IUIM
Figure 1.6 - The structures of different UBDs in complex with ubiquitin. The
UBDs are coloured and the ubiquitins are grey. The TAB2 NZF domain inserts
itself between the extended conformation of Lys63 diubiquitin (PDB ID 3A9J).
The hHR23A VBA2 domain sandwiches between the two ubiquitins of Lys48
diubiquitin (PDB ID lZ06). The UBAN domain of NEMO forms a coiled coil
which binds to two linear diubiquitins (PDB ID 2ZYO). The ZnF4 A20 binds to
three ubiquitins (PDB ID 3013). The Rabex 5 binds to ubiquitin at two sites, the
IUIM binds to Ile44 and the A20 ZnF binds to Asp58 (PDB ID 2FIF). The
residues which link the diubiquitin moieties are shown as dark grey spheres.
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1.4.1 Ubiquitin recognition by UBDs
The recognition of ubiquitin by different UBDs is extremely important. Ubiquitin
recognition by single-domain proteins has been studied thoroughly'", although the
recognition of polyubiquitin chains by multi-domain proteins has only recently
begun to be explored. Binding to ubiquitin using both conformational selection
and induced fit mechanisms have been suggested'Y". Many other factors also
contribute to ubiquitin recognition including, the accessibility and orientation of
the hydrophobic patch in different polyubiquitin chains', the flexibility of
polyubiquitin chains'", polyubiquitin chain length'", the structure of the UBD80
and the ability of UBDs to bind to non-canonical surfaces on ubiquitin'". A
combination of these factors enables the UBDs to interpret the different signals of
the ubiquitin code.
Ubiquitin is able to adopt different conformations dependent on its binding
partner. One study highlighted that for each bound ubiquitin structure there is an
equivalent unbound structure, supporting the conformational selection theoryJ3.
Another study showed that the region surrounding the binding site on ubiquitin
undergoes more pronounced conformational changes compared to the rest of the
molecule, suggesting induced fit optimisations are made after binding. A
molecular dynamics simulation study also hinted at interplay between the two
mechanisms'", During a binding event, a scaffold structurally similar to the bound
conformation is chosen by conformational selection, while the binding interface is
subsequently optimized for specific interactions via induced fitl7.
In polyubiquitin chains, the linkage determines the positioning of the ubiquitin
moieties for their recognition by UBDss. The same UBD can interact with
different types of polyubiquitin chain, but exhibit a preference for a specific type
of chain Iinkage+ 91. As well as differences in the affinity of UBDs for different
linkages, differences in affinity are also observed between polyubiquitin chains of
different lengths. The affinity of most UBD-ubiquitin interactions is modest, but
high affinity can be achieved using avid binding to polyubiquitin chains92,93.
Chains must be long enough to provide sufficient binding affinity through avidity.
However, chains that are too long may bind so tightly that they prevent
dissociation when required", Multi-domain proteins must therefore bind to chains
of sufficient length to amplify the signal, yet short enough to permit dissociation
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of the complex. The structure of the UBD is therefore critical in order to
discriminate between the different ubiquitin signals and optimise binding to
certain types of chains'",
When the structures of polyubiquitin chains in isolation and in complex with
different UBDS are explored discrepancies between them were observed. These
differences highlight the flexibility within polyubiquitin chains. A recent
investigation using Lys48, Lys63 and linear FRET labelled diubiquitin showed
that UBDs were able to select pre-existing conformations. Certain conformations
of open chains, such as Lys63 and linear chains, are able to be selected by UBDs;
whereas, closed chains, such as Lys48 chains, are opened to conformations which
can be recognised'". This study showed that a combination of conformational
selection and chain remodeling are key factors in ubiquitin recognition.
Most UBDs bind to the hydrophobic patch on ubiquitin, although some bind to
other regions on ubiquitin". Most of the other binding sites are found close to the
hydrophobic path, permitting multi-domain proteins to engage multiple binding
sites simultaneously. The family and therefore the structure of the UBD often
determines which region on ubiquitin is recognised". For example UIM domains
interact with the pS strand, UBA domains bind to the hydrophobic patch and
DUBs bind to the C-terminal tail of ubiquitin'". When individual interactions are
probed further, different residues at the binding interface form distinct contacts
with different UBDs. Ile44, the centre of the hydrophobic patch is often critical
for an interaction, although in some cases it has a minor role in the affinity of the
interaction IS.
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1.4.2 Ubiquitin-associated domains (UBA domains)
UBA domains were the first type of motif discovered to bind to ubiquitin. They,
as many other UBDs, are a-helical structures. UBA domains fold to form a
compact three helix bundle. The structure is arranged to form a large hydrophobic
patch around the first flexible loop region which links helices 1 and 295,96,97,98.
These domains possess very little sequence homology but are structurally very
similar (figure l.7). An MGF motif in loop 1, a di-Leucine motif at the end of
helix 3 and the hydrophobic patch are features common to many different UBA
domains. CUE domains also fold to form three helix bundles, making these two
families the most similar of the UBD families.
S art End
resid
al c.U res id
Sample
OQl UBA 546 SS6
UBQL _MOUSE 539 579
OBQL2-HUMAN/hPLTC2 581 621
UBQLLHUMAN 5S8 598
OBQL3JruMAN 6 6 652
DSK2p UBAb 331 373
MUDl UBA 295 332
HHR23A USA 162 204
HHR23A tJBA2 3 9 363
Ed!} UBAb 3 41
CUE2-1- YEASTb 8 54
Figure l.7 - The sequence alignment of some UBA domains and the structurally
related CUE domain in the Cue2-1 protein in yeast. The helices and conserved
regions are indicated. The MGF motif in loop 1and the di-Leu in helix 3 are
highlighted in green. Taken from Zhang et at9.
Crystal and solution structures of UBAs alone and in complex with ubiquitin are
available for a variety of proteins. The complex structures reveal that the
hydrophobic patch on the UBA binds to the hydrophobic patch centred on Ile44
on ubiquitin. Examples include one of the human homologues of the yeast Rad23
protein (hHR23A)95, DskllOO, Mudl1ol, Edel97 and E3 ubiquitin ligase EDDlo2.
Structures identified to date highlight residues in loop 1 and helix 3 at the binding
interface, suggesting a conserved interaction surface is used by UBA domains to
bind to ubiquitin (figure 1.8).
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EDD UBA Edel UBA
Figure 1.8 - The structures of the EDD UBA (PDB ID 2QHQ) and Edel UBA
(PDB ID 2G3Q) in complex with ubiquitin. The three helix bundle of the UBA is
coloured blue or red for the EDD UBA and Edel UBA respectively. Ubiquitin is
coloured light grey. UBA domains bind to ubiquitin using residues in loop I and
helix 3 highlighting a conserved interaction surface is used by UBA domains.
UBA domains bind to both monoubiquitin and polyubiquitin chains, with many
UBAs preferentially binding to polyubiquitin chains 103.Despite binding to the
hydrophobic patch on ubiquitin and utilizing a conserved binding interface, a
preference for a particular linkage is not displayed by UBA domains'l". UBAs
domains bind to polyubiquitin chains of different length and linkage with different
affinities. For example, the hHR23A UBA2 domain exhibits a preference for
Lys48 chains over both Lys63 chains and monoubiquitm'I":". It binds to Lys48
diubiquitin in a sandwich-like mode where the UBA inserts itself between the two
adjacent ubiquitin molecules enabling it to simultaneously contact both units
(figure 1.6)54. In contrast, the two UBA domains of Drm2 bind to Lys63 chains
with higher affinity than Lys48104. Some UBAs, such as Ubiquillin-I UBA, show
no particular preference for chain linkage. This UBA binds to both Lys48 and
Lys63 chains in a similar manner with comparable affinities99.
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1.4.3 Deubiquitinases (DUBs)
Protein ubiquitination is a reversible modification; therefore, a specific family of
enzymes known as deubiquitinases (DUBs), have evolved to oppose the action of
E3 ligases and remove ubiquitin from the target protein. DUBs bind to the C-
terminal tail on ubiquitin and hydrolyse the isopeptide bond between ubiquitin
and target proteins as well as isopeptide bonds between ubiquitin moieties in
polyubiquitin chains. Approximately eighty five active DUBs are encoded by the
human genomel'". DUBs can be divided into five structurally distinct classes,
ubiquitin C-teminal hydrolases (UCHs), ubiquitin specific proteases (USPs),
ovarian tumour proteases (OTUs), Josephins and MNP+ metalloproteases'Y'".
The largest of the DUB families are the USPs, with 56 members. Despite having
to substitute ubiquitin for an analogue, the structures of DUBs in complex with
the ubiquitin analogue are available for many DUBs (figure 1.9).
OTUl
Figure 1.9 - The structures of some DUBs in complex with ubiquitin. A member
of the OTU family, OTU I in complex with ubiquitin (3BY4) is shown on the top
left. A member of the Josephin family, ATXN3 in complex with ubiquitin is
shown op the top right. A member of the UCH family, UCH-L3 in complex with
ubiquitin is shown at the bottom. Ubiquitin in all cases is shown in light grey.
Ile44 is shown as dark grey spheres.
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All families, with the exception of MNP+ metalloproteases, are Cys proteases
which rely of a catalytic diad or triad of residues where a nearby His side chain
lowers the pKa of the catalytic Cys residue to permit the nucleophilic attack on
the desired isopeptide bond, The third residue, usually an Asn or Asp, for those
with a catalytic triad, polarizes the catalytic His107. Rather surprisingly the
catalytic residues of all Cys protease DUBs when superimposed show only very
small deviations from each other despite the families displaying vastly divergent
structures I07.
Insights into the molecular recognition of ubi quit in by DUBs have been shown by
biochemical studies. The C-terminus of ubiquitin extends to the ubiquitin binding
site in the catalytic domain of the DUB where it is held in place for catalysis. The
DUB recognizes Arg74 and Gly75 as critical residues in ubiquitin'l". Many DUBs
have been shown to possess linkage specificity, but like other UBDs the
specificity is not restricted to certain families. The proteasome-assisted USP 14
shows a preference for Lys48 chainsl09 , whereas, CYLD has been shown to bind
Lys63 and linear chains with higher affinity'!", Some DUBs have also been
shown to disassemble unanchored polyubiquitin chains, a process which involves
slightly different recognition of ubiquitin. The extensively studied iospeptidase T
(IsoT) is one such DUB. It utilizes a ZnF domain to recognize the C-terminal Gly-
Gly motif of ubiquitin to ensure that only unanchored chains are disassembled III.
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1.5 SQSTMlIp62 protein
Over the past few decades protein communicators termed scaffold proteins have
been discovered. Scaffold proteins are proteins which function to bring together
interacting proteins but have no catalytic activity or specific function of their
own". One such scaffold protein to be identified is sequestosomel (SQSTM1), or
p62 as it is more commonly known. The p62 protein is encoded by the SQSTMI
gene and was originally identified as binding partner of the atypical protein kinase
C (aPKC)II2. This thesis focuses on the role ofp62 in NF-Kl3 signalling'{'. p62 is
capable of binding to a multitude of different proteins, including ubiquitin, to
regulate a variety of cellular processes including, cell survival and cell death 114,
shuttling proteins to the proteasome for degradatiou'{", selective
macroautphagy'P''!", bone homeostasisl18,119 and NF-K13activationI20,121.In vivo
the p62 is often found in sequestosomes which contain large numbers of PB 1
mediated oligomers and ubiquitinated proteins 122,123.
At the N-terminus lies an oligomerisation domain and at the C-terminus a UBA
domain resides (figure 1.10). Between the two termini lies a zinc finger domain
and a flexible, unstructured region containing several protein binding motifs. The
domains of the p62 and the NF-K13signalling pathway are discussed further.
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aPKCs, NBR1,
MEKK3, ERKl • NF-KB signaling ~
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Figure 1.10- A schematic diagram of the p62 protein, its binding partners and
functions. The 3 folded domains, the PB I, ZZ and UBA domains occupy residues
3-102, 122-167 and 387-436 respectively. Protein binding sites are located in the
unstructured region between the ZZ domain and UBA: the TRAF-6 binding site
(TBS) between residues 228-233, the LC3-interacting region CUR) between
residues 332-345 and the Keap l-interacting region CKIR) between residues 344
and 356. The 2 PEST domains, occupying residues 266-294 and 345-377, are also
indicated. Some of the proteins which bind to the different regions of the p62 are
shown in boxes and the pathway the interaction with p62 affects is shown below.
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1.5.IPhoX and Bemlp (PBI) domain
The N terminal domain (residues 3 - 102) of the p62 protein is an oligomerisation
domain known as a PhoX and Bem Ip (PB I) domain. PB I domains fold into a
UhL scaffold with two a helices flanking a five stranded mixed p sheet. PB 1
domains are divided into 3 different classes, type I, type II and type VII, based on
their oligomerisation capabilities. Type I contain a conserved highly acidic motif
of around twenty eight amino acids known as the OPCA motif. Type II contains a
conserved Lys residue capable of binding the OPCA motif on the face opposite.
Type VII contain both conserved features and can bind in a back to front manner
to other PB I domains (figure 1.11) 124. Type VII are therefore also capable of self
oligomerisation which is inherently problematic in in vitro structural studies, often
with insoluble aggregates formed,
The p62 PBI domain is a type VII PBI which has been problematic until recently.
The NMR structures of the p62 PB I monomer'P and dimerl26 have now been
elucidated by introducing mutations to the conserved OPCA motif. The solution
structures reveal two acidic clusters in the OPCA interface which are denoted Al
and A2 and are common to type I and type VII PBI 'so The opposite face reveals 2
basic clusters referred to Bland B2·. These basic regions vary in size amongst
type II and type VII PB 1. The aPKC is also classed as a type VII PB 1 domain but
is unable to self-oligomerise due its small basic regions. These distinctly charged
surfaces highlight the importance of electrostatics in PB I binding. The mutations
introduced to the p62 PB I monomer and dimer are able retain the electrostatic
potential of the interfaces to permit bindingI25.126• Another PBI containing
scaffold protein known as Next to BRCAI (NBRI) was found to have the highest
degree of homology to the p62 PBII27.
The p62 PBI domain functions to bind to other PBI domains, including NBRI,
aPKC and MEKK3. The p62 PBI domain is also able to bind to the
proteasome". There has been some speculation that the PBI and UBA domains
of the p62 interact with each other as observed by other UbL-UBA proteinsl29.130.
The PB I domain is structurally distinct from a UbL domain, but it does possess a
ubiquitin fold therefore there is potential for an interaction; however, no such
interaction has been observed to date!",
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Figure 1.11- The ubiquitin-like structure of the p62 PB I domain (PDB ID
2KKC). The side chain for Lys7 (the conserved Lys) is depicted in ball and stick
format.
1.5.2 Zinc finger domain (ZZ domain)
The next binding motif from the N terminus is a Zinc finger domain (lZ domain).
Comprised of residues 122-167 this particular type of zinc binding domain was
first identified in dystrophin 132. lZ domains have two co-ordinating zinc ions
which are arranged in a tetrahedral manner via conserved Cys and His residues at
opposing ends of a small p sheet. These domains are found in many scaffold
proteins linked to ubiquitination and even form the basis of one of the four classes
of ZZ domains. The p62 lZ domain is an example of a scaffold ubiquitination
class of ZZ domain. The p62 II domain functions to bind to a serine threonine
kinase known as receptor interacting protein (RIP). The interaction occurs through
RIP's intermediary domain. The association between the lZ domain and RIP
links the aPKC pathway to NF-lCB activation via TNF-a stimulation, a pathway
that RIP is an intricate part ofl33.
1.5.3 Protein binding motifs
With a role as a scaffold protein it is not surprising that several different protein
motifs are contained within the p62 structure. For example the p62 protein was
found to be a common component of inclusion bodies associated with diseases
linked to protein aggregation'P. Further study revealed a link to the degradation
pathway autophagy'i", whereby a small membrane bound sac known as an
autophagosome, engulfs cytoplasmic matter. A protein known as microtubule-
associated protein light chain 3 (MAP-LC3) is essential for autophagosome
formation. The p62 protein binds to the MAP-LC3 protein via a twenty two amino
acid motif known as LC3 interacting region (UR) which occupies residues 332 -
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245116• The LIR therefore targets the p62 and its associated cargo for degradation
by autophagy.
Immediately after the LIR lies a newly discovered motif. This motif is known as
the Keap I-interacting region (KIR) because it interacts with a protein called
Keapl. The KIR occupies residues 344-356. Keapi is an adapter protein which
regulates the activation of a transcription factor called Nrf2. Nrf2 is able to
regulate the expression of various detoxification enzymes.
Another important motif is the TNFR-associated factor 6 (TRAF6) binding motif.
This short motif is located between residues 228-233. TRAF6 is an E3 which
synthesises Lys63 linked polyubiquitin chains and is a crucial element of the NF-
ill activation pathway. Stimulation of TRAF6 autoubiquitination via Lys63 is
mediated by the interaction with p62. p62 binds to TRAF6 via the TRAF6 binding
motif is the interacting point of the p62 protein135• Recruitment of the TRAF6
protein to a protein/receptor complex activates the downstream pathway to
directly regulate osteoclast maturation 136.
Two regions rich in Pro (P), Glu (E), Ser (S), and Thr (T) known as PEST motifs
lie close to the C-terminal of p62. The PEST sequences occupy residues 266-294
and 345-377 and have been shown to be completely unstructured. Although these
are not sites for p62 interaction with other proteins, the function of these
sequences is thought to be linked to protein degradation. The PEST sequence is
contained within many proteins with short half-lives and it is thought that the
PEST sequence itself is a degradation signaI137•138•
1.5.5 Ubiquitin-associated (UBA) domain
The C-terminal UBA domain occupies residues 387 to 436. The solution NMR
structures of p62 UBA domain 139 and the domain in complex with ubiquitin 140
have been solved by the Searle group. It has been shown more recently by both
NMR and X-ray crystallography that the p62 UBA exists as a highly stable C2
symmetric dimer!": 141. This feature makes the p62 UBA different to most other
UBA domains, although there are a few examples of UBA dimers (discussed in
chapter 6). The somewhat unusual formation of a highly stable UBA dimer was
shown to tightly regulate ubiquitin binding due to the ubiquitin binding patch
being partially occluded by the dimerisation interface by the C terminus of helix
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3. The dimerisation interface is formed along helix 2 of the three helix bundle
(figure 1.12). An antiparellel dimer with symmetry along the C2 axis was
revealed'f '.
The p62 UBA domain functions to bind to ubiquitin. The p62 UBA has been
shown to bind both monoubiquitin and polyubiquitin chains 140. Although a
preference for chain linkage in polyubiquitin chains has not been observed in
vitrol42, it is expected that a preference for both Lys63 and linear chains is clear in
vivo due to the involvement with the NF-KB signalling pathway. In addition to a
functional role the UBA has also been shown to have a protective role by
preventing the p62 from being degraded by the proteasome+", This is similar to
other proteins which contain a C-terminal UBA domain 144.
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Figure 1.12- The model of the p62 UBA dimer (POB ID 2KNV). A) the view
along the C2 axis and B) rotated by 90 "C . Helix 2 and some residues in helix 3
form the dimerisation interface.
1.5.6 The p62 protein's role in NF-K.8 signalling
Although p62 has a role in several signalling pathways, this project is focused on
the role p62 has in NF-ICB signalling. NF-lCB is a highly conserved transcription
factor involved in activating genes responsible the differentiation and maturation
of osteoclasts which are vital to maintain bone architecture. NF-lCB proteins can
be divided into two distinct groups, one group are synthesised as transcriptionally
active proteins, whereas the other group exist as precursor molecules which
require proteolytic processing to make them biologically active. Inactive
precursors are bound to an inhibitor known as 1kB, whereas active NF-KB proteins
contain a IkB-like domain which prevents the binding of IkB 145,146.
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The p62 protein is involved in the receptor activated NF-K13 (RANK) activation
pathway ofNF-KB, which involves releasing the IkE protein from inactive NF-K.8
(figure 1.13). A complex is formed when RANK binds to a protein known as
Rank ligand (RANKL)147. The RANKIRANKL complex then stimulates the
recruitment of TRAF6, which is responsible for the formation of Lys63
polyubiquitin chains and is crucial for RANKL signalling v'". The p62 protein
contains a TRAF6 binding site. The p62 protein appears to initiate downstream
signalling by recruiting the aPKC to the complex via interaction with its PB I
domain. The formation of the TRAF6-p62-aPKC ternary complex then stimulates
TRAF6 to ubiquitinate itself via interaction with the p62 UBA domain, leading to
the formation of a Lys63 Iinked chain 148,113.TAB2 and TAK I are then recruited to
the complex to form a large multimeric complex. TAB2 phosphorylates TAK 1
which causes Lys63 ubiquitination of NEMOI49.150. NEMO then activates
phosphorylation of IkB by IkB kinase (IKK). The resultant conformational change
in IkB triggers Lys48 ubiquitination and subsequent degradation of lkB. NF-K13
is then free to translocate to the nucleus where it regulates expression of genes
associated with osteoclastogenesis 148,151.
Figure 1.13 - A schematic diagram of the RANK induced pathway leading to NF-
KB activation. RANKL binds to RANK to recruit TRAF6 and signal downstream
activity. Lys63 ubiquitination is represented by the extended ubiquitin chains and
Lys48 ubiquitination by compact ubiquitin chains. Phosphorylation events are
depicted by P. The NF-KB is released from the IkE inhibitor rendering it free to
translocate to the nucleus where is regulates gene expression. Adapted from
151Crockett et al .
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1.5.7 p62 UBA and Paget's disease of bone (PDB)
Paget's disease of bone (PDB) was first described by Sir James Paget in 1876.
The disorder is primarily characterised by excessive bone turnover and like many
osteolytic diseases is associated with excessive osteoclastic activitylS2. A
secondary increase in osteoblast activity combined with increased numbers of
osteoclasts causes pagetic lesions in bones, which accounts for many of the
symptoms associated with PDB. These lesions are the result of abnormal bone
architecture. PDB affects 1-3% of white adults over the age of 55 in Britain153 and
although there isn't a clear pathogenesis, common symptoms include skeletal
deformity, bone pain, susceptibility to pathological fractures and osteoarthritis, all
of which are more serious problems in elderly patients. Mild side effects such as
deafness can also occur. In many cases PDB is asymptomatic allowing polystatic
progression of the disease, meaning multiple bones can become affected. A more
severe complication of PDB is osteosarcoma which affects I% of PDB patients.
Although this percentage is low, the risk factor of developing osteosarcoma is
1000 times greater for PDB patients 154. PDB is widespread in Caucasian
populations. The disease is most prevalent in the UK but is also common in
Western Europe and. British migrants to Australia, New Zealand and South
AfricaI55.156.
The onset of PDB has been linked to genes encoding SQSTMlIp62 inferring a
strong genetic link in Paget's disease. There is evidence for both genetic1S7 and
environmental factors158 contributing to the prevalence of the disease, with the
genetic side linking PDB to the p62 protein. Genetic factors have been linked to
the onset of both familial and sporadic forms of PDB. Numerous studies over the
past 20 years have revealed several susceptible loci, denoted PDB 1 to
PDB7157.IS9,160which could all be linked to a genetic predisposition of PDB. The
locus mapped to chromosome 5q35-QTER (PDB3) is associated with the gene
SQSTM 1 which codes for the scaffold protein p62. The locus was explored
further to reveal several mutations which lie within or in close proximity to the
UBA domain of the p62 protein.
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Initially a point mutation at position 392, P392L, was describedl61• Other PDB
mutants include P387L, G411 S, M404V, G425R, S399P, 0423X, G425E,
Y383X, A427D and I424S 162,163,164,165,166,167,168. To date over thirty separate PDB
mutations have been identified. However mutations outside the UBA domain,
including K378X169, have also been described. The consequences of these non-
UBA mutations have yet to be established. Broadly speaking the POB mutations
can be classed as either missense or truncating mutations. Multiple studies have
indicated that a loss of ubiquitin binding, which is amplified in the binding of
longer polyubiquitin chains occurs for PBO mutantsI70,17I. Interestingly, most of
the POB mutations are located outside of the hydrophobic patch implicated in
ubiquitin binding (figure 1.14), suggesting that ubiquitin recognition by residues
outside of this binding interface also have a key involvement in regulating
ubiquitin bindingl72. The discovery of the UBA dimer adds further complexity to
understanding the molecular mechanism which regulate ubiquitin binding.
Figure 1.14 - The positions of some of the more prevalent Paget's disease
mutations on the p62 UBA dimer (POB ID 2KNV). The mutations are shown on
both subunits of the UBA dimer. The mutations are not confined to the ubiquitin
binding patch, suggesting other factors are involved in regulating the affinity for
ubiquitin.
Substantial efforts into understanding the structural, biophysical and biological
effects of the PDB mutants has been conducted as part of a collaborative project
by the Searle and Layfield groups (University of Nottingham). The POB missense
mutants P392L, S399P, M404V, M404T, G411S and G425R have all been
characterised structurally and biophysically. The studies highlighted no single
mechanism to account for the loss of ubiquitin binding associated with PDB
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mutations. Evidence for loss of structural integrity, stability of the dimer and
changes to the ubiquitin binding surface have been exhibited by the PDB mutants,
with a combination of the effects likely to factor into the resultant affinity for
ubiquitinI43•173•
Changes in the affinity of the P392L mutant were minimal, consistent with its
location away from both the dimerisation and binding interfaces. The prevalent
P392L mutation is located at the N-terminus of helix 1 and does not form part of
the hydrophobic patch or the dimerisation interface. This particular mutation
involves structural modifications extending the N-terminus of helix 1 and moving
the cap of the helix back towards residue Pr0388139• The S399P showed a
decreased affinity as a result of a disruption to the structure of helix 1.
Conversely, the G425R mutant appeared to enhance the stability of the dimer,
leading to a decrease in the population of monomer at equilibrium, which in tum
lowers the affinity of the interaction. However, the M404V and M404T mutations
cause the biggest decrease in stability and are associated with a drastic reduction
in binding affinity. This result was not surprising as the Met404 residue forms part
of the conserved MFG motif in loop 1 which binds to ubiquitin 173.
Biological binding studies have using the PDB mutants have also been completed
since the p62 UBA has been shown to exert a preference for binding to
polyubiquitin chainsI70•I7I• Moreover, the p62 UBA has been shown to be non-
selective between Lys48 and Lys63 linked chainsl42• Pulldown binding studies
have been able to explore the binding of polyubiquitin chains in detail140 The
binding of wild type p62 UBA and some of the POB mutants (in the isolated
domain) for Lys48 and Lys63 linked polyubiquitin chains is shown in figure 1.15.
A slight loss of binding exhibited by the PDB mutants is also evident from these
studies, although the trend of binding to polyubiquitin chains over monoubiquitin
was also still present. The preference for tri and tetraubiquitin chains by both the
wild type and the PDB mutants is likely reflect a preference for chains of these
lengths in vivo. Again the M404V, M404T and G425R mutations seem to exert
the biggest effects, as no evidence for binding is observed by these mutants. The
molecular basis for a lack of binding is obvious for these mutants; however, the
molecular mechanisms which underlie other PDB mutations are not clear.
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Figure 1.15 - In vitro binding assays which show the affinity of the isolated p62
UBA domain for polyubiquitin chains. The affinity of wild type p62 UBA and
some of the more prevalent PDB mutations were investigated when bound to
Lys48 or Lys63 linked polyubiquitin chains. The various UBAs were immobilized
on glutathione-Sepharose beads and used to precipitate polyubiquitin chains. The
precipitated proteins were then detected using Western blotting using a ubiquitin-
reactive antibody. A slight reduction in affinity is observed by the PBD mutants
when compared to the wild type p62 UBA. Also no preference for Lys48 or
Lys63 chains is observed, but tri and tetraubiquitin chains are shown to bind with
the highest affinity for both the wild type p62 UBA and the PBD mutants. Taken
'
140from Long et a .
Despite structural and biophysical characterization overall only small changes in
affinity are exerted by these PDB mutants, with more pronounced effects
observed in the binding of polyubiquitin chains over monoubiquitin. It is therefore
predicted that the small changes in affinity are raised to high affinity interactions
by oligomeric p62. Moreover, these mutants exhibited differences in affinity when
inserted into the isolated domain and the full length p62 protein 170, J71, suggesting
that other factors are also involved in regulating ubiquitin binding by p62. The
presence of the non-UBA PDB mutations supports this hypothesis. Since all of the
structural investigations have occurred in the isolated UBA domain, the structure
of the full length protein is a long term aim. Despite significant advances to the
field, the molecular mechanisms which underlie PDB remain unknown.
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1.6 Aims of this investigation
The ubiquitin modification is far more complex than any other protein PTM,
owing to the large size of the covalent modification and the ability of ubiquitin to
polymerise forming a variety of structurally distinct polyubiquitin chains. These
polyubiquitin chains present different surfaces for interaction with UBDs. The key
to 'cracking the ubiquitin code' potentially lies in the ability ofUBDs to recognise
polyubiquitin chains of a specific linkage and length. The mechanism of binding
by UBDs has shown to be diverse despite only a limited number of structures
being available.
Defective ubiquitin recognition and binding has been implicated in patients with
PDB. The genetic evidence clearly points to mutations within the p62 UBA
contributing to the onset of PDB. The experiments conducted in this thesis focus
on ubiquitin binding by the p62 UBA. It is likely that, a combination of factors are
able to act in concert to tightly regulate the affinity of the p62 UBA. Differences
in the affinity of the UBA in the isolated domain and the full length protein have
been observed, suggesting factors outside of the UBA are also involved in
regulating affinity.
In the UBA, factors, such as phosphorylation and the discovery of the p62 UBA
dimer, have been shown to influence the affinity of the p62 UBA. We aim to
explore the effects of dimerisation (chapter 6) and phosphorylation (chapter 7) in
ubiquitin binding using structural and biophysical techniques. Mutations at the
dimer interface in the isolated p62 UBA domain (T414A, R415K, Q418A,
T419A, T414K, R415K, Q418K and T419KA) were used to gain an insight into
the role dimerisation has on UBA affinity. Phosphomimetic mutants (S403D and
S403E) and a dephosphorylated control (S403A) were also engineered in the
isolated p62 UBA domain and used to investigate the effects phosphorylation has
on UBA affinity. A greater understanding into how ubiquitin binding is regulated
by the p62 UBA may aid in understanding the molecular mechanisms which
underlie PDB. The small changes in affinity exhibited by the PDB mutants could
be amplified if the stability or structural integrity of the dimer is altered or
whether the UBA is phosphorylated or not.
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Full length p62 functions as a molecular scaffold which can regulate multiple
pathways simultaneously. However, in order to investigate the ability of p62 to
bind multiple proteins is hindered by the problems associated with purifying the
full length protein. Full length p62 is difficult to study due to its highly oligomeric
nature and large unstructured region. Recently it has emerged that p62 has a role
in another degradation pathway known as selective autophagy. As the p62
contains both a UBA and a LIR it is capable of binding to both ubiquitin and
MAP-Le3. The p62 can bind to ubiquitinated proteins and deliver them to either
the proteasome or target them for degradation by autophagy. Our objective is to
study the interactions with both MAP-Le3 and ubiquitin and investigating
whether a p62 mediated ternary complex is able to be formed by the three proteins
(chapter 8) and whether an allosteric relationship exists between the binding
proteins. The p62 ternary complex was investigated using a p62 subfragment
encoding residues 300-440, which encompasses the interaction site for both
binding proteins. This was mutated to a e331 S p62 300-440 variant in order to
prevent disulphide bonds forming between molecules.
Full length p62 is found in cellular speckles due to its ability to self oligomerise
via N-terminal PB 1 interactions. Therefore, arrays of UBA domains are presented
to polyubiquitin chains in vivo. The affinity of the individual UBA-ubiquitin
interactions can therefore be amplified by avidity effects. The small decreases in
affinity observed by PBO mutants are likely to be enhanced in patients suffering
from the disease. Avidity effects could potentially explain the subtle changes in
affinity observed by the highly prevalent P392L POB mutation. The main aim is
to discover how weak p62 UBA:ubiquitin interaction are 'levered' to
physiologically relevant high affinity interactions (chapter 9). In order to achieve
this, a model of the full length protein was designed. The model contained GST
dimers to mimic PB 1 domains and fragments of the p62 extending back from the
Cvterminus containing the UBA (GST-p62 UBA, GST-p62 341-440, GST-p62
300-440 and GST -p62 261-440). The model was used to probe differences in
affinity of the UBA when binding to either monoubiquitin or linear diubiquitin.
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2.0 Biophysical techniques
, This thesis focuses mainly on the p62 UBA and its interaction with ubiquitin;
however, longer subfragments of the p62 were expressed and purified in order to
investigate the behaviour of the full length p62 and its interactions with other
proteins, such as the MAP-LC3 protein. In order to probe protein structure and
study protein-protein interactions a variety of techniques can be used. The
techniques which were used throughout the course of this study are described
further.
2.1 Electrospray ionization mass spectrometry (ESI-MS)
Mass spectrometry is a sensitive technique used to detect proteins at physiological
concentrations. The two most widely used types of mass spectrometry are matrix-
assisted laser desorption/ionisation (MALDI) and electrospray ionisation (ESI)174.
Molecules are ionized and transferred to the gas phase from solution in both
MALDI and ESI-MS. The use of electrospray as a ionization technique has
revolutionized the field of mass spectrometry as it overcomes the tendency of
large molecules, such as proteins, to fragment during ionization. In recognition of
the achievement, its inventor Prof John Bennett Fenn was awarded the Nobel
prize in Chemistry in 2002175• A range of information can be deduced from ESI-
MS including molecular mass, the stoichiometry of non-covalent protein
complexes and the affinity of the interactions within protein complexes'f", The
soft ionization process of electrospray enables fragile protein complexes to be
transferred to the gas phase intact even if the interaction is weak. Larger
macromolecular complexes can be studied using nanospray ESI, a miniature
version ofESI-MSI77.
A mass spectrometer consists of three mains parts, an ion source, a mass detector
and a mass analyser (figure 2.1). Samples are dissolved in a polar, volatile solvent
and are pumped through a narrow steel capillary. A high voltage is applied to the
tip of the capillary where the liquid becomes unstable as it is forced to hold more
and more charge. Eventually the liquid reaches a critical point where it can hold
no more charge and Coulombic explosion occurs. The liquid is then dispensed as
a fine aerosol of highly charged droplets. The droplets decrease in size as a result
of solvent evaporation producing ions which are released from the droplets. A
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nebulising gas, such as nitrogen, normally flows outside of the capillary and is
sprayed towards the mass spectrometer. A spectrum of multiple charge states is
visualised and separated according to their mass to charge ratio (m1z).
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Figure 2.1 - A schematic representation of an electrospray ionisation source,
showing the different regions that the sample travels through before detection in
the mass analyser
Mass spectrometry has become very useful to the study of proteins and protein
complexes. Its main advantage over other techniques is its ability to use very low
sample concentrations which are much nearer to physiological concentrations.
This is especially useful for proteins which are prone to aggregation at higher
concentrations. Moreover the data collection can occur in minutes. However,
there has been much debate as to whether the spectrum produced is a true
representation of molecules in solution. For example non specific aggregates can
form which are not present in solution. In protein-protein interactions the type of
interaction can also play a major role in the spectrum that is produced.
Hydrophobic interactions are weakened but not completely abolished in vacuo
due to the absence of water which drives the hydrophobic effect I 78,179. Whereas
electrostatic interactions are greatly enhanced in vacuo because of the absence of
solvent shielding'f". Therefore, some protein-protein interactions can be more
difficult to monitor than others using ESI-MS.
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2.2 Far Ultra-violet circular dichroism (Far UV-CD)
Circular dichroism (CD) spectroscopy measures the difference In absorption
between left and right handed circularly polarized light. Polarized light can either
be linear or circular. Linear polarized light is light which oscillates only in one
plane, circularly polarized light occurs when the direction of the electric field
rotates about its propagation direction (figure 2.2). When polarized light passes
through an asymmetric molecule elliptically polarized light is generated, which is
known as CD signal.
A B
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Figure 2.2 - A diagram showing the electric vectors of A) linearly polarized light
and B) circularly polarized light at a moment in time. Electromagnetic
radiation consists of an electric (E) and magnetic (B) field that oscillate
perpendicular to one another and the propagating direction (k). Linearly
polarised light occurs when the electric field vector oscillates only in one plane
whereas, circularly polarized light occurs when the direction of the electric field
vector rotates about its propagation direction.
Molecules which have structural asymmetry exhibit positive and negative CD
signals; whereas, symmetrical structures exhibit a CD signal of zero. Proteins are
optically active molecules due to their asymmetric chiral centres, meaning they
emit a CD signal. Far UV -CD refers to wavelengths between 190-250 nm and is
ideally suited to monitor the extent of secondary structure within proteins'f '. Near
UV-CD refers to the wavelength range 250-300 nm and can reveal information on
the tertiary structure of proteins.
When amide polypeptide bonds are aligned in regular arrays, such as a helices or
~ sheets, the different secondary structure elements produce characteristic far UV-
CD spectra (figure 2.3). Proteins with disordered structures can also be readily
identified by their CD spectra as they have very low ellipticity above 210 nm and
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a negative band at 195 run 182. Proteins with a large a helical content produce
negative bands at 222 nm and 208 run and a positive band at 193 run183. Whereas
proteins with well defined ~ sheets produce a negative band at 218 run and a
positive band at 193 run 184.
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Figure 2.3 - The characteristic CD spectra for the different secondary structure
elements of proteins. The a helix and ~ sheet are shown by the black and blue
lines respectively. Proteins with a random coil structure also produce distinctive
CD spectra as indicated by the green line.
Since the secondary structure elements possess such distinguishing CD spectra,
the unfolding of proteins can also be monitored using Far UV -CD. Unfolding
profiles can be collected as a function of temperature'f', denaturant or
osmolyte'f". The free energy of folding can be determined from CD
measurements as a function of these factors if the change in CD is due to a
transition between two states, the folded and unfolded state. The free energy of
folding is linearly dependent on the concentration of denaturants, such as urea or
guanidine, or increasing temperature which both cause a loss of ellipticity.
Osmolytes, for example trimethylamine N-oxide (TMAO) or sucrose, increase the
stability of proteins and cause an increase in ellipticity. These types of experiment
can be particularly useful if used to determine whether the stability has been
affected by certain mutations. Thermal unfolding experiments, as used in this
thesis, were recorded at 222nm, as this is the wavelength where the greatest
difference in CD signal is observed between a helical structures and random coils.
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2.3 Isothermal titration calorimetry (ITC)
lsothennal titration calorimetry (lTC) is a highly sensitive technique used to
monitor binding events, whether the interaction is protein-protein or protein-
ligand. During a binding event there is a change in the Gibbs free energy as a
result of bond formation or bond breaking and the uptake or release of water
molecules. Therefore various entropic and enthalpic factors contribute to the
formation of a complex. Despite its more common application to monitoring
association events, ITC has also been shown to be a useful technique for
monitoring protein dimer dissociations 187.
The ITC calorimeter consists of two identical cells, the sample cell and a
reference cell which contains water or buffer (figure 2.4). For both types of
experiment a protein of known concentration is loaded into a syringe which is
injected into the sample cell. For binding events the ITC experiment involves
sequentially injecting one protein into another; whereas, for dissociations a
dimeric protein is injected into a cell which contains a degassed buffer solution.
Ligand Injection
protein Calibra on
heater
Reference cell Sample cell
Adiabatic Jacket
Figure 2.4 - a schematic diagram of the ITC calorimeter. The diagram shows
typical set up for a binding experiment, whereby one protein is loaded in the
sample cell and the ligand (or second protein) in the injector syringe. In a
dissociation experiment the protein in the sample cell is replaced with a degassed
buffer solution.
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Both the sample cell and reference cell are made of an efficient thermal
conducting material and are enclosed by an adiabatic jacket. Sensitive
thermophile circuits regulated by a feedback control system are used to detect any
change in temperature. These circuits also ensure that the two cells are kept at
thermal equilibrium throughout the experiment. Prior to the start of an
experiment, a constant power is applied to the reference cell. This directs a
feedback circuit, activating a heater located on the sample cell. Temperature
changes in the sample cell are compared to the reference cell after each injection
in the experiment. In an exothermic reaction heat is generated which causes an
increase in the temperature within the sample cell. This causes the feedback
circuit to decrease the power to the sample cell. In contrast, in an endothermic
reaction, heat is taken in causing the feedback circuit to increase its power to
return the temperature back to thermal equilibrium with the reference cell.
The raw ITC data consists of a series of spikes of heat flow, each corresponding to
an injection (figure 2.5). As the experiment continues these spikes decrease in size
until they reach complete saturation. The area under each peak is then integrated
with respect to time and plotted against the molar ratio of the components. The
data is then fitted to the appropriate binding or dissociation model. Binding
affinities (Ka) or Dissociation constants (Kd), enthalpy changes (11H) and the
stoichiometry (n) of a reaction can all be directly determined from a single ITC
experiment. Gibbs energy changes (/'1G) and entropy changes (/'15) can then be
determined indirectly to generate a full thermodynamic profile.
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Figure 2.5 - The raw heat response generated by the IIC for A) a typical 1:1
binding interaction and (B) a typical dimer dissociation.
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2.4 Nuclear magnetic resonance (NMR) of proteins
Nuclear magnetic resonance (NMR) is a powerful technique used to determine the
structure of proteins. NMR produces data in atomic detail enabling a structure of
the molecule to be deduced. Although large amounts of protein (up to 1mM) and
the time required to collect high quality data can be lengthy, the benefits of using
NMR to study protein structure and protein-protein interactions far outweighs any
of its limitations. NMR can also provide information on protein dynamics,
intramolecular bonding patterns and protein folding.
NMR experiments are normally conducted in solution. Native-like structures are
generated because the data is obtained using near-physiological conditions.
Although, the development of solid state NMR has advanced significantly,
providing substantial insights into the structures of membrane bound
proteins188,189. The use ofNMR in structure determination is usually restricted to
smaller proteins; however, the use of high-field spectrometers and highly sensitive
cryogenic probes have dramatically improved the quality of the data enabling
larger proteins to also be studied'", Proteins with a highly ordered tertiary
structure produces resonances with a wide dispersion of chemical shifts, whereas,
intrinsically disordered proteins produce somewhat more complicated spectra due
to significant overlap of resonances.
2.4.1 Monitoring the purity and folding of proteins
A one dimensional (ID) spectrum is normally recorded on an unlabelled protein
sample in order to check the suitability of the protein sample for further NMR
experiments. From the spectra any small molecule contaminants from the
purification can be detected. These contaminants produce sharp peaks with much
stronger intensity. These contaminants can sometimes be identified from the
resonance ppm they appear at. The contaminants should ideally be removed
before proceeding with further NMR experiments. Perhaps more importantly the
1D spectrum can also indicate whether the protein is folded. A wide dispersion of
peaks is normally indicative of a folded protein. If a narrow distribution of peaks
between 7.5 and 8.5 ppm are observed the protein is likely to be unfolded. Once
the 1D spectrum has been recorded for a protein and it appears to be in its correct
conformation then more complex NMR experiments can be conducted.
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Figure 2.6 - The ID proton spectrum of the UBA2 domain of the hHR23A
protein. The characteristic frequency ranges of the various resonances are
highlighted. The wide dispersion of peaks suggests that this domain is folded.
2.4.2 Monitoring protein-protein interactions using NMR
Since NMR produces atomic level data, information on each residue during a
binding event can be monitored. NMR has therefore been used extensively to
study protein-protein interactions. During the binding event the amino acids
which interact usually undergo a conformational change which can be detected
using NMR. NMR is particularly useful for probing weak protein-protein
interactions due to the sensitivity of the chemical shift of the observed resonances
to their local environment!".
One of the most useful NMR experiments is the IH_15N heteronuclear single
quantum coherence (HSQC), which correlates the IH_15Nchemical shifts of amide
groups 192,193.The backbone of the protein contains an amide group for each amino
acid thus in a IH_15NHSQC experiment a single peak appears for all amino acids
except Pro, which lacks a backbone amide group. Peaks are also observed for
nitrogen-bound protons in the side chains of Arg, Lys, GIn and Asn residues. The
chemical shifts of the peaks observed in a IH_15NHSQC experiment are highly
sensitive, with movement being observed by resonances directly involved in an
interaction. Chemical shift perturbations (CSPs) are therefore considered to be a
powerful tool to monitor changes upon binding to another protein, or ligand. In
general the bigger the CSP, the closer to the binding pocket the residue is.
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The use of the IH_1sN HSCQ experiment is usually limited to smaller proteins.
The tumbling rate for larger proteins is slower which leads to shorter relaxation
times, line broadening and poor resolution. The introduction of IH_15Ntransverse
relaxation optimized spectroscopy (TROSY) experiments as an alternative to the
IH_1sN HSQC experiment permits the study of larger proteins. The IH_1sN
TROSY experiment reduces the line width by selecting for the effects of dipole-
dipole coupling and chemical shift anisotropy (CSA) which mutually cancel,
giving rise to a single sharp peak in the spectrum 194.
Titration experiments, whereby one protein is gradually titrated into another, are
often conducted using IH_1sNHSQC/IH-1SN TROSY experiments. The sensitivity
of the backbone amide group chemical shift to its local environment can be
exploited to study structural changes in the protein. Such structural alterations can
be caused by mutation, construct extension or binding events. The changes in
chemical shifts between the free and bound forms of the protein can mapped to
the surface of the molecule to identify binding patches. During the titration, the
chemical exchange regime adopted by the protein can be established. This can
often provide information on the strength of an interaction. There are three types
of chemical exchange which can be utilized by proteins during a binding event,
namely slow, intermediate and fast exchange (figure 2.6). Different chemical
exchange processes arise from the size of the rate constant with respect to change
in chemical shift. In fast exchange the rate is larger than the difference in
chemical shift between the two states resulting in peaks which are a population
weighted average being observed in the spectrum. This allows peaks to be tracked
by movement between the free and bound forms. In slow exchange signals for
both the free and bound forms are observed because the rate is less than the
difference in chemical shift. The intensities of the peaks change during the course
of the titration and are proportional to the populations of each species.
Intermediate exchange is a somewhat more challenging regime to interpret as
signals from both fast and slow exchange are observed resulting in very broad
signals.
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In order for titration data to be used to map the residues involved in binding onto
the surface of a protein, the IH_15N heteronuc1ear experiments need to be fully
assigned. This can be achieved using a variety of different experiments, which are
discussed later.
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Figure 2.7 - Fast and slow chemical exchange regimes. In slow exchange (left),
signals for both the free and bound forms are observed. When a binding ligand is
added the intensity of the peaks corresponding to the free form decrease as the
equilibrium shifts to favour the bound form, Concurrently peaks corresponding to
the bound form increase in intensity. In fast exchange (right), a population
weighted average is observed which moves from the free to the bound form.
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2.4.3 Determining protein flexibility using NMR
The conformational flexibility of proteins is directly linked to its function.
Motions in proteins are required for both substrate recognition and binding events;
therefore, the ability to monitor the dynamic nature of proteins is crucial to
understanding their biological function. The heteronuclear NOE eSN eH) NO E)
experiment is the most extensively used NMR experiment to determine protein
backbone dynamics in solutionl95,196,197.Motions on a fast time scale (picoseconds
- microseconds) in atomic detail can be detected using this type of experiment'j".
The IH_15NNOE values are calculated by taking the ratio of 15Nsignal intensities
recorded in the presence and absence of proton saturation preceding the evolution
of 15Nmagnetization' ". The experiments are recorded as two interleaved IH_15N
HSQCs. Since the intensity ratio of the two independent experiments is taken, a
complete recovery of 15N magnetization during the delay is critical to obtain
accurate NOE values.
Structured and unstructured regions of proteins can be readily identified in
heteronuclear NOE experiments. The motion of individual amide bonds relative to
the tumbling rate of the overall protein can be calculated, yielding IH_15NNOE
values with different signs and magnitudes. Positive NOE values correspond to
amide bonds which are tumbling with a correlation time comparable to the overall
protein. Amino acids which produce positive NOE values are found in folded
regions of the protein. Large negative NOE values represent unstructured, highly
flexible regions of the protein and are produced by residues with amide bond
motions that occur on a faster time scale relative to the overall tumbling rate of
the protein. One major disadvantage to the heteronuclear NOE experiment is that
is has inherently low sensitivity, which is approximately ten times lower than the
standard IH_15N HSQC. However, the use of cryoprobes in recent years has
helped to overcome this problem and improve the sensitivity of the experiment.
The effects of 15Nchemical shift anisotropy and IH_15Ndipole are greater when
larger magnetic fields are used so this should be taken into consideration when
calculating NOE valuesl99, In order to obtain the maximum information from a
heteronuc1ear NOE experiment a full assignment of the protein is required.
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2.4.4 Protein backbone assignment
The backbone of a protein refers to the Ha, NH, NH, Co, C~ and C' resonances. A
protein of n amino acids contains n spin systems which can be assigned to a
particular residue within the protein sequence. In order to assign the protein
backbone various different approaches can be made using unlabelled, 15Nlabelled
or I3C/ISN labelled proteins. The natural abundance of 14Nand 12Cfar outweighs
that of the 15N and I3C isotopes; therefore, isotopic labelling of proteins is
required for larger proteins. More complicated NMR experiments which require
isotopic labelling tend to take longer to obtain high quality data. For unstable
proteins these types of experiment are often unsuitable; however, the development
of SOFAST200 and BEST201 pulse sequences in which increased signal-to-noise
ratios are achieved has helped to overcome such problems.
Unlabelled proteins are used to conduct 2D homonuclear experiments as they only
contain proton nuclei which can be detected by NMR. The homonuclear
experiments commonly used for backbone assignment are 2D Nuclear Overhauser
effect spectroscopy (NOESY) and 2D total correlation spectroscopy (TOCSY). In
a 2D NOESY experiment magnetization is transferred from one spin system to
another through space as a result of a relaxation process known as the Nuclear
Overhauser effect. In a TOCSY experiment magnetization is transferred between
spins which are connected to one another through chemical bonds. The TOCSY
experiment is used to identify amino acid type; whereas, the NOESY experiment
is used to sequentially connect the amino acid sequence. The experiments are
usually run together as they complimentary to each other.
It is possible to attain a full backbone assignment using only a 15N labelled
protein. However, this only possible for small proteins due to the high degree of
resonance overlap observed by larger proteins. The experiments used for double
resonance backbone assignment are the IsN HSQC-NOESY and the ISN HSQC-
TOCSy202,203,204.These experiments have one nitrogen dimension and two proton
dimensions. Assignment is achieved using the same approach as for the
homonuclear NOESY and TOCSY experiments.
For proteins which are bigger than 10 kDa, isotopic labelling with both 15Nand
J3C are required to the complete assignment. When proteins have been IsN/13C
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labelled triple resonance NMR experiments can be conducted to assign the protein
backbone. These experiments have three dimensions - one proton, one nitrogen
and one carbon dimension.
In order to visualise ether double or triple resonance 3D spectra strips are
required. Strips are 2D segments which are narrowed in two of the three
dimensions but show the total width of the third dimension. The simplest way to
visualise a 3D experiment is to think of the 2D experiment which has been
extended into a third dimension. The 2D experiments are normally a IH_1sN
HSQC or IH_1sNTROSY for triple resonance experiments or ISNHSQC-NOESY
or ISN HSQC- TOCSY for double resonance experiments. By selecting a peak
from the 2D which is defined by a IH and ISN value, a strip showing the
resonances present in the third dimension can be seen.
In order to determine Ca and C~ chemical shifts HNCACB20S and
HN(CO)CACB206 experiments were conducted. In addition to this a HNCA
experiment was recorded to ensure detection of Ca chemical shifts because the
HNCACB and HN(CO)CACB experiments were optimized for C~ chemical
shifts. The HNCACB experiment correlates the amide proton and nitrogen to the
Ca and C~ for both the i and i-I residues. Therefore four peaks should be
observed for any given strip, except those containing a Gly residue, which lacks a
C~. One of the most useful features of the HNCACB experiment is that the
correlations of the Ca and C~ nuclei are in opposite phasing making them easy to
identify. The HN(CO)CACB experiment is complementary to the HNCACB
because it identifies the Cn and C~ for the ;-1 residue. Therefore 2 peaks are seen
for all amino acids except Gly. When the two are overlaid the Ca and C~
chemical shits belonging to the l and i-I residue can be confirmed. The HNCA207
208experiment shows the Ca for the i and i-I residues and can be used to aid
identification where the Ca chemical shifts were either weakly detected or not
observed. The HNCA experiment is quite useful as it is more sensitive than either
the HNCACB or HN(CO)CACB experiments due to the decreased effect of
carbonyl chemical shift anisotropy. In all experiments the coupling to the Ca and
C~ chemical shifts of the i residue is stronger meaning these peaks will appear
with greater intensity in the spectra. The flow of magnetization in all these
experiments is shown in figure 2.7.
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Figure 2.8 - The transfer of magnetization for the HNCACB, HN(CO)CACB and
HNCA triple resonance NMR experiments which were used in this thesis. These
experiments were used to identify the chemical shifts of Ca and C~209.
In order to determine the carbonyl carbon (C') chemical shifts HNC0207,208,210and
HN(CA)C0211 experiments were conducted. The HNCO identifies the C' for the i
residue; whereas, the HN(CA)CO identifies the C' for both the i and i-I residues.
Like the HNCA, the HNCO experiment is very sensitive. The HNCO and
HN(CA)CO experiments are complementary to each other much like the
HNCACB and HN(CO)CACB. When overlaid the C' belonging to either the i or
the [:I residue can be confirmed. Again in these experiments the C' resonances
belonging to the i residue have a greater intensity than those observed for the i-I
residue. These spectra are harder to use because there is still a significant degree
of overlap due to a smaller frequency range in the carbon dimension. Once
identified the C' shifts are linked to the Ca and C~ chemical shifts. The flow of
magnetization in all these experiments is shown in figure 2.8.
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HNCO HN(CA)CO
i-1 i-1
Figure 2.9 - The transfer of magnetization for the HN(CA)CO and HNCO triple
resonance NMR experiments which were used in this thesis. The transfer of
magnetization in the experiments used to identify the chemical shifts of C,209.
The chemical shifts for the Ca and C~ resonances are used for the sequential
assignment of proteins. The range of chemical shifts for Ca and C~ nuclei for
different amino acids is quite narrow in the carbon dimension. However, a few
residues are quite distinctive which can be used as starting points in a sequential
assignment strategy (figure 2.9 A). Gly residues, as indicated earlier, are
distinctive because they lack a C~ resonance. Ser and Thr residues have C~
resonances located above 60 ppm, which is much higher than other amino acids.
Moreover, Ala residues have C~ resonances located below 22 ppm. All other
amino acids have C~ resonances located between 25 and 45 ppm (approximately).
A chart highlighting the typical chemical shift range for Ca and C~ resonances is
shown in figure 2.9 B.
Amino Acid CA & CB Chemical Shirts
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Figure 2.10 -the average chemical shifts for Ca and C~ resonances for all the
amino acids. The Ca and C~ ranges are indicated in blue and red respcctively'i".
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3.0 Materials and methods
The proteins listed below were used in the studies detailed in this thesis. The gene
segments for the full length p62 (residues 1-440), the p62 subfragment encoding
residues 341-440, p62 UBA (residues 387-436) and hHR23A UBA2 (residues
319-363) were previously cloned into the pGEX-4T-l plasmid by the group of Dr
Robert Layfield (School of Biomedical Sciences, University of Nottingham). The
MAP-Le3 protein was previously cloned into the pGEX-4T-3 plasmid also by the
Layfield group. The p62 subfragments encoding residues 261-440 and 300-440
were personally cloned into the pGEX-4T-l plasmid and confirmed by DNA
sequencing. Proteins cloned into pGEX plamsids are cleaved from a GST tag
leaving a short extension at the start of the sequence (see table 3.6). The gene for
yeast ubiquitin was cloned into the pkk223-3 plasmid previously by Dr Geoff
Platt (formerly of the Searle group). Linear diubiquitin was cloned into the pt7-7
plasmid by Paul Sheppard (formerly ENZO Life Sciences). Once cloned into the
various plasmids the genes were transformed into suitable Escherichia coli (E.
coli) cell lines for subsequent growth and purification protocols.
p62 (Homo sapiens)
MASLTVKAYLLGKEDAAREIRRFSFCCSPEPEAEAEAAAGPGPCERL
LSRVAALFPALRPGGFQAHYRDEDGDLVAFSSDEELTMAMSYVKDDI
FRIYIKEKKECRRDHRPPCAQEAPRNMVHPNVICDGCNGPVVGTRYK
CSVCPDYDLCSVCEGKGLHRGHTKLAFPSPFGHLSEGFSHSRWLRKV
KHGHFGWPGWEMGPPGNWSPRPPRAGEARPGPTAESASGPSEDPSVN
FLKNVGESVAAALSPLGIEVDIDVEHGGKRSRLTPVSPESSSTEEKS
SSQPSSCCSDPSKPGGNVEGATQSLAEQMRKIALESEGRPEEQMESD
NCSGGDDDWTHLSSKEVDPSTGELQSLQMPESEGPSSLDPSQEGPTG
LKEAALYPHLPPEADPRLIESLSQMLSMGFSDEGGWLTRLLQTKNYD
IGAALDTIQYSKHPPPL*
Ubiquitin (Saccharomyces cerevisiae)
MQIFVKTLTGKTITLEVESSDTIDNVKSKIQDKEGIPPDQQRLIFAG
KQLEDGRTLSDYNIQKESTLHLVLRLRGG*
Linear diubiquitin (Homo sapiens)
MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAG
KQLEDGRTLSDYNIQKESTLHLVLRLRGGMQIFVKTLTGKTITLEVE
PSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKES
TLHLVLRLRGG*
49
hHR23A UBA2 (Homo sapien)
QEKEAIERLKALGFPESLVIQAYFACEKNENLAANFLLSQNFDDE*
MAP-Le3 (Homo sapien)
MPSEKTFKQRRTFEQRVEDVRLIREQHPTKIPVIIERYKGEKQLPVL
DKTKFLVPDHVNMSELIKIIRRRLQLNANQAFFLLVNGHSMVSVSTP
ISEVYESEKDEDGFLYMVYASQETFGMKLSV
3.1 Materials
All chemicals were purchased from Sigma, Melford or Fisher chemical companies
and were supplied at analytical grade
3.2 Molecular biology techniques
3.2.1 Sterilisation
A sterile environment was maintained during the growth of all proteins. All bench
surfaces were decontaminated regularly with Trigene. Before use 100% ethanol
was used to clean the surfaces further and all growth experiments were conducted
in close proximity to a strong blue Bunsen flame. Disposable equipment (petri
dishes, 20 ml universals, syringes, needles and filters) were supplied sterile.
Pipette tips, eppendorfs, growth media and all buffers were sterilised by heating to
121°C in an autoclave (Philip Harris, Status Autoclave) before use. Heat sensitive
reagents were filtered using a 0.22 urn filter (sartorius stedim) before use in the
purification protocol.
3.2.2 Luria Agar plates
Luria Agar powder (40 g/L) was dissolved in Milli-Q water and sterilised in an
autoclave. Sterile solidified agar was then heated in short bursts until melted. The
liquid was then cooled under a cold tap to approximately 40°C for addition of
sterile filtered antibiotics. Ampicillin at a final concentration of 270 JlM was
added to select for cells with ampicillin resistance. All plasmids used in these
experiments had ampicillin resistance. Addition of tetracycline at a final
concentration of 140 JlM was required for the XLI-Blue strain of E.coli (XLI-
blue are tetracycline resistant). The agar was poured into sterile Petri dishes,
sealed and allowed to set at room temperature. Unused plates were stored at 4 °C
until needed.
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Solutions
Luria Agar (Sigma): 10 giL tryptone, 5 giL yeast extract, 10 giL NaCl, 15 giL
agar, autoclaved at 121°C for 15 minutes.
3.2.3 Overnight E.coli cultures
Individual isolated E.coli colonies (C4l (DE3) or Xl.l-blue) grown on Luria agar
plates were used to inoculate 10 ml Luria Broth (LB) containing the appropriate
antibiotic selections. The cultures were incubated at 37°C with 180 rpm agitation
for a minimum of 16 hours. A control containing the growth medium and the
antibiotics alone was also prepared. The fully grown 10 ml culture was used to
create glycerol stocks which stored several copies of the plasmid containing the
gene of interest. Subsequent inoculations therefore involved scraping cells from
the glycerol stock using a sterile pipette tip instead of obtaining the cells from the
agar colony.
Solutions:
LB broth (Sigma): 10 gIL tryptone, 5 giL yeast extract, 10 giL NaCI, autoclaved
at 121°C for 15 minutes.
3.2.4 Glycerol stocks
Aseptic 30 % (w/v) glycerol and cells from an overnight culture were added to a
sterile eppendorf at a 1 : 1 ratio and sealed under sterile conditions. The new
stocks were stored at -80°C until required for inoculation of overnight cultures.
3.2.5 Plasmid purification
High quality plasmid DNA was purified from Xl.l-blue E.coli cells containing the
gene of interest. Overnight cell cultures containing tetracycline (selective for
XLl- blues) and ampicillin (selective for the plasmid) were cultivated. The cells
were harvested by centrifugation at 1000 ref for 10 minutes and the resultant
supernatant was discarded. The plasmid DNA was subsequently purified using a
QIAprep® Miniprep kit (Qiagen) as per the manufacturer's instructions. DNA is
lysed from the bacterial cells using an alkaline lysis methodology. Precipitation of
cellular debris and genomic DNA occurs after the lysis reaction is neutralised.
Separation of the plasmid DNA from the precipitate was achieved using
centrifugation. The plasmid DNA is absorbed into a silica membrane and eluted
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from the membrane in 50 ul of elution buffer (EB) and stored at -20 "C until
required.
Solutions:
EB Buffer: 10 mM Tris.Hel (pH 8.5) (Qiagen)
3.2.6 Agarose gel electrophoresis
Agarose gels were used to separate DNA molecules according to their molecular
weight. Mini-sub® cell GT apparatus (BioRad) was assembled as per the
manufacturer's instructions. Agarose gels, 0.5-2% (w/v), were generated by
dissolving agarose in 42 ml Tris Acetate EDTA (TAE) buffer. The solution was
heated gently until boiling. Ethidium bromide, a DNA intercalator, was then
added at a final concentration of 0.1 ul/ml to visualise the DNA. The heated
solution was poured into the assembled apparatus, a comb inserted and the
solution allowed to cool. Once fully set the comb was removed and the gel
submerged in TAE buffer. DNA samples were treated with 6 x loading dye
(Promega), 1 ul dye to 5 ~1 DNA, and loaded onto the gel. A 70 Volts (V)
potential was applied until the bands had separated sufficiently (20-60 min).
Bands were visualised under a GBOX UV transluminator (Syngene) and their
molecular weights determined in comparison to a 2-log ladder (NEB) used as a
marker.
Solutions
TAE buffer: 40 mM Tris.Hel, 20 mM acetic acid, 1 mM EDTA (PH 5.0)
2-10g loading ladder: 0.1-10kb containing 19 differently sized fragments used as
molecular weight standards
3.2.7 DNA concentration
DNA concentration was measured using a Nanodrop ND-IOO spectrophotometer
(NanoDrop). The nanodrop measures the ultraviolet (UV) absorbance at 260 nm
for DNA samples. The absorbance at 260 nm was then entered into the Beer-
Lambert equation to calculate concentration.
S2
Beer-Lambert law
Where A is absorbance (A260), c is concentration (M), E is the molar extinction
coefficient and I is the path length (cm). The molar extinction coefficient of
double stranded DNA is taken as E 260 = 0.02 (ng/ul)" cm-1213•
3.2.8 Cloning the p62 subfragments into the PGEX-4T-l plasmid
3.2.8.1 peR gene amplification
The gene of interest was amplified by PCR in preparation for its insertion into the
pGEX-4T-l plasmid. Oligonucleotide primers were synthesised by the School of
Biomedical Sciences, University of Nottingham. Primers were designed according
to standard guidelines. The p62 sub fragment encoding residues 261-440 was
cloned between the EcoRl and XhoI restriction sites; whereas, the sub fragment
encoding residues 300-440 was cloned between the BamHI and XhoI restriction
sites. The details of the forward and reverse primers are listed in the appendix.
Plasmid template (50 ng ur', 1 Ill), 10 x reaction buffer (5 Ill, Stratagene), excess
forward and reverse primers (125 ng ur', 1 III each primer) and dNTP mix (10
mM each nucleotide, 1 Ill, Stratagene) were added to a sterile PCR tube and
placed on ice. Piu Turbo® DNA polymerase (2.5 U ur', 1 Ill, Stratagene) was
added to the reaction last to make the total volume 50 Ill. The reaction was
transferred to a thermocycler (Techgene) according to the following program. The
PCR reaction utilised the parental DNA denauration, primer annealing and primer
extension stages. The number of cycles of the PCR was increased for gene
amplification when compared to site directed mutagenesis to amplify sufficient
DNA for cloning experiments.
1 cycle
95°C for
95 °C for
60°C for
72 °C for
4 °C for
30sec
30sec
30sec
30sec
1 cycle
30 cycles
00
S3
Solutions:
10 X Reaction Buffer: 10 mM KC1, 10 mM (NH4hS04, 20 mM Tris-HCI (pH
8.8),2 mM MgS04' 0.1% Triton® X-lOO, O.lmglmrl nuclease free bovine serum
albumin (BSA).
3.2.8.2 Vector restriction digests
The plasmid DNA was prepared using a miniprep kit as outlined in section 3.2.5.
The pGEX-4T-1 was digested with the appropriate restriction endonucleases
(Promega) as reactions summarised in table 3.1. Single digests required the use of
the buffer supplied with that enzyme. Double digests buffers were calculated
using the promega website (see table 3.2) to maximise the enzymatic activity of
both endonucleases. Uncut DNA and single cut controls were also prepared to
verify that all enzymes were cutting. The reactions were completed in a total
volume of 40 III and incubated at 37°C for 4 hours. The restriction endonucleases
were denatured at 65°C for 15 minutes upon reaction completion. To prevent self
ligation of the newly generated sticky ends, Antarctic phosphatase (Biolabs) was
added to each reaction at a concentration of 5 units/ul (see table 3.3). The total
reaction volume was increased to 50 III with the addition of the phosphatase,
phosphatase buffer and water. The reaction returned to 37°C for 10 minutes. The
antarctic phosphatase was also heat inactivated as described for the restriction
endonucleases. The digested products were separated from the denatured enzymes
on a 1% (w/v) agarose gel as outlined in section 3.2.6, visualised using a UV light
source and excised from the gel for further purification.
Solutions
Buffer E: 60 mM Tris.HC} (pH 7.5), } M NaCl, 60 mM MgCh, 10 mM DTT
Buffer H: 900 mM Tris.HC} (pH 7.5), 500 mM NaCl, 100 mM MgCh
Buffer D: 60 mM Tris.HC} (pH 7.9), 1.5 M NaCI, 60 mM MgCh, 10 mM DTT
Buffer C: 100 mM Tris.HC} (PH 7.9), 500 mM NaCl, 100 mM MgCh, 10 mM
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Antarctic phoshatase buffer: 50 mM Bis Tris-Propane, (pH 6.0), 1 mM MgCh, 0.1
mMZnCh
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Table 3.1 - The vector restriction digest conditions used in this study. Each
. h 1 1 f 40 1reaction as a tota vo ume 0 Ill.
Reaction Uncut Single Single Single Double Double
composition plasmid cut cut cut digest p62 digest
(Jil) control BamHI EcoRI XhoI 300 - 440 p62261
(BamHI + -440
XhoI) (EcoRI
+XhoI)
Milli-Q water 28.5 26.5 26.5 24.5 22.5 22.5
(~l)
10 x buffer 4 4 4 4 4 4
(JlI)
Plasmid DNA 6.5 6.5 6.5 6.5 6.5 6.5
(120ngl~l)
(ul)
50 x BSA (Ill) 1 1 1 1 1 1
(Ill)
BamHI (10 N/A 2 N/A N/A 2 N/A
units/ill) (Ill)
EcoRI (12 N/A N/A 2 N/A N/A 2
units/ul) (Ill)
XhoI (10 N/A N/A N/A 4 4 4
units/ill) (JlI)
Table 3.2 - The lOX buffer used in vector restriction digests. The buffer was
h h f11 .c osen to maximise t e activity 0 a enzymes contained within the reaction.
Reaction lOx buffer used
Uncut plasmid control Buffer E
Single cut BamHI Buffer E
Single cut EcoRI Buffer H
Single cut XhoI Buffer D
Double digest BamHI +XhoI BufferC
Double digest EcoRI +XhoI Buffer H
3.2.8.3 Insert restriction digests
The PCR amplified gene inserts were gel extracted (see section 3.2.8.4) and the
concentrations measured using a NanoDrop ND-100 spectrophotometer
(NanoDrop). The inserts were subsequently digested under identical conditions to
those used in the vector restriction digests. Conditions include the Molarity of
DNA being digested, units of restriction endonuclease and time of digestion. The
reactions were set up as outlined in table 3.4 and incubated at 37°C for 8 hours.
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Only double digests were completed because the restriction sites are located at the
ends of the amplified DNA insert. Digestion therefore results in a very small size
change in the DNA fragment which is unable to be detected by agarose gel.
Buffers were chosen for the double digestions as outlined in table 3.2 (section
3.2.8.2).
Solutions
Buffer H: 900 mM Tris.HCI (pH 7.5), 500 mM NaCI, 100 mM MgCh
Buffer C: 100 mM Tris.HCI (pH 7.9), 500 mM NaCI, 100 mM MgCh, 10 mM
DTT
Table 3.4 - Insert restriction digests. The difference in the volume of insert DNA
. b d th tr ti f the i rt d t . db h dIS ase on e cone en a Ion 0 mse as e ermine >yt e nano rop.
Reaction composition (,...1) Double digest p62 Double digest p62
300 - 440 (8amlll + 261- 440 (EcoRI +
XhoI) XhoI)
Milli-Q water (J-lI) 18 34
10 x buffer (ul) 5 5
Insert DNA (12nglfl for 300-440) 20 4
(42ng/J-ll for 261-440) (J-ll)
50 x BSA (J-lI) 1 1
BamHI (10 units/ul) (fll) 2 N/A
EcoRI (12 units/ul) (ul) N/A 2
XhoI (10 units/ul) (J-ll) 4 4
3.2.8.4 Gel extraction purification
DNA purification of fragments 70 base pairs (bp) to 10 kilo bases (kb) from
enzymatic reactions were performed using a QuikChange ® gel extraction kit
(Qiagen) as per the manufacturer's instructions. The step was necessary after
enzymatic reactions (PCR gene amplification and restriction digests for both
vector and insert DNA) in order to obtain high quality pure plasmid DNA by
removing unwanted primers, enzymes and other impurities. The plasmid DNA is
isolated using agarose gel electrophoresis. The band of interest is excised from the
gel and is subsequently solubilised using a buffer containing the chaotrophic NaCI
guanidiunium thiocyanate. In this environment the plasmid DNA preferentially
binds to the QIAquick silica membrane. The DNA is washed and eluted in 50 ul
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using a buffer with low NaCI under basic conditions. The eluted pure DNA is
stored at -20°C until required.
Solutions:
EB Buffer: 10 mM Tris.HC} (pH 8.5) (Qiagen)
3.2.8.5 Ligations
The digested vector and digested insert were ligated together using a T4 DNA
ligase (Promega). A 4: I insert:vector ratio was used to ensure the ligation was
successful. The total volume of insert and vector did not exceed 11 J-lI,with the
total volume of each reaction being 20 J-ll (table 3.5). A control reaction
containing only vector was also set up. The ligations were completed at 16°C for
16 hours. The T4 DNA ligase was denatured at 65°C after reaction completion.
Table 3.5 - Ligation reaction compositions. The same control was used for both
ti th b th tai d th f DNAreac IOns as eyo con me e same content 0 vector
p62300-440 p62261-440 Control
Vector DNA (7ng/J-ll for 300- 4 4 4
440) {9ng/J-l1for 261-440l_(g_l}
Insert DNA (4ng/J-ll for 300- 6 7 N/A
440){6ng/J-lI for 261-440) UtI)
Milli-Q water {J.ill_ 7 6 13
T4 ligase buffer (ul) 2 2 2
T4 ligase (3 units/ul) (J-l1) 1 1 1
Solutions
T4 DNA ligase buffer: 300 mM Tris.HCI (pH 7.8), 100 mM MgCIz, 100 mM
DTT, 10 mM ATP
3.2.9 Site directed mutagenesis
3.2.9.1 Polymerase chain reaction (peR)
All p62 UBA mutants and the C331 S p62 300-440 mutant (outlined in section
1.6) were generated using a QuikChange@ Site directed mutagenesis kit
(Stratagene). Oligonucleotide primers containing the desired mutations were
designed according to Quikchange guidelines and synthesised by the School of
Biomedical Sciences, University of Nottingham. The details of the forward and
reverse primers are listed in the appendix. A 50 ml reaction was prepared in a thin
walled 0.2 ml PCR tube on ice. Plasmid template (50 ng ur', 1 ul), 10 x reaction
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buffer (5 Ill, Stratagene), excess forward and reverse primers (125 ng Ilrt, 1 III of
each primer) and dNTP mix (10 mM each nucleotide, 1 Ill, Stratagene) were
added to the sterile PCR tube. Piu Turbo® DNA polymerase (2.5 U, 1 Ill,
Strata gene ) was added last and the reaction was transferred to a thermocycler
(Tech gene) according to the program detailed below. PCR consists of 3 main
stages, parental DNA denaturation, primer annealing and primer extension.
1 cycle 95°C for 30sec
n cycles 95°C for 30sec
1 cycle
55°C for
68 °C for
4 °C for
60sec
1 minlkb plasmid length
00
(point mutations n = 12, single amino acid changes n = 16, multiple amino acid
changes n = 18).
Solutions:
10 X Reaction Buffer: 10 mM KC1, 10 mM (NH4)zS04, 20 mM Tris-HCl (pH
8.8),2 mM MgS04, 0.1% (v/v) Triton® X-lOO, O.lmg/ml-l nuclease free bovine
serum albumin (BSA).
3.2.9.2 Dpn1 Digestion
All mutagenesis PCR reactions were treated with restriction enzyme Dpnl. Dpnl
(0.2 U Ill-I) was added to the PCR reaction tube and heated to 37°C for 1 hour.
Parental DNA is digested by Dpnl, which is selective for methylated or
hemimethylated DNA. The remaining undigested DNA should therefore contain
the desired mutation.
3.2.10 Transformation into XL-l blue E.coli
3.2.10.1 Preparation of chemical supercompetent cells
Glycerol stocks of XLI blue E.coli were used to inoculate 10 ml LB without
antibiotic selection and left to grow at 37°C for 16 hours with 180 rpm agitation.
These cells were used to inoculate another 10 ml LB at 1 : 50 dilution and grown
until the OD595 was 0.3. Cells were spun at 1000 ref in a centrifuge for 10
minutes, resuspended in 4 ml 50 mM CaCh and left on ice for 3 hours. The cells
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were centrifuged again (as above), resuspended in 800 ul 50 mM CaCh and left
for 30 minutes to make them chemically competent.
3.2.10.2 Heat shock trans/ormation 0/DNA into host cells
Chemically competent XLI-blue aliquots (loa J.lI)were treated with 1 ul or 3 ul
DNA from site directed mutagenesis reactions or ligation reactions respectively.
The aliqouts were then chilled on ice for 30 minutes. The cells were subsequently
heat shocked at 42°C for 30 seconds to uptake the plasmid DNA and returned to
ice for a further 2 minutes. A small volume of LB (400 J.lI)was added to the
aliquots and they were allowed to grow at 37°C for I hour. The cells were spread
onto Agar plates containing ampicillin (270 J.lM) and tetracycline (140 J.lM) and
incubated at 37°C for 16 hours or until colonies had grown.
The E.coli strain XLI-blue were chosen because they can repair nicked DNA.
Xl.l-blue are endonuclease A (endA) and recombination A (recA) deficient. EndA
deficiency enables high quality DNA to be produced from miniprep kits; whereas,
recA deficiency increases the stability of the inserted DNA within the plasmid.
3.2.11 DNA sequencing
All newly cloned plasmids and PCR mutants were verified by DNA sequencing.
The DNA was purified using a miniprep kit (section 3.2.5) and taken to the DNA
sequencing facility (School of Biomedical sciences, University of Nottingham) for
confirmation. A 5J.ll DNA sample (40 - 100 ng/ul) was sufficient for the
sequencing reaction and the forward and reverse primers (both > 10 pmol/ul)
were supplied by the DNA sequencing facility. The DNA was sequenced using
the standard Sanger method214• A chromatogram was produced and visualized
using Chromas 2.21 (Technelysium).
3.2.12 Transformation into C41 (DE3) E.coli
Overnight cultures containing no antibiotic selection were inoculated with C41
(DE3) glycerol stocks. Chemically competent cells were prepared as outlined in
2.2.10.1. Transformations were completed as outlined in 2.2.10.2 but with agar
plates selective for ampicillin (270 J.lM)only.
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3.3 Protein overexpression
3.3.1 Overexpression plasmids
The details of the plasmids and proteins used in this study are summarised in table
3.6. The restriction sites the genes are located between and the amino acid
extension left from thrombin cleavage, where applicable, are also indicated. The
plasmid maps of all plasmids used throughout this study can be found in the
appendix.
The pGEX expression system (GE healthcare) is a highly efficient system which
is used to express glutathione S-transferase (GST) fusion proteins. The gene
which codes for the GST protein from Schistosoma japonicum (bloodworm) had
been previously cloned into the PGEX plasmids by the supplier. The gene
encoding the protein of interest was cloned downstream of the GST gene in the
multiple cloning site. A tac promoter, a functional hybrid derived from the trp and
lacUV5 promoters", is located upstream of the gene which encodes the GST tag
and the multiple cloning site.
Overexpression of the desired protein is regulated by the tac promoter which is
controlled by T7 RNA polymerase. Under normal conditions gene expression is
driven by the addition of a lactose metabolite called allolactase, which binds to the
lac repressor. When isopropyl-thio-jl-Dsgalatoside (IPTG), a non hydrolysable ~
galactosidase analogue, is added it binds to the lac repressor protein in both the
bacterial host DNA and the pGEX plasmid DNA. When IPTG binds to the lac
repressor in the bacterial DNA the lacUV5 promoter drives the expression of T7
RNA polymerase from the bacterial genome. In the plasmid DNA IPTG also
binds to the lac repressor protein allowing the T7 RNA polymerase to bind to the
tac promoter to initiate transcription of the desired gene. The T7 RNA polymerase
is not produced by the bacterial cells therefore the bacterial genome needs to be
modified to encode the gene for the T7 RNA polymerase.
The pGEX-4T-I and pGEX-4T-3 plasmids, as used in this study, express GST
fusion proteins. The GST protein is a very soluble protein capable of enhancing
the solubility of the fused protein. Separation of the fusion protein is achieved
using the proteolytic enzyme thrombin. The thrombin recognition sequence, Leu-
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Val-Pro-Arg-Gly-Ser, is located between the GST and the cloned protein of
interest. Thrombin cleaves between the Arg and Gly residues leaving a minimum
of a Gly-Ser extension after cleavage. The extension length is dependent on the
restriction sites the gene of interest was cloned into within the multiple cloning
site. The details of the restriction sites and the thrombin cleavage extension used
for each protein are indicated in table 6.
The pKK233-3 also possesses a tac promoter upstream of the gene of interest;
however, the pt7-7 plasmid contains a T7 promoter. The T7 promoter also permits
high efficiency transcriptiorr'l", The desired gene is transcribed from the T7
promoter by T7 RNA polymerase in much the same way as the tac promoter does.
The main difference between these plasmids and the PGEX expression system is
that these plasmids lack a GST affinity tag. Ubiquitin is a highly studied protein
and is known to be soluble at a variety of pH's. An affinity tag to aid protein
solubility was therefore not required.
Table 3.6 - A table summarising the plasmid details of all the proteins used in this
dstu ly
Protein Plasmid Restriction sites Affinity tag Extension
P62341-440 pGEX-4T-l EcoRI-XhoI GST GSPEF
P62300-440 pGEX-4T-l BamHI-XhoI GST GS
P62261-440 pGEX-4T-l EcoRI-XhoI GST GSPEF
P62 UBA _pGEX-4T-l BamHI-XhoI GST GS
MAP-LC3 _pGEX-4T-3 EcoRI-SalI GST GSPNS
hHR23A UBA2 pGEX-4T-I BamHI-XhoI GST GS
Ubiquitin pKK233-3 EcoRI-HindIII None None
Linear diubiquitin pt7-7 NdeI-EcoRI None None
3.3.2 Protein overexpression using C41 (DE3) E.co/i
The E. coli strain C41 (DE3) was modified from BL21 (DE3) strain in order to
express proteins which are toxic to the BL21 (DE3) cells217• 218.C41 (DE3) E. coli
have been shown to be effective in expressing recombinant proteins from all
classes of organisms. This strain has at least one uncharacterised mutation, which
prevents the cell death associated with the expression of toxic recombinant
proteins. The A. prophage DE3, which encodes for the T7 RNA polymerase after a
lacUV5 promoter, had been previously inserted into the BL21 bacterial DNA. The
lacUV5 promoter is recognised by the E. coli RNA polymerase and is induced by
the presence of IPTG. Also like the parental BL21 (DE3) strain, C41 (DE3) is
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deficient in Ion and ompT proteases which allows for better isolation of intact
recombinant proteins. C41 (DE3) cells possess no intrinsic antibiotic resistance.
3.3.3 Growth media
3.3.3.1 LB media
Luria broth (LB) medium was used for the expression of unlabelled proteins,
except ubiquitin. 25 g LB powder was dissolved in 1 litre of Milli-Q water and
transferred to a 2 litre baffled flask. The media was subsequently autoclaved to
sterilise.
Solutions:
LB broth (Sigma): 10 gIL tryptone, 5 g/L yeast extract, 10 g/L NaCI, autoclaved
at 121°C for 15 minutes.
3.3.3.2 M9 minimal media
M9 minimal media was used to overexpress unlabelled ubiquitin and all ISN and
13C/lsN labelled proteins. M9 minimal media was prepared in a 2 litre baffled
flask by dissolving M9 NaCls in 1 litre of Milli-Q water and autoclaved to
sterilise. The media was supplemented with 20 ml of sterile filtered (0.22 J..1m
sartorius stedim) M9 nutrient solution and biotin and thiamine to a final
concentration of 10 mg/l after sterilisation.
Solutions:
M9 NaCls: Calcium chloride dehydrate (15 mg/l), Di-Sodium orthophosphate (6
gil), Magnesium sulphate (0.5 gil), Potassium dihydrogen orthophosphate (3 gil),
NaCI (1 gil).
M9 nutrient solution: 1 g Ammonium Chloride, 4 g glucose in 20 ml Milli-Q
water.
3.3.3.3 Isotopic labelling
For NMR experiments, proteins were isotopically labelled with either ISN or a
combination of ISN and 13C219.Thus ISN-enriched ammonium chloride and 13C_
enriched glucose are required to replace the naturally abundant 14N-ammonium
chloride and 12C-glucose components of the M9 nutrient solution. The ammonium
chloride and glucose were the sole source of nitrogen and carbon respectively
62
meaning that proteins expressed from this media will possess the appropriate
isotopic labelling. The media was prepared and autoclaved as normal. The
isotopically labelled M9 nutrient solution was added along with ampicillin, biotin
and thiamine as previously outlined. For 15N/13C proteins the amount of I3C_
glucose was halved.
Solutions:
ISN nutrient solution: 1 g ISN-ammonium Chloride, 4 g glucose in 20 ml Milli-Q
water.
ISN/I3C nutrient solution: 1 g ISN-ammonium Chloride, 2 g 13C-glucose in 20 ml
Milli-Q water.
3.3.4 Small scale protein overexpression
An overnight culture was inoculated with C41 (DE3) E.coli containing the desired
protein and was grown at 37°C with 180 rpm agitation for 16 hours. The
overnight culture was used to inoculate 10 ml LB containing ampicillin (270 JlM)
at a 1 in 50 dilution and grown at 37°C with 180 rpm agitation until the ODs9s
was 0.7 (1-3 hours). Protein expression was induced by the addition of IPTG at a
final concentration of 1 mM. The culture transferred to 30°C for protein
expression. A 1ml sample was taken prior to IPTG addition. Further 1 ml samples
were taken at 2, 3, 4, 5, 6 and 16 hours after protein induction and the ODs9s
checked. The samples were centrifuged at 13,000 ref for 10 minutes and the
supernatant discarded. The resultant cell pellet was resuspended in 300 JlI lysis
buffer A for proteins expressed using the pGEX expression system and 5 x AE for
monoubiquitin and linear diubiquitin. The 1 ml samples were sonicated in a
soniprep 150 sonicator (MSE) for 10 seconds (x2) at 10 microns. The sonicated
samples were centrifuged once more. Samples (20 ul) were taken before (total cell
lysate) and after (soluble fraction) centrifugation and visualised on an SDS PAGE
gel to observe protein expression
Solutions
Lysis buffer A: 10mM Tris.HCI, 150mM NaCI (pH 7.4)
5 x AE buffer: 250 mM acetic acid, 10 mM EDTA, pH 4.0
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3.3.5 Large scale overexpression
Once successful overexpression had been observed on a small scale, large scale
growths ensued. Overnight cultures were made in LB media. Glycerol stocks
containing the desired plasmid in C41 (DE3) E.coli were used to inoculate the
overnight cultures. Large baffled flasks containing either 1 litre of sterilised LB or
M9 minimal media were inoculated with overnight cultures. Each litre of
autoc1avedLB was inoculated with 20 ml overnight culture whereas each litre of
autoc1avedM9 minimal media was inoculated with 45 ml (3 x 15 ml) overnight
cultures. Cells used to inoculate LB were added directly to the LB media. Cells
used to inoculate M9 minimal media were centrifuged at 1000 g for 10 minutes
and the supernatant discarded. The cell pellets were resuspended in M9 minimal
media which had been enriched with the M9 nutrients, biotin and thiamine. The
cells were returned to 37 ·C and shaken at 180 rpm for 30 minutes before adding
directly to M9 minimal media. Ampicillin at a final concentration of 270 IlM was
added to the media at inoculation as all proteins expressed in this study possessed
ampicillin resistance.
The inoculated growths were then left to grow at 37°C with 180 rpm agitation
until the 00595 was 0.7. Prior to protein induction the incubator was cooled to
30°C. The cells were induced with IPTG at a final concentration of 1 mM and
returned to the incubator to induce at 30°C. A further 270 IlM ampicillin was
added at induction to replace the ampicillin metabolised by the E.coli. Proteins
expressed in LB were induced for 4-10 hours (table 7). Proteins expressed in M9
minimal media were induced for a minimum of 16 hours (table 3.7). When the
OD595 approached 1.8 the cells were harvested by centrifugation (Sorvall) at 3000
ref for 10 minutes. The resultant cell pellet was scraped into a Falcon tube. The
remaining cells were resuspended in lysis buffer A for proteins expressed using
the pGEX expression system and 5 x AE buffer for monoubiquitin and linear
diubiquitin and added to the Falcon tube containing the cell pellet. The cells were
centrifuged at 5000 ref for 15 minutes, the supernatant discarded and the pellet
stored at -20°C until needed. 1 ml gel samples were taken before induction and
harvesting. The gel samples were spun, resuspended and sonicated as described in
the small scale overexpressions.
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T bl 37Th th di . fi 11 h d i h' da e - egrow con mons or ate protems use m t IS stu ly_.
Protein Growth Induction Induction Induction
temperature temperature time in LB time in M9
rC) CC) _(hours) {hours}_
P62341-440 37 30 8 16
P62300-440 37 30 8 16
P6226l-440 37 30 8 16
P62 UBA 37 30 8 16
MAP-LC3 37 30 10 N/A
hHR23A UBA2 37 30 4 16
Ubiquitin 37 30 N/A 16
Linear diubiquitin 37 30 8 16
Solutions
Lysis buffer A: 10mM Tris.HCI, l50mM NaCI (pH 7.4)
5 x AE buffer: 250 mM acetic acid, 10 mM EDTA, pH 4.0
3.3.6 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE)
Polyacrylamide gel apparatus (Biorad) were assembled as per the manufacturer's
instructions. The gel contained a 20% acrylamide resolving layer beneath 4%
acrylamide stacking layer. The resolving layer consisted of a 20% acrylamide
stock containing ammonium persulfate (APS) (0.5% v/v) and N,N,N,N-
tetramethylethylethylenediamine, (TEMED) (1% v/v). Additon of APS and
TEMED catalysed the formation of a solid gel. The stacker, consisting of a 4%
acrylamide stock solution, contained identical concentrations of APS and TEMED
to those described for the resolving layer. The stacking layer was prepared once
the resolving layer had polymerised. A comb was inserted quickly to the setting
stacking layer to form the loading wells. Protein samples, 20 Ill, were mixed with
10 III 2 x protein loading dye, containing 20% DL-dithiothreitol (DTT) for sample
denaturation. The samples were heated at 90°C for 2 minutes. The gel assembly
containing the set gel was transferred to the electrophoresis pack, the area
between the two gels filled with 1 x SDS and the combs removed. A low
molecular weight marker (Sigma) or Novex prestained protein standard marker
(Invitrogen) was loaded as a size standard and 8 III samples were subsequently
loaded. The gel was run at 200 mV, immersed in 1 x SDS buffer, for 1 hour.
Proteins were visualised by Coomassie Blue stain and destained with 25% acetic
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acid and 10% methanol. The protein bands were visualised and photographed
using a trans illuminating light box.
Solutions:
TE buffer: 10 mM Tris-Hel (pH 7.4),1 mM EDTA.
20 % Acrvlamide solution: 20% Protogelf (20 % (w/v) acrlamide, 0.4 % (w/v)
bis-acrylamide (National Diagnostics), 375mM Tris-Hel (pH 8.8), 0.1 % SOS.
Stacking solution: 2 % Protogel" (National Diagnostics), 125 mM Tris-Httl (pH
6.8), 0.1 % (w/v) SDS.
2 x protein loading buffer: 100 mM Tris-Hel (pH 6.8), 4 % (w/v) SDS, 20 %
(w/v) glycerol, 0.2 % (w/v) bromophenol blue, 200 mM dithiolthreitol (OTT).
Low molecular weight marker (Sigma): albumin (66 kDa), ovalbumin (45 kDa),
glyceraldehydes-3-phosphate dehydrogenase (36 kDa), carbonic anhydrase (29
kDa), trypsinogen (24 kDa), trypsin inhibitor (20kDa), a-lactalbumin (14.2 kDa)
and aprotinin (6.5 kDa).
Novex prestained protein standard marker (Invitrogen): 12 pre-stained protein
bands in the molecular weight range of 3.5 kDa to 260 kDa.
SOS running buffer: 25 mM Tris base, 250 mM glycine (pH 8.3), 0.1 % (w/v)
SDS.
Staining Solution: 0.25 % (w/v) Brilliant Blue R-250 (Fisher), 45% (v/v)
methanol, 10% (v/v) glacial acetic acid.
Destaining Solution: 25 % (v/v) methanol, 10% (v/v) glacial acetic
3.4 Protein Purification
Different columns attached to an AKTA prime (Amersham Pharmacia) FPLC
system were utilised to purify the different proteins and their mutants. All proteins
cloned into the pGEX-4T-1 and pGEX-4T-3 plasmids contain an N-terminal
thrombin-cleavable GST tag. GST tagged proteins were subjected to a gravity
flow talon column containing a glutathione Sepharose resin. The GST fusion
proteins bind to the glutathione beads and are either cleaved from the beads using
thrombin or eluted as a GST fusion protein. To elute from the column reduced
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glutathione was applied to out compete the GST tag for binding to the beads. Both
thrombin cleaved proteins and GST fusion were subjected to two further columns
which separate proteins according to their size and shape. First a gel filtration
column was utilised to remove any undesired products from the thrombin
cleavage. Finally proteins were applied to a desalting column in order to remove
any excess NaCI which could be detrimental to any subsequent NMR
experiments. Nearly all proteins were lyophilised after the gel filtration and desalt
columns to concentrate the protein. In the case of the MAP-LC3, the protein was
concentrated using a spin concentrator between gel filtration and desalting steps.
Monoubiquitin (Saccharomyces cerevisiae) was previously cloned into the
pKK223-3 plasmid whereas linear diubiquitin (Homo sapien), was a kind gift
from Paul Sheppard pre-cloned into the pt7-7 plasmid. Neither of these plasmids
possesses a purification tag. Untagged monoubiquitin and linear diubiquitin were
also purified using gel filtration and desalt columns but prior to gel filtration, a
cation exchange column, which purifies protein based on charge, was used. Both
monoubiquititn and linear diubiquitin are positively charged at pH 4, a pH where
many proteins are insoluble. This fact makes these proteins relatively easy to
isolate using a cation exchange column at this pH. Both proteins were lyophilised
after the gel filtration and desalt stages of the purification protocol. Monoubiquitin
was lyophilised after the cation exchange column; whereas, linear diubquitin was
applied directly to the gel filtration column as 10 ml fractions.
3.4.1 Protein sonication and clarification
Frozen E. coli C41 (DE3) cell pellets containing the protein of interest were
removed from the -80°C freezer and allowed to thaw gently. 100 J.1laliquots of
DNase I (Sigma) and protease inhibitor cocktail containing EDTA (Sigma) were
added to the thawed pellet and the cells resuspended in the appropriate buffer.
GST tagged proteins were resuspended in 6ml lysis buffer B containing DTT,
EDTA and Triton X. Monoubiquitin and linear diubiquitin were resuspended in
20 ml per litre 5 x AE buffer. The cells were lysed by sonication at! 0 microns in
an ice bath (30 sec bursts, 5 min total on time). Cellular debris was separated from
cell lysate by two rounds of centrifugation at 4°C (40,000 ref for 30 mins) using
Avanti J-25 centrifuge with JL-20 rotor (Beckman). For monoubiquitin and linear
diubiquitin a further 10 ml per litre 5 x AE buffer was added to the supernatant
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between spins. Addition of 5 x AE buffer caused precipitation of impurities aiding
the overall purification procedure as well as dragging the protein to pH 4 where
the protein is positively charged.
Solutions
DNAse 1 Stock (Sigma):10 mg/ml (50,000 V/ml) 1M MgCh, O.lM MnCh.
Protease inhibitor cocktail (Sigma): AEBSF (2 mM), Aprotinin (0.3 J.lM), Bestatin
(130 JlM), EDTA (1 mM), E-64 (14 JlM), Leupeptin (1 JlM)
Lysis buffer B: 10 mM Tris.HCI, 150 mM NaCI (pH 7.5), 4 mM OTT, 15 mM
EOTA, 0.1% (v/v) Triton X-lOO.
5 x AE buffer: 250 mM acetic acid, 10 mM EOTA, pH 4.0
3.4.2 GST Gravity Flow Talon Column
The supernatant of sonicated GST tagged proteins was applied to a column
containing glutathione sepharose 4B beads (GE Healthcare). The sepharose beads
were pre-equilibrated with 3 column volumes of lysis buffer A. The protein was
tumbled slowly at 4 °C for 2-4 hours depending on protein stability. The tumbling
process allowed GST tagged proteins to bind to the beads. Non-GST tagged
proteins were collected in the flow through and washed out with 3 x column
volumes (3 x 10ml) lysis buffer A washes. For aST cleaved purifications,
proteins were subjected to an on-column cleavage by the protease thrombin. The
column was initially washed with 3 column volumes of cleavage buffer to re-
equilibrate the beads. The lid was then placed on the tip of the gravity flow
column. Thrombin (5 units) was mixed with 990 ul thrombin cleavage buffer and
applied to the column and tumbled at 4 °C for 16 hours. For aST fusion protein
purifications 5 ml elution buffer was applied to the column after the lysis buffer A
washes. The column was tumbled at 4 °C for a further 30 minutes. The
glutathione contained in the elution buffer competes with the aST tagged protein
for binding sites on the beads. A further 4 x 1 ml elution buffer is added to the
column to remove any proteins still attached. The eluted protein was collected in a
universal tube.
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Solutions
Lysis buffer A: 10 mM Tris.HCI, 150 mM NaCI (pH 7.5)
Cleavage buffer: 20 mM Tris.HCI, 150 mM NaCI, 2.5 mM CaCh (pH 8.4)
Elution buffer: 10 mM reduced glutathione, 50 mM Tris.HCI (pH 8.0)
3.4.3 Ion exchange chromatography
The supernatant from sonicated monoubiquitin and linear diubiquitin pellets was
diluted to 150 ml with degassed Milli-Q water and filtered with a 0.45 urn filter
(Minisart®, Sartorius) to remove any aggregates. The 150 ml solution was loaded
onto a cation exchange column, pre-equilibrated with cation binding buffer, using
a 50 ml superloopt'" (Amersham Biosciences). Bound protein was eluted by
increasing the NaCI concentration incrementally. Cation elution buffer was
applied using a linear gradient. For monoubiquitin a sharp gradient of 0 -100%
over 100 ml was applied. Linear diubiquitin utilised a more shallow gradient of 0-
60 % over 500 ml. Both cation binding and elution buffers had been filtered with
a 0.45 um cellulose nitrate membrane (Whatman) and degassed before use.
Fluorophores within the protein allowed the elutent to be visualised by absorbance
at 280 nm. The protein was collected as 10 ml fractions. Fractions corresponding
to the absorbance peak were confirmed by SDS-PAGE and combined.
Solutions:
Cation binding buffer: 50 mM acetic acid, 2 mM EDTA, pH 4.0, filtered and
degassed
Cation elution buffer: 50 mM acetic acid, 2 mM EDTA, 2 M NaCl, pH 4.0,
filtered and degassed
3.4.4 Gel filtration chromatography
Gel filtration is a technique which relies on separating proteins according to their
size and shape. Larger proteins are eluted first whereas smaller, more compact
proteins are able to weave between the pores of the column. A HiLoad™
Superdexi'" 200 (Amersham biosciences) gel filtration column was used for all
GST fusion proteins. A HiLoad™ Superdex''" 75 (Amersham biosciences) gel
filtration column was used for monouniquitin, linear diubiquitin, C33lS p62 300-
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440 and MAP-LC3. A HiLoad™ Sephacrylt'< S-IOO (Amersham biosciences) gel
filtration column was used for all thrombin cleaved p62 UBA and hHR23A UBA2
proteins. All gel filtration columns were pre-equilibrated with 3 x column volume
(360 ml) potassium phosphate buffer before use. The phosphate buffer was
filtered with a 0.45 urn cellulose nitrate membrane (Whatman) and degassed
before column equilibration. Lyophilised monoubiquitin from the ion exchange
column was resuspended in 2 ml Milli-Q water and loaded onto the gel filtration
column. Linear diubiquitin was eluted in 10 ml fractions from the ion exchange
column and loaded directly onto the gel filtration column using a 10 ml superloop
(Amersham biosciences). Thrombin cleaved proteins were eluted from the GST
gravity flow talon column in 2.5 ml and loaded directly onto the gel filtration
column. Prior to loading, EDTA at a final concentration of 15 mM was added to
the thrombin cleaved protein samples to bind any free calcium ions from the
thrombin cleavage buffer. The AKTA prime (Amersham Pharmacia) FPLC was
run at 3-4 mllmin for the HiLoad™ Superdex ™ 200 and 75 columns and
1.5mllmin for the HiLoad™ Sephacryl'v S-100 column. Proteins were collected
in 10 ml fractions. Protein containing fractions were confirmed by SDS PAGE
and subsequently lyophilised.
Solutions:
Gel Filtration Buffer: 30 mM potassium phosphate, 100 mM NaCI (pH 7.0),
filtered and degassed.
3.4.5 Desalting chromatography
Protein desalting was performed using 5 x 5ml HiTrapTM columns (Amersham
Biosciences) pre-equilibrated with filtered and degassed Milli-Q water. The Milli-
Q water was filtered with a 0.45 urn cellulose nitrate membrane (Whatman) and
degassed before use. Lyophilised gel filtration samples were dissolved in 2 ml
Milli-Q water and filtered using a 0.45 IlM filter (Sartorius). The filtered sample
was loaded onto the desalt column. The protein was eluted from the column first,
followed by the NaCt. The protein containing fractions were confirmed by SDS
PAGE. MAP-LC3 was unable to be desalted in water so the water was substituted
for ammonium acetate which could also be freeze dried.
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Solutions
Milli-Q water: filtered and degassed
Ammonium acetate: 25mM (pH 7), filtered and degassed
3.4.6 Lyophilising protein
Between the various columns attached to the AKT A prime and after the final
desalt column protein containing fractions were concentrated by lyophilisation.
The only exceptions to this were linear diubiquitin between cation exchange and
gel filtration columns and MAP-Le3 between gel filtration and desalt columns.
Proteins were snap frozen in liquid Nz and applied to a micromodulyo freeze drier
(Thermo Savant) for 24 - 48 hours or until all the liquid had been removed. MAP-
Le3 was lyophilised in ammonium acetate after desalting and was additionally
resuspended in water and re-lyophilised a further two times to remove any
remaining ammonium acetate.
3.4.7 Spin concentrating protein
Where proteins could not be lyophilised, as is the case for the MAP-Le3 protein
between gel filtration and desalt columns, proteins were spin concentrated using a
Vivaspin20 spin concentrator (Vivascience). This spin concentrator had a 3000
Da molecular weight cut off Polyethersulfone (PES) membrance to remove small
molecule and small protein contaminants.
3.4.8 Protein yield quantification
Desalted lyophilised protein was quantified by mass weight using a ALJ 120-4
balance (Kern). The desired amount of protein was weighed and dissolved in the
appropriate buffer according to which experiments it was required for. Where
protein could not be accurately weighed, concentration was calculated by
measuring UV spectroscopy. A NanoOrop NO-lOO spectrophotometer
(NanoDrop) recorded the UV absorbance of the protein at 280 nm. The
absorbance value was subsequently entered into the Beer-Lambert law.
Beer-Lambert law A=Ecl
Where A is absorbance (Az8o), e is the molar extinction co-efficient (M-1 cm"), c
is concentration (M), I is path length (cm). e 280 nm is calculated from the additive
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contributions from Cys (125 M-I cm"), Tyr (1490 M-Icm-I) and Trp (5500 M-I
ern") residues=".
3.5 Biophysical techniques
3.5.1 Electropray ionisation mass spectrometry (ESI-MS)
All electrospray ionisation mass spectrometry (ESI-MS) experiments were
performed on a SYNAPyrM electrospray ionisation, high definition mass
spectrometry (HDMSTM) system with a Triwave™ ion mobility separation cell
coupled to a quadrapole-time of flight (qTOF) mass analyser (Waters). A 100 ~I
syringe (Hamilton) was used to inject samples to the spectrometer at a rate of 5 ul
min-I. A standard electro spray source (Waters) or nanospray source (Waters) was
attached to the mass spectrometer to transfer ions to the gas phase. For solvent
exposed ESI-MS experiments, neat acetonitrile was placed in the electrospray
source. Instrument control and initial data analysis was performed using the
Masslynx'[" software (Waters). Further analysis calculations were completed
using Microsoft Exce12007.
Solutions
ESI-MS buffer: 25mM Ammonium acetate
Nanospray ESI-MS buffer: 200mM Ammonium acetate
3.5.1.1 Native mass measurements
In order to confirm the identity of the protein or mutant native mass
measurements were taken. Lyophilised protein was dissolved in ammonium
acetate buffer to an approximate final concentration of 5 ~M. ESI-MS was
recorded in positive ion mode with an applied capillary voltage of 2.5 kV over 2-3
minutes. A sample cone voltage of 30 V, a 100 Llhour desolvation gas at 323.15
K and trap and transfer collision energy voltages of 7.0 V and 6.0 V respectively
and trap pressure of 2 mbar were also applied.
Data analysis:
The molecular mass was calculated from the mass to charge ratios observed in the
mass spectrum using the mass lynx software. Each mass to charge ratio can be
used to calculate the molecular mass using equation I.
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Equation 1 MWt=(MZ)-Z
Where MWt is the molecules molecular weight, M is the measured mass to charge
ratio of the ion and Z is the charge state of that ion.
3.5.1.2 ESI-MS dilutions
ESI-MS dilution experiments were conducted in order to monitor the
oligomerisation state of the p62 UBA mutants. The populations of monomeric and
dimeric forms of the UBA vary with concentration, therefore all p62 UBA
mutants were subjected to dilution experiments in a concentration range of 8 JlM
to 1 JlM. ESI-MS was recorded in positive ion mode with an applied 2.5 kV
capillary voltage over a time of 2-3 minutes. A sample cone voltage of 30 V, a
100 IJhour desolvation gas at 323.15 K and trap and transfer collision energy
voltages of 7.0 V and 6.0 V respectively and trap pressure of 2 mbar were applied.
Data analysis:
The apparent concentrations of monomer and dimer could not be accurately
calculated. Where the mass and charge are both doubled an identical m1z value is
recorded meaning peaks for the monomer and dimer overlap. Solvent exposed
surface areas were therefore estimated using the average charge state221• The
average charge state of the monomer was calculated using equation 2. The
average charge state was subsequently plotted as a function of concentration,
whereby changes in average charge state are easily visualised and used as an
indicator of concentration dependent changes in monomer and dimer populations.
Equation 2 Zav= <LZI)/(~J)
Where Zav is the average charge state for the species, Z is the charge state of a
given ion of that species and I is the intensity of the given ion.
3.5.1.3 ESI-MS titrations
ESI-MS titrations were performed to measure binding affinities for the interaction
between the S403 p62 UBA mutants (outlined in section 1.6) and ubiquitin.
Moreover the stoichiometry of the newly formed complex could also be
determined. Ubiquitin was titrated into mutant p62 UBA using the following
concentrations of p62-UBA:ubiquitin (11M) 1:0.5, 1:0.75, 1:1, 1:1.25, 1:1.5 and
1:2. Competitive binding experiments containing all three S403 mutants were
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mixed with ubiquitin (equimolar, 5 and 1 ~M experiments). In order to measure
the stoichiometry and confirm the formation of a ternary complex between
ubiquitin, p62 and MAP-LC3 the three were mixed at the following
concentrations of p62:ubiquitin:MAP-LC3 (~M) of 3: 1.5: 1.5 and 4:2:2. ESI-MS
was recorded in positive ion mode with a 2.5 kV capillary voltage over a time of
2-3 minutes. A sample cone voltage of 30 V, a 100 Llhour desolvation gas at
323.15 K and trap and transfer collision energy voltages of 7.0 V and 6.0 V
respectively and trap pressure of 2 mbar were applied.
Data analysis:
The apparent concentrations of free protein ([PD, protein-ligand complex ([PLD
and free ligand (Protein 2) ([LD were calculated from the concentrations of total
protein and ligand used, and the signal intensities. Plots of [PL]/[P] vs. [L] yield a
straight line of which the gradient is the association constant (Kai22• Equation 3 is
rearranged to give equation 4. This was subsequently used to ca1cluate the Kd
using equation 5. The method relies on the assumption that complexes are
transferred to the gas phase without significant perturbation to the forces
responsible for their association. It also assumes that the intensities of ions
recorded by the mass spectrometer are proportional to the concentrations of each
of the species observed.
Equation 3 Kd = ([P][L))/[PL]
Where Kd is the dissociation constant, [P] is the concentration of protein 1, [L] is
the concentration of ligand (or protein 2, as it is in this case) and [PL] equals the
concentration of their complex.
Equation 4 [PL] / [P] = K. [L]
Where K, is the association constant, [P] is the concentration of protein 1, [L] is
the concentration of ligand (or protein 2) and [PL] equals the concentration of
their complex.
Equation 5
Where Kd is the dissociation constant and K, is the association constant.
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3.5.1.4 nanospray ESI-MS
The GST fusion proteins were not able to be detected using the standard ESI-MS
technique. The electrosrapy source was replaced with a nanospray source which is
ideally suited to larger proteins. Using the standard nanospray source (Waters) a
spectrum of the GST -p62 UBA construct was able to be recorded in order to
confirm the molecular mass. Moreover titrations with monoubiquitin and linear
diubiquitin were also recorded using this construct. ESI-MS was recorded in
positive ion mode with a 1.5 kV capillary voltage over a time of 5 to 20 minutes.
A sample cone voltage of 3DV, a 100 Llhour desolvation gas at 323.15 K and trap
and transfer collision energy voltages of 50 V and 30 V respectively and trap
pressure of 2 mbar were applied.
3.5.2 Far-UV Circular dichroism (CD)
All far-UV Circular Dichroism (CD) experiments were recorded on an Pi-Star-
180 Spectrophotometer (Applied Photophysics) interfaced with an Acorn
Archimedes computer with inbuilt software (Applied Photophysics). The optical
system was configured with a 75 W Xe lamp, circular light polarizer and end
mounted photomultiplier. The temperature was regulated using an RTE-300
circulating programmable water bath (Neslab Inc) and a thermoelectric
temperature controller (MeIcor). Far UV -CD experiments were recorded using
one of two quartz cuvettes. Higher protein concentrations (range of 1.5 - 0.1
mg/ml) utilised a 300 JlI cuvette with a 1mm path length; whereas, lower protein
concentrations (range of 0.15 - 0.01 mg/ml) a 3 ml cuvette with a 10 mm path
length was used. All CD data was converted using the APL data converter version
3 (Applied Photophysics) and analysed using Microsoft Exce12007.
Solutions
CD Buffer: 10 mM potassium phosphate (pH 7.0)
3.5.2.1 Far UV-CD scans
Far UV -CD scans were used to check the proteins had folded into the correct
conformation and to confirm secondary structure. Scans were recorded in the
wavelength range between 190 to 260 nm, data points were recorded at every 1
nm step. The number of counts was set to 10,000, adaptive sampling was enabled
and set to 500,000 and entrance/exit slits of 3 om were employed. All samples
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were equilibrated at the appropriate temperature for 15 minutes prior to data
collection.
Data analysis:
Ellipticity values recorded directly from the spectrophotometer were converted
into molar ellipticity using equation 6 which corrects for wavelength and
concentration 181.
Equation 6 [9)molar). = (100 x 9).) I (m x d)
Where [S]molar1equals the molar ellipticity, Sl is the observed ellipticity (degrees)
at wavelength (1), m is the protein concentration (decimolar) and d is the path
length (cm). The units for molar ellipticity are deg cm2 dmol'.
3.5.2.2 Thermal unfolding
Thermal unfolding studies were conducted in order to calculate the apparent
midpoint (Tm) of unfolding. Far UV-CD monitored temperature melts were
initially recorded between 278.15 K and 368.15 K using 0.5 K intervals. The
temperature was controlled by a thermoelectric temperature controller (Melcor)
with 0.2 K fluctuations from the specified temperature. The starting temperature
was raised to 293.15 K when the recorded ellipticity of the previous melt
remained constant between 278.15 K and 293.15 K. The ellipticity was recorded
between 222 run and 224 nm as this wavelength range represented the greatest
difference between an ordered a helical structure and random coil.
Data analysis:
The apparent mid point of unfolding was calculated by using the first derivative of
the folding curve as outlined by Greenfield et a/Iss. This approach was used as an
alternative to fitting the curve as the curve produced from the thermal unfolding
profiles did not produce a defined end point.
3.5.2.3 Dilutions
Dilution experiments were recorded on the p62-UBA dimer mutants (outlined in
section 1.6) in order to observe the presence of multiple species at equilibrium.
CD spectra as well as thermal unfolding profiles were recorded at each point in
the dilution The apparent Tm values were calculated from the thermal unfolding
76
data in order to detect any changes over the concentration range. Changes in Tm is
indicative of multiple species at equilibrium. All mutants were monitored in the
concentrations range 173 JlM to 1 JlM and were recorded by systematic 1:I
dilutions with CD Buffer. After dilution the samples were equilibrated for 15
minutes at room temperature before starting the next point in the dilution
experiment. All concentrations were confirmed using a NanoDrop ND-IOO
spectrophotometer (NanoDrop).
Data analysis:
The apparent mid point was calculated at each concentration in the dilution by
using the first derivative of the folding curvel85• The apparent midpoint was
plotted as a function of concentration to produce a concentration dependent
apparent Tm graph. The Tm values for the dimer and monomer can be estimated
from these graphs.
3.5.3 Isothermal titration calorimetry (ITC)
All isothermal titration calorimetry (ITC) experiments were performed on a VP-
ITC high sensitivity titration calorimeter (MicroCal, Inc) at 298 K. All buffers and
protein samples were degassed under vacuum for a minimum of 10 minutes
before each experiment to remove any air bubbles and ensure efficient mixing and
injection.
Solutions
nc Buffer: 50 mM potassium phosphate, 50 mM NaCI (pH 7.0)
3.5.3.1 dilution Ire
Dilution ITC was used to monitor changes in heat upon dimer dissociation.
Concentrated protein samples (250 JlM - 300 JlM) were titrated into a cell
containing buffer alone. As the concentration of protein in the cell increases the
heat change associated with dimer dissociation decreases producing a dissociation
curve. The concentrated protein samples were prepared in phosphate buffer and
degassed under a vacuum for a minimum of 10 minutes. Titrations consisted of 55
successive injections of 5 JlI protein into buffer. A 300 second interval was
permitted between injections. A constant stirring speed of 300 rpm ensured
mixing during the titration. A reference power of 5 JlCal/sec was used. Data were
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analysed and fitted to a dimerisation dissociation model using Origin software
(MicroCal).
Data analysis
The origin software calculates the dissociation affinity constant (Kdim) and the
change in enthalpy (AH). These parameters were subsequently used to determine
both the free energy of dissociation (AG) and the change in entropy of dissociation
(AS) according to equations 7 and 8 respectively.
Equation 7 AG = -R.T.ln(Kdim}
Where AG is the free energy of dissociation (Kl/mol), R is the molar gas constant
(8.314 J morl KI) and T is the temperature in Kelvin (298K) and Kdim is the
dissociation affinity constant (JlM).
Equation 8 AG=AH-T.AS
Where AG is the free energy of dissociation (Kl/mol), AH is the change In
enthalpy (Kl/mol), T is temperature in Kelvin (298K) and AS is the change in
entropy of dissociation (J/mol).
3.6 Nuclear magnetic resonance (NMR)
Nuclear magnetic resonance experiments were performed on either an Avance™
III 600 MHz spectrometer (Bruker) fitted with a TXI triple resonance probe with
Z-axis gradients (Bruker) or an Avance™ III 800 MHz spectrometer fitted with a
Quadruple Resonance Inverse Detection QCI Cryoprobe, with Z-axis gradients.
Solvent suppression was achieved using either WATERGATE223 or excitation
sculpting pulse scquencesv". All spectra were acquired using standard Bruker
pulse sequences and all samples were prepared in 90% H20 andIO % 020. All
experiments had transmitter frequencies set to water at 2823 and 3763 Hz for the
600 MHz and 800 MHz spectrometers respectively (4.7 ppm). The IH chemical
shifts were referenced internally to the methyl peak of 4,4-dimethyl-4-silapentane-
I-sulphonic acid (DSS) at 0.00 parts per million (ppm). ISN and I3C spectra were
referenced indirectly using DSS and the IUPAC standard chemical shift ratios of
0.101 and 0.251 for ISN:IH and I3C:IH respectiveli2s. Spectral processing was
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carried out using Topspin 2.1 software. Protein assignments were achieved using
CCPNMR software (version 2.1.2).
Data processing
A112D and 3D spectra were phase corrected, baseline corrected, zero filled and an
exponential window function applied to improve the signal to noise ratio and the
resolution. The data was zero filled to 2048 in the indirect dimension(s),
optimised with a shifted sine bell in all dimensions and an automatic polynomial
baseline correction was applied. All processing was completed using Topspin 2.1.
3.6.1 Sample preparation
Lyophilised samples were dissolved in 600 III of NMR buffer to final
concentrations within the range of 10 IlM - 1 mM. Low concentration samples
(10 IlM - 100 IlM) could only be used on the highly sensitive 800 MHz
spectrometer. Whereas high concentration samples (> 100 IlM) could be used on
either the 600 MHz or 800 MHz spectrometers. Once dissolved the sample was
centrifuged at 13, 000 rpm for 1 minute in a bench top centrifuge before
transferring to a standard 5 mm NMR tube. For experiments conducted on the
Bruker Avance 600 MHz spectrometer a 528-PP-7 NMR tube (Wilmad) was used.
For experiments conducted on the Bruker Avance 800 MHz spectrometer a 535-
PP-7 NMR tube (Wilmad) was used.
Solutions
NMR buffer: 25 mM potassium phosphate pH 7, 25 mM NaCI, 10% DzO and
0.04% (w/v) sodium azide
3.6.21DNMR
1D NMR was used to check the protein had folded into the native state and the
protein's suitability for further NMR experiments. Unlabelled protein samples of
different concentrations (10 IlM - 1 mM) were prepared. Spectra were recorded
using a proton excitation sculpting pulse sequence224• The number of scans varied
for different proteins, the concentration of the sample and the sensitivity of the
machine being used; however, a range of 4 - 64 scans was normal. Spectral
widths also varied but a range from 12 - 15 ppm was sufficient for all samples,
with 12 ppm being used for the p62 UBA constructs and mutants.
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3.6.3 2D NOESYand 2D TOCSY
The 2D homonuclear NMR experiments used in this thesis were the 2D
NOESy226 and 2D TOCSy227. These experiments were used to assign residues in
the p62 UBA mutants which had perturbed significantly from those observed for
the free form of the wild type p62 UBA. Unlabelled protein samples in the
concentration range 250 ,....Mto 1 mM were prepared. Spectra were acquired by
collecting 2048 points in the direct dimension and 512 points in the indirect. Since
this is a homonuclear experiment both dimensions are proton dimensions. A
spectral width of 12 ppm was used in both dimensions. The number of scans was
set to 64. The mixing times for the NOESY and TOCSY were 63.5 ms and 120
ms respectively.
Data analysis
The data obtained from the NOESY and TOCSY were used to assign residues
which could not be assigned based on the IH_15Namide chemical shifts reported
for wild type. The TOCSY spectrum was used to identify the amino acid type as
all amino acids have a pattern of cross peaks. The NOESY shows cross peaks
between residues adjacent in sequence, therefore sequential assignment could be
achieved. When the NOESY and TOCSY spectra are overlaid the peaks which
belong to that particular amino acid and peaks which belong to nearby residues
can be identified. These spectra are particularly useful for spectra that have been
partially assigned.
3.6.4 IH_15N HSQC and IH_15N TROSY
The 2D heteronuclear NMR experiments used in this thesis were the IH_15N
HSQcI92. 193and IH_1SNTROSyI94. These experiments provide the correlation
between the nitrogen and amide proton. All residues therefore produce an
observable peak in the spectrum, with the exception of proline residues which
lack an amide proton. For proteins less than 15 kDa the IH_1sNHSQC was used
whereas proteins over 15kDa the IH_15NTROSY experiment was utilized. The
IH_1sN HSQC/IH-1SN TROSY is recorded for the assignment of resonances so
that each amide peak can be assigned to a particular residue in the protein. These
experiments use the sensitivity of the backbone amide groups to study structural
perturbations caused by mutation, construct extension and protein-protein
80
interactions. Using the amide chemical shifts previously reported for the wild type
p62 UBA 140 resonances which have shifted in mutants or longer constructs can be
identified. Titration studies were used extensively in this thesis to monitor the
binding events between various p62 constructs and mutants to ubiquitin or linear
diubiquitin. Dilution studies were also completed to monitor the monomer-dimer
equilibrium of the p62 UBA mutants.
3.6.4.11HYN HSQclHYN TROSYtitrations
Titrations whereby an unlabelled protein is titrated into a 15N labelled protein
were used to probe protein-protein interactions. Experiments involving titrating
unlabelled ubiquitin into 15Nlabelled p62 UBA or a longer p62 construct (herein
referred to as forward titrations) were recorded for T414A, T414K, T419K and
S403D p62 UBA mutants as well as GST-p62 UBA, GST-hHR23A UBA2 and
the longer GST -p62 constructs. Forward titrations whereby linear diubiquitin was
titrated in were performed for the GST -p62 UBA and GST -hHR23A UBA2.
Depending on the size of the complex formed either the IH_15NHSQC or IH_15N
TROSY was recorded for the free and fully bound samples as well as each point
in the titration. A ID spectrum was recorded before each IH_15NHSQC or IH_15N
TROSY experiment.
A 1200 III sample of 15Nlabelled protein was prepared and split into two 600 III
samples. One sample was used as the unbound sample. Lyophilised unlabelled
protein was added to the other sample at a 4: 1 molar ratio to form a fully bound
sample. If the titration was completed on the 600 MHz spectrometer a 1 mM
sample was split into two 500 11Msamples and 2mM ubiquitin was added. If the
titration was completed on the 800 MHz spectrometer a 500 11Msample was split
into two 250 IlM samples and 1mM ubiquitin was added. The two samples were
mixed in various quantities according to equation 9 to generate a range of
concentrations of unlabelled protein. A specific volume was removed from the
free sample and replaced with the same volume from the fully bound sample. This
way the 600 III volume was maintained whilst titrating in the ubiquitin or
diubiquitin.
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Equation 9 Vl =«MI-M3)*Vl)/(MI-Ml)
Where V2 equals the volume which is removed from the unbound sample. This
volume is replaced by the fully bound sample. M 1 is the concentration of the
current sample, M3 is the desired concentration, VI is the volume of the sample
and M2 is the concentration of the concentrated stock.
For the intermediate points in the forward titrations 2048 points and 64 points
were acquired in the proton and 15Ndimensions respectively. A spectral width of
13 ppm was used for the proton dimension. A spectral width of 40 ppm was used
for the 15Ndimension. The number of scans was set between 32 and 64 depending
on the protein used. For the free and fully bound samples a higher resolution
spectrum was recorded whereby the number of points in the nitrogen dimension
and the number of scans were increased.
Titrations whereby 15N-ubiquitin was titrated into unlabelled p62 UBA (herein
referred to as reverse titrations) were also recorded. Reverse titrations were
recorded for the S403A, S403D and S403E p62 UBA mutants as well as GST -p62
UBA. A reverse titration whereby unlabelled GST -p62 UBA was titrated into 15N
linear diubiquitin was also completed. The reverse titrations also used the method
outlined in equation 9. For the points in the reverse titrations 2048 points and 64
points were acquired in the proton and 15N dimensions respectively. A spectral
width of 13 ppm was used for the proton dimension. A spectral width of 40 ppm
was used for the 15Ndimension. The number of scans was set to 32. For the free
and fully bound samples a higher resolution spectrum was recorded whereby the
number of points in the 15Ndimension and the number of scans were increased.
Data analysis
Changes in the chemical shifts of amino acids were used to identify binding
patches and determine binding affinities. Chemical shift perturbations were
calculated using equation 10.
Equation 10
Where IIIHand 1l15Nare the observed changes in proton and ISNchemical shift in
response to binding.
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Reverse titrations were used to calculate an apparent K,for the interaction. Final
CSP values greater than 0.05 ppm were entered into IGOR Pro Version 5.0.57
(Wavemtrics) and fitted using equation 11.
Equation 11 a =Aa ([L] /(Kd + [L))
Where B is the observed esp at a given ligand concentration, AB is the final CSP
at saturation and [L] is the unlabelled protein concentration.
Kd values whereby the competitive processes of dimerisation and binding were
taken into account were calculated according to equation 12. The Kd values
produced from fitting in IGOR Pro is used as the Kobs and Kdim values were
calculated from ITC dilution experiments.
Equation 12
3.6.4.2 1H_I5 N TROSY tltrations to form a p62 mediated ternary complex
For the titrations to form the p62 mediated ternary complex a different approach
was used. A 250 JlM sample of the e331 S mutant of the p62 300-440
sub fragment was prepared by dissolving lyophilized protein in 600 JlI NMR
buffer. MAP-LC3 was added to the e33IS p62 300-440 followed by ubiquitin
and vice versa. A concentrated stock of ubiquitin was used to spike in various
concentrations up to 1 mM (4:1 molar ratio). The MAP-Le3 was insoluble above
250 JlM so a concentrated stock could not be spiked in. Therefore a 250 JlM (1: 1
molar ratio) sample was prepared by dissolving lyophilized protein in water and
splitting into aliquots. The aliquots were subsequently free dried and added to the
free e331 S p62 300-440 or bound to ubiquitin complex NMR sample. The
interaction of the p62 with ubiquitin (via the UBA) and MAP-LC3 (via the LIR)
have been previously reported separately, providing indications into the
concentrations of these proteins required for saturation of the p62 construct.
All spectra within the titration were recorded with 2048 points in the proton
dimension and 128 points in the 15N dimension. Spectral widths of 16 ppm in the
proton dimension and 35 ppm in the ISN dimension were applied. The number of
scans used for each point in the titration was just 4 scans due to the highly
sensitive nature of the e331 S p62 300-440.
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3.6.4.3 lH_I5NHSQCffROSY dilutions
Wild type p62 UBA, the T419K p62 UBA mutant and the GST-T419K p62 UBA
were diluted from either 500 JlM (for T419K) or 250 JlM (for wild type p62 UBA
and GST-T419K). The starting concentration was reduced by 50 JlM and a
spectrum recorded. This was repeated until the concentration was 50 JlM. After
this concentration systematic I: I dilutions with NMR buffer was used to make
concentrations of 25 JlM, 12 JlM and 6 JlM (6 JlM was only used in the wild type
p62 UBA dilution). Wild type data was recorded as a control whereas, the T419K
and GST-T419K were recorded to observe what concentration the dimeric species
is no longer observable. The p62 UBA mutants T414A and T414K were not
systematically diluted. Spectra for a high concentration sample (500 JlM) and a
low concentration sample (l0 JlM) were recorded only due to the highly sensitive
nature of these mutants. This high and low concentration approach was also
applied to the p62 UBA mutants S403A, S403D and S403E in the interest of
saving time. Thus 12 JlI of the 500 JlM sample was added to 488 JlI NMR buffer
to make the 10 JlM sample.
The wild type p62 UBA and all p62 UBA mutants used IH_1sNHSQC; whereas,
the GST-T419K used the IH_1sN TROSY. The spectra were recorded with 2048
points and 64 points in the proton and 15N dimensions respectively. Spectral
widths were set to 12 ppm in the proton dimension and 35 ppm in the 15N
dimension. The number of scans increased when the concentration was decreased
over the course of the dilution. As a general rule when the sample concentration
was halved the number of scan should be multiplied by four to get the same
quality spectrum.
3.6.4.415N Heteronuclear NOE r5N rH) NOE)
The 15N heteronuclear NOE eSN eH) NOE) was measured using a 15N_HSQC
based pulse sequences with and without proton saturation during the relaxation
delay prior to the starting 90° 15N pulsel9s• The experiments were run as
interleaved ISNHSQCs which were subsequently split into a pair of 15NHSQCs,
one with proton saturation and one without.
An experiment was performed on the T419K mutant at a concentration of 25 JlM
in order to observe the flexibility of the monomeric form of this mutant. This
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experiment was performed by collecting 2048 and 512 points in the proton and
15Ndimensions respectively. Spectral widths of 13 ppm for the proton dimension
and 35 ppm for the 15Ndimension were also employed. The number of scans was
set to 52.
Experiments were also performed on the C331 S p62 300-440 bound to either
monoubiquitin or MAP-LC3 or both proteins as part of a ternary complex. These
experiments were performed by collecting 2048 and 256 points in the proton and
15Ndimensions respectively. Spectral widths of 16 ppm for the proton dimension
and 35 ppm for the 15Ndimension were also employed. The number of scans was
set to 40.
Data analysis
The interleaved data was separated into two HSQC spectrums, one with and on
without proton saturation using the split2 command in Topspin 2.1. The 15NeH)
NOE values were calculated using Excel2007 using equation 13.
Equation 13 15 1N( H) NOE = (Isat/Ieqm)
Where Isat is the intensity of of a particular peak with proton saturation and Ieqm is
the intensity of the same peak without proton saturation.
3.6.5 3D 15N-HSQC-NOESY and 3D 15N_HSQC_TOCSY
The 3D double resonance NMR experiments used in this thesis were the 15N_
HSQC_NOESy193,192,228,229and 15N_HSQC_TOCSyI93,192,230. These spectra
contain two proton dimensions and one 15Ndimension. These experiments were
used to assign residues in the p62 UBA mutants which had perturbed significantly
from those observed for the bound form of the wild type p62 UBA. A fully bound
sample was prepared using a 4: 1molar ratio ofubiquitin:UBA.
Spectra were acquired by collecting 2048 points in the direct proton dimension
over a spectral width of 12 ppm. 128 increments per plane in the indirect proton
dimension and 32 increments per plane for the IsN dimension were recorded.
Spectral widths of 12 ppm for the indirect proton and 35 ppm for the IsN
dimensions were applied. The number of scans was set to 16. The mixing time was
200 ms and 60 ms for the IsN-HSQC-NOESY and ISN-HSQC-TOCSY
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respectively. The quality of the HSQC- TOCSY could have been vastly improved
by using a longer mixing time (120 ms to 200 ms).
Data analysis
The data obtained from the 15N-HSQC-NOESY and 15N-HSQC-TOCSY were
used to assign resonances which had deviated from the chemical shifts reported
for the wild type p62 UBA. The data was analysed using a similar approach to the
2D NOESY and 2D TOCSY, whereby the amino acid type could be identified
using the 15N-HSQC-TOCSY and the 15N-HSQC-NOESY is subsequently used to
connect the amino acids in a sequence.
3.6.6 3D triple resonance NMR
Standard back bone assignment experiments for the assignment of protein NH,
HN, C', Co and Cp chemical shifts were performed on a free 250 JlM 15N_I3C
labelled C331S p62 300-440 sample and bound to MAP-LC3 (250 JlM) and
ubiquitin (I mM) forming a ternary complex. The 3D triple resonance
experiments were recorded to assign the p62 LIR and any UBA peaks which have
shifted in the free or bound forms. The NHCACB206, HN(CO)CACB206 and
HNCA208 experiments were used to identify the Ca and Cp carbons whereas the
HNC0208,231 and HN(CA)C0208 experiments were used to identify the C· carbons.
For the HNCACB and HN(CO)CACB experiments 1024 points were acquired in
the proton dimension. Also 32 increments per plane in the indirect 15Ndimension
128 increments per plane in the indirect I3C dimension were recorded. The
spectral widths were set to 12,35 and 75 ppm for the proton, nitrogen and carbon
dimensions respectively. The number of scans was set to 24 per increment.
For the HNCA experiment 1024 were acquired in the proton dimension. Also 32
and 64 points per increment were recorded in the indirect 15Nand I3C dimensions
respectively. The spectral widths were set to 12, 35 and 32 ppm for the proton,
15N and I3C dimensions respectively. The number of scans was set to 32 per
increment.
For the HNCO and HN(CA)CO experiments 1024 points were acquired in the
proton dimension. Also 32 increments per plane in the indirect ISNdimension and
64 increments per plane in the indirect I3C dimension were recorded. The spectral
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widths were set to 12, 35 and 25 ppm for the proton, 15N and 13C dimensions
respectively. The number of scans was set to 32 per increment.
Data analysis
The spectra were processed using topspin 2.1. Copies of the processed data were
made and the copies imported into CCPNMR analysis software (version 2.1.2).
Standard protein backbone assignment methodologies were used employed to
assign the p62 LIR (in the free and bound forms) and p62 UBA (bound form).
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4.0 Purification of monoubiquitin and linear diubiquitin
4.1 Introduction
Results chapters 6 to 9 involve the binding of p62 constructs containing the UBA
domain or p62 UBA mutants to ubiquitin ligands. For the purpose of these studies
it was therefore necessary to engineer both monoubiquitin and linear diubiquitin.
Monoubiquitin (S. Cerevisiae) was previously cloned by Dr Geoff Platt (formerly
of the Searle group) into the pKK223-3 plasmid between the EcoRI and HindII!
restriction sites in the multiple cloning site. The plasmid was purchased from
Amersham Pharmacia and contains ampicillin resistance. Linear diubiquitin
(Homo Sapien) was received pre-cloned into the pt7-7 plasmid between the
restriction sites Ndel and EcoRI as a gift from Paul Sheppard (formerly ENZO
life Sciences). The pt7 -7 plasmid also contains ampicillin resistance. Despite
using ubiquitin from different organisms, the difference between the ubiquitin
orthologues is only three residues, with the tertiary structures shown to be
virtually identical.
Previous work, as part of a collaborative project between the Searle and Layfield
groups (both University of Nottingham), have shown that the p62 UBA shows an
enhanced binding affinity for polyubiquitin chains over monoubiquitin in pull
down assays using immobilised p62140. In order to monitor the increased affinity
as potentially a result of the avidity effect, monoubiquitin binding was compared
to diubiquitin binding (chapter 9). Of the eight different types of diubiquitin,
linear diubiquitin was chosen for these binding studies due to its structural
similarity to Lys63 linked diubiquitin", The p62 protein is involved in the NF-KB
signalling pathway, a pathway that is known to be regulated by both linear74,76,77
and Lys63 linked polyubiquitin chains?'. Lys63 is located very close to the C
terminal causing structures that differ subtly in the linker region, rather than in the
orientation or compactness of the subunits. Many UBDs have been shown to
preferentially bind Lys63 and linear chains over Lys48 chains232,233, emphasising
their structural similarities. Linear chains can be expressed and purified by
cloning one ubiquitin moiety after the other into plasmids, meaning they have the
advantage of not requiring specific ubiquitination enzymes as well as being a
more financially viable.
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4.2 Results
4.2.1 Protein overexpression
Both monoubiquitin and linear diubiquitin DNA were purified from XL-l blue
E.coli. The DNA was transformed by heat shock into C4I (DE3) E.coli and plated
onto agar plates containing ampicillin only. The C41 (DE3) strain was used
because, like the BL2I (DE3) strain it was modified from2l7, it is deficient in Ion
and ompT proteases which allows for better isolation of intact recombinant
proteins, but unlike the BL21 (DE3) strain it is able to express toxic proteins. C41
(DE3) E.coli is a cell line which contains the T7 polymerase under the control of
the IPTG inducible tac promoter. The hybrid tac promoter contains the lac
promoter sequence, enabling the use of IPTG to initiate protein overexpression.
IPTG, a p galactosidase analogue, permits T7 polymerase activity by binding to
the lac repressor at the lac promoter sequence releasing the repressor from the
DNA allowing the plasmid gene of interest to be expressed.
Small scale protein overexpression trials were completed In IOml universals.
After confirmation of protein expression by SOS PAGE, large scale growths
ensued. Overnight cultures were grown and used to inoculate media (1 x 20 ml or
3 x 15 ml cultures for 1 litre of luria broth or M9 minimal media respectively).
Ampicillin was added at inoculation to select for plasmid containing cells which
possess antibiotic resistance. Monoubiquitin was expressed in M9 minimal media
as both an unlabelled and l5N labelled protein to increase the purity of the
expression and prevent overgrowth of cells. Ubiquitin is an extremely stable and
tolerant protein, it was not unsurprising overgrowth of cells could occur in a
nutrient rich media. Linear diubiquitin showed poor expression in M9 minimal
media but expressed well in luria broth. Luria broth media was therefore chosen
for large scale overexpression of linear diubiquitin as an unlabelled protein. M9
minimal media was utilised for l5N labelling of linear diubiquitin. The cells of the
inoculated media were grown at 37°C until the 00595 reached 0.7, a density
where the cells have reached an exponential growth rate. The majority of cells are
at their optimum for protein expression at 00595 0.7. Subsequently overexpression
was induced by the addition of IPTG. Over time the ampicillin was metabolised
by the E. coli cells, therefore further ampicillin was added to maintain the
selection for plasmid containing cells only. The incubation temperature was
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lowered to 30 DC for both monoubiquitin and linear diubiquitin at induction.
Monoubiquitin was expressed for 16 hours whereas linear diubiquitin was
expressed for 8 hours as an unlabelled protein and 16 hours as a 15N-labelled
protein. The duration of expression reflects the difference between the two
different medias used for growth. The cells were harvested in a centrifuge once
the ODs95 could not get any higher. The cell pellets were stored at -80 DC until
needed for purification. Gel samples were taken prior to protein induction and cell
harvesting. The gel samples were visualised on a 20 % acrylamide gel. This
percentage of acrylamide was used due to the small molecular weights of
monoubiquitin and linear diubiquitin. The expression of monoubiquitin is shown
in figure 4.1 whereas the expression of linear diubiquitin is included in figure 4.2
The difference in the intensity of the bands corresponding to the overexpressed
monoubiquitin and linear diubiquitin reflects the media used for the
overexpression.
15 kDa
10 kDa
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30 kDa
20 kDa
1 2 3 4 5
Figure 4.1 - A 20 % acrylamide SDS PAGE gel of the overexpression of
monoubiquitin in C41 (DE3) Ecoli in M9 minimal media. A Novex prestained
protein standard marker (Invitrogen) was used as a size standard (lane 1). The
total and soluble fractions of cell lysate prior to protein induction with IPTG are
shown in lanes 2 and 3 respectively. The total and soluble fractions of cell lysate
16 hours after the addition of IPTG are depicted in lanes 4 and 5 respectively.
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Figure 4.2 - A 20 % acrylamide SDS PAGE gel of the overexpression of linear
diubiquitin in C41 (DE3) E.coli in luria broth nutrient rich media. A Novex
prestained protein standard marker (Invitrogen) was used as a size standard (lane
I). The total and soluble fractions of cell lysate prior to protein induction with
IPTG are shown in lanes 2 and 3 respectively. The total and soluble fractions of
cell lysate 8 hours after the addition of IPTG are depicted in lanes 4 and 5
respectively.
4.2.2 Protein purification
Despite different overexpression conditions, both monoubiquitin and linear
diubiquitin were both purified using a virtually identical purification protocol.
Three purification columns were utilised for this, a cation exchange column, a gel
filtration column and a desalt column. Confirmation of protein containing
fractions was achieved by visualising on an SDS PAGE gel (figures 4.3 and 4.4).
Cell pellets were removed from -80 "C storage and allowed to thaw in a minimal
volume of 5 x AE buffer and DNase I (0.01 mg/ml). Further 5 x AE buffer was
added to drag the pH of monoubiquitin or linear diubiquitin to pH 4, where
several other proteins are insoluble. The cells were subsequently lysed by
sonication, releasing the overexpressed protein into solution. Two rounds of high
speed centrifugation removed the unwanted cellular debris and insoluble protetin
content. The ubiquitin containing supernatant was diluted to 150 ml with degassed
Milli-Q water, filtered and degassed and loaded onto a pre-equilibrated cation
exchange column attached to an AKTA prime FPLC system. Monoubiquitin and
linear diubiquitin have a pI value of approximately 6.79, making them positively
charged at pH 4. All positively charged proteins are capable of binding to the
negatively charged resin of the column. The protein was then eluted from the
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column by applying a linear NaCl gradient whilst the absorbance at 280 nm is
recorded. The gradients applied to the proteins differed due to the presence of
extra proteins expressed in the luria broth media the linear diubiquitin was grown
in. Monoubiquitin was eluted using a sharp gradient of 0 -100 % over 100 ml. A
shallower gradient of 0 - 60 % over 500 ml was applied to elute linear diubiquitin.
A contaminant protein with a similar molecular weight to linear diubiquitin meant
that altering the elution gradient on the cation exchange column was the only way
of removing the contaminant. The protein was collected in both cases as 10 ml
fractions. Monoubiquitin fractions were pooled and snap frozen in liquid N2 prior
to 48 hours on the freeze drier. Linear diubiquitin showed some difficulties on the
freeze drier, probably due to the increased NaCl content. Linear diubiquitin was
therefore applied directly to the next column, the gel filtration column, as the 10
ml fractions collected from the cation exchange column.
Gel filtration was used to remove any non-specific binders from the fractions
collected from the cation exchange column. Both monoubiquitin and linear
diubiquitin utilised a Superdex 75 gel filtration column. Freeze dried
monoubiquitin was diluted to 2.5 ml with phosphate buffer and loaded onto the
gel filtration column, whereas linear diubiquitin was loaded as 10 ml fractions
from the cation exchange column using a 10 ml superloop. A peak corresponding
to the protein is recorded by monitoring the absorbance at 280 nm. Monoubiquitin
typically eluted after 280 - 300 ml and linear diubiquitin after 260 - 300 ml. All
gel filtration experiments were conducted in phosphate buffer to ensure any
contaminant acetate signals had been completely removed ensuring suitability for
NMR experiments. Again the proteins were collected as 10 ml fractions, with the
protein containing fractions being snap frozen in liquid N2 prior to freeze drying
for 48 hours. Linear diubiquitin was more dilute after gel filtration than the cation
exchange column. The reduced salt content permitted freeze drying the fractions.
The final step of the purification was a desalt column. The desalt column, like the
gel filtration column separates molecules according to their size and shape. The
protein is therefore eluted before the NaCl bound to the protein to enhance its
stability. Removing excess NaCI ensures the protein is viable for biophysical
analysis. Lyophilised monoubiquitin and linear diubiquitin fractions from the gel
filtration column were diluted to 2 ml with Milli-Q water and loaded onto a 5 ml
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HiTrap desalt column. A peak corresponding to the protein IS recorded by
monitoring the absorbance at 280 run. Both proteins typically eluted after 7 ml
and were snap frozen in liquid N2 and freeze dried for 24 hours. Approximately
10 - 20 mg pure protein was produced from a 1 litre growth for both proteins.
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Figure 4.3 - A 20 % acrylamide SDS PAGE gel of a cation exchange column of
monoubiquitin expressed in C41 (DE3) E.coli. A low molecular weight marker
(Sigma) was used as a size standard (lane 1). Samples were taken prior to protein
induction with IPTG, 16 hours after the addition of lPTG and the soluble cell
lysate fraction are depicted in lanes 2-4 respectively. Cation exchange fractions 2,
21,22 and 23 are present in lanes 5-8. Fraction 2 was used as a control. Fractions
22 and 23 were shown to be the monoubiquitin containing fractions however both
fractions contain some impurities. The fractions were snap frozen in liquid N2
separately and freeze dried for subsequent purifications.
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Figure 4.4 - A 20 % SDS PAGE gel of a cation exchange column and gel
filtration fractions of linear diubiquitin expressed in C41 (DE3) E.coli. A low
molecular weight marker (Sigma) was used as a size standard (lane 1). Cation
exchange fractions 1-5 reflecting the increasing the NaCI gradient used to elute
from the column are shown in lanes 2-6. Fraction 3 from the cation exchange
column (lane 4 in this gel) was directly loaded onto a gel filtration column. Gel
filtration fractions corresponding to fractions 25 -31 are depicted in lanes 7-13.
The protein containing fractions (27-29) were pooled for desalting.
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5.0 Purification of cleaved and uncleaved proteins cloned into
pGEX pJasmids
5.1 Introduction
Various p62 constructs, hHR23A UBA2 and the MAP-LC3 were expressed and
purified for subsequent study in chapters 6 to 9 of this thesis (table 5.1). All
proteins that were purified from these plasmids utilised a very similar purification
protocol as both plasmids possess an N-terminal GST tag, have ampicillin
resistance and are under the control of a lac promoter. A lac promoter is a hybrid
promoter derived from sequences of the trp and lac UV5 promoters permitting
higher efficiency transcription of genes. The tac promoter is repressed by the lac
repressor and activated with the ~ galactosidase analogue IPTG. The subtle
differences in the purification procedures were attributed to the different intrinsic
properties of each protein or mutant. The proteins purified in chapters 6 to 9 can
be broadly divided into four categories, (i) p62 UBA helix 2 dimerisation
interface mutants, (ii) p62 UBA phosphomimetic mutants, (iii) those required for
the formation of a p62 mediated ternary complex and (iv) GST tagged proteins
used to model the full length p62 protein. The GST fusion of the hHR23A UBA2
protein was used as a control where appropriate. This domain has been studied
extensively and has been confirmed to exist as a monomer95,96.
Table 5.1 - The various proteins cloned into pGEX plasmids and used throughout
this study. The restriction sites indicate those which the gene of interest were
cloned between. The tag found within the plasmid and the extension which
f h b' I I . di d f h teiremams a ter t rom m c eavage are a so m cate or eac pro m.
Protein Plasmid Restriction Affinity Extension after
sites tag cleavage
P62387-436 pGEX-4T-l BamHI-XhoI GST GS
(UBA)
P62261-440 pGEX-4T-l EcoRI-XhoI GST GSPEF
P62300-440 pGEX-4T-l BamHI-XhoI GST GS
P62341-440 pGEX-4T-l EcoRI-XhoI GST GSPEF
hHR23A pGEX-4T-l BamHI-XhoI GST GS
UBA2
MAP-LC3 pGEX-4T-3 EcoRI-SalI GST GSPNS
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5.2 Results
5.2.1 Cloning
The different p62 constructs and hHR23A UBA2 were all cloned into the vector
PGEX-4T-l. The hHR23A UBA2, the p62 UBA domain (corresponding to
residues 387-436) and the p62 subfragment corresponding to residues 341-440
were previously cloned by the Layfield group. The MAP-Le3 protein was also
cloned by the Layfield group but into the pGEX-4T -3 plasmid.
Fragments of the p62 corresponding to residues 300-440 and 261-440 were
personally cloned into the multiple cloning site of the pGEX-4T-I plasmid
between the BamHI and XhoI sites and the EcoRI and XhoI sites respectively. The
p62 sub fragments were amplified by peR and the product purified from
enzymatic material using a gel extraction kit. Equivalent restriction digest
reactions for both the plasmid and the amplified peR insert were set up in thin
walled peR tubes and heated at 37 "C until reaction completion. The restriction
endonucleases in these reactions produced complementary staggered ends by
cutting double stranded DNA at a specific sequence. Both the plasmid and insert
were purified from other components of the restriction digest reaction by further
gel extraction. The plasmid and the insert were subsequently ligated together
using a T4 DNA ligase which functions to repair the breaks within DNA
sequences. The ligated DNA was transformed into XLI-blue E.coli and plated
onto agar plates containing ampicillin and tetracycline antibiotics. Ampillicin was
used to select for the plasmid whereas tetracycline was used to select for XLI-
blue. The DNA produced by the E.coli was purified using a DNA miniprep kit
and sent for DNA scqucncingi'" to confirm the presence and integrity of the insert
within the plasmid.
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5.2.2 Site directed mutagenesis
The site directed mutagenesis reactions for the helix 2 Ala mutants, the C331 S
p62 300-440 mutant and the S403E mutant were completed previously by Dr Jed
Long, Miss Jill Sollenberger and Miss Alice Goode respectively (all of the Searle
group, University of Nottingham).
Complementary forward and reverse primers, between 30 and 40 base pairs, were
designed based on the E.coli tRNA codon usage and used for the production of
the helix 2 Lys mutants and the Ser403A and S403D mutants. The desired
mutation was located in the centre of the primers (see primer design in appendix),
with each end of the primers terminating in one or more G or C bases. These
bases are able to form an extra hydrogen bond with the template DNA providing a
more stable interaction between the two strands. PCR mutagenesis reactions were
performed on a thermal cycler. The program consisted of denaturing, annealing
and extension steps, which were cycled 16 times to incorporate the single amino
acid change. The double helix of the parental DNA was denatured allowing the
primers to anneal to the correct positions within the separated strands using
Watson and Crick base pairing. The primers were elongated by Piu turbo DNA
polymerase to produce complementary strands containing the desired mutation.
Upon reaction completion Dpnl endonuclease was added to the reaction to digest
parental DNA. This enzyme is selective for methylated DNA found in genomes.
Therefore any plasmids containing either one or both strands as methylated DNA
will be digested leaving behind only newly mutated DNA. Gel samples were
taken before and after the addition ofDpnl and visualised on a 1% (w/v) agarose
gel (figure 5.l).
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Figure 5.1 - 1 % (w/v) agarose gel of the peR product from the site directed
mutation reaction of the T414K, R415K, Q418K and T419K mutants A 2-log
ladder (lane 1) was used as a size standard reference. Lanes 2 and 3 are other
mutagenesis reactions completed at the same time as the lysine mutants. Lanes 4,
5,6 and 7 correspond to T414K, R415K, Q418K and T419K respectively. All
samples were taken after the addition of Dpn 1 restriction enzyme and therefore
respresent newly mutated DNA. The T4I9K reaction was unsuccessful on this
attempt.
The PCR product was subsequently transformed into supercompetent XLI-blue
and plated onto agar plates containing both ampicillin (selective for the desired
plasmid containing the PCR product) and tetracycline (selective for XLI-blue
E.coli). Heat shock was used for plasmid DNA uptake into the host system. A 10
ml overnight culture containing the antibiotic selections outlined above was
inoculated with a single isolated colony grown on the agar plate. The DNA
produced by the XLI-blue in the overnight culture was purified using a miniprep
kit and sequenced using the standard Sanger method to verify the mutation. The
XLI-blue strain of E. coli was chosen because of their ability to produce high
quality DNA from a miniprep kit. XLI-blue are endonuclease (endA) and
recombination (recA) deficient which improve the purity of the DNA and increase
the stability of the inserted DNA within the plasmid respectively.
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5.2.3 Protein overexpression
All of the cleaved proteins, namely the p62 UBA mutants, the C331 S 300-440
construct and MAP-LC3 protein were purified using the same methodology as
that used for wild type p62 UBA, but with minor alterations to suit each
individual protein or mutant. The purified DNA from XLI blue E.coli was
transformed using the heat shock methodology to C41 (DE3) E.coli and plated
onto agar plates containing ampicillin only. The C41 (DE3) strain is deficient in
Ion and ompT proteases, which allows effective expression of recombinant
proteins from all classes of organisms. The C41 (DE3) strain also contains at
least one mutation compared to its parental BL21 (DE3) strain which permits the
expression of proteins that are toxic to other cell lines/!", Colonies were grown on
ampicillin resistant agar plates were used to make the glycerol stocks required for
further protein production.
Large scale protein overexpressions were completed in 2 litre conical flasks after
confirmation of protein expression had been achieved in small scale tests. The
Q418K mutant was unable to be expressed in either BL21 (DE3) or C41 (DE3)
strains of E.coli, it was therefore deemed a lethal mutation. A 20 ml overnight
culture was grown and used to inoculate luria broth for unlabelled proteins. M9
minimal media was used for the production of 15Nand 13C_15Nlabelled proteins
and 3 x 15 ml overnights were used to inoculate this media. The cells were grown
at 37°C until the OD595reached 0.7, the optimum density for protein induction.
The temperature was cooled to 30°C at OD5950.7 and protein overexpression was
induced by the addition of IPTG. Supplementary ampicillin was added to maintain
the selection for plasmid containing cells. The cells were induced for the 4 to 16
hours, depending on the protein and whether it was isotopically labelled. Finally
the cells were harvested when a higher OD reading could not be obtained. In both
small and large scale overexpressions gel samples were collected before and after
protein induction and visualised on a 20 % acrylamide SDS PAGE gel (figures 5.2
and 5.3). In the pGEX-4T-I plasmid a second unknown band appears at around 29
kDa after induction with IPTG. In 20 % acrylamide SDS PAGE gels the GST-p62
UBA or mutant UBA expression band is just above the expression band
corresponding to the unknown protein. When expressing longer GST p62
constructs there is greater separation between these two bands.
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Figure 5.2 - A 20 % acrylamide SDS PAGE gel showing the overexpression of
the Q418A and T419A mutants in the p62 UBA construct. All mutants were
expressed in C41 (DE3) E.coli in luria broth media. Lane 1 contains a low weight
molecular weight marker used as a size standard. The total cell lysate and soluble
fraction of uninduced Q418A are present in lanes 2 and 3 respectively. The total
cell lysate and soluble fraction of induced Q418A are present in lanes 4 and 5
respectively. Lanes 6-9 show the same samples but for the T419A mutant.
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Figure 5.3 - A 20 % acrylamide SDS PAGE gel showing the overexpression of
the C33lS p62 300-440 construct in C41 (DE3) E. coli in luria broth media. A
Novex prestained protein standard marker (Invitrogen) was used as a size standard
(lane I). Lanes 2 and 3 contain the total cell lysate and soluble fraction of the
uninduced sample Lanes 4 and 5 contain the total cell lysate and soluble fraction
of the induced sample.
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5.2.4 Protein purification
All proteins were purified in three stages, a gravity flow talon column containing
a glutathione Sepharose resin, gel filtration chromatography and desalting
chromatography. The only difference in the protocol between cleaved proteins
and GST fusions was that the proteins were either subjected to an on-column
cleavage using thrombin or eluted as GST fusions from the gravity flow column.
Confirmation of protein containing fractions was achieved by visualising on an
SOS PAGE gel (figures 5.4 and 5.5).
Cell pellets were removed from storage at -80°C resuspended in 6 ml Tris.HCI
lysis buffer, DNase I and a protease inhibitor cocktail. The cells were lysed to
release protein into solution by sonication (30 second bursts). The cellular debris
was subsequently clarified by centrifugation at 40,000 ref for 30 minutes. The
supernatant was applied an equilibrated gravity flow column and tumbled at 4 °C
for 2-4 hours depending on mutant stability. The T414A, T414K, C331S p62 300-
440 and the GST fusion proteins were tumbled for 2 hours, whereas all other p62
UBA mutants were tumbled for 4 hours. During this time the mutants bound to
the sepharose 4B beads. Non-bound proteins were washed from the column using
the same Tris.HCI lysis buffer. The column was re-equilibrated with Tris.HCI
thrombin cleavage buffer. Iml of this buffer was added to 5 units of thrombin, the
mixture was applied to the gravity flow column and tumbled at 4 °C for 16 hours.
The thrombin cleaves the N-terminal GST tag leaving a GS, GSPEF or GSPNS
linker attached to the protein of interest. The thrombin cleaved proteins were
eluted as a 1ml solution but the column was washed with a further 1.5 ml to
remove any proteins still attached to the column. GST fusion proteins were eluted
from the sepharose beads by the addition Tris.HCI buffer containing reduced
glutathione. The reduced glutathione out competes the GST tag for binding to the
glutathione Sepharose beads. To maximise the efficiency of the reduced
glutathione 6 ml Tris.HCI containing reduced glutathione was added and the
column tumbled at 4 ·C for 30 minutes before eluting. A further 4 ml was washed
through the column to ensure proteins were completely removed from the column.
A gel filtration column was utilised to ensure any remnant proteins from the
gravity flow column were removed. Since gel filtration column separate proteins
100
according to their size and shape any incorrectely cleaved proteins would also be
removed. A Superdex 200 gel filtration column was utilised for all aST fusion
proteins. A Superdex 75 column was used for the purification of the C331S p62
300-440 construct and the MAP-LC3 protein. A sephacryl S-100 column was
employed to purify the various p62 UBA mutants. All cleaved proteins eluted
between 170 and 230 ml. All aST fusion proteins eluted between 150 and 210 ml.
A large sharp peak was recorded by monitoring the absorbance at 280 nm. The
proteins were collected as 10 ml fractions, with the protein containing fractions
being snap frozen in liquid N2 prior to freeze drying for 48 hours. The MAP-LC3
protein was spin concentrated to 2.5 ml after gel filtration as it was unable to be
freeze dried at this stage of the purification.
Finally a desalt column was used to decrease the NaCI content for biophysical
analysis. Protein containing fractions from the gel filtration column were diluted
to 2 ml and loaded onto a 5 ml HiTrap desalt column. A peak corresponding to the
protein was recorded by monitoring the absorbance at 280 nm. Desalts were
completed in degassed deionised water with the exception of the MAP-LC3
protein which was desalted in 25 mM ammonium acetate.
Proteins were lyophilised on a freeze drier after gel filtration and desalt steps. The
MAP-LC3 purification required spin concentrating after the gel filtration as it was
unable to be freeze dried at this stage of the purification. Moreover after MAP-
LC3 had been desalted and subsequently freeze dried it was required to be
resuspended in deionised water and freeze dried again to remove ammonium
acetate that might still be bound.
Typical yields for the p62 UBA mutants were between 3-6 mg per Litre. The
MAP-LC3 protein was able to obtain yields of up to 8 mg per Litre. The C331 S
p62 300-440 construct achieved a low yield of3 -4 mg per Litre.
All p62 UBA mutants and MAP-LC3 were able to be purified to a single
homogenous species. The aST fusion proteins and the C331S p62 300-440
construct all showed some signs of degradation. For the aST -p62 UBA, aST
hHR23A UBA2 and the cleaved C331 S p62 300-440 construct this degradation
was minimal. However, the aST fusions of the longer p62 constructs, all showed
significant degradation.
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Figure 5.4 - A 20 % acrylamide SDS PAGE gel showing the purification of the
S403D mutant of the p62 UBA expressed in C41 (DE3) E.coli in luria broth
media. A Novex prestained protein standard marker (invitrogen) was used as a
size standard (lane 1). The total and soluble fractions of cell lysate are shown in
lanes 2 and 3. The thrombin cleaved protein is shown in lane 4. Gel flitration
fractions 16 to 19 are shown in lanes 5 to 8 respectively. Fractions 18 and 19 are
the protein containing fractions.
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Figure 5.5 - A 20 % acrylamide gel showing the purification of GST -p62 UBA in
C41 (DE3) E.coli in luria broth media. A low molecular weight marker was used
as a size standard (lane 1). Lanes 2 and 3 correspond to the total cell lysate and
soluble fraction respectively. Lane 4 is the flow through from the sepharose
column. As you can see not all the protein has bound to the sepharose beads. For
the GST -p62 UBA only the flow through was re-applied to the column to increase
the overall yield. Lane 5 corresponds to the protein eluted from the sepharose
beads. Lanes 6-9 correspond to gel filtration fractions 19-22. Fractions 20-22 are
the protein containing fractions. Some slight degradation was observed but was
not considered to affect overall yield.
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6.0 Investigating the p62 UBA dimer by introducing mutations
along helix 2 which forms the dimerisation interface.
6.1 Introduction
6.1.1 UBA dimerisation
Most of the UBA structures which have been deposited into the Protein databank
form monomeric structures. Until recently it was thought that all UBA domains
existed as monomers. To date structural characterization has occurred for the
UBA dimers of the c_Cbt234, Cbl_b23s, XIAp236 and doubles ex (Drosophila
melanogaster)237 proteins. The dimerisation interface is distinct in each of these
cases, despite the c-Cbl and Cbl-b being closely related (figure 6.1). The different
structures reveal different roles for dimerisation in ubiquitin binding.
CbI proteins are a small class of E3 ubiquitin ligases which are important
regulators of many receptor-tyrosine kinases. In the case of the Clb-b UBA, quite
different interfaces are used for dimerisation and ubiquitin binding, with
dimerisation being regulated by ubiquitin binding23s. However, the c-Cbl UBA
doesn't appear to bind to ubiquitin suggesting that the functional role of the dimer
is not linked to regulating ubiquitin interactions+", The XIAP UBA, like the Dsk2
UBA, contains a 310 helix as well as the conserved three helix bundle. The
dimerisation interface is composed of residues mainly located in the 310helix and
helix 1, causing the ubiquitin binding surfaces to be exposed on opposite ends of
the 'bowtie' structure236. It is therefore speculated that dimerisation confers the
UBA to preferentially bind to Lys63 and linear chains over Lys48 chains.
Interestingly the XIAP protein, like the p62 protein, has been linked to NF -KB
activation238. The doubles ex transcription factor rather unusually contains a UBA
domain capable of dimerisationi'". The UBA domain has been shown to be able to
bind very weakly to ubiquitin using a surface that is structurally separate from the
dimerisation interface. This is the first example of a UBA fold within a
transcription factor.
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Although currently only a few examples of UBA dimers have been reported, it is
likely that many more are yet to be discovered. The function of certain UBAs may
have adapted from evolutionary pressure to cause the formation of dimers, which
are likely to have a downstream role in ubiquitin binding. Dimers thus far have
provided evidence for both up-regulation and down-regulation of ubiquitin
binding as well as being able to confer linkage specificity in polyubiquitin chain
recognition. It is predicted that newly discovered UBA dimers will also have roles
in regulating ubiquitin recognition and binding.
c-Cbl UBA __./
XIAPUBA
Cbl-b UBA
Doublesex UBA
Figure 6.1 - A comparsion of the structures of different UBA dimers. The c-Cbl
UBA (pnB ID 2009), Cbl-b UBA (PDB ID 200A) and doublesex UBA (PDB
ID lZVI) were all deposited into the Protein databank as dimers. The XIAP UBA
(pnB ID 2KNA) was deposited as a UBA monomer. The dimer structure was
created based on the HADDOCK model described by Tse et aP36.
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6.1.2 The p62 UBA dimer and its role in ubiquitin binding
It has emerged in the last few years that the p62 UBA domain exists as a highly
stable dimer as shown by the solution NMRI41 and the 1.4 A crystal structure'<'.
The dimer is arranged with symmetry along the C2 axis. Helix 2 from each half of
the dimer line up in an antiparallel fashion to form the core of the dimerisation
interface. The interface itself buries an area of 667 A2 and is formed from
hydrophobic residues in helices 2 and 3 (figure 6.2). The side chain from Trp 412
interacts with the side chain of Leu 416 from the other subunuit of the dimer
(denoted Leu 416 '). lIe 431 is found at the C terminal end of helix 3. This residue
interacts with its complementary residue (lIe 431 ') in the other half of the dimer
forming a critical hydrophobic interaction. Such hydrophobic interactions
combined with the extensive size of the dimerisation interface enable the
formation of a highly stable dimer. Some additional electrostatic interactions were
observed in the crystal structure which would futher enhance the stability of the
hydrophobic core. Met 404 bonds to Glu 432' and Arg4lS bonds to Gly 410' and
Gly 411'. The solution NMR structure also observes a hydrogen bond between
Thr 419 and Glu 409' in an interaction that is facilitated by the presence of the di-
glycine insertion in loop 1, a feature unique to p62 UBA.
Figure 6.2 - a zoom of the p62 UBA dimerisation interface (PDB ID 2KNV).
Residues which stabilize the interface are highlighted and with their side chains
shown as sticks
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The p62 UBA dimer has an apparent Ka for the monomer-dimer equilibrium
(Kdim) of 4.1 uM, indicating a very strong preference for the dimeric species at
physiological concentrations. The dimer dissociates in the presence of ubiquitin to
an unstable monomeric form which subsequently binds to ubiquitin to form a
stable complex (figure 6.3). The dissociation and binding events are mutually
exclusive due to the partial overlap of the interfaces. It is this overlap which
allows the dimer to tightly regulate the affinity for ubiquitin. The unstable
monomer has been shown to be the biologically active form because only this
form is capable of binding to ubiquitin. The p62 UBA monomer binds to the
canonical binding patch centred on Ile44 and Val 70 on ubiquitin and involves a
conserved MGF motif in loop 1 and residues in helix 3 of the UBA. The
interaction with ubiquitin utilises the hydrophobic patches on both proteins.
Some structural differences have been observed between the dimer and monomer,
the most notable being an extension of helix 3 in the monomer. In the dimeric
form helix 3 is defined by residues Gly 425 to Ile 431; however, in the monomeric
form helix 3 extends by half a turn to terminate at Tyr 433. This extra half turn in
the dimer prevents association of the two subunits. This helical extension
represents another level of control by the p62 in regulating ubiquitin binding.
Dissociation Binding
UBA2 !+ 2UBA + 2Ub !:+ 2[UBA:Ub]
Slow Fast
Dimer Monomer Complex
Figure 6.3 - The mechanism of binding by the p62 UBA. The highly stable dimer
(PDB ID 2KNV) exists in solution but in the presence of ubiquitin the dimer
dissociates to the free monomeric form (PDB ID 1Q02) which is then able to bind
forming a complex. The complex is a representation made from the PBDs of
ubiquitin and the bound monomer (PDB ID's 1UBQ and 2JY8).
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6.1.3 Summary and aims
With the discovery of the p62 UBA dimer, we aim to probe the dimerisation
interface. By introducing mutations along helix 2, which forms the dimerisation
interface (figure 6.4), it is postulated that weaker dimers and monomeric UBAs
will be produced. A study conducted in 2010 highlights Lys as being the least
favourable interface residue239. Charged residues, such as Lys, contribute greatly
to the accessible surface area. The bulky lysine side chain is therefore able to
cause steric clashes with residues on the other half of the dimer, disrupting the
interface. The mutants T414K, R415K, Q418K and T419K were therefore
generated (table 6.1). These residues are surface exposed in the wild type dimer,
allowing mutation of these residues to affect the electrostatic interactions formed
at the dimerisation interface. The corresponding Ala mutants, namely T414A,
R415A, Q418A and T419A, had been previously designed when searching for a
secondary ubiquitin binding site on the UBA before the discovery of the dimer.
By mutating to Ala any side chains capable of forming stabilising interactions at
the interface are removed, which in theory can disrupt dimer formation. These
four mutants were therefore also generated (table 6.1). Of these eight mutations
the T419K mutant was predicted to be the most destabilising. The T419 residue
forms a hydrogen bond with the E409 residue in the opposite half of the dimer
(denoted E409') stabilising the interaction at the interface (figure 6.4).
Table 6.1 - A list of all the p62 UBA helix 2 mutants. The mutated residue is
shown for each mutant in red
Mutant Helix 2 sequence (residues 413 - 420)
T414A L A R L L Q T K
R415A L T A L L Q T K
Q418A L T R L L A T K
T419A L T R L L Q A K
T414K L K R L L Q T K
R415K L T K L L Q T K
Q418K L T R L L K T K
T419K L T R L L Q K K
Perhaps the most interesting feature of the p62 UBA is that in order to bind to
ubiquitin the dimer must first dissociate. It is the regulation of binding by
dimerisation that is the focus of this part of the project. Knowledge gained on the
monomer-dimer equilibrium and its role in modulating ubiquitin binding may
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provide a key link to the impaired ubiquitin binding experienced by patients with
Paget's disease. With so many PDB mutations now known, combined with the
fact that most of the mutations are not confined to the ubiquitin binding patch,
highlights the need to better understand the molecular mechanisms which underlie
PDB. It is clear that structural alterations in the ubiquitin binding patch are not
solely responsible for defective ubiquitin binding and that other factors, including
dimerisation, must also playa role.
By generating mutants designed to disrupt dimer formation and characterising
them using structural and biophysical approaches, a greater understanding of the
role of the dimer in ubiquitin recognition can be gained. The effects of
dimerisation can subsequently be explored in the PDB mutants. If these mutants
are able to prevent dimer formation and exist as monomers, the biologically active
form could also be characterised. Little is known about the wild type monomer
due to its low population at equilibrium and high instability.
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Figure 6.4 - The p62 UBA dimerisation interface (PDB ID 2KNV) A) the side
chains of the surface exposed residues which were mutated in this study are
shown as sticks. B) Helix 2 rotated by 90° horizontally and zoomed. C) The
dimerisation interface rotated by 90° vertically to highlight the T419, E409 and
G410 residues at the ends of helix 2. D) A zoom of the hydrogen bond which is
formed between T419 and E409'.
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6.2 Results
6.2.1 Biophysical studies on the monomer-dimer equilibrium
6.2.1.1 Far UV-CD dilution experiments
In order to probe the effects of mutation on the thermal stability of the helix 2
mutants, concentration dependent thermal unfolding studies were performed using
Far UV-CD spectroscopy. The far UV-CD spectrum of a protein is highly
sensitive to perturbations in secondary structure. Small changes in secondary
structure can lead to large changes in the CD signal. Although Far UV-CD does
not provide atomic level detail an average measure of the change in the overall
structure can be provided. Far UV-CD is therefore an ideal technique to study the
thermodynamic properties or folding mechanisms of proteins.
Far UV -CD scans were recorded between 200-260 nm at temperatures of 298K
prior to thermal melting. These scans checked for helical content to ensure the
mutants were folded into the native state prior to thermal denaturation. The
ellipticity at 222 nm was subsequently recorded as a function of temperature at 0.5
K intervals between 278.15 K and 368.15 K. The apparent midpoint of the
unfolding transition (Tm) was calculated from these experiments using the first
derivative method suggested by Greenfield et a1185• Initial concentrations (170 JlM
- 200 JlM) were serially diluted by a factor of two over eight different
concentrations. At higher concentrations the dimer is favoured whereas at lower
concentrations a shift in the monomer-dimer equilibrium occurs to favour the
monomer. A shift in the Tm value in a concentration dependent manner therefore
represents a shift in the equilibrium. Thus multiple species in equilibrium can be
detected using these thermal unfolding profiles. Experiments on the wild type p62
UBA have been previously completed by the Searle group allowing the thermal
stabilities (Tm) of the mutants to be compared to the values observed for the wild
type.
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A far UV -CD spectrum which corrects for wavelength and concentration was
visualised by plotting Molar ellipticity against wavelength. The Far UV -CD
spectrum produced for each mutant across the concentration range exhibited
strong negative bands at 222 nm and 208 nm, indicating a large helical content.
The band at 222 nm is observed due to the strong hydrogen bonding environment
of a helical conformations, whereas the intensity at 208 nm is associated with the
length of a helices240• The far UV-CD spectra indicate that the compact three
helical bundle is maintained for all p62 UBA dimer mutants (figure 6.5). The
negative bands at 208 and 222 nm are observed at each concentration throughout
the course of the dilution highlighting that both species, the dimer and the
monomer, stayed largely helical.
Despite this, some differences were observed by some of the p62 UBA mutants
compared to the wild type p62 UBA. The T414A and R415A p62 UBA mutants
produced curves which were highly similar to wild type suggesting that these
mutations have little effect on the overall structure of UBA domain. All other p62
UBA mutants produced noticeably stronger bands at 208 and 222 nm, indicating
that these mutations have a greater effect on the helical content of the domain. In
general the intensities at 208 and 222 nm are used to estimate helical content=",
The T414K mutant exhibits the strongest negative bands at 222 and 208 nm,
suggesting that this mutation has a more drastic effect compared to the other
mutations.
Since the recorded far UV-CD spectrum for all of the p62 UBA mutants at each
concentration showed the characteristic negative bands at 208 and 222 nm
indicative of a solely helical protein, it is highly likely that the mutations have
caused local changes to structure only. A rearrangement of the protein backbone
is unlikely given the consistency of the spectra with helical conformations across
the concentration range. The CD signal is extremely sensitive to small structural
perturbations, making it an ideal technique to monitor secondary structure.
However, experiments using techniques which have atomic resolution such as x-
ray crystallography or NMR would be required to probe any detailed local
changes to structure.
110
A5000 --r--------------
250 260
-20000 -'---------------
Wavelength (nm)
-T414A
-R41sA
-Q418A
-T419A
-wild type
B
10000 --r--------------
5000 1--------------
-25000 -'---------------
Wavelength (nm)
260
-T414K
-R41sK
-T419K
-wild type
Figure 6.5 - The far UV-CD spectrum of the p62 UBA helix 2 mutants. A) p62
UBA Ala mutants (T414A, R415A, Q418A and T419K) .B) p62 UBA Lys
mutants (T414K, R415K and T419K). The strong negative bands at 208 and 222
nm indicate an a helical conformation. The wild type data is shown on both
spectra as a comparison. The data was recorded in 10 mM potassium phosphate,
pH 7 and 298K.
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A fully folded protein was required to ensure an accurate Tm value was calculated
from the thermal unfolding studies. Once the Far UV -CD scans had been
completed to check for helical content, a thermal melt ensued. The thermal
stabilities of the mutants were measured as a function of temperature in the
unfolding profiles (figure 6.6). Each mutant was serially diluted by a factor of two
over eight different concentrations. During the dilution a noticeable change in
thermal stability occurs at lower concentrations « 30 11M). The change represents
the presence of a second species, in this case the appearance of the monomer. The
Tm values for the monomer and dimer of each mutant are listed in table 6.2 and
are shown graphically in figure 6.7.
The thermal unfolding data suggests that the majority of mutations are able to
destabilise both the dimer and monomer species. This is shown by the decreased
values of Tm when compared to wild type protein. The only exception is the
T419A mutant which showed an increase in the thermal stability for both the
dimer and the monomer. The wild type p62 UBA showed a sharp decrease in
thermal stability (a change of 6 K) over the concentration rangel41, representing
the transition from dimer to predominantly monomer. The R415A, Q418A and
T419A mutants also showed a strong decrease in thermal stability over the
concentration range, with changes between 5 K and 8 K observed for these
mutants.
However, the R415K and T419K mutants show a much weaker change in thermal
stability as they only change by 2 K and 3 K respectively. The T419K monomer
showed a Tm value that is only 2 K lower than the wild type monomer. However,
the difference in the Tm values observed for the dimers was much greater at 5 K.
This would suggest that the T419K mutation has had a much greater effect on the
thermal stability of the dimer, consistent with the breaking of the hydrogen bond
formed by the wild type p62 UBA dimer. The results for the R415K mutant are
similar to the T419K mutant, except both species show a greater destabilization
than the T419K. This is unusual for a like-for-like mutation such as R415K.
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Figure 6.6 - Far UV -CD thermal unfolding curves recorded at 222 run for A) the
T4l4A mutant at 9 IlM and 77 IlM and B) the T419A mutant at 6 IlM and 73 IlM.
The curve for the lower protein concentration in each case has been scaled to
show approximately the same change in Molar ellipticity. The T419A mutant
shows unfolding curves which highlight the difference in the midpoint of
unfolding at different concentrations; whereas, the T4l4A has a similar midpoint
of unfolding at high and low concentrations.
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Interestingly, the two mutants at position 414, T414A and T414K both show no
real evidence of a change in thermal stability. This means that the Tm value does
not noticeably change across the concentration range. The Tm values calculated
for the monomer and dimer of these mutants are substantially reduced compared
to the wild type, suggesting considerable thermal destabilization in these mutants.
Thr414 is therefore likely to have a role in maintaining the stability of the both
species. The lack on an observable change in Tm suggests the presence of a single
species rather than an equilibrium between two species. The more likely scenario
is that the thermal stabilities of the monomeric and dimeric species of these
mutants are therefore very similar to each other making them indistinguishable
using this technique. If this is the case, the T414A and T414K dimers, have been
more dramatically affected than the monomer, as the wild type dimer is more
thermally stable than the monomer.
Table 6.2- The apparent Tm values for the dimer and monomer using Far UV -CD
thermal unfolding curves. The Tm values were calculated using first derivatives
h d r db G fi Id t85met 0 out me ,y reen le et a
Mutant p62 UBA r,dimer (K) Tm monomer (K) L1Tm (K)
Wild type 345 339 6
T414A 331 331 0
R415A 343 335 8
Q418A 338 333 5
T419A 350 342 8
T414K 324 324 0
R415K 338 336 2
T419K 340 337 3
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Figure 6.7 - Concentration dependence of the Tm values recorded for the helix 2
mutants, showing the upper (Tm dimer) and lower limits (Tm monomer) of thermal
stability over the concentration range of 1 -200 11Min blue and red respectively.
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6.2.1.2 ITe dilution experiments
The data produced from the thermal unfolding CD studies indicated the presence
of a single species in equilibrium for the T414A and T414K mutants. In order to
check the monomer-dimer equilibrium exists for all of the helix 2 mutants,
dilution studies using ITC were conducted. When substances dissociate heat is
absorbed. That heat can be measured by the ITC calorimeter to produce a
dissociation curve. Dilution ITC is therefore an suitable technique for probing
dimer dissociations. If a significant endothermic heat response is not observed by
the T414A and T414K mutants it is likely that these mutants are monomeric.
Proteins which are monomeric, such as the hHR23A UBA2, produce only a small
exothermic heat response after each injectiorr'", generating a trace which is
indistinguishable from injecting water into water.
Concentrated samples between 240 IlM and 260 IlM were prepared in 50 mM
potassium phosphate, 50 mM NaCl, pH 7 and sequentially injected to a cell
containing degassed buffer. Upon entering the low concentration of the cell the
dimers dissociate. As the concentration of the cell increases the endothermic heat
spikes decrease in intensity until dissociation in the cell is not longer significant.
The resultant dimer dissociation curve was fitted to a dimer dissociation model to
produce accurate Kdim and AH values (figure 6.8). From these values AG and AS
values can be calculated to generate a full thermodynamic profile.
Time (min)
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Molar Ratio
Figure 6.8 - The raw ITC dissociation curve for the R415A p62 UBA mutant at
240 IlM. This dissociation curve is representative for all the helix 2 p62 UBA
mutants. Experiments were performed in 50 mM potassium phosphate, 50 mM
NaCl, pH 7.
0 50
0.14
0.12
0.10
o 0.08
Q)
I/) 0.06::::
co
o 0.04
~
0.02
0.00
0.00
100 150 200 250 300
0.04 0.05
115
All data, except those recorded for the T419K mutant, fitted well to a dimer
dissociation model. The T419K mutant produced slightly confusing results despite
repeating the experiment across a range of concentrations (l mM, 500 11M and
250 11M). The initial 2-3 injections showed a slight increase in the intensity of the
endothermic heat spikes before the normal dissociation curve resumed. This
prevented the data from being accurately fitted. A poor fit was able to be
produced from an experiment conducted on a 250 11M sample by removing the
first data point.
The Kdim values for the R415A, Q418A, T419A and R415K mutants were in
excellent agreement with the Kdim observed for wild type p62 UBA. The wild type
p62 UBA was previously shown to have a Kdim of 4.1 ± 0.6 11M141.Significantly
weaker Kdim values were recorded for the T414A, T414K and T419K mutants.
The value for the T419K mutant is likely to be less accurate due to the poor fit of
the dissociation curve; however, if this mutant was wild type-like then it would
have produced better data.
The thermodynamic profile for each of the helix 2 mutants is shown in table 6.3.
The thermodynamic profile for the dissociation process revealed positive values
for L1H and L1G and negative values for L1S. This highlights that dimer dissociation
is not spontaneous and that reverse process, the association of two monomers, is
the spontaneous process. This suggests that the monomeric form is less stable than
the dimer, consistent with previous findings for wild type p62 UBAI41. Although
the monomer is unstable, the negative value for L1S indicates a favourable change
in entropy occurs during dimer dissociation. The larger value for AH compared to
L1S suggests that the reaction is enthalpy driven. When you compare the
thermodynamic profiles of the p62 UBA dimer mutants, the values for AH are
quite similar suggesting a similar amount of energy is required for dissociation.
However, the AS values are significantly lower for the T414A, T414K and T419K
p62 UBA mutants indicating changes in the distribution of thermal energy of
these mutants indicative of a substantial change in the populations of monomer
anddimer.
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Table 6.3 - The enthalpy change and dissociation constants for the helix 2
mutants calculated from dilution ITC experiments and fitted using a dimer
dissociation model.
Mutant Kdim (±)I JlM t1H (±)/ J/mol t1S (±)I JIKImol t1G298(±)1IU/mol
Wild type 4.1 ± (0.6) 60.7_{±1.°1 -102.93 (±1.3) 30.7 (±0.3)
T414A 141.0(± 1.0) 68.9{±1.01 -73.48 (0.06) 22.0 (±0.02)
R415A 3.8 (±0.4) 64.9 (±2.2)_ -103.59 (±0.9) 30.9 (±0.3)
Q418A 3.7 (±OA) 79.3 (±2.7) -103.71 (±0.9) 31.0 (±0.3)
T419A 4.5 (± 0.5) 45.2 (±1.5) -102.22 (±0.9) 30.5 (±0.3)
T414K 146.0 (± 1.5) 67.5 (±1.5) -73.20 (±0.09) 21.9 (±0.03)
R415K 3.7 (± 0.5) 65.1 (±2.6) -103.81 (±1.04) 31.0 (±0.3)
T419K 165.0 (±30.0) 38.1 (±1.6) -72.28 (±1.39) 21.6 (±0.4)
Overall the dilution ITC data is in good agreement with the thermal stabilities
produced from the far UV-CD unfolding studies. The T414A, T414K and T419K
mutants all show larger values of Kdim and reduced thermal stabilities suggesting
that weaker dimers are formed which are not as stable as the wild type protein.
This was expected for the T419K mutant due to the breaking of the hydrogen
bond it normally forms with E409'. Residue T414 is located at the N-terminal end
of helix 2, mutation of this residue could cause larger structural perturbations than
any of the other mutations, such as helical unwinding, although NMR experiments
would need to be conducted to confirm this.
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6.2.1.3 ESI-MS dilution experiments
ESI-MS is a type of mass spectrometry which has been developed to observe
macromolecules and macromolecular complexes in vacuo. Molecules are
transferred to the gas phase without fragmenting using a fine aerosol known as
electro spray. Samples are dissolved in a volatile solvent, such as ammonium
acetate, and pushed through a small capillary where a high voltage is applied
causing the formation of ionized droplets. The droplets reduce in size due to
solvent evaporation and eventually are separated by a mass analyser according
values of mass to charge ratio (m/z) and detected by a detector. A series of
different charge states at different relative abundances are observed and a
spectrum representing a "snap shot" in time is visualized. From the spectrum
produced a variety of information can be deduced, including information on non
covalent protein-protein interactions and stoichiometry of molecular assemblies as
well as simple confirmation of molecular weights.
Initially it was important to check the molecular weight of the mutants to confirm
the successful insertion of the mutation to the purified proteins. Samples were
prepared by dissolving lyophilised protein in 25 mM ammonium acetate, pH 7.
The molecular mass of each of the mutants was confirmed using native ESI-MS
on a 5 JlM sample. This technique allowed more accurate confirmation than
visualisation by SDS PAGE alone. The observed masses were in good agreement
with the predicted masses for all seven helix 2 mutants (table 6.4).
Table 6.4 - The molecular weights observed by ESI-MS compared to the
di d 1 I . ht B th . ht d t th UBApre rete mo ecu ar weigi s. 0 weigi s corres pon 0 e monomer
Mutant Predicted mass of monomer Mass observed by ESI-MS
T414A 5709.4 5714.2
R415A 5654.3 5659.0
Q418A 5682.3 5687.2
T419A 5709.4 5714.2
T414K 5766.5 5771.3
R415K 5711.4 5716.2
T419K 5766.5 5771.4
.
For all mutants, the observed spectrum was very similar. Ions corresponding to
the +2 to +6 charge state were observed for the monomer. The observation of a
dimeric species was apparent from the +5 charge state in which a corresponding
peak for the monomer would exist as an impossible half charge state. The
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intensity of the +5 ion for the dimer is low and no other ions corresponding to odd
numbered charge states of the dimer were observed, highlighting the low
abundance of the dimer in the gas phase. During ionization, the dimeric species is
unfavoured as the UBA dimer is stabilized by hydrophobic contacts which in the
absence of a polar solvent are considered to be much weaker and can be very
difficult to study in the gas phase. The visualization the dimer, albeit low, is likely
to be the result of the stabilizing electrostatic interactions which are also formed at
the dimerisation interface. The charge state distributions and the dominant
monomeric species observed for the mutants is consistent with the data previously
recorded for the wild type p62 UBA. Also no higher order oligomers were
detected at this concentration, again consistent with data previously collected for
the wild type protein. The charge states are low with a low distribution indicating
that both species are likely to be folded242• Although the monomeric species was
the visually dominant species, accurate quantification of the two species was
precluded by overlap of peaks where the mass and the charge were both doubled
giving the same rnIz value.
In the case of these experiments the monomer-dimer equilibrium was the focus of
study. In order to probe this equilibrium the helix 2 dimer mutants were subject to
dilution ESI-MS experiments (figure 6.9). Each mutant was monitored in the
concentration range of 8 IlM to 1 IlM. Ions were observed for both the monomeric
and dimeric species in distributions as outlined above. Again no higher order
oligomers were observed. The overlap of most peaks in the spectrum prevented
the accurate determination of the populations of both species. Despite this,
changes in the populations of the monomer and dimer can be observed as the
intensities of the mass ions change during the dilution. A value for the average
charge state can therefore be calculated from the observed ions in each spectrum.
In this case, the average charge state of the monomer was calculated as this was
the predominant species. The average charge state is believed to be proportional
to the solvent exposed area during ionization=". The monomer and the dimer have
different solvent exposed surface areas, meaning that they would have differing
average charge states. As the concentration decreases, the equilibrium would be
expected to favour the monomer with concentration dependent changes in the
average charge state reflecting an increase in the populations of monomer.
119
1
P:P+S p+2
0 1 1
1000 1500 2000 2500 3000
B MlZ
100
p+4
I PPM
O~----~I~.~~~~~--~~._~~~~~~~~
1000 1500
A
100
p+4 p+3
p+s
pH
p+3
2000
MlZ
2500 3000
Figure 6.9 - The native ESI-MS of the Q418A p62 UBA mutant at A) 8JlM and
B) IJlM. Spectra were recorded in 25 mM ammonium acetate, pH 7. The labels
correspond to the dominant monomeric species (denoted P) except for the +5 ion
for the dimer (denoted P:P) which doesn't overlap with a monomer peak. The
changes in the monomer-dimer equilibrium are easily visualized in these two
spectra by the changes in intensities by the observed ions.
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The average charge state was plotted against the concentration of the sample and
the values compared the data to that previously reported for the wild type p62
UBA (figure 6.10). The average charge state for the wild type p62 UBA showed a
clear concentration dependence. As the concentration decreases, the average
charge state increases, reflecting that the solvent exposed surface area increases.
This is consistent with a shift in the equilibrium to favour the monomer. The
mutants also showed an increase in the average charge state as the concentration
decreases, suggesting that the equilibrium is shifting to favour the monomer at
lower concentrations as it does for the wild type protein. Despite the correlation
between the mutants and the wild type, the magnitude of change in the observed
concentration range is not as large as it was for wild type p62 UBA. This
highlights a weaker concentration dependence. The only mutant with a similar
magnitude of concentration dependence is the T419K mutant.
The Q418A mutant show average charge states similar to those observed for wild
type protein suggesting that this mutation has had very little effect on the
monomer-dimer equilibrium. Interestingly the R415A, T419A and R415K
mutants show decreased values for the average charge state when compared to
wild type p62 UBA, suggesting that these mutants have a decreased solvent
exposed surface area. The T414A, T414K and T419K mutants all show
significantly larger values for the average charge state when compared to the wild
type protein, highlighting an increase in the solvent exposed surface area for these
mutants. This data therefore suggests these mutants have significantly reduced
populations of dimer compared to wild type p62 UBA. Alternatively partial
unfolding could responsible for the increase in the solvent exposed surface area.
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Figure 6.10 - The average charge state was calculated from the intensity of the
ions recorded in the ESI-MS spectrum. Spectra were recorded for mutant p62
UBA samples at 8 uM, 4 flM, 2 uM and I flM. The diagram shows the average
charge state (Z) plotted against concentration of p62 UBA: A) the p62 UBA Ala
mutants and B) the p62 UBA Lys mutants. The wild type (wT) data is also shown
as a comparison. The data shows that as the concentration decreases the average
charge state increases. This change represents the change in populations of
monomer and dimer at each concentration. Also the T414A, T414K and T419K
mutants have a higher average charge state than wild type p62 UBA, indicating
that these mutants have an increased solvent exposed surface area.
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The dimer was detected in much lower abundance than expected. The low
abundance of dimer was not evident from the far UV-CD and ITC dilution studies
for the mutants or any of the previous work conducted on the wild type p62 UBA.
Itwas therefore decided to repeat the native ESI-MS dilutions in the presence of a
small reservoir of acetonitrile (5 ml). The presence of a neutral solvent, such as
acetonitrile, in the electrospray source has the effect of lowering the charge states
and decreasing the intra-molecular and intermolecular repulsion between two
positively charged species generated by ionizationr". In the case of the p62 UBA
the two monomeric units appear to dissociate due to the effect of Coulomb
repulsion causing low detection of the dimer which is not observed outside of the
gas phase. By adding acetonitrile to the ionization source a more native-like
distribution of species, as present in solution, should be observed.
The same samples prepared for the native ESI-MS experiments were used to
repeat the dilution experiments but in the presence of acetonitrile (figure 6.11).
The spectra recorded for the mutants were very similar. A narrower charge state
distribution was observed compared to the native ESI-MS spectra, whereby ions
corresponding to the monomer were seen for the +2 to +4 charge states. The +3
charge state was the most populated ion in all cases. The +5 charge state of the
dimer was also present and in significantly higher abundance than in the native
ESI-MS spectra. However, the data still indicated that the monomer was the
dominant species in the gas phase, despite the acetonitrile increasing the amount
of dimer present. The dimer is largely stabilized by hydrophobic interactions at
the dimer interface. Hydrophobic interactions have been shown to be significantly
weakened in the gas phase and although the acetonitrile has the ability to reduce
the effects of columbic repulsion it is unable to prevent hydrophobic interactions
from dissociating in the gas phase.
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Figure 6.11 - The native ESJ-MS of the Q418A mutant at A) 8~M and B) 1~M.
Spectra were recorded in 25 mM ammonium acetate, pH 7. A small reservoir of
neat acetonitrile was placed in the electrospray source. The labels correspond to
the dominant monomeric species (denoted P) except for the +5 ion for the dimer
(denoted P:P) which doesn't overlap with a monomer peak. The changes in the
monomer-dimer equilibrium are easily visualized in these two spectra by the
changes in intensities by the observed ions.
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6.2.2.4 NMR dilution experiments
In order to probe the effects of mutations on the structure of the protein
experiments using NMR spectroscopy ensued. The advantage of using NMR over
the biophysical techniques is that data is produced at an atomic level. Residues
with chemical shift deviations compared to the wild type can readily be identified
as a full assignment of the p62 UBA dimer and monomer have already been
reported!". Only the weak dimer mutants, namely the T414A, T414K and T419K
mutants, were investigated by NMR as these are the one which the biophysical
data indicated formed weaker dimers. All NMR experiments were conducted in
25 mM potassium phosphate, 25 mM NaCl, pH 7. All experiments were
performed at 298 K. The buffer and temperature conditions had been optimised
previously by Dr Thomas Gamer'".
Heteronuclear IH-15N-HSQC experiments were completed on the weak dimer
mutants at a range of concentrations between 500 JlM and 10 JlM (figures 6.12
and 6.13). The T414A and T414K mutants were sensitive and low yielding
mutants therefore only a high concentration (500 JlM) and a low concentration (10
JlM) sample were prepared in the interest of saving time and minimizing protein
degradation. Wild type p62 UBA had been previously shown to be fully dimeric
at higher concentrations. Data was recorded on the wild type protein and was in
excellent agreement with data previously recorded by our collaborator Dr M.
Pandya at the University of Sheffield. The populations of monomer and dimer
were shown to vary across the concentration range. At 6 JlM the wild type protein
shows roughly equal populations of monomer and dimer exist at equilibrium.
However when diluted to 1.5 JlM the equilibrium shifts towards the monomer
with the monomer now being the dominant species (approximately 80 %
monomer).
The 15N-T419K mutant was diluted to 12.5 JlM across a range of concentrations.
At higher concentration (> 50 JlM) peaks corresponding to three species at
equilibrium were visible. The intensity of the peaks showed concentration
dependence, which is consistent with a monomer-dimer equilibrium. The three
species were easily identified from the three clearly distinct Trp side chain peaks.
The third species showed a chemical shift distribution similar to wild type and it
maintained the C2 symmetry as only a single set of peaks were observed. The
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presence of an additional species had been previously observed by the E409K and
G410K p62 UBA mutants'?'. The three species were identified as the native
monomer and dimer, with the third species corresponding to a second
uncharacterised dimer. As the concentration decreases, the intensity of the peaks
corresponding to two of the species decreases until they disappear completely.
Since the resonances corresponding to the native dimer are lost at similar
concentration to the other species, it is likely that this third species also
corresponds to the same previously unobserved dimer, especially given that the
T419 residue forms a hydrogen bond with E409'. Moreover, the ESI-MS data
showed the presence of no higher order oligomers. This alternative dimer is
significantly populated at 500 jlM. At this concentration there is a ratio of
approximately I: I :I between the dimer, monomer and the alternative dimer is
observed. This ratio was deduced from integrating the intensities of the three Trp
side chain peaks, which were similar shapes. At lower concentrations « 50 uM)
peaks corresponding to the monomer are visible only. During the course of the
dilution the intensity of the monomer peaks increases until it becomes the most
dominant species.
Data recorded for the ISN-T414A and ISN-T414K p62 UBA mutants showed
spectra that were highly similar to those previously recorded for wild type p62
UBA at similar concentrations. Moreover, the two mutant spectra correlated well
to each other highlighting that the different mutants possess a similar tertiary
structure to one another. At high concentration, a single species corresponding to
the dimeric form, is observed. The peaks corresponding to the dimeric species for
both mutants are well dispersed, indicative of a folded protein. At low
concentration the spectrum becomes less clear. The dispersion of peaks becomes
narrower, with most peaks between 7 and 8 ppm in the IH direct dimension. A
narrow distribution of peaks would suggest partial unfolding of the protein. Partial
unfolding of these mutants was initially indicated by larger solvent exposed
surface areas relative to wild type p62 UBA in ESI-MS dilution studies. There is
also evidence for protein degradation as highlighted by the poor definition of the
peaks in the spectrum. Based on this information, it would appear that the
monomer has been significantly destabilized, potentially as a result of partial
unfolding, consistent with the ESI-MS observations for these mutants.
126
• I
. .
.,', .
.,. ..
, • I.", • • •
\. . I,. r :
..
.. " e .':.:'
10.0 '.5 '.0 '.5 '.0 ',S 1.0 '.5
'II a I ....
•.,
-, .
, .'~'"" • • I
• ,...,'~I';' :
~: .,_._ I
,,'" ' ....' ...
. ~.'..,', • • I(t •
. ',. ::.
. ,
'f'
• •
..
.
•
• 0
o •
125
101 105
110 110
'. ...
115 ri•
.-: .
., . "
I II '"
,'. 0
'. .... I,
..
'" .
O'
o
..
125
130 no
10.0 '.5 '.0 • . , '.0 '.5 '.0 1.5
'N • J PPIII
110
lOS
115 .~
..
US
no
10.0 '.S '.0 1.5 '.0 1.a 1.0 '.1
11 a I PS-
D)15N-wild type p62 UBA
Figure 6.12 - High concentration (500 J.lM)HSQC spectra for the p62 UBA weak
dimer mutants. (A) T414A p62 UBA, B) T414K p62 UBA, C) T419K p62 UBA
and D) wild type p62 UBA. All spectra were recorded in25 mM potassium
phosphate, 25 mM NaCI, pH 7. For wild type p62 UBA at 500 J.lMresonances
corresponding to the dimer only are observed in the spectrum, as indicated by 1
Trp side chain peak in the bottom left comer of the spectrum. Similar to wild type
p62 UBA, the spectra for theT414A and T414K mutants shows resonances for the
dimer only. The T419K spectrum is more complex and reveals 3 species in
equilibrium (as shown by the 3 Trp side chain peaks). This highlights how the
equilibrium has shifted towards the monomer as resonances for both the monomer
and dimer are visible at 500 J.lM.The third species corresponds to an alternative
dimer.
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Figure 6.13 - Low concentration (10 JlM) HSQC spectra for the weak dimer
mutants A) T414A p62 UBA, B) T414K p62 UBA, C) T419K p62 UBA and D)
wild type p62. All spectra were recorded in 25 mM potassium phosphate, 25 mM
NaCl, pH 7. At 10 JlM wild type p62 UBA, T414A p62 UBA and T414K p62
UBA show resonances for 2 species, the monomer and dimer. The 2 species are
shown by the 2 Trp side chain peaks in the bottom left comer of the spectrum. A
reduced stability is observed for the T414A and T414K mutants the quality of the
spectra is low. The T419K spectrum shows resonances for a single species, the
monomer. At this concentration the 2 dimer species have dissociated to the
monomeric form. The T419K spectrum highlights how far the equilibrium has
been shifted in the T419K mutant.
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6.2.2.5 Low concentration NMR on the T419K monomer
The T419K mutant was the only mutant which showed the presence of the
monomer at high concentrations indicating a substantial shift in the equilibrium
towards the monomer. Since a fully monomeric NMR spectrum was recorded at
concentrations below 50 11Minvestigations into the flexibility of the monomer
could be conducted. There is some speculation about the flexibility of the
monomer because in this form an extra half turn is formed by helix 3. No
structural work on the monomer in isolation has been completed because the
monomer is so lowly populated at concentrations required for NMR. The T419K
mutant has shifted the equilibrium significantly enough to overcome this problem.
In order to study the flexibility of the T419K monomer 15N-heteronuclear NOE
experiments were conducted. In order to calculate IH_15NNOE values from the
data, the interleaved IH_15NHSQC experiments need to be separated and fully
assigned.
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Figure 6.14 - The assigned IH_15NHSQC spectrum for the T419K p62 UBA free
monomer. The assignment numbers are based on the residue number within the
UBA construct plus the N-terminal GS extension which remains after thrombin
cleavage. The data was recorded on a 25 11M sample in 25 mM potassium
phosphate, 25 mM NaCl, pH 7 and 298 K.
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The assignment of the T419K monomer was completed to approximately 90 %
using previous assignments for the wild type monomer despite numerous residues
in helix 2 showing significant changes in chemical shift. Most of the shifts were
small enough to transfer the assignments across from the wild type protein.
Resonances corresponding to Leu416, Leu417, Gln418 and Lys419 (the mutated
residue) showed substantial chemical shift deviations and required further NMR
experiments in order to complete the assignment. These residues were assigned
using 2D NOESY and TOCSY experiments. Using an 800 MHz spectrometer and
a TXI cryoprobe, NOESY and TOCSY experiments were conducted on a 25 JlM
sample. This concentration ensured that only resonances belonging to the
monomer were detected. The fully assigned spectrum is shown in figure 6.14.
Once the T419K monomer had been assigned a IH_15N heteronuclear NOE
experiment was recorded on the T419K monomer using a 25 JlM sample. These
experiments are commonly used to probe the flexibilities of proteins. The
experiment was recorded as two interleaved IH_15NHSQCs, one in the presence
of proton saturation and one without. The two spectra were separated and IH_15N
heteronuclear NOE values calculated by taking the ratio of 15Nsignal intensities
recorded in each spectrum (figure 6.15). In both cases weak signal intensities were
recorded for all peaks. This is caused from the combined effects of low sample
concentration as well as the weakened sensitivity of the heteronuclear NOE
experiment. The residues with the largest ISN-heteronuclear NOE values are
found in the most rigid parts of the molecule. Negative values can be produced
from completely unstructured parts of the protein as these regions are
conformationally flexible. Heteronuclear NOE values ranging between 0 and 0.6
generally indicate relatively dynamic regions of the protein.
The T419K monomer displays heteronuclear NOE values which are very close to
0.6 for most residues. An average value of 0.62 was calculated. These values
indicate the presence of an ordered structure which still exhibits some flexibility.
The mutated residue Lys419 is the most flexible residue with a heteronuclear
NOE value of 1.03. Gly411 also has a high NOE value ofO.87. The heteronuclear
NOE values of both these residues are greater than the theoretical maximum value
of 0.82244, but in practice errors can occur when measuring signal intensities,
creating larger NOE values. Gly residues are usually quite dynamic. Gly411 is
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found in the loop I region and it IS not surprising that this residue exhibits
conformational flexibility.
Glu389, Lys435 and His436 were all only detected in the spectrum with proton
saturation. These peaks have broadened significantly and are unable to be detected
in the spectrum without proton saturation. This indicates these residues are highly
flexible, consistent with these residues being located close to the termini of the
T4l9K. The heteronuclear NOE values produced for these three residues were
inaccurate and were therefore excluded from the analysis. In addition to this the
heteronuclear NOE values for residues Ile431 to Ser434 are all positive, in
agreement with the wild type p62 UBA monomer, in which helix 3 extends by an
extra half tum. If residues Ile431 onwards exhibited strongly negative signals, it
would be expected that these were forming part of the flexible C-tenninus.
1.2
Figure 6.15 - The 15N-heteronuclear NOE values for the T419K p62 UBA free
monomer. The 15N-heteronuclear NOE experiments were recorded on a 25 IlM
sample in 25 mM potassium phosphate, 25 mM NaCl, pH 7 and 298 K. The
values were calculated using CCPNMR version 2.1.2 software. Values for
Glu389, Lys435 and His436 were inaccurate and were subsequently excluded
from the analysis. Most of the values are close to 0.6 indicating that the monomer
shows limited structural flexibility.
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6.2.2 NMR binding studies on the p62 UBA weak dimer mutants
6.2.2.115N-T419Kp62 UBA titrations
The dilution NMR study indicated a significant population of the monomer at
higher concentrations. In order to investigate if the shift in equilibrium towards
the monomer has an effect on binding affinity an NMR titration whereby
unlabelled ubiquitin was titrated into 15N-T419K p62 UBA was performed. At
high concentration peaks corresponding to the monomer could be visualised. The
monomer peaks could then be tracked from the free to the bound form to calculate
a Kd for binding.
Peaks corresponding to the free monomer were assigned in the free 15N-T419K
UBA 500 urn spectrum. The assigned peaks exhibited mixture of strengths in
signal intensity. Some were quite weak; whereas, others were quite strong. It was
assumed that the weak peaks corresponded to the monomer only. The strong
intensity of the other peaks was likely to be caused by the presence of either or
both of the dimers which produce resonances which overlap with the monomer.
Since the chemical shift rather than peak intensity was used for analysis, this was
not considered to be problematic.
Up to 2 mM unlabelled ubiquitin was titrated into a 500 J..lM15N-T419K p62 UBA
sample. Concentration dependant chemical shifts were observed upon the addition
of ubiquitin consistent with the binding of the UBA to ubiquitin. A mixture of
slow and fast chemical exchange regimes were seen, similar to the titration
between wild type p62 UBA and ubiquitin, suggesting that a similar mechanism
of dimer dissociation is occurring prior to ubiquitin binding by the monomer,
despite the presence of a second uncharacterised dimer. During the titration peaks
corresponding to the two dimeric species decreased in intensity whilst the peaks
corresponding to the free monomer increased in intensity. Whereas, fast exchange
was observed between the free and bound forms of the monomer. Saturation was
observed at 500 J..lM,a 1:1 molar ratio. Wild type p62 UBA doesn't reach
saturation until 2 mM ubiquitin, a 1:4 molar ratio; therefore, the T419K mutant
shows a significant increase in the binding affinity.
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Figure 6.16 - IH_15NHSCQ spectrum for the free 15N-T419K p62 UBA at 500
IJM (black) overlaid with the bound to ubiquitin spectrum at 1:4 molar ratio (red).
The 3 species in the free spectrum move to a single bound species upon the
addition of ubiquitin. The Trp side chain region is enlarged to visualise the 3
species (dimerl 'Dl', dimer 2 'D2' and monomer 'M') in the free spectrum and
the 1 species in bound spectrum (bound 'B'). The spectra were recorded in 25
mM potassium phosphate, 25 mM NaCI, pH7 and at 298 K.
The three species observed in the free IH_15NHSQC spectrum all move to a single
species, the bound monomer form (figure 6.16). The bound T4l9K monomer
form has resonances with chemical shifts which are nearly identical to those
previously observed for wild type. Small CSPs were observed for residues
Trp4l2, Leu4l3, Arg4l5, Leu416, Leu417, Gln418, Asn42l and Tyr422. All of
these residues were able to be assigned as they had not moved significantly. Only
Lys4l9 and Lys420 were unable to be identified from the bound spectrum without
the aid of the dilution data which displayed the free monomer form. However,
these residues were able to be tracked from the free to the bound monomer form,
thus completing the assignment of the bound form. Unfortunately the presence of
the third species produced complicated spectra which precluded the ability to
assign the two dimer species without I3C and 15Nlabelling.
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Changes in the chemical shift between the free and bound forms were plotted
against residue number to identify which residues showed the greatest
perturbations during the titration (figure 6.17). The pattern of changes in chemical
shift correlated well to the data obtained for the wild type monomer, highlighting
the MGF motif in loop 1 and residues in helix 3 as the biggest movers. The
similarity between the bound form of the T419K and wild type p62 UBA
confirms that the mechanism of binding had not been altered by the mutation and
that the same bound form was reached. The alternative dimer would appear to
maintain the ability to bind to ubiquitin. The faster saturation was the direct result
of an enhanced affinity interaction. Since the T419K has a significantly higher
population of monomer at 500 JlM compared to wild type protein it was expected
that an increased affinity for ubiquitin would occur.
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Figure 6.17 - Residue specific CSP for the backbone NH groups for the IsN_
T419K p62 UBA monomer between the free and bound forms. The gaps
correspond to residues which were unable to be assigned. The largest CSPS are
seen for Met404 and Gly40S in the conserved MGF motif in loop 1 and residues
in helix 3. These large CSPs highlight the T419K mutant binds to ubiquitin using
a similar mechanism to wild type p62 UBA.
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By globally fitting the residues with large changes in chemical shift between the
free and bound forms (CSP >0.05 ppm) to a simple 1:1 binding model using
IGOR Pro an apparent Kd could be produced. A total of 24 curves were
subsequently fitted to produce a Kd value of 185.9 ± 8.7 IlM. The curves fitted
well to a 1:1 binding model. The Kd value is best described as the observed Kd
(Kobs) because the fit does not take into consideration the competitive processes of
dimerisation and binding. By using the relationship between Kobs and Kdim
(equation 12, chapter 2), which takes into account the two competing equilibria, a
more accurate Kd value can be calculated. A new Kd value of 175.1 ± 20.4 IlM
was therefore calculated using the Kdim value 165 ± 30 IlM determined from the
I'TC. However, as mentioned earlier the fit produced for the T419K mutant was
poor. The wild type p62 UBA monomer was previously shown to have a Kd of 40
± 10 IlM. It is clear from the titration data that the T419K has a tighter interaction
with ubiquitin because saturation occurs 4-fold quicker than it does for wild type.
The Kd for binding calculated using Kobs and Kdim is likely to have been seriously
affected by the inaccurate Kdim value.
The residues which showed a CSP of more than 0.1 ppm were considered to be
significant movers. These residues were plotted onto the surface of the wild type
bound monomeric UBA and used to identify the binding surface (figure 6.18,
PDB ID 2JY8). The darkest red colour indicated residues with the greatest the
change in chemical shift. The MGF loop which protrudes from the surface of the
structure is coloured red, highlighting this as the interacting surface. It is therefore
likely that the T419K monomer maintains the interaction between the MGF loop
and the I1e44/Va170 hydrophobic patch.
180·
Figure 6.18 - Large CSPs for the 15N_T419K mutant plotted onto the surface of
the bound monomeric UBA (PDB ID 2JY8). The darker the red, the greater the
perturbati on.
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6.2.2.215N-T414A and 15N-T414Kp62 UBA titrations
In order to investigate if the T414A and T414K p62 UBA mutants also showed an
enhanced affinity for ubiquitin, binding studies using NMR spectroscopy were
completed. These mutants did not have the added complication of an alternative
dimer; however, even at concentrations as high as 500 flM some additional weak
peaks were observed in the free IH_15NHSQC for both the 15N-T414A and 15N_
T414K mutants when the contour levels were increased. These peaks were
believed to correspond to the free monomer as the biophysical data indicated that
the equilibrium had shifted towards the monomer. The extra resonances were not
assigned as an incomplete set of monomer resonances were observed at high
concentrations. Unfortunately these mutants were too unstable to conduct low
concentration NMR titrations whereby a full set of peaks corresponding to the free
monomer can be visualised.
The IH_15N HSQC spectra for the free 15N-T414A and 15N-T414K mutants
showed peaks with a similar pattern of dispersion to wild type p62 UBA. The
spectra for the 15N-T414A and 15N-T414K UBAs were near identical, although a
considerable number of resonances had chemical shifts which had deviated from
the wild type (figure 6.19). For some resonances the assignments could be
transferred from the wild type to the mutant, but others showed changes which
prevented unambiguous assignment. The unassigned residues showed larger
changes in chemical shift compared to wild type p62 UBA and were mainly
clustered in the vicinity of the mutation site in loop 1 and helix 2. The unassigned
residues were assigned using NOESY and TOCSY data recorded on a 1 mM
sample of the T414A mutant. Since the chemical shifts were so similar for the two
mutants, NOESY and TOCSY spectra were only recorded for the T414A mutant.
The IH_1sNHSQC spectra for the bound forms unsurprisingly also showed some
resonances with considerable changes in chemical shift compared to wild type
p62 UBA. The resonances which were different this time were located in helix 1
as well as loop I and helix 2. Some of these residues were able to be assigned
using the assignments previously reported for wild type p62 as they were located
in isolated regions of the spectrum. For residues which were unable to be assigned
a 15N-HSQC-NOESY and 15N-HSQC-TOCSY were run on a fully bound 125 flM
ISN-T414A sample (1:2 molar ratio ISN-T414A:unlabel1ed ubiquitin). Again the
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bound form of both the T414A and T414K mutants were so similar that the
assignments could be transferred between the spectra.
Leu413
•
Gly40S
Tyr422 •
Figure 6.19 - H- N HSQC for the free form of 15N_wild type p62 UBA (black),
15N-T414A p62 UBA (blue) and 15N-T414K p62 UBA (red) at 250 11M. Regions
of the spectrum where resonances for the two mutants show changes in chemical
shift compared to wild type are expanded. The mutated residue, Thr414, is also
labelled. All spectra were recorded in 25 mM potassium phosphate, 25 mM NaCI,
pH7 and at 298 K.
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Titration studies whereby unlabelled ubiquitin was titrated into 15N-T414A and
15N-T414K were conducted. Up to 1 mM unlabelled ubiquitin was added to 250
flM 15N-T414A and 15N-T414K, as separate experiments (figures 6.20 and 6.21).
At 250 JlM, the weak additional peaks had increased in intensity, again consistent
with them corresponding to the monomer. Concentration dependent changes in
chemical shift were observed in both titrations, consistent with a binding event.
Saturation occurred after the addition of 500 JlM ubiquitin (1:2 molar ratio mutant
UBA:ubiquitin) in both cases. The mutants therefore showed an increased affinity
for ubiquitin, as the wild type saturated at a 1:4 molar ratio (UBA:ubiquitin).
However, these mutants do not show as strong interaction as the T419K mutant. A
mixture of fast and slow exchange was observed consistent with the data obtained
for the wild type p62 UBA. The two different chemical exchange regimes
correspond to two separate events, the dimer dissociation and ubiquitin binding.
The peaks corresponding to the dimer decrease in intensity whilst the peaks
corresponding to the monomer increase in intensity. Concurrently the peaks
corresponding to the monomer move in fast exchange to the bound form.
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Figure 6.20 - IH_1SNHSQC spectrum of the free ISN-T414A at 250 11M(black)
overlaid with the bound to ubiquitin spectrum at 1:4 molar ratio (red). The spectra
were recorded in 25 mM potassium phosphate, 25 mM NaCI, pH7 and at 298 K .
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Figure 6.21 - IH_15NHSQC spectrum of the free 15N-T414K at 250 11M(black)
overlaid with the bound to ubiquitin spectrum at 1:4 molar ratio (red). The spectra
were recorded in 25 mM potassium phosphate, 25 mM NaCl, pH7 and at 298 K.
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By plotting the changes in chemical shift between the free and bound forms on a
per residue basis, the regions of the molecule that have been affected were
identified (figure 6.22). The correlation between the CSPs observed by the T414A
and T414K datasets was near identical. At this concentration the combined effects
of the transition from dimer to monomer as well as binding by the free monomer
are visualised, resulting in large CSPs. An accurate determination of the Kd for
binding was therefore not obtainable from this data. However, the CSP pattern is
in good agreement with the CSPs previously obtained for the wild type p62 UBA
at high concentrations, suggesting the mechanism of binding is the same for the
wild type and the two mutants. Residues with large CSPs in helix 2 and the C-
terminal of helix 3 are caused from the dimer dissociation; whereas, large CSPs in
loop 1 and helix 3 are caused from ubiquitin binding.
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Figure 6.22 - Residue specific CSPs for the T414A and T414K p62 UBA mutants
upon ubiquitin binding. Large CSPs are exhibited by residues in helix 2 and helix
3. Helix 2 corresponds to dimer dissociation whereas the effects observed in helix
3 are exerted by both dimer dissociation and ubiquitin binding.
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Residues which showed a CSP of more than 0.05 ppm were considered to be
significant movers. These residues were plotted onto the surface of the wild type
monomeric UBA in the bound form (figure 6.23, PDB ID 2JY8). A large
proportion of the molecule is affected due to the two processes. Residues which
have been coloured red respresent regions of the molecule which have been
affected by binding, with the darker red colour corresponding to the bigger CSPs.
Residues which have turned black in colour indicated the residues with the biggest
CSPs. Regions of the molecule which have turned black in colour correspond to
residues in helix 3 which are affected by both dimer dissociation and ubiquitin
binding. Residues in helix 2 are coloured the darkest reds, with Leu413 also
coloured black. These residues have been perturbed from dimer dissociation. The
MGF loop is also coloured red indicating binding to ubiquitin has occurred using
these residues.
B
Figure 6.23 - Large CSPs for the 15N-T414A and 15N-T414K p62 UBA mutants
plotted onto the surface of the bound monomeric UBA (PDB ID 2JY8). The
darker the red colour, the greater the perturbation. The observed CSPs are caused
by both dimer dissociation and ubiquitin binding. Residues T430, 1431, Q432 and
S434 are coloured black and correspond to residues which have the greatest CSPs.
These residues are affected by both dimer dissociation and ubiquitin binding.
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6.3 Discussion
The competitive equilibrium between dimerisation and ubiquitin binding
represents a highly sophisticated control mechanism, which is able to regulate the
affinity the UBA has for ubiquitin. The p62 UBA dimerisation interface is
primarily composed of residues in helix 2, although residues at the C-terminal end
of helix 3 also playa part in maintaining dimer stability. Upon dissociation to the
monomer an extension in helix 3 has been proposed which is able to prevent
dimerisation, as well as facilitate the interaction with ubiquitin. The dimer
therefore has an inhibitory role which opposes the effects of ubiquitin binding.
Understanding the relationship between these two factors, and potentially others,
is crucial to understanding the molecular basis of Paget's disease.
Despite the formation of significantly weakened dimers, none of the mutants
studied in this chapter were able to form solely monomeric structures. The only
mutant which permitted the study of the monomer was the T419K mutant, which
was solely monomeric at concentrations below 50 ~M. The study by Isogai et al
which produced the crystal structure for the p62 UBA dimer also generated
mutants to probe the monomer-dimer equilibrium. They used an approach which
targeted the key hydrophobic interactions at the interface and were able to
produce monomeric UBAs at 100 ~M for six of the seven mutants 131. Although
targeting the hydrophobic residues at the binding interface showed a greater shift
in the monomer-dimer equilibrium, these mutants also formed dimers at higher
concentrations. Taken together, it is clear that the dimer is the preferred
conformation at physiological concentrations.
In addition to this, the UBA dimer might also have a role in determining the life
span of the full length p62 protein. The p62 is not normally degraded by the
proteasome; however, deletion of the C-terminal eight residues prevented dimer
formation but interestingly also promoted proteosomal degradation 131. A
protective role for C terminal UBA domains has been demonstrated by UBA in
the Rad23 and Dsk2 proteins!", although these domains did not form dimer
structures. These UBA monomers were able to prevent generation of initiation
sites for degradation, which are required for interaction with the unfolding
machinery of the proteasome. This is a feature which could be shared by the p62
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UBA dimer, or alternatively the dimer might be prevented from binding to the
proteasome due to steric clashes linked to dimer formation.
When the p62 UBA dimer was discovered only a few examples of UBA dimers
had been reported. The UBA domains of the c-Cbl and Cbl-b proteins and the
doubles ex UBA from Drosophila melanogaster had all been previously shown to
exist as dimers234.23s,237,24s.Also since the discovery of the p62 UBA dimer, the
structure of the XIAP UBA dimer has also been reportedi", Interestingly all of
these proteins form structurally distinct UBA dimers, with the C2 symmetry only
exhibited by the p62 UBA dimer. And rather more surprisingly not all of these
UBA dimers appear to regulate ubiquitin binding. No other UBA dimer possesses
overlapping dimerisation and ubiquitin binding interfaces. This would suggest that
the p62 UBA dimer has specifically evolved under pressure to regulate function.
Many UBA-ubiquitin interactions have been shown to be weaktOt,s4, although
examples of higher affinity interactions have also been reported98,99. Of the UBA
dimers a range of affinities has also been determined. The Cbl-b UBA has been
reported to have a higher affinity interaction (Kd 53 ±3 JlM)24s;whereas, the XIAP
UBA shows a weaker interaction (Kd 249 ± 19 JlMi36. Many UBAs have been
shown to bind to different types of polyubiquitin chains, with certain chains
preferred over others. Itwould therefore appear the UBAs are able to intrinsically
regulate their binding affinities dependent on the polyubiquitin chains they are
binding. The p62 UBA thus far exhibits no linkage preference, but does show
enhanced binding to polyubiquitin chains over monoubiquitin in GST pull
downsI70,I7I. Due to the highly oligomeric nature of the p62 in vivo, it is likely
that multiple UBAs are presented to polyubiquitin chains. This would suggest
binding of the p62 is mediated by avidity effects, which favour the open
conformation of Lys63 linked chains'", Avidity effects are likely to filter out the
non-specific interactions and amplify the correct UBA-ubiquitin interactions. The
UBA dimer however adds complexity to this model since high concentrations of
UBA are likely to promote dimer formation and repress ubiquitin binding. The
overall binding affinity of the UBA in oligomeric p62 also involves competitive
effects between UBA dimerisation and avidity. It is therefore speculated that
changes in affinity as a result of the formation of weaker dimers are amplified by
avidity effects.
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6.4 Conclusions
The main aim of this chapter was to probe the monomer-dimer equilibrium by
disrupting or preventing dimer formation. By introducing mutations to helix 2,
which forms the dimerisation interface, the structural integrity of the dimer and
changes in the equilibrium were monitored using structural and biophysical
techniques. The presence of the UBA dimer has an inhibitory effect on NF -KB
activation by decreasing the affinity for ubiquitin 141. By altering the strength of
the dimer, the equilibrium can be shifted causing an increase in the population of
the monomer, thereby increasing the affinity for ubiquitin. The mutants studied in
this chapter produced a mixture of wild type like dimers and weak dimers. Of the
eight designed mutants, seven were able to be successfully expressed and purified
in C41 (DE3) E. coli. Four of the mutants formed dimers similar to wild type p62
UBA and three formed significantly weaker dimers. Only the Q418K p62 UBA
mutant was unable to be expressed, suggesting that this mutation was the most
detrimental to dimer structure and stability.
The R415A, Q418A, T419A and R415K mutants all produced dimers which were
not too dissimilar from the wild type. All of these mutants exhibited small
differences in thermal stability and the solvent exposed surface area relative to
wild type, as shown by Far UV -CD and ESI-MS dilution studies. Moreover, the
structural integrity of the dimer was not significantly altered as shown by ITC.
The Q418A mutant was shown to have the biggest increase in solvent exposed
surface area as well as displaying the biggest thermal destabilisation. Whereas, the
T419A mutant was shown to have the weakest Kdim value. Most of the Ala
mutants did not seem to significantly affect the monomer-dimer equilibrium,
suggesting that these residues did not form critical interactions at the dimer
interface. The data also suggests that the hydrophobic residues which form the
dimer interface are the driving force in maintaining dimer stability. The only Lys
mutant which retained properties close to wild type p62 UBA was the R415K
mutant, which was not unsurprising as the mutant involves a like-for-like change
in amino acid.
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However, the T414A, T414K and T419K mutants all produced dimers weaker by
at least an order of magnitude compared to wild type protein, as shown by the Kdim
values calculated from ITC dilution studies. Kdim values of 141 ± 1 IlM, 146 ± 1.5
IlM and 165 ± 30 IlM were recorded for the T414A, T414K and T419K mutants
respectively; whereas, the Kdim for the wild type p62 UBA is 4.1 ± 0.6 IlM. The
far UV-CD data for the T414A and T414K mutants reveal the thermal stability of
both the monomeric and dimeric species are significantly weaker than those
reported for the wild type protein. The T414A and T414K mutants show a 14 K
and 21 K decrease in dimer stability respectively. The monomer is destabilized to
a lesser extent than the dimer, however a large decrease in observed compared to
the wild type. Decreases of 8 K and 15 K for the T414A and T414K monomers
were observed respectively. In addition, the Tm values of the both the monomer
and dimer for these two mutants were shown to be indistinguishable, highlighting
the dimer as the species most affected by the mutation. The far UV -CD scans
highlighted weaker intensity bands at 208 and 222 nm for the T414A mutant
relative to wild type p62 UBA, suggesting a decrease in the average helical
content.
The dilution NMR studies confirmed the presence of a partially unfolded
monomer at low concentration (10 IlM) for the T414A and T414K mutants. Low
concentration NMR spectra for these mutants showed peaks with poor resolution
and dispersion. It is likely that the partial unfolding of these mutants is linked to
their decreased thermal stabilities. Whereas, the dilution NMR experiments for the
T419K mutant revealed the presence of a third species. This third species had
been previously observed by the E409K and 0410K mutants 141. This additional
species was thought to be an alternative dimer which despite forming a different
structure maintained the C2 symmetry along the dimerisation interface. Although
the fit used to produce the Kdimfor the T419K was poor, the other biophysical data
indicated that this mutant formed a weak dimer. The presence of the monomer at
high concentrations clearly shows that the equilibrium has moved towards the
monomer.
The affinity of the weak dimer mutants was also investigated. Binding studies
using NMR spectroscopy revealed that these mutants had an increased affinity for
ubiquitin. The T414A and T414K mutant saturated at a 1:2 molar ratio. These
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mutants showed a 2 fold increase in affinity compared to the wild type p62 UBA.
The CSPs observed between the free and bound forms of the T414A and T414K
mutants showed a very strong correlation with each other and were highly similar
to wild type. The T419K mutant saturated at a 1:1 molar ratio. This mutant
showed the biggest increase in affinity, a 4 fold increase, compared to wild type.
This is consistent with the increased population of monomer at high concentration
(500 JlM). There is an obvious correlation between dimer strength and affinity for
ubiquitin. The weaker the dimer, the further the equilibrium has shifted towards
the monomer, the higher the affinity for ubiquitin. This is also consistent with
only the monomeric form capable of binding.
The T414A and T414K mutants highlight residue Thr414 as a critical amino acid
in the stability of the p62 UBA dimer. Also, as predicted, the T419K mutation
showed the ability to severely affect the strength of the UBA dimer. The hydrogen
bond formed by the Thr419 with Glu409 can no longer be formed, significantly
destabilizing the dimer. The affect is so drastic that an alternative dimer is formed
by the mutant. This alternative dimer was also observed by the E409K and G410
mutants 141•
Taken together, a relationship between dimer stability and affinity for ubiquitin is
observed. The data indicates that the equilibrium in the weak dimer mutants has
shifted towards the unstable biologically active monomer causing an increase in
the population of monomer at equilibrium. The larger population of monomer in
tum raises the affinity for ubiquitn. Since no solely monomeric species were
observed it is concluded that the dimer is the preferred oligomerisation state for
the p62 UBA dimer. The dimers regulatory role in NF -ill signalling is evident
and ablation of dimer formation would be severely detrimental to this pathway.
However, by mutating residues along the dimerisation interface we can produce
weak dimers with a higher affinity for ubiquitin.
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6.S Future work
The results from this chapter as well as previous work on the wild type p62 UBA
and E409K and G410K p62 UBA mutants clearly indicate a preference for the
dimeric form of the UBA. Taken together, these results indicate that the
monomeric form is weakly populated, as dissociation only occurs in the presence
of ubiquitin and drives the formation of the complex. In order to gain a greater
insight into the p62 UBA monomer by obliterating dimer formation completely a
strategy involving multiple mutations along the dimerisation interface could be
employed. Double, triple or even quadruple mutations at key interacting residues
along the interface which target both the hydrophobic interactions and solvent
exposed residues are more likely to prevent the dimer forming at all. Hydrophobic
residues in helix 3 should also be considered when designing such mutants.
The T419K monomer could have been studied further. A Kd for binding could
have been calculated by conducting binding experiments using ITe or ESI-MS.
However, the mutations by Isogai et al were published before these experiments
could be conducted. It was therefore deemed unnecessary to continue
investigating the T419K mutant.
It would also be worthwhile inserting the T419K mutation or any of the mutations
outlined by Isogai et al into some of the PDB mutants, such as P392L, M404V
and G425R and monitoring the effects on ubiquitin binding. The P392L mutation
is the most common mutation found in patients with Paget's disease, the critical
MGF motif has been mutated in the M404V mutant and the G425R mutation is
associated with a complete loss of ubiquitin. By studying the monomeric form of
the UBA the role that dimerisation has in the various PDB mutants can clearly be
established. Experiments using longer polyubiquitin chains and chains of various
linkage could also be explored using the monomeric PDB mutants, as these are
more likely to be the natural ligands. The different PDB mutants could show
differences in affinity for certain linkages and could provide an insight into the
onset of the disease.
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7.0 Investigating phosphorylation of the p62 UBA
7.1 Introduction
7.1.1 Phosphorylation
Protein phosphorylation involves the addition of phosphate groups to certain
amino acids in a protein. The most commonly affected amino acids in eukaryotic
cells are Ser, Thr and Ty?46,247. These residues contain an exposed hydroxyl
group cable of being phosphorylated (figure 7.1). Recently the evolution of
phosphorylation sites from acidic amino acids has been exploredi". Protein
phosphorylation is a reversible process with many enzymes and receptors in cell
signaling pathways being regulated by their state of phosphorylation.
Phosphorylation is such a fundamental PTM that two diverse families of enzymes,
kinases and phosphatases, have evolved to phosphorylate and dephosphorylate
other proteins respectively ". Protein phosphorylation, like protein ubiquitination,
is responsible for the maintenance of a hugely diverse range of processes in the
cell, including the cell cycle, metabolism and neuronal differentiation. It is
estimated that approximately 30 % of proteins encoded by the human genome are
subject to phosphorylation246,25o. In fact most proteins are phosphorylated at more
than one site in a process known as multi site phosphorylatiorri". The significance
of phosphorylation to the world of science was recognized when Edmond Fischer
and Edwin Krebs were awarded the Nobel Prize in Physiology and Medicine in
1992 for its discovery'".
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Figure 7.1 - The structures of the phosphorylated Ser, Thr and Tyr amino acids.
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7.1.2 Phosphomimetic mutations in proteins
As discussed, Ser, Thr and Tyr amino acids are subjected to phosphorylation in
vivo. Mimicking phosphorylation of Ser and Thr amino acids in proteins can be
achieved by mutating these residues to Asp or Glu residues. The 3D structures of
both Asp and Glu amino acids are very similar to that of phospho Ser and Thr
(figure 7.2). Several studies have shown the insertion of such phosphomimetic
mutations to proteins which have permitted the study of phosphorylated
. 252253254 Th d f h h T 'd .protems ' '. e stu y 0 p osp 0 yr res] ues is significantly more
complicated. Despite Tyr possessing a more unique structure, substituting for Asp
or Glu residues has been shown to be effective in some cases255,256.
Figure 7.2 - The 3D structures of Ser, phospho-Ser and Glu. The 3D structure of
Glu is very similar to phosphor-Ser and is therefore considered an ideal way to
mimic phosphorylation in vitro.
7.1.3 Ser403 is phosphorylated in the p62 UBA
A recent in vivo study by Matsumoto et al identified eight phosphorylation sites in
the full length p62 protein257. Of these eight sites, there were seven phospho Ser
and one phospho Thr (figure 7.3). These phosphorylation sites were identified
from NeurnZa cells transfected with GFP tagged p62 under proteasome inhibited
conditions using liquid chromatography coupled to tandem mass spectrometry.
p62 is primarily degraded by autophagy rather than the proteasome, it was
therefore necessary to prevent autophagy in order to detect phosphorylated p62.
Cells transfected with full length p62 phosphorylated at one of the eight
phosphorylation sites were examined. Only Ser 403 phosphorylated p62 levels
increased under autophagy inhibited conditions suggesting that Ser 403
phosphorylation may enhance p62 entry to autophagosomes.
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Figure 7.3 - a schematic diagram of the full length p62 protein showing all eight
phosphorylation sites. Taken from Matsumoto et aP57.
The phosphomimetic mutant S403E was generated in full length p62 and used to
investigate the interaction of S403 phosphorylated p62 with ubiquitin. A
dephosphorlyated control, S403A, was also engineered in full length p62. The
results of the study revealed that the S403E mutant showed an increased affinity
for polyubiquitin chains both in vitro and in vivo. The S403A mutant showed a
reduced affinity when compared to wild type p62 UBA. When linkage selectivity
was probed by these mutants the S403A mutant displayed a strong preference for
Lys63 linked polyubiquitin chains much like wild type p62 UBA. However, the
S403E mutant showed enhanced binding for both Lys48 and Lys63 polyubiquitin
chains, suggesting that p62 UBA phosphorylation transforms the p62 UBA to a
state which is has a higher affinity for ubiquitin.
A protein kinase which phosphorylates the p62 UBA at Ser403, known as CK2,
was also identified in the study. The consensus sequence for CK2 is not perfectly
matched to the p62 UBA sequence resulting in only partial p62 UBA
phosphorylation. The CK2 consensus sequence is SIT -X-X-D/E; whereas, the
sequence found in human p62 UBA reads S-M-G-F-S-D. This sequence of the
p62 UBA also contains the conserved X-G-F-X motif found in UBA domains
which functions to bind to ubiquitin. The motif, Met 404, Gly 405, Phe 406 and
Ser 407, as found in human p62 UBA, generates a binding surface that is
complementary to ubiquitin, both hydrophobically and electrostatically,
facilitating an interaction with the hydrophobic patch centered on lie 44 in
ubiquitin. Ser 403 is located at the C-terminal end of helix 1, immediately prior to
the ubiquitin binding motif.
The article concludes that a dynamic equilibrium between the phosphorylated and
dephosphorylated form exists in vivo. The phosphorylated form becomes favoured
when the polyubiquitined protein level is increased permitting the phosho
UBA:ubiquitin complex to be recruited to the sequestosome (figure 7.4).
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7.1.4 Summary and aims
In full length p62 the phosphomimetic mutant S403E showed enhanced ubiquitin
binding relative to wild type p62; whereas, the S403A dephosporylated mutant
continued to show weak binding. The main aim of this chapter was to investigate
how phosphorylation at Ser403 is able to alter the affinity for ubiquitin using the
isolated UBA domain. The p62 UBA mutants S403D and S403E were generated
to study the phosphorylated form of the p62 UBA and a control S403A mutant
was produced to study the dephosphorylated form.
We aim to probe the structure of phosphorylated p62 UBA and rationalise the
basis for ubiquitin recognition using NMR spectroscopy. We also aim to
characterise the Ser403 p62 UBA mutants using biophysical techniques to provide
an insight into the properties of phosphorylated p62 UBA. Since the previous
study only measured affinity using pull down assays, we also aim to calculate
affinities for the S403 mutants and compare those to previously obtained values
for wild type p62 UBA. Moreover, competitive binding studies using ESI-MS
could highlight if a preference for ubiquitin is observed by Ser403 phospho p62
UBA in vitro, Biological assays and GST pull down studies, as part of a
collaborative project (group of Dr Robert Layfield, University of Nottingham),
were also conducted by Miss Alice Goode.
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Table 7.1 - A list of the phosphomimetic p62 UBA mutants. The mutated residue
is shown for each mutant in red.
Mutant Helix 1 sequence (residues 392 - 404)
S403A P R LIE S L S Q M L A M
S403D P R L I E S L S Q M L 0 M
S403E P R L I E S L S Q M L E M
The results of chapter 6 clearly show that weaker p62 UBA dimers have increased
affinity for ubiquitin. The equilibrium shifts to favour the biologically active
monomer meanmg there are more monomeric UBAs available for binding.
Another main aim of this chapter was to investigate whether the structural
integrity of the UBA dimer had been altered by phosphorylation at Ser403. It was
postulated that the equilibrium would be largely unaffected as the position of
Ser403 is not found at the dimerisation interface (figure 7.5).
PDB mutations in the p62 UBA have previously been shown to have a slightly
reduced affinity for ubiquitin 170, 171. Such subtle effects are unlikely to
dramatically affect downstream signalling III the NF-KB pathway and
subsequently cause abnormal osteoclastogenesis. It would be interesting to
determine whether phosphorylation in PDB mutants leads to more drastic changes
in the affinity the p62 UBA has for ubiquitin. Since the Ser403 phosphorylation
site is located close to the ubiquitin binding patch, it is possible that a relationship
between ubiquitin binding and phosphorylation exists. Therefore, a combination
of the effects of ubiquitin binding, dimerisation and phosphorylation are likely to
playa role in the onset of PDB.
A
Dimerisation interface
B
Figure 7. 5 The positioning of Ser403 in the p62 UBA dimer (PDB ID 2KNV). A)
the ribbon diagram. B) the surface plot. The C2 symmetry of the p62 UBA dimer
prevents both Ser403 residues from being seen.
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7.2 Results
7.2.1 Monitoring the monomer-dimer equilibrium in the S403 mutants
7.2.1.1ESI-MS dilution experiments confirm the presence of a monomer-dimer
equilibrium
In order to check how Ser403 affects dimer stability and therefore the monomer-
dimer equilibrium, dilution experiments were conducted using ESI-MS. ESI-MS
experiments are performed at low sample concentrations which is ideally suited to
monitoring the monomer-dimer equilibrium compared to other biophysical
techniques. ESI-MS was considered an excellent starting technique to begin
studies on the monomer-dimer equilibrium of the various S403 mutants. The same
experiments had been used to monitor the equilibrium of the helix 2 dimerisation
interface mutants studied in chapter 6.
Initially native ESI-MS was conducted using 5 JlM samples to check the
molecular masses of all 3 mutants. Samples were prepared by dissolving
lyophilized protein in 25 mM ammonium acetate, pH 7 and diluting to the
appropriate concentration. A spectrum consisting of multiple charge states was
observed in all cases. Mass ions corresponding to the monomeric and dimeric
species of each mutant were visualized, but no higher order oligomers. Masses of
5727.0, 5770.9 and 5785.9 Daltons were reported for the S403A, S403D and
S403E p62 UBA mutants respectively. The masses recorded by the masslynx
software were in excellent agreement with the predicted masses of 5723.4, 5767.4
and 5781.4 Daltons for S403A, S403D and S403E respectively.
Native ESI-MS dilution studies were conducted across the concentration range 8
JlM to 1 JlM. Initially an 8 JlM sample was prepared in 25 mM ammonium
acetate, pH 7 and this sample was serially diluted to 1 JlM. A spectrum containing
multiple charge states was visualized (figure 7.6), as outlined above. Mass ions
corresponding to the +2 to +6 charge state of the monomer were observed at 8
JlM. The ion corresponding to the +2 charge state was not visible at lower
concentrations. The distribution of charge states varied across the concentration
range, however the +3 and +4 mass ions tended to be the most abundant in the
spectra.
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Figure 7.6 - The native ESI-MS spectrum of the S403E p62 UBA mutant at A)
8)lM and B) lu M. Spectra were recorded in 25 mM ammonium acetate, pH 7.
The labels correspond to the monomeric species (denoted P) except for the +5 ion
for the dimer (denoted P:P) which doesn't overlap with a monomer peak. The
changes in the monomer-dimer equilibrium are easily visualized in these two
spectra by the changes in intensities by the observed ions.
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As discussed in chapter 6, mass ions for the monomer and dimer overlap where
both the mass and charge are doubled preventing accurate concentrations of each
of the species from being calculated. The m1z value for each charge state recorded
different intensities at different concentrations enabling an average charge state to
be calculated. Changes in the average charge state have been reported to reflect
changes in the solvent exposed surface area22I, which is different for the two
different species.
The calculated average charge state was plotted against concentration and
compared to values reported for the wild type p62 UBA (figure 7.7). The values
recorded for all 3 mutants were similar to the wild type values highlighting
minimal changes to the surface exposed surface area, which in theory reflects
minimal changes to the monomer-dimer equilibrium. All 3 mutants showed a
slightly lower average charge state across the concentration range than those
recorded for the wild type. This is indicative of a slight decrease in the solvent
exposed surface area for the S403 mutants. The phosphomimetic mutants S403D
and S403E have virtually identical average charge states across the concentration
range highlighting how these mutants are very similar to one another in terms of
solvent expo ed surface area throughout the dilution. Moreover, the magnitude of
change across the concentration range was comparable to that observed by the
wild type p62 UBA for each mutant.
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Figure 7.7 - The observed average charge state plotted against concentration of
UBA. The wild type data is also shown as a comparison. The data shows that as
the concentration decreases the average charge state increases. This change
represents the change in populations of monomer and dimer at each concentration.
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The native ESI-MS dilution experiments were repeated in the presence of solvent
vapour. The technique involved placing a small reservoir of solvent, in this case
acetonitrile, into the atmospheric region of the electrospray source. This has the
effect of reducing the charge states of the protein ions sprayed from aqueous
buffers, such as ammonium acetate243• The aim was to see if the intensity of peaks
corresponding to the dimeric species would increase in the gas phase. Other
biophysical techniques which are conducted in solution, such as NMR and lTC,
show the dimer as the dominant species. By decreasing the charge states using
solvent exposure, Coulumb repulsion which can drive unfolding and dissociations
in the gas phase can be reduced, permitting a more native-like distribution of
species.
Using the same samples and conditions as the native ESI-MS dilution
experiments, spectra were recorded in the presence of solvent vapour.
Approximately 5 ml neat acetonitrile was placed into a small plastic dish in the
electro spray source. For all mutants at all concentrations the charge states
visualised in the spectra were reduced when compared to the charge states
observed in the native ESI-MS spectra. A narrower charge state distribution of +2
to +4 was observed in the presence of the solvent (figure 7.8). In addition to
charge state reduction the solvent exposed ESI-MS spectra showed the intensity
of the +5 charge state of the dimer increased dramatically. This reflected an
increase in dimer population as a result of decreased dimer dissociation. Despite
the increase, the monomer remained the predominant species in the gas phase,
even at 8 JlM. The presence of the solvent to reduce dimer dissociation was not
sufficient to cause a completely native-like distribution of species. The ability of
the wild type p62 UBA to dissociate so readily in the gas phase is likely to be the
result of the predominantly hydrophobic interaction between the two subunits.
Hydrophobic interactions have been shown to be significantly weakened in the
gas phase I 78,179. The dimerisation interface does not contain the mutation,
therefore the hydrophobic contacts between the subunits should not be altered.
The S403 dimers are therefore likely to dissociate as readily as the wild type p62
UBA does during ionisation. Since the monomer remained the dominant species
in the gas phase under these conditions, all further ESI-MS experiments were
completed using standard native conditions.
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Figure 7.8 - The native ESI-MS spectrum for the S403E p62 UBA mutant in the
presence of acetonitrile at A) 81lM and B) IIlM. Spectra were recorded in 25 mM
ammonium acetate. A small reservoir of neat acetonitrile was placed in the
electrospray source. The labels correspond to the monomeric species (denoted P)
except for the +5 ion for the dimer (denoted P:P) which doesn't overlap with a
monomer peak. The intensities of the +5 charge state for the dimer have increased
in both spectra highlighting more dimer in the gas phase under these conditions.
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7.2.1.2 NMR dilution experiments confirm the monomer-dimer equilibrium observed
byES/-MS
In order to reinforce the results of the dilution ESI-MS experiments, dilution
experiments were conducted using NMR spectroscopy. Using an 800 MHz
spectrometer fitted with a cryoprobe, high quality data using concentrations as
low as 10 JlM could be obtained. NMR has the advantages that it can provide
information on the relative populations of monomer and dimer as well as the
extent of protein folding. Experiments using NMR are also completed in solution
and are more likely to reflect the in vivo environment. Dilution NMR studies were
also used to monitor the equilibrium of the helix 2 dimerisation interface mutants
studied in chapter 6. The results highlighted that some of the mutations across the
helix 2 dimerisation interface caused significant structural changes.
Dilution NMR studies on wild type p62 UBA had previously identified the dimer
as the dominant species at concentrations above 6 JlM, with 47 resonances
corresponding to backbone amide protons observed (see chapter 6 for IH_15N
HSQC spectra). Both the dimer and monomer exhibited a high degree of
symmetry, as resonances belonging to each subunit were not observed by NMR.
At much lower concentrations the monomer was able to be detected. A 2: 1 ratio
of dimer:monomer was observed at 10 JlM and roughly equal populations were
detected at 6 JlM.
A IH_1sNHSQC experiment was conducted on a high concentration sample (500
JlM) and a low concentration sample (10 JlM) of each of the S403 mutants (figure
7.9). Spectra recorded on samples less than 10 JlM showed poor resolution,
therefore 10 JlM was considered to be the lower limit for samples recorded using
the 800 MHz spectrometer. Serial dilution experiments were not completed in the
interest of saving time. The 500 JlM sample was prepared by dissolving
lyophilized protein in 25mM potassium phosphate, 25 mM NaCI, pH 7. The 10
JlM sample was subsequently made from the 500 JlM sample. All spectra were
recorded at 298 K.
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Figure 7.9 - The 'H_15N HSQC spectrum recorded for the S403 p62 UBA
mutants: S403A p62 UBA at A) 500 11M and B) 10 11M, S403D p62 UBA at C)
500 11M and D) 10 11M and S403E p62 UBA at E) 500 11M and F) 10 11M. All
spectra were recorded in 25 mM potassium phosphate, 25 mM NaCl, pH 7 and at
298 K. At 500 11M resonances which correspond to the dimer only are observed
for the S403 mutants. At 10 11M the number of resonances in the spectrum
doubles for all 3 mutants. The additional resonances correspond to the monomer.
At 10 11M the Trp side chain peaks in the bottom left region of the spectrum
reveal a 2: I dimer:monomer ratio for all 3 S403 mutants. A 2: 1 ratio was also
observed by wild type p62 UBA at 10 11M. Since the spectra for the S403 mutants
at 500 11M and 10 11M is similar to the spectra for the wild type p62 UBA at these
concentrations the data suggests that the monomer-dimer equilibrium is in a
similar position to wild type p62 UBA.
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The results for the three S403 mutants at both concentrations were extremely
similar to the results observed for the wild type p62 UBA. At high concentrations
47 peaks corresponding to a single species (the dimer) were observed in the IH_
15N HSQC spectra for the S403 mutants. At low concentration the number of
peaks doubles suggesting a concentration dependent change in the observed
species. Peaks corresponding to the monomer become visible at lower
concentration as the equilibrium shifts to favour the monomer. No substantial
differences in peak shape were observed between the two species enabling the
intensity of the peak to be used to measure the relative populations of monomer
and dimer. By integrating the peaks which correspond to the two Trp side chains
in the 10 J.lMspectrum a ratio of dimer:monomer was calculated for each mutant.
At 10 J.lM all the S403 mutants show a 2: lratio, much the same as the results
recorded by wild type p62 UBA; highlighting, that the monomer-dimer
equilibrium has not been altered by mutation at position 403.
The spectra recorded for all three S403 mutants show a wide dispersion of peaks.
For the wild type p62 UBA the distribution of resonances corresponding to each
of the species is comparable, but some resonances in helix 3 showed a large
change in chemical shift in the monomeric form. The spectra recorded for the
S403 mutants show very similar distribution of resonances at both high and low
concentrations reflecting that both forms of the mutants have folded into their
native conformations. All resonances were observed between 6 and 10.5 ppm, the
same spectral width as observed by wild type p62 UBA. Both forms of the
mutants are likely to possess native-like tertiary structures. This contrasts the
results observed for the T414A and T414K mutants discussed in chapter 6, which
showed a narrower dispersion of peaks indicative of the partial unfolding of these
mutants.
When the IH_15N spectrum for the wild type p62 UBA at 500 J.lMis overlaid with
the spectra for three S403 mutants (also 500 J.lM) it is clear that no major
structural rearrangements have occurred. When probed further it was clear that the
phosphomimetic mutants caused more chemical shift perturbations than the
S403A mutant. The S403A mutant shows perturbations for Gln400 and Met404
only; whereas S403D and S403E show perturbations of more residues which span
the mutation site (discussed later in section 7.2.2.1)
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7.2.1.3 ITC dilutions confirm that that the structural integrity of the dimer is not
significantly altered as similar values of Kdim are produced by the S403 mutants
The ESI-MS and NMR dilution studies provided evidence for both a monomeric
and dimeric species in equilibrium, with a population distribution very similar to
that observed for wild type p62 UBA. In order to obtain some quantitative data to
confirm the resulted obtained by NMR, dilution ITC experiments were set up. The
apparent Kd for the transition from dimer to monomer (Kdim) could be calculated
using this technique and the data produced compared to values previously
reported for wild type p62 UBA.
Samples between 240 J!M and 260 J!M of the S403A, S403D and S403E were
prepared by dissolving lyophilized protein in 50 mM potassium phosphate, 50
mM NaCI, pH 7. The samples were then degassed as required. The concentrated
UBA samples were loaded into the syringe (as separate experiments). Sequential
injections of UBA into the cell which contained a degassed buffer solution were
recorded in order to observe the calorimetric response of dimer dissociation. A
series of endothermic heat spikes with decreasing intensity were recorded
generating a dimer dissociation curve. The decrease in signal intensity of the
endothermic heat spikes correspond to the decrease in dimer dissociation which
occurs as the concentration of the UBA in the cell increases. The dissociation
curve was fitted to a dimer dissociation model in order to generate a Kdim and iJH
from which a full thermodynamic profile can be generated.
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Figure 7.10 - The raw ITC dilution curve for the S403E p62 UBA mutant at 240
J!M. This dissociation curve is representative for all three S403 p62 UBA mutants.
Experiments were performed in 50 mM potassium phosphate, 50 mM NaCI, pH 7.
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All three S403 p62 UBA mutants produced relatively smooth dissociation curves
(figure 7.10). The dissociation isotherms for all three mutants fitted well to a
dimer dissociation model and produced Kdim and AH values consistent with data
previously reported for wild type p62 UBA. Subsequent calculations of AG and
L1S were therefore also in agreement with the thermodynamic profile calculated
for wild type protein. Kdim values of 3.5 ±0.5 ).1M,6.7 ±0.6 ).1Mand 4.2 ±0.5 ).1M
were recorded for the S403A, S403D and S403E mutants respectively (table 6.1).
The errors associated with Kdim were all small indicating a high degree of
accuracy in the fit. The values of Kdim for the S403A and S403E mutants were in
excellent agreement with 4.1 ).1Mobserved for the wild type protein!", The
S403D mutant recorded the biggest change in Kdim when compared to the wild
type p62 UBA, however the difference is only a factor of two.
The thermodynamic profiles of the S403 mutants vastly differ to the
thermodynamic profile of the weak p62 UBA dimer mutants (T414A, T414K and
T419K).
Table 7.1 - the full thermodynamic profiles of the S403 p62 UBA mutants as
d . db ITCenve ,y
Mutant Kdim (±)I J.lM AH {±)I J/mol L1S (±)I J/K/mol L1G298 (±)/KJ/mol
Wild type 4.1 (±0.6) 60.7 (±l.O) -102.93 (±1.3) 30.7 (±0.3)
S403A 3.5 (±0.5) 55.4 (±2.21 -105.5(±1.1) 31.1(±0.3)
S403D 6.7{±0.6) 48.8 (±1.1) -98.9 (±0.7) 29.5 (±0.2)
S403E 4.2{±0.5) 49.5 (±1.7) -102.8 (±0.9) 30.6 (±0.3)
The ITC data is consistent with both the ESI-MS and NMR data. Overall the data
highlights that Ser 403 in wild type p62 UBA is not a critical residue linked to
dimer formation or its stability. The positioning of the Ser 403 residue as a residue
outside of the dimerisation interface is the likely cause of the consistency in the
Kdim values recorded for the S403 mutants. Any changes in affinity for ubiquitin
by the S403 mutants can therefore not be attributed to a shift in the equilibrium to
favour the biologically active monomer.
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7.2.2 Investigating how phosphorylation affects binding to ubiquitin using NMR
spectroscopy
Phosphorylation at position 403 has been reported to enhance the affinity the p62-
UBA has for ubiquitin. In order to investigate how phosphorylation at this site
affects the p62-UBA binding, one of the phosphomimetic mutants, namely the
S403D p62 UBA mutant was used to conduct forward NMR titrations studies.
Unlabelled ubiquitin was therefore titrated intoISN-S403D. Titrations whereby
unlabelled ubiquitin was titrated into ISN-S403E and ISN-S403A are being
completed by Miss Alice Goode (unpublished data). All NMR experiments were
conducted in 25 mM potassium phosphate, 25 mM NaCI, pH 7 and at 298 K.
NMR is a technique that can provide information on binding affinity by observing
changes in chemical shift to individual residues. The S403 mutants exist in
monomer-dimer equilibrium whereby the dimer dissociates to the monomer
before the monomer can bind to ubiquitin. In order to visualize the monomer
peaks low concentration (10 JIM) samples were used for each point within the
titration (figure 7.11). The monomer peaks were subsequently used to calculate a
Kd for binding by tracking the movement of peaks between the free and bound
forms. In order to gain an insight into the residues involved in binding and how
that differs to wild type p62 UBA the titration data must be fully assigned.
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Figure 7.11 - The free ISN-S403D p62 UBA IH_1sNHSQC spectrum at 10 JlM.
The spectrum was recorded in 25 mM potassium phosphate, 25 mM NaCl, pH 7
and 298 K. The spectrum shows double the number of peaks compared to a
spectrum at 500 JlM due to the presence of both the monomer and dimer species.
7.2.2.1 Assigning the free dimer and bound monomer of S403D
The 10 JlM sample of the free ISN-S403D p62 UBA showed resonances
corresponding to the monomeric and dimeric species (figure 7.11). Of these
resonances 39 were assigned to the monomer and 47 to the dimer. Most of the
resonances corresponding to both species were easily assigned as they were
located at the same chemical shifts as those for the wild type p62 UBA. It was
easiest to transfer assignments from the wild type dimer to the ISN-S403D dimer
and then transfer the assignments to the 10 JlM ISN-S403D spectrum. The 10 JlM
spectrum was significantly more complicated as it contained almost double the
number of resonances. The monomer peaks were assigned once the dimer peaks
had been assigned, against based on chemical shifts reported for the wild type
monomer.
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A spectrum of the 15N-S403D spectrum at 500 JlM, whereby only the dimer peaks
were visible, showed most resonances were located at the same chemical shift as
reported for wild type p62 UBA. Significant differences in chemical shifts were
observed for a small number of resonances (figure 7.12 A). It was therefore
assumed the resonances corresponding to the same residues in the free monomer
would also show differences in chemical shift in the 10 JlM spectrum. These
resonances corresponded to residues Gln400, Met401, Leu402, Asp403, Met404,
Gly405 and Phe406 in the wild type protein. These changes in chemical shift are
for residues located in close proximity to the mutated residue Asp403 only.
The fully bound 15N-S403D spectrum showed 46 assignable backbone resonances
corresponding to the bound monomer form (figure 7.12 B). There was a strong
correlation between the wild type and the 15N-S403D spectra, however differences
in chemical shift were observed again for some resonances. The resonances which
had moved corresponded to the same residues which had moved in the free form.
These residues, Gln400, Met401, Leu402, Asp403, Met404, Gly405 and Phe406,
spanned the mutation site. It is noticeable that the MGF motif, residues Met404,
Gly405 and Phe406, are perturbed in the 15N-S403D bound spectrum highlighting
that these residues have changed their chemical environment and therefore their
position in this complex, perhaps facilitating a stronger interaction with ubiquitin.
Of the residues which showed large chemical shift deviations from wild type p62
UBA Leu402 and Gly405 were stilI able to be assigned based on the wild type
assignments. However further experiments needed to be completed to assign
residues Gln400, Met401, Asp403 (the mutated residue), Met404 and Phe406 in
both the free monomer and dimer. A NOESY and TOCSY experiment was run on
a 500 JlM sample to complete the assignment of the dimer. In addition to this, a
15N-HSQC-NOESYand 15N-HSQC-TOCSY was run on 15N-S403D fully bound
sample (1:4 15N-S403D: unlabelled ubiquitin) to complete the assignment for the
bound monomer. The type of amino acid could be identified using the TOCSY
and 15N_HSQC TOCSY for the dimer and bound monomer respectively. Each
amino acid has a distinct chemical shift correlation pattern to its backbone NH.
Sequential assignment of the cross peaks of the NH region were used in the
NOESY and 15N_HSQC NOESY (again for the dimer and bound monomer
respectively) where the amino acid type could not be easily identified.
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Once the bound monomer peaks were assigned the peaks could be tracked back to
the free fonn as the binding event occurs in fast exchange. For the wild type
protein at low concentration (10 JlM), resonances for monomeric residues Glu389,
Arg393, Met401, Leu402 and Glu409 were visible but these residues were not
assignable in the 10 JlM ISN-S403D spectrum. A 10 JlM NOESY to aid
assignment was recorded but the data collected was of poor quality and was
unable to aid the assignment of the remaining residues. The peak for dimeric
Gly410 is very weak and not visible as a monomer in the wild type spectrum. The
peak for Gly410 is undetectable as either a dimer or a monomer for the 15N_
S403D. The monomer peaks which were not assigned could potentially have
overlapping chemical shifts with the dimer. These would therefore need to be
distinguished from one another using 3D NMR techniques. Since nearly all
resonances were able to be assigned in the 10 JlM ISN-S403D spectrum it was
decided that 3D data collection was unnecessary.
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Figure 7.12 - A) IH_15NHSQC of the free 15N-S403D p62 UBA dimer overlaid
with the free wild type p62 UBA dimer (black and red respectively). B) IH_15N
HSQC of the 15N-S403D p62 UBA bound monomer overlaid with the wild type
p62 UBA bound monomer spectrum (black and red respectively). Both spectra
were recorded in 25 mM potassium phosphate, 25 mM NaCI, pH7 and 298 K.
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7.2.2.2 Identifying which residues on the S403D mutant are involved in ubiquitin
binding (forward titration using NMR spectroscopy)
Monitoring the changes in chemical shift for the monomer resonances between
the free and bound forms will allow a Kd for binding to be calculated. The binding
event occurs as a fast event on the NMR timescale meaning that the peaks which
are visualized are a population weighted average of the free and bound forms.
Peak movement is therefore easy to track and the CSP can be used to calculate the
affinity the S403D mutant has for ubiquitin. Using a 10 JlM ISN-S403D p62 UBA
sample, peaks for both species are observed in a ratio of 2: 1 dimer:monomer. The
low signal intensities recorded at 10 JlM precluded the use of lower concentrations
for titration purposes.
The wild type monomer has been reported to be unstable'Y. This instability was
also observed for the S403D mutant. An initial attempt to complete a titration
using the methodology utilised by other titrations in this thesis resulted in the
sample undergoing sufficient proteolysis causing loss of NMR signal mid way
through data collection. A new strategy involving fresh 10 JlM ISN-S403D
samples combined with lyophilized ubiquitin of known concentrations for each
point was adopted.
Up to 20 molar equivalents (i.e 200 JlM) of ubi quit in was titrated into 10 JlM ISN_
S403D (figure 7.13). The results showed concentration dependent changes for
both the monomeric and dimeric species. Saturation occurred after 10 molar
equivalents (100 JlM) of ubiquitin had been added. Saturation for the wild type
p62 UBA occurred at the addition of 20 molar equivalents (200 JlM) of ubiquitin,
highlighting a greater affinity of the ISN-S403D mutant for ubiquitin. As the
ubiquitin is titrated in the monomer-dimer equilibrium is shifted to favour the
monomer. Similar to the transition from dimer to monomer for the wild type p62
UBA, this event occurs in slow exchange. Consequently, the peaks corresponding
to the ISN-S403D dimer decrease in intensity simultaneous to an increase in
intensity for the monomer peaks. The peak intensities are therefore proportional to
the populations of each species. Resonances belonging to the dimer showed a
significant decrease in peak intensity in the presence of 2 molar equivalents (20
JlM) of ubiquitin. Eventually the peaks belonging to the dimer disappeared
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completely, leaving only the monomer peaks, which are capable of binding to
ubiquitin.
Peaks corresponding to the free 15N-S403D monomer move in a concentration
dependent manner to the bound form. Fast exchange is seen for nearly all
resonances corresponding to the monomeric species. Substantial peak broadening
occurs for peaks corresponding to Gly405, Gly425 and Leu428 during the
titration. However, these residues are in intermediate exchange and thus return to
measurable intensity before saturation occurs.
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Figure 7.13 - IH_15N HSQC spectra for 15N-S403D p62 UBA at 10 11Mshowing
peaks corresponding to the monomer and dimer (black) overlaid with the 15N_
S403D saturated with ubiquitin (red). The spectra were recorded in 25 mM
potassium phosphate, 25 mM NaCl, pH 7 and 298 K.
The CSPs for the monomer (39 peak pairs correlating to the free and bound
forms) were plotted against the residue number to produce a residue specific CSP
plot (figure 7.l4). The gaps in the plot are where a free and bound peak could not
be assigned for that residue. The pattern of CSPs was highly similar to that
observed for the wild type p62 UBA monomer, with the biggest CSPs being found
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at the end of helix 1 and loop 1. Moreover larger CSPs were observed for helix 3,
again correlating well to the wild type data. The CSP plots clearly show the 15N_
S403D mutant still utilizes the conserved MGF motif in loop 1 to bind to
ubiquitin.
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Figure 7.14 -Residue specific CSP for the backbone NH groups for the 15N_
S403D p62 UBA monomer between the free and bound forms. The gaps
correspond to residues which were unable to be assigned. The largest CSPS are
seen for Gly40S in the conserved MGF motif in loop 1 and residues in helix 3.
These large CSPs highlight the S403D mutant binds to ubiquitin using a similar
mechanism to wild type p62 UBA.
The residues which showed a CSP of more than O.OS ppm were considered to be
significant movers. These residues were plotted onto the surface of the wild type
bound monomeric UBA to identify the binding surface (figure 7.1S, PDB ID
2JY8). The darker the red colour, the greater the change in chemical shift. Peaks
for the monomeric Leu402 and Met404 were not able to be detected and assigned.
If these resides were assigned, it was postulated that they would have large CSPs
and a clear binding patch centered on the MGF motif would be identified. The
MGF loop appears to be utilized by the 15N-S0403D mutant meaning an
interaction with the canonical Ile44Nal70 patch on ubiquitin is likely to occur.
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The MGF motif forms a surface which protrudes from the 3D structure of the p62
UBA monomer, which is capable of binding to ubiquitin. The observed large
CSPs for the MGF loop between the wild type and the 15N-S403D mutant
suggests that these residues have changed their orientation to favour a tighter
affinity interaction.
M404
F406
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Q400
Figure 7.15 - CSPs greater than 0.05 for the 15N-S4030 mutant plotted onto the
electrostatic surface of the bound monomeric UBA (POB ID 2JY8). The darker
the red colour, the greater the perturbation. The observed CSPs are caused by
ubiquitin binding. Residues in loop 1 and helix 3 have the greatest CSPs,
highlighting that the S4030 binds to ubiquitin using a similar mechanism to wild
type p62 UBA.
By globally fitting the residues with large changes in chemical shift between the
free and bound forms (CSP >0.05 ppm) to a simple 1:1 binding model using
IGOR Pro an apparent Kd could be produced. A total of 19 curves were fitted to
generate a value of 229 ±34 )..lM.The curves fitted well to a 1:1 binding model.
The Kd value is best described as the observed Kd (Kobs) because the fit does not
take into consideration the competitive processes of dimerisation and binding. By
using the relationship between Kobs and Kdim (equation 12, chapter 3), which takes
into account the two competing equilibria, a more accurate Kd value can be
determined. The S403D mutant was shown to have a Kdim of 6.7 ± 0.6 J-lMas
calculated using ITC dilutions (section 7.2.1.3). Therefore a Kd of39.l ± 4.7)..lM
was calculated for the interaction between the S403D monomer and ubiquitin.
The wild type p62 UBA monomer had been previously shown to have a Kd of 40
± 10 )..lMI41.Rather unusually the S403D mutant therefore does not show a
significant increase in affinity relative to the wild type. However, small changes in
affinity for ubiquitin are also observed by many of the PDB mutations.
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7.2.2.3 Identifying the binding site for the phosphomimetic mutants on ubiquitin
(reverse titrations using NMR)
In order to investigate how the phosphomimetic mutants affect binding to
ubiquitin unlabelled S403D and S403E p62 UBA were titrated into 15N-ubiquitin.
The dephoshorylated mutant S403A was also titrated into 15N-ubiquitin as a
control. The wild type p62-UBA has been shown to bind to the canonical
Ile44/Va170 binding site. Since NMR spectroscopy can provide information on
each residue involved in binding it can identify if the canonical ubiquitin binding
site is still utilized by these mutants. Assignments for wild type ubiquitin have
been previously determined8 and could therefore be used to assign the data
obtained from the reverse titrations.
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Figure 7.16 - The IH 15N HSQC spectrum of ubiquitin (black) and when bound to
S403E p62 UBA mutant (red). The spectra were recorded in 25 mM potassium
phosphate, 25 mM NaCl, pH 7 and 298 K. The 144 and V70 residues which form
the canonical ubiqutin binding patch are highlighted as well as other residues
which move significantly (A46 and K6). Residues R42, K48 and L71 which
broaden upon titration with mutant UBA and do not reappear are also labelled.
This spectrum is representative for all three S403 p62 UBA mutants.
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The addition of up to 2 mM mutant UBA was titrated in to 500 JlM 15N-ubiquitin.
Concentration dependent chemical shifts were observed for each residue
consistent with a binding event (figure 7.16). Saturation was observed for the
phosphomimetic mutants at 500 JlM (a 1:1 mutant UBA : ubiquitin molar ratio).
The S403A control mutant was saturated at 1 mM, a 1:2 molar ratio, indicating
that this mutant has weaker binding to ubiquitin when compared to the
phosphomimetic mutants. 15N-ubiquitin is saturated by wild type p62 UBA after
the addition of 4 molar ratios of wild type p62 UBA.
The binding event is fast on the NMR timescale resulting in peaks which are in
fast exchange. The only exceptions to this are peaks corresponding to residues
Arg42, Ile44, Lys48, Gly53 and Leu71 which are all in intermediate exchange. In
intermediate exchange the transition between the signals observed for fast and
slow exchange is seen causing broad and often non-observable signals. Peaks for
Arg42, Lys48 and Leu71 become undetectable after 100 JlM unlabelled mutant
UBA has been added and do not reappear in the concentration range used in these
experiments. These peaks are all located within the canonical Ile44Nal70 binding
patch, which is not unusual as intermediate exchange is often observed for
residues found in binding patches. The peaks for Arg42 and Leu71 have weak
intensities and both partially overlay with other peaks in the free ubiquitin
spectrum. The initial weak intensities of these signals make it more likely that the
signal will be lost during the titration. The peaks corresponding to Ile44 and
Gly53 are also in intermediate exchange with signals that broaden at 100 JlM and
250 JlM respectively. These peaks, unlike peaks for Arg42, Lys48 and Leu71,
sharpen to strong detectable signals when nearing the saturation point. Typically
peaks which are in intermediate exchange would be expected to sharpen to
considerable intensity once the fully saturated form is reached, however this does
not seem to be the case for residues Arg42, Lys48 and Leu7l. These particular
residues have been shown to behave in the same manner when wild type p62-
UBA is titrated into 15N-ubiquitin, highlighting a conserved mechanism of
binding between the wild type protein and the S403 mutants.
As previously mentioned, the vast majority of peaks are in fast exchange during
the binding event. This means that the observed chemical shift at any
concentration is a weighted average of the chemical shifts observed for the free
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and fully bound forms of the protein. The CSP between the free and bound forms
can be plotted against residue number to observe changes on a per residue basis
(figure 7.17). The greatest CSPs in all cases were observed for the Ile44 and
Val70 residues confirming that the canonical ubiquitin binding site is utilized by
these mutants. The movement of the Val70 peak in the titration with the S403A
mutant was not as great as it was for either of the phosphomimetic mutants. In the
titrations with S403D and S403E p62 UBA, the Val70 peak merges with the peak
for Lys6; however, in the S403A titration there are two distinct peaks close in
proximity but not merged. Two separate peaks for Val70 and Lys6 are also
observed for ubiquitin when wild type p62 UBA is titrated in. The CSP for Val70
is greater for the S403A mutant than it is for wild type protein indicating a
stronger interaction for the S403A mutant and ubiquitin when compared to wild
type p62 UBA. The Val70 CSP is much higher for the S403D and S403E mutant
again highlighting a much tighter interaction with ubiquitin than observed for the
wild type p62-UBA or S403A mutant.
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Figure 7.17 - Residue specific CSPs for ubiquitin when bound to the different
S403 p62 UBA mutants: S403A (blue), S403D (red) and S403E (black). The
CSPs were generated from reverse NMR titrations whereby unlabelled p62 UBA
mutants were titrated into 15N-ubiquitin. The strong correlation in the data
highlights that all 3 mutants bind the canonical Ile44Nal70 binding patch on
ubiquitin.
60 70
174
When you compare at the CSPs for the S403D and S403E mutants with the
S403A value you can determine the effects of mimicking phosphorylation
compared to the control on a per residue basis (figure 7.18). Two patches of
perturbed residues are observed which centre on the Ile44 and Val70 residues. In
addition to this Lys6 shows a large CSP as a result of phosphorylation.
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Figure 7. I - Re idue specific CSPs for the S403D (blue) and S403E (red) values
minus the 403A SP values. The effects of phosphorylation are visualised per
re idue. The re idu most affected by phosphorylation are Lys6, Leu8, Ile44 and
Va170.
Residue with large SP were plotted onto the surface of ubiquitin (figure 7.19,
POB ID IUBQ). A large patch centered on the cannonical Ile44/Va170
hydrohobic patch, confirming that this is indeed the binding patch utilized in
binding to the 403 mutants. The darker red colour indicates the residues which
are more perturbed by binding. The black residues correspond to Arg42, Lys48
and LeuZl , which are in intermediate exchange. From these surface plots it is
clear that the three 403 mutants are affected in slightly different ways. The
phosphomimetic mutants S4030 and S403E have more residues which are
affected by binding.
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Figure 7.19 - CSPs used for binding to the S403 mutant UBAs plotted onto the
surface of ubiquitin (POB ID 1UBQ): A) S403A p62 UBA, B) S4030 p62 UBA
and C) S403E p62 UBA. The darker the red, the larger the CSl". Residues Arg42,
Lys48 and Leu7 broaden during the titrations and are coloured black. A more
extensive binding patch is revealed in the phosphomimtetic mutants indicative of
tighter binding interface.
The residues which had moved significantly (CSP > 0.05 ppm) between the free
and bound forms were used to calculate the binding affinity (Kd) of a the
interaction. Kdvalues of373 ± 19 uM, 337 ± II)lM and 319 ± 11)lM were
calculated for the S403A, S4030 and S403E mutants respectively. These values
were obtained by globally fitting all residues with a esp greater than 0.05 ppm to
a I: I binding model in IGOR Pro. The full details are listed in table 6.2. A value
of 540 ± 45 )lM was previously reported for wild type p62 UBA 140. The Kd values
calculated for all the S403 mutants are lower indicating that all three mutants have
a stronger interaction with ubiquitin than wild type p62 UBA. Despite there being
only subtle differences in Kd, there is a slight preference for the phosphomimetic
S403D and S403E mutants over the S403A non-phosphorylated control.
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Table 7.2 - The Kd values produced from globally fitting residues with a CSP
t th 0 OS lculat db IGOR Pgrea er an . ppm as ea e )y roo
p62 UBA mutant Kd(IlM) Number of Saturation point
residues with a (Ub;UBA molar
CSP >O.OSppm ratio)
Wild type 540 (±4S) 12 4:1
S403A 373 (±19) 18 2:1
S403D 337(±11) 22 1:1
S403E 319(±11) 26 1:1
Although the reverse titrations have the advantage of ubiquitin moving from its
free to bound forms using fast exchange, it also has the disadvantage that the p62
UBA is the invisible part of the NMR experiment. This therefore means that the
Kd values calculated from global fitting are not a true reflection of binding alone,
since dimerisation of the UBA and ubiquitin binding are competitive processes 141.
The dissociation of the dimer to the monomer which precedes binding is not taken
into consideration by IGOR Pro as the determined values are the product of the
two competing equilibria. Hence the previously determined Kd is best described as
the observed Kd (Kobs). Values of Kdim were calculated using ITC dilutions (section
7.2.1.3) and by using the relationship between Kobs and Kdim (equation 12, chapter
3), which takes into account the competitive processes of dimerisation and
binding in the case of the p62 UBA, a more accurate Kd value to be determined.
Based on the values of Kobs and Kdim previously reported for wild type p62 UBA a
Kd value of 47.l ± 10 IlM is produced. Using the same methodology, values of
10.3 ± 0.5, 7.1 ± 0.2 and 8.7 ± 0.4 IlM were calculated for the S403A, S403D and
S403E mutants respectively. An enhanced affinity for the three S403 mutants
compared to wild type p62 UBA was observed. Again, there was a slight
preference for the two phosphomimetic mutants over the S403A mutant.
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7.2.3 Investigating how phosphorylation affects binding to ubiquitin using ESI-MS
ESI-MS titrations were performed as a complementary technique to back up the
findings from the NMR titrations. Binding experiments using ITe were not
possible as the data generated is unable to produce an accurate Kd value as it can
not distinguish between the dissociation event and the binding event. ESI-MS
titrations could be performed at concentrations low enough to minimize the
effects of dimer dissociation. Moreover ESI-MS is able provide an insight into the
stoichiometry of the interaction. All spectra were recorded in 25 mM ammonium
acetate, pH 7.
7.2.3.1ESI-MS titrations
ESI-MS titrations whereby ubiquitin was titrated into the various S403 p62 UBA
mutants were performed. Up to 2 ~M ubiquitin was titrated into 1 ~M of each of
the S403 mutants (as separate experiments). All three mutants produced nearly
identical spectra with mass ions corresponding to the free S403 mutant, free
ubiquitin and a I: I complex between the S043 mutants and ubiquitin (figure
7.20). No higher order oligomers or complexes with a different stoichiometry
were observed. Mass ions corresponding to the complex showed weak intensities
due to the interaction being largely hydrophobic. However, the intensities of the
complex peaks for the two phosphomimetic mutants, S403D and S403E, are
greater than those observed for the S403A mutant; indicating a stronger
interaction for the phosphomimetic mutants. The complex peaks observed for the
S403A mutant are barely above the noise level of the spectrum.
The peak corresponding to the +5 charge state for the dimer (m1z 2292, 2309 and
2315 for the S403A, S403D and S403E mutants respectively) was not visible at I
~M in all cases confirming that the dimer is barely populated at this concentration
and the K/s produced reflect ubiquitin binding only.
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Figure 7.20 - The ESI-MS spectrum of] 11M p62 UBA mutant A) S403A, B)
S403D and C) S403E, mixed with 2 11M ubiquitin. The spectra were recorded in
25 mM ammonium acetate, pH 7. P represents the particular S043 mutant used in
the experiment, L represents ubiquitin and P:L represents their complex.
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By plotting [PL] against [L] a linear correlation is produced with a gradient of K;
is produced. From this the Kd values for each mutant can be calculated222• Kd
values of71.4 ± 5.5 J.1M,45.5 ± 2.1 J.1Mand 27.8 ± 0.8 J.1Mwere obtained for the
S403A, S403D and S403E p62 UBA mutants respectively (table 6.3). These
results, like the NMR reverse titrations, show a slight preference for the
phosphomimetic mutants S403D and S403E over the S403A mutant. However,
the Kd values are likely to be inaccurate due to the inability of the complex to
remain intact once transferred to the gas phase. The complex is mainly stabilised
by hydrophobic interactions between the two proteins, meaning that the mass
spectrometer is inherently biased against complex formation in this case.
Table 7.3 - The Kd values for the S403 mutants and wild type p62 UBA as
determined by ESI-MS titrations.
p62 UBA mutant Kd(±)/J,lM
S403A 71.4 ± 5.5
S403D 45.5 ± 2.1
S403E 27.8 ±O.8
7.2.3.2 Competitive binding studies between the S403 mutants and using ESI-MS
The reverse titration studies by NMR confirmed that all three S403 mutants bind
to the canonical Ile44Nal70 hydrophobic patch on ubiquitin. Since all three
mutants bind to the same patch on ubiquitin, competitive binding studies where all
three S403 p62 UBA mutants, which have different molecular weights, were used
in a single experiment to determine which of the mutants has the greatest affinity.
Despite the interaction between the S403 mutants and ubiquitin being
hydrophobic, ESI-MS was the only technique capable of conducting this type of
experiment as it can identify the small differences in molecular weight between
the S403 p62 UBA mutants. By limiting the number of ubiquitin molecules
compared to UBA binding sites, the S403 mutant with the greatest affinity could
be established.
An experiment whereby all three S403 mutants and ubiquitin were mixed at
equimolar concentrations (5 IlM) was set up. An identical experiment using 1 IlM
of all the S403 mutants and I IlM ubiquitin was also performed to minimize the
effects of UBA dimerisation. Both experiments produced very similar spectrums,
however the 5 IlM spectrum showed more visible complex ions (figure 7.21).
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Figure 7.21 - The ESI-MS spectrum of the competitive binding experiment where
5 uM all S403 p62 UBA mutants was mixed with 5 )lM ubiquitin. Spectra were
recorded in 25 mM ammonium acetate, pH 7.• is the S403A mutant, • is the
S403D mutant, • is the S403E mutant andA is ubiquitin. ~ ,~and 1iI' are
the S403A:Ub, S403D:Ub and S403E:Ub complexes respectively. The greater
affinity of the phosphomimetic mutants S403D and S403E can be easily observed
in this spectrum. Inset a zoom of the +6 charge state for all 3 complexes.
Similar to the individual binding experiments, complex formation was low given
that the interactions were still relatively weak hydrophobic interactions being
monitored in the gas phase. Peaks corresponding to the +3 to the +5 charge states
of the free mutant UBAs were observed as well as the +5 to +6 for unbound
ubiquitin. Peaks which correspond to the +5 to +7 charge state for all three
complexes are also observed (inset figure 7.21), although the signal to noise ratio
was low.
When the region of the spectrum where the complexes are formed (mlz 2000-
3000) is enlarged there is an apparent preference for ubiquitin by the two
phosphomimetic mutants S403D and S403E, compared to the dephosphorylated
mutant S403A. The intensities corresponding to the S403D:Ub and S403E:Ub
complex are almost double those observed for the S403A:Ub complex. From the
intensities of the mass ions observed in the spectrum percentages of the free
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mutant UBAs, and free ubiquitin can be calculated (table 6.3). From the
percentages of ubi quit in and S403 mutant UBA bound within both the 5 JlM and 1
JlM reactions, a preference for the phosphomimetic mutants is clear. The
percentages are only likely to be accurate if it is assumed that the maximum
amount of complex has been formed. The amount of complex formed in the gas
phase is unlikely to be accurate for these complexes because, as outlined earlier,
the interaction is primarily hydrophobic.
Moreover, the S403 p62 UBA mutants were expected to ionise in the same way
due to their similar size and solvent exposed surface area, although some slight
variations in intensities of the free and complex ions for each mutant was
observed. This would suggest that there are some small differences in the
efficiency of ionisation, or that there are slight differences in the concentrations of
the S403 p62 UBA mutants used in the experiment.
Table 7.4 - A table showing the percentage of the S403 mutants and ubiquitin
which binds to form the complex in both the 5 JlM and 1 JlM eqimolar
experiments
5 JlM eqimolar 1 JlM eqimolar
experiment experiment
p62 UBA %UBA % ubiquitin %UBA % ubiquitin
mutant bound bound bound bound
S403A 1.28 0.88 0.62 0.37
S403D 2.13 2.27 0.71 1.16
S403E 2.49 2.19 0.8 1.28
7.2.4 Investigating phosphorylation using GST pull downs and biological assays
All of the binding studies detailed in this chapter are to monoubiquitin rather than
polyubiquitin chains. Full length p62 has been shown to have a greater affinity for
polyubiquitin chains'", thus it was important to determine some binding affinities
to longer polyubiquitin chains. Part of the study conducted by Matsumoto et al
used immunoprecipitation assays to detect the amount of polyubiquitin proteins
that coimmunoprecipitated with the S403A and S403E mutants. The results of
these experiments showed that the S403E mutant bound more ubiquitinated
proteins compared to wild type; whereas, the S403A mutant bound slightly less
than wild type.
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To confirm the enhanced affinity of the S403E mutant, Miss Alice Goode
conducted GST pull down assays on the S403A and S403E mutants. These
mutations were investigated in both the isolated p62 UBA and full length p62
constructs. Binding was investigated using Lys63 linked polyubiquitin chains as
well as monoubiquitin. The results of these pull down experiments showed a
slight preference for ubiquitin by the S403E mutant, as indicated by a more
intense band in the gel which represents the bound complex.
The effects of phosphorylation in specific PDB mutants, namely G425R, P392L,
1424S and M404V, are also currently being investigated using GST pull down
assays. Further biological assays are being conducted in cells on the PDB mutants
by Miss Alice Goode. These assays aim to probe the effects of phosphorylation on
the PDB mutants in vivo. The Layfield group has exclusive rights to the
monoclonal antibody developed by Matsumoto et at that specifically recognizes
S403-phospho p62. This antibody will determine if phosphorylation of the UBA
occurs in the PDB mutants and how much of the phosphorylated form exists in
vivo.
The effects of phosphorylation in the 1424S PBO mutant are also being explored
using biophysical techniques. Early signs show that the combined effect of the
PDB mutation and phosphorylation markedly decreases the affinity of the
interaction. For example, the 1424S mutant alone was shown to have a Kd of 112.2
± 5.1 J.lM, a value which is much weaker than the wild type p62 UBA (40 ± 10
J.lM). However, when the S403E mutation is also inserted to the 1424A mutant a
Kd of 198.4 ± 6.2 is calculated, highlighting an even weaker interaction for the
double mutant (Miss Alice Goode, unpublished data). This is quite odd
considering phosphorylation in the wild type p62 UBA shows an enhanced
affinity. Moreover, the 1424S mutant was shown to be a 5 fold weaker dimer with
a Kdim of 19.8 ± 1. By inserting the S403E mutation into the 1424S mutant the
dimer becomes considerably weakened (Kdim 79.1 ± 3.3). The double mutant
therefore shows a 20 fold decrease in Kdim relative to wild type (Miss Alice
Goode, unpublished data). Again weaker dimers have been shown to have a
higher affinity for ubiquitin. The 1424S data highlights the interplay between
different factors which combine to regulate the affinity. In the case of the 1424S
mutant thermal stability is likely to also have an effect.
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7.3 Discussion
The function of phosphorylation as a regulatory PTM is well documented'". In
the simplest of models a phosphorylated form and dephosphorylated form exist in
equilibrium, whereby one form is biologically active. Complications occur when
proteins are phosphorylated at several different sites, thereby producing various
phosphoisoforms, each with a potentially different role in vivo. Similar to protein
ubiquitination, multiphosphorylation of a single polypeptide chain can occur,
generating a greater number of phosphoisoforms+", The study by Matsumoto et al
identified eight different phosphorylation sites in the full length p62 protein;
highlighting, that p62 has the potential for several biologically active phospho
isoforms. Many of the phosphorylation sites on the p62 are found in regions
linked to protein degradation pathways, therefore different phospho isoforms
could regulate the p62s ability to shuttle proteins between different degradation
pathways.
Since phosphorylation has the ability to alter the affinity of the interaction
between the p62 UBA and ubiquitin, it is conceivable that phosphorylation at
other sites in the full length protein could alter the affinity of p62 to bind to other
proteins. Perhaps the most intriguing of the p62 phosphorylation sites is Ser332
which is located in the LIR and links p62 to autophagy. It has recently been
shown that phosphorylation of the LIR in the optineurin protein, at residue
Ser177, increases the affinity optineurin has for MAP-LC3 and subsequently
increase the autophagic clearance of cytosolic Salmonellai'". It is also plausible
that other LIR containing proteins, for example NBRl, will have enhanced
binding to MAP-LC3 when phosphorylated. NBRI shares the same domain
architecture as p62, has a role in selective autophagy and functions as a scaffold
protein. Moreover, NBR I contains a Ser as the first residue in the LIR, which
corresponds to Ser332 in p62.
Some of the other phosphorylation sites in the p62 have also begun to be
investigated. The cyclin dependent kinase cdkl has recently been shown to
phosphorylate p62 at both Thr269 and Ser272, both of which are located in the
first PEST domain260• Disordered regions of proteins have been shown to have
important roles in cell signaling pathways, with PEST sequences reportedly acting
as internal degradation signalsI37•138• Phosphorylation in PEST domains have been
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reported to influence ubiquitin mediated protein degradation 138. The activity of
cdk 1 is regulated by the levels of cyclin Bland phosphorylation of these sites on
p62 has been shown to be crucial for control in the transition of cells through
mitosis260• Interestingly, phosphorylation in the p62 PEST sequences was shown
to have an effect on cyclin B 1 stability. Cyclin B 1instability is inactivated by
phosphorylation of p62 at Thr269 and Ser272. Furthermore, cyclin B I provides
another link between the p62 and the UPS via Lys 11 polyubiquitination. Cyclin
B 1 is ubiqutinated with Lys 11 chains by the APC and is subsequently degraded
by the proteasome. Although the exact molecular details of the interplay between
the various degradation pathways remains unknown, p62 appears to have a central
role in determining which proteins enter which degradation pathway, with the
different pathways activated in response to specific cellular triggers.
Recently ubiquitin binding by the adaptor protein syntenin-I was shown to be
regulated by phosphorylation'?'. The two termini of syntenin-I are required for
the interaction with ubiquitin. Head-to-tail syntenin-I dimers, mediated by two
central PDZ domains, permit high affinity binding to two ubiquitin molecules.
Synentin-I dimerisation thus offers high avidity binding to ubiquitin. Dissociation
of the syntenin-I :ubiquitin complex occurs when the ubiquitin binding motif in
syntenin-I is phosphorylated. The interaction with ubiquitin is therefore tightly
regulated by both dimerisation and phosphorylatiorr'". A similar control
mechanism could also be employed by the p62 UBA, although dimerisation
would downregulate and phosphorylation would upregulate ubiquitin binding.
Although there are no other reported examples of phosphorylated UBAs to date,
the p62 UBA is most likely to be the first of many. Most ubiquitin:UBA
interactions have been shown to be very weak with affinities that are not
physiologically relevant. It is possible that phosphorylation could increase the
affinity of other UBA interactions to high affinity interactions which promote the
activation of specific cell signaling pathways. Unlike the p62 UBA, not all UBAs
are found in proteins which can form higher order oligomers and are therefore
unable to increase the affinity of the interaction via avidity effects. It therefore
seems likely that other factors such as phosphorylation or linkage specificity play
a role in regulating the interaction between other UBAs and ubiquitin in order to
activate downstream cell signalling.
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7.4 Conclusions
The wild type p62 UBA had been shown to form a highly stable dimer with a Kdim
of 4.1 JlM141.Studies in chapter 6 of this thesis revealed that dimerisation was
able to regulate the affinity for ubiquitin. A recent study also highlighted the
phosphomimetic mutant S403E as having a greater affinity for ubiquitin than wild
type full length p62. The main aim of the experiments conducted in this chapter
was to investigate the role of phosphorylation had in regulating the affinity for
ubiquitin. The phosphomimetic mutants S403D and S403E were generated as well
as a control S403A mutant to represent the dephosphorylated form.
In order to study any changes in affinity associated with the S403 mutants, it was
first important to establish that the monomer-dimer equilibrium has not been
altered by the introduced mutation. Dilution studies using ESI-MS, NMR and ITC
similar to those performed for the helix 2 dimerisation interface were also
conducted for the S403 mutants. The data from the dilution studies using different
techniques correlated well to each other. Evidence for two species in equilibrium
was detected in all cases. The NMR data highlighted the relative populations of
monomer and dimer to be very similar to those observed for wild type protein at
low concentration (10 JlM). Another crucial observation determined from the
NMR data was that all the mutants showed a spectrum with a similar dispersion of
chemical shifts to wild type protein. The mutants were likely to possess a native-
like protein fold. When examined closer only a few residues, all of which were in
close proximity to the mutation site, showed chemical shift deviations compared
to the wild type p62 UBA. The idea of a native-like fold was confirmed by the
ESI-MS dilutions, which highlighted the solvent exposed surface area to be
similar to wild type. Moreover, values for Kdim produced by ITC dilution studies
were in excellent agreement with the Kdim value of 4.1 ± 0.6 JlM observed for wild
type p62 UBA. Taken together the data indicates that the three S403 mutants form
stable dimers with similar Kdim values to each other and to wild type p62 UBA.
With the confirmation that mutations at position 403 having little effect on the
structural integrity of the dimer attentions were turned to binding studies using
NMR and ESI-MS. A forward NMR titration whereby unlabelled ubiquitin was
titrated into ISN-S403D p62 UBA showed saturation occurred after the addition of
10 molar equivalents of ubiquitin. Wild type experiments showed saturation after
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20 molar equivalents, meamng the S403D mutant an increased affinity for
ubiquitin compared to wild type p62 UBA. The reverse NMR titrations, whereby
unlabelled mutant UBA was titrated into 15N-ubiquitin, highlighted that ubiquitin
had a preference for the phosphomimetic mutants, S403D and S403E p62 UBA.
Saturation occurred for these mutants at 1 molar equivalent; whereas, saturation
for the S403A and wild type p62 UBA occurred at 2 and 4 molar equivalents
respectively. Larger chemical shifts were observed in the binding patch on
ubiquitin when bound to the phosphomimetic mutants, again providing evidence
for a stronger interaction. However, when Kd values for the interaction were
calculated the data revealed only small differences in affinity between the
mutants.
ESI-MS titrations where ubiquitin was titrated into the S403 p62 UBA mutants
visually showed a clear preference for the phosphomimetic mutants over the
S403A mutant. This finding was backed up by the competitive binding study,
whereby the mutant UBAs were mixed together. The competitive ESI-MS showed
a clear preference for the phosphomimetic mutants over the S403A mutant.
Inaccuracies in the Kd values were likely to be caused by the gas phase and that
the is principally hydrophobic.
Table 7.5 - A summary of the calculated Kdim and Kd values for wild type p62
UBA and the S403 mutants using various biophysical techniques. An ESI-MS
experiment was not completed for wild type p62 UBA, therefore a Kd could not be
calculated
p62 UBA Kdim (±)/ ~M Kd(±)/ ~M Kd(±)/ ~M Kd(±)/ ~M
mutant (lTC) (fwdNMR) (revNMR) (ESI-MS)
Wild type 4.1 (±0.6) 40 (±10) 47.1 (±10)
S403A 3.5 (±O.5) N/A 10.3 (±0.5) 71.4 (±5.5)
S403D 6.7 (±0.6) 39.1 (±4.7) 7.1 (±O.2) 45.5 (±2.1)
S403E 4.2 (±O.5) N/A 8.7 (±OA) 27.8 (±O.8)
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Overall small differences in affinity were observed for the S403 mutants only.
This is similar to the effects to the PDB mutations, in which subtle decreases,
rather than increases, in affinity occur. The small differences in affinity can be
amplified by oligomeric p62 in vivo because of the avidity effect (discussed in
chapter 9). The potential for arrays of Ser403 phosphorylated UBAs to be
presented to long polyubiquitin chains is likely when oliogomerisation occurs via
the N-terminal PB 1 domain. The avidity effects enhanced further due to the
dimerisation of the p62 UBA itself. The binding studies in this chapter were only
conducted using monoubiquitin which precludes the analysis of the role of
avidity. In addition to this the role of linkage specificity exhibited by the
phosphorylated p62 UBA has not been investigated by the experiments completed
in this chapter.
The phosphorylation site found in the UBA, Ser403, is found adjacent to the MGF
motif in loop 1 which binds directly to the hydrophobic Ile44Nal70 patch on
ubiquitin. Therefore the phosphorylated form of the UBA could induce small
structural changes in the binding motif to produce a better fit between the
molecules. Structural perturbations were observed by NMR for residues
surrounding the mutation site but a significant structural rearrangement of the
whole UBA was not seen. This is consistent with local changes to the binding site
to produce a surface that has a greater complementarity to ubiquitin. By plotting
CSPs to the surface of the ubiquitin, a more extensive binding patch and tighter
binding interface are observed for the two phosphomimetic mutants, despite
affinity differences of only 2-3 fold.
Mutating to Ala, as in the S403A mutant, substitutes a polar amino acid for a
hydrophobic one. Since Ser403 is located in the hydrophobic patch which binds to
ubiquitin, the presence of an additional hydrophobic residue could facilitate a
slightly stronger interaction between the S403A UBA and ubiquitin. This possibly
explains why the S403A mutant does not act as a perfect non-phosphorylated
control. Mutating to the S403D and S403E mutants alters the charge, which also
has the potential to favour electrostatic interactions at the binding interface
between the UBA and ubiquitin and could be a reason why phosphorylation has
been shown to enhance the interaction.
188
Taken together, experiments in this chapter, as well as those conducted by
Matsumoto et aI, phosphomimetic mutants of the p62 UBA have shown that the
phosphorylated form of the UBA has an enhanced affinity for monoubiquitin both
in vitro and in vivo. In vivo phosphorylated p62 UBA has been shown to target
more polyubiquitinated proteins to sequestosomes for their degradation by
autophagy. Although the extent of phosphorylation in vivo remains unknown, it
seems likely that the proposed equilibrium between the phosphorylated and the
dephosporylated forms of the p62 UBA exists and that the degree of
phosphorylation occurs In response to the polyubiquitinated protein level.
Phosphorylation at Ser403 therefore seems to be an important regulator in
determining the fate of ubi quit inated proteins.
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7.5 Future work
The data collected in this chapter clearly indicate some structural alterations in the
MGF loop for the phosphomimetic S403D and S403E p62 UBA mutants. These
alterations were not observed for the S403A mutant. An extension to the project
could be to investigate the changes caused by mutation in the phosphomimetic
mutants further. A complete set of NMR experiments, including 3D triple
resonance experiments, could be used to generate structures of the phoshomimetic
mutants in both the free and bound to ubiquitin forms. Molecular modelling
experiments using the phosphomimetic mutants and ubiquitin could be conducted
to back up the NMR structure. Both of these techniques would provide the exact
details of how the binding interface has been affected by mutation.
Another extension to the work outlined in this chapter could be to perform both
NMR and ESI-MS titrations using the phosphomimetic mutants and longer
polyubiquitin chains. GST pull downs had highlighted the p62 UBA an increased
affinity for polyubiquitin chains over monoubiquitin 170,171 , therefore larger
changes in affinity might be observed by longer chains, especially as only small
changes were observed in monoubiquitin binding. Longer chains would also be
expected to demonstrate higher affinity interactions in the presence of oligomeric
p62 in vivo, as a result of the combined synergistic strength of the individual
interactions, known as avidity. Such avidity effects would be amplified if the
individual interactions were with the phosphorylated form of the p62 UBA.
Additionally chains of different linkage could be used to probe linkage specificity.
A dramatic increase in the affinity for Lys48 linked polyubiquitin chains, as well
as a slight increase for Lys63 linked polyubiquitin chains, was observed by
Matsumoto et al in GST pull down assays using the S403E mutant p62.
A final extension to the project could be to investigate the other phosphorylation
sites. The phosphorylation site found in the LIR at position Ser332 is perhaps the
most obvious first choice, especially as phosphorylation has been observed in the
optineurin LIR and the affinity for MAP-Le3 has been shown to increase in its
phosphorylated form2s9•
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8.0 The p62 protein mediates the formation of a ternary complex
between ubiquitin and MAP-LC3
8.1 Introduction
8.1.1 Autophagy
Autophagy is a degradation pathway which is highly conserved among eukaryotes
(figure 8.1). The process involves sequestering misfolded/aggregated proteins and
damaged organelles to autophagosomal vesicles for their degradation by
lysosomes262,263.The down regulation of autophagy has been linked to
neurodegeneration and cancer as well as regulating immunity264,114,265.Broadly
speaking autophagy can be divided into three main types microautophagy,
chaperone-mediated autophagy (CMA) and macro autophagy depending on the
delivery route of the material to a membrane bound organelle known as an
autolysosomef". Macroautophagy is considered to be the most common route, as
a well as being the most extensively studied and is referred to as autophagy
hereafter.
Autophagy is regulated by a protein kinase known as Tor266.Tor is responsible for
the phosphorylation of proteins which inhibit the initiation of autophagy. When
these proteins are dephosphorylated autophagy is activatedi'", In autophagy, a
phagophore is formed by the nucleation of an isolated membrane. The exact
origin of the membrane involved in phagophore formation is not yet clearly
known, however examples have been shown for its origin in various membranous
structures such as the endoplasmic reticulum and golgi bodies267. When the
phagophore is sealed it becomes a double membrane and is termed an
autophagosome. The autophagosome then undergoes a maturation process
culminating in fusion with a lysosome. This structure, now termed an
autolysosome, is capable of degrading the intracellular material. The breakdown
occurs via acidic hydro lases found within the lysosome263,268.Autophagy is an
essential process during times of cell starvation enabling the cell to use the
degraded materials as sources of energl63.
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Figure 8.1 - Schematic representation of autophagy in the cell. The formation of
the autophosome, its maturation and the degradation of its contents are depicted.
8.1.2 Microtubule-associated protein I light chain 3 (MAP-LC3) protein
MAP-LC3B (the human isoform used throughout this study) is a human
homologue of the yeast protein Atg8 which is essential for autophagy. MAP-LC3
proteins belong to the microtubule-associated protein (MAP) family and are small
ubiquitin-like proteins with molecular weights of around 15 kDa. Within the
autophagic pathway, MAP-LC3 has been shown to have a crucial role in the
formation of autophagosomes with the N-terminal a helices being fundamental in
membrane fusion269. There are 6 human homologues of the yeast Atg8, MAP-
LC3A, MAP-LC3B, MAP-LC3c, GABAA receptor associated protein
(GABARAP), GABARAPLI and GABARAPL2 (which is also known as GATE-
16). Little is known about GABARAPLI and GABARAPL2; however, the 3
isoforms of MAP-LC3 and GABARAP have been studied more extensively+".
Structurally, human MAP-LC3 proteins are similar to other mammalian
homologues despite having low sequence homology. MAP-LC3 proteins possess
two subdomains and are comprised of 4 a-helices and a central mixed p-sheet
(figure 8.2). The p sheet contains 4 strands denoted SI to S4. SI and S4 are
parallel strands located in the centre of the sheet, whereas S2 and S3are
antiparallel to S I and S4 respectively. Helices 1 and 2 form the N-terminal
subdomain. Helices 3 and 4 and the p sheet form a ubiquitin-like fold and is
referred to as the C-terminal subdomain. The two subdomains subsequently fold
into a single compact globular structure driven by hydrophobic patches within
each subdomain27o.
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In its full length form MAP-LC3s (the human isoform used throughout this study)
is known as ProMAP-LC3. ProMAP-LC3 is cleaved by a cysteine protease known
as Atg4B leaving an exposed Gly residue at the C-terminal. In its cleaved
cytosolic form it is known as MAP-LC3-I. The terminal Gly residue is
subsequently conjugated to phosphatidylethanolamine via the actions of E I and
E2 like enzymes, enabling MAP-LC3 to lo.calise to the autophagosome. This
membrane bound lipidated structure is referred to as MAP_LC3_n271.
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Figure 8.2 - The structure of the MAP-LC3s protein (PDB ID IV49) A) A
surface plot ofMAP-LC3B depicting the two hydrophobic pockets (coloured blue)
which bind to the conserved WXXL motif in the LIR of the p62. The pockets are
labelled according to the residue which they bind. B) Ribbon representation of the
MAP-LC3B protein. The hydrophobic residues are again highlighted in blue.
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8.1.3 The role of p62 in autophagy
The full length p62 protein acts as a molecular scaffold which links target proteins
to two degradative pathways: autophagy and the ubiquitin proteasome system
(UPS). The UPS is involved in the disposal of short lived proteins; whereas long
lived proteins and organelles which have become damaged are removed by
autophagy. Ubiquitin mediated selective autophagy involves the formation of an
autophagosome which contains ubiquitinated proteins bound to p62.
Ubiquitinated proteins are often delivered to the proteasome for degradation but
are also commonly found in autophagosomes the p62 where they are degraded by
autophagy. The p62 is able to transfer target ubiquitinated proteins to different
routes of degradation. There is mounting evidence for cross talk between
autophagy and the UPS272.273,although the molecular mechanisms responsible for
this remain unknown. Also rather interestingly the p62 protein is degraded by
autophagy74 but is protected from degradation by the proteasome by its C-
terminal UBA 143.
The p62 protein contains a 22 residue MAP-LC3 interacting region (LIR) which
binds directly to the MAP-LC3 protein, linking the p62 protein to the autophagy
pathwayl16. 117.The p62 LIR is located between residues 332 and 345, with a
conserved WXXL motif used for direct interaction with the p62116• 275.This motif,
WTHL as it is found in the p62 protein, spans residues 338-341 and has been
shown to exhibit an extended ~ conformation. An intermolecular parallel p-sheet
is formed between the WTHL motif of the p62 and the ~2 of the MAP-LC3 C-
terminal subdomain. The Trp338 side chain interacts with the hydrophobic pocket
formed at the interface between the two subdomains of the MAP-LC3; whereas,
the Leu341 sidechain binds to the hydrophobic pocket on the C-terminal
subdomain275. The p62 LIR also contains an acidic patch consisting of three
consecutive Asp residues at positions 335 to 337. This patch has been shown to
interact with basic residues at the N-terminal of the MAP-LC3117.
The p62 protein is very similar in domain structure to neighbour of BRCA gene 1
(NBRl) protein, with each containing an N-terminal PB 1 domain, a C-terminal
UBA domain and an LIR (figure 8.3, A). The LIR and UBA enable these two
proteins to bind to both MAP-LC3 and ubiquitin. Both proteins have been shown
to exhibit roles as adaptor proteins in selective autophagy. More recently a role for
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ubiquitin has been discovered in selective autophagy, since these adapter proteins
are involved in the delivery of polyubiquitinated misfolded substrates which are
degraded by autophagyI16,276.Both are capable of polymerising or aggregating via
their PB 1 domains and can recognise substrates required for selective
autophagyi". It has been recently proposed that self oligomerisation via the PB I
domain is a prerequisite for targeting to the autophagosome, rather than MAP-
LC3 binding. The proteins are subsequently incorporated into the autophagosome
in a process that is most likely MAP-LC3 dependent although the exact details
have yet to be elucidated". Despite their similarities, some diversity between p62
and NBRI has been observed, p62 has been shown to possess a specific role in
cell protection by targeting invading bacteria to the autophagy pathway, unlike
NBRlI34.
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Figure 8.3 - A) the domain structure of the p62 and NBRI scaffold proteins. The
NBRI protein possesses coiled coil motifs in addition to the PBI, ZnF, UBA and
LIR which are shared by both proteins. Both of NBRI and p62 are capable of
binding to both ubiquitin and MAP-LC3 and have roles in selective autophagy.
The crucial interacting residues of both LIRs are provided. Taken from Kirkin et
aP79. B) a schematic model for selective autophagy mediated by p62. Taken from
lchimura et atll7. The p62 binds to target proteins and both proteins become
trapped within the autophagosome and are subsequently degraded.
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As more LIR regions in different proteins have been discovered some variability
has been shown. The WXXL motif has now been modified to a more general
exxr sequence, where e represents an aromatic amino acid and r represents a
hydrophobic residue (table 8.l). It has also been noticed that negatively charged
residues and amino acids which are capable of being phosphorylated are also
common features to LIRs. Since the residues are only partially conserved within
different LIRs, investigations into how critical the amino acids are within the
oxxr sequence280.
LIR containing protein LIR amino acid sequence LIR location
P62 SGGDDDWTHLSS 332-345
NBRI SASSEDYIILPE 727-738
Nix W36 AGLNSSWVELPM 30-41
Nix W140 SADWVSDWSSRPENIP 137-152
Atg4B TLTYDTLRF 5-13
Se Atg19 ALTWEEL 409-415
Table 8.1 - A comparison of the LIR sequences in different proteins. The
aromatic and hydrophobic amino acids are shown in red and blue respectively.
8.1.4 Summary and aims
The separate interactions between the p62 LlR and MAP-Le3 and the p62 UBA
and ubiquitin have both been reported by NMR275,14o. However the interaction
with MAP-Le3 was provided by using a p62 peptide corresponding to the LIR
region only. Since the full length p62 protein functions as a scaffold protein it is
highly likely that the p62 can bind to multiple binding partners simultaneously to
regulate different signalling pathways. Moreover, the p62 protein provides a
molecular link between ubiquitination and autophagy so it therefore seemed
logical to see if a p62 mediated ternary complex could be formed between p62,
MAP-Le3 and ubiquitin (figure 8.4). We also aim to investigate if there is an
allosteric relationship between the two binding proteins.
To date no structural work has been conducted on the full length p62 protein or
any of the potential multimeric protein complexes the p62 protein could form. In
order to gain an insight into the p62s ability to regulate cross talk between the
UPS and autophagy, binding studies using NMR spectroscopy were completed.
We aim to rationalise the structural basis for recognition of both MAP-Le3 and
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ubiquitin by the p62. Insights into the molecular recognition of one protein whilst
the other is pre-bound, is crucial to understanding the p62s ability to regulate of
the two degradation pathways. It was also unknown if any contacts between
MAP-LC3 and ubiquitin occur once simultaneously bound to the p62. NMR
would be able to identify if such contacts are formed. In order to back up any
findings by NMR, binding experiments using ESI-MS were also conducted. ESI-
MS has the advantage of using low sample concentrations and quick data
collection times. Moreover, it would be possible to detect if an interaction
between the MAP-LC3 protein and ubiquitin occurred, for which NMR is a
unique tool.
The full length p62 had previously been shown to be difficult to purify, due to a
large unstructured region between the ZZ domain and the UBA which encodes
two PEST domains. PEST domains are thought to function as internal degradation
signals 137, 138, although this is unconfirmed in the p62. Therefore a fragment of the
p62 extending back from the C-terminal which encompassed both the UBA and
the LlR, but minimised the unstructured region was engineered. This construct,
denoted p62 300-440, consisted of eighty seven amino acids of unstructured
protein and the folded UBA domain. The p62 300-440 construct was mutated to a
C331 S variant to eliminate the potential to form an intermolecular disulphide
bond .
./
,/
Figure 8.4 - a schematic representation of the C331 S p62 300-440 construct
bound to the MAP-LC3 and ubiquitin. The image was made from the MAP-LC3
protein complex to the p62 LIR (PDB ID 2K6Q) and the ubiquitin-p62 UBA
complex. The ubiquitin-p62 UBA complex is a representation made from the
PBD's of ubi qui tin and the bound monomer (PDB ID's IUBQ and 2JY8). Black
lines are used to define the LIR in the schematic.
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8.2 Results
8.2.1 Purification of the C331S p62 300-330 reveals partial degradation
The C33I S p62 300-440 construct was able to be purified to a low yield
(approximately 3 mg / Litre). A fully homogenous sample was not able to be
obtained as the sample progressively degraded throughout the purification, despite
the addition of a protease cocktail at each stage of purification. The degradation
was able to be visualised by SDS PAGE; however, the intensity of the fragmented
bands was weak compared to the intensity of the full length protein (figure 8.5). It
is possible that degradation is an intrinsic property of the sequence, since the
C331S p62 300-440 fragment encodes one of the two PEST domains.
Unfortunately there was no way to quantify the amount of degradation caused.
The nanodrop which was used to check concentrations would detect the
flourophores in the fragments as well as the full length C33I S p62 300-440. It
was difficult to determine exactly where the degradation was occurring as several
recognition sequences for proteases were contained in the linker region. The gel
suggests a cleavage close to the UBA as a band appears close to the 6.5 kDa
marker. Since the intensities of the fragmented bands were weak it was decided
that the level of degradation was not enough to alter protein concentration
significantly. With this in mind it was decided to proceed with NMR experiments.
29 kDa
20 kDa
~ degradation
12345678
Figure 8.5 - A 20 % acrylamide SDS PAGE gel of the purification of the C331 S
p62 300-440 construct which had been in expressed in C41 (DE3) E.coli .. A low
molecular weight marker was used as a size standard (lane 1). Gel filtration
fractions 13, 14, 15, 16 and 17 are shown in lanes 2 -6 respectively. Desalt
fractions 2 and 3 are shown in lanes 7 and 8. C331 S p62 300-440 containing
fractions are gel filtration fraction 15 and desalt fraction 2. The degradation has
become more evident after desalting as shown by the appearance of faint bands
beneath the main protein band.
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8.2.2 NMR studies on the p62 mediated ternary complex between C331S p62 300-
440, MAP-LC3 and ubiquitin
All NMR samples were prepared by dissolving lyophilised protein in 25 mM
potassium phosphate, 25 mM NaCI, pH7 buffer. All spectra were recorded at
298K. Initial experiments to confirm the suitability of the ISN-C331S p62 300-440
construct for NMR experiments were conducted prior to IH_1sN TROSY
titrations, IH_1sN heteronuclear NOE experiments and 3D triple resonance
experiments for protein backbone assignment.
8.2.2.1 The In uN TROSY experiment confirms the e331S p62 300-440 contains both
folded and unstructured regions
A 250 JlM sample of ISN-C331S p62 300-440 was prepared and it's conformation
checked using a IH_1sNTROSY (figure 8.6). The IH_1sNTROSY spectrum shows
two distinct regions of the C331 S p62 300-440 protein, an unstructured region and
the folded UBA. The unstructured region is represented by the boxed region in the
centre of the spectrum eH dimension 7.9 - 8.5 ppm, 15Ndimension 112 - 128
ppm). These peaks show poor dispersion with a significant degree of overlap and
are very strong in intensity. All of these features are characteristic of unstructured
regions of proteins. In this construct, residues 300-387 correspond to part of the
intrinsically disordered region of the p62. The well dispersed peaks on the outer
most parts of the spectrum (generally outside the boxed region) correspond to the
p62 UBA. These peaks show near identical chemical shifts to those reported for
the free form of the isolated UBA domain. These peaks are significantly weaker
than the unstructured peaks.
It was also noticed that the spectrum was relatively clean. Some peaks
corresponding to degraded fragments of proteins were observed in the central
lower region of the spectrum eH dimension 7.5-8.5 ppm, 15Ndimension 125-130
ppm) when the levels were increased. However, in agreement with the SDS
PAGE analysis it was deduced that significant proteolysis of the 15N-C331S p62
300-440 construct had not occurred.
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Figure 8.6 - The IH_15N TROSY spectrum for the free C331S p62 300-440
construct (black) and the p62 UBA (red). The UBA peaks in both constructs
overlay weI!. The central region containing the unstructured amino acids in the
C331 S p62 300-440 construct is shown by the dotted box. Both spectra were
recorded in 25 mM potassium phosphate, 25 mM NaCI, pH 7 and 298 K. The well
dispersed peaks on the edges of the spectrum belong to the folded UBA; whereas,
the central highly overlapped region corresponds to the unstructured region
located N-terminally to the UBA domain.
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8.2.2.2 NMR titrations reveal binding of MAP-Le3 and ubiquitin is not allosteric
A titration involving the binding of unlabelled MAP-LC3 protein to the 15N_
C331 S p62 300-440 construct then adding unlabelled ubiquitin to the MAP-LC3
bound form was conducted. A reverse titration involving adding ubiquitin first,
then MAP-LC3 was also conducted. An initial attempt at a titration revealed that
the lifespan of the 15N_C311S p62 300-440 is only approximately 48 hours. After
this time period the 15N-C331S p62 300-440 shows substantial degradation.
Attempts were made to shorten the length of the experiment by using the
SOFAST pulse sequence on the IH_15NTROSY; however, extensive Tl noise
caused a large streak through the centre of the spectrum. This noise confirmed
that this type of experiment was not beneficial to this particular protein. With this
in mind the subsequent titrations were completed using the lowest number of
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scans whilst maintaining signal to norse. This time reduction permitted the
titrations to be started and finished on the same day in order to reduce sample
degradation as much as possible. The titrations show that both proteins bind to the
p62 and bind independently of occupation of the other binding site. The data also
revealed that there is not an allosteric relationship between MAP-Le3 and
ubiquitin. Both proteins bind to the 15N_C33IS p62 300-440 construct with similar
affinities to those reported for the separate interactions, as saturation is reached at
similar points in the titrations.
The addition of up to 250 J!M unlabelled MAP-LC3 to 250 J!M 15N-e331S p62
300-440 resulted in concentration dependent changes in chemical shift. A mixture
of fast and slow exchange was observed for the resonances which were perturbed
upon MAP-LC3 binding. Slow exchange means that two peaks per residue are
observed during the titration, one for the free form and one for the bound form.
On the other hand, fast exchange visualises a population weighted average
between the free and bound forms enabling the movement of peaks to be tracked.
The UR is just twelve amino acids in length, with the conserved binding motif
consisting of just four residues. This means that only a small part of the 15N_
C33IS p62 300-440 fragment is altered upon binding to MAP-LC3. Significant
changes in chemical shift are observed for approximately fifteen residues, with no
changes in chemical shift observed for residues previously assigned to the UBA
(figure 8.7).
The interaction between the LIR of the p62 and MAP-LC3 is of a higher affinity
than the interaction observed for the UBA and ubiquitin, with saturation occurring
around 1:I molar equivalents. This is consistent with the previous study between
the p62 LIR peptide and MAP-LC3. It would therefore appear that using a longer
fragment of the p62 does not dramatically alter the affinity the p62 has for MAP-
Le3. Moreover, it agrees well with the interaction between the URI of NBRI
and MAP-LC3 o; 0.62 ± 0.06 J!M, determined using ESI_MS)281. The NBRI
protein is structurally and functionally very similar to p62; therefore, the
mechanism of binding and the affinity for MAP-Le3 is likely to be similar.
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Figure 8.7 - The free 15N-C331S p62 300-440 IH 15N-TROSY (black) overlaid
with the IH_15NTROSY of the 15N-C331S p62 300-440 bound to MAP-LC3
(red). Inset a zoom of the Gly region. The spectrum was recorded in 25 mM
potassium phosphate, 25 mM NaCI, pH 7 and 298 K The residues in the UBA
with previous assignments do not shift and are labelled. The peaks which show
CSPs upon binding to MAP-LC3 in this region are likely to correspond to the Gly
residues in the LIR.
Up to 1mM unlabelled ubiquitin was added to the 15N-C33IS p62 300-440-MAP-
LC3 binary complex. More ubiquitin was added than MAP-LC3 because the
affinity the p62 UBA has for ubiquitin is known to be weak due to the competitive
processes of dimerisation and binding. Again, concentration dependent changes in
chemical shift were observed for resonances corresponding to the UBA (figure
8.8). This was indicative of a binding event involving the UBA domain.
Saturation of the 15N-C331S p62 300-440 occurred around 1 mM, a 1:4 molar
ratio. This was similar to the observed saturation point for the p62 UBA domain
in isolation, highlighting that the affinity has not been significantly altered in the
longer construct. The addition of ubiquitin resulted in a mixture of slow and fast
chemical exchange regimes, again in accordance with the data previously
obtained for the p62 UBA and ubiquitin. This would suggest that the mechanism
of binding is not affected in the longer p62 construct.
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Figure 8.8 - The free 15N-C331S p62 300-440 IH_15NTROSY (black) overlaid
with the IH_15NTROSY of the 15N-C331S p62 300-440 bound to both MAP-LC3
and ubiquitin (red). Inset a zoom of the Gly region. The spectrum was recorded in
25 mM potassium phosphate, 25 mM NaCI, pH 7 and 298 K. Significant CSPs are
observed for nearly all residues in this region. The peaks corresponding to the
UBA show similar CSPs to those previously reported when bound to ubiquitin.
One particularly interesting observation was that some resonances corresponding
to the bound form of the UBA in the C331 S p62 300-440 construct had deviated
from the chemical shifts previously reported for the isolated UBA domain. The
resonances corresponding to the UBA only move on the addition of ubiquitin,
ruling the possibility of a MAP-LC3-UBA complex. The data therefore suggests a
different conformation of the ubiquitin bound UBA in this p62 construct, which
could also occur in full length p62 in vivo. When examined in detail around half
the UBA peaks showed chemical shifts perturbations. Moreover, many could not
be unambiguously identified due to their chemical shifts being located within the
crowded central region. The conserved MGF motif utilised by the UBA to bind to
ubiquitin critically did not show significant CSPs indicating that the mechanism
of the interaction with ubiquitin was not affected. The resonances which shifted
corresponded to residues in helices 2 and 3 as well as the C-terminus (figure 8.9),
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which interestingly have different chemical shifts in the UBA dimer and
monomer. This 'alternative bound form' was observed in both titrations
highlighting that it was not an artefact of MAP-LC3 binding first. Moreover,
because the 'alternative bound form' was observed in the titration where ubiquitin
is bound first suggesting that the alternative form is not the result of a direct
contact between the MAP-LC3 and ubiquitin.
The C-terminus is likely to adopt a different chemical environment in the longer
construct as it is conformationally flexible. However, further investigation into the
movement of the peaks in helices 2 and 3 would be required to determine if
indeed an 'alternative bound form' exists. This form could provide insights into
how the UBA functions as part of the full length p62 protein.
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Figure 8.9 -The amino acid sequence of the p62 UBA. The residues in red are
assigned and the residues in black not assigned in the bound form. The red
residues are the assigned residues of the UBA in the bound form. Helices 2 and 3
and the C-terminal are unable to be assigned. These residues either show different
chemical shifts than observed for wild type p62 UBA, or are located in the
clustered central region of the spectrum and are unable to be unambiguously
assigned.
8.2.2.3 Backbone assignment of the free J5N_C331S p62 300-440
The C33IS p62 300-440 construct has a molecular weight of 15.4 kDa. Including
the GS extension left from thrombin cleavage, the construct is 143 residues in
length. Proteins greater than 10 kDa require high spectral resolution. Triple
resonance experiments are required to assign the protein backbone in larger
proteins. Separating into a third dimension should reduce overalapping resonances
in the 'H_'5N TROSY. Therefore a 250 11M 13C'5N-C331S p62 300-440 was
prepared by dissolving lyophilised protein in 25 mM potassium phosphate, 25
mM NaCI, pH 7. HNCACB, HN(CO)CACB, HNCA, HNCO and HN(CA)CO
experiments were set up with the total time not exceeding 48 hours. The HNCA
experiment was also recorded to ensure Ca. signals were detected as ~ optimised
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data was collected on the HN(CO)CACB. Due to the highly degradable nature of
the C331 S p62 300-440, the HNCACB and HN(CO)CACB experiments were
collected as Band-selective Excitation Short-Transient (BEST) experiments.
These experiments shorten the delay between consecutive scans dramatically
reducing data acquisition times whilst maintaining the signal to noise ratio in
order to collect high resolution data.
However due to the unstructured nature of this construct and the high prevalence
of Pro, Glu, Ser and Thr residues of the PEST sequence a full backbone
assignment was unlikely. It was therefore decided that assignment of the LIR and
UBA only would be the most sensible option. The LIR is only 12 residues in
length and it contains a unique and distinctive Ser-di-Gly motif at the start. Both
Ser and Gly residues have characteristic Ca and Cp chemical shifts making them
easy to assign using the classical backbone assignment experiments, especially
when connected in a sequence. Moreover, the assignments for the UBA had been
previously reported and transferring the assignments to the longer construct
should not be a difficult task.
Despite the collection of good quality data many of the peaks corresponding to the
UBA were not detected by the triple resonance experiments at this concentration.
This was not problematic in the free form as the assignments for the UBA were
able to be transferred to the C331 S p62 300-440. As predicted the assignment of
the full length protein would have been challenging. Assigning the Co, Cp and
CO peaks to individual spin systems were difficult due to the considerable peak
overlap which remained despite separating into three dimensions. This prevented
the ability to link up distinguishable sequences. The automated assignment panel
was also unreliable since it suggests potential residues corresponding to the i+1
residue and its suggestions were poor.
The assignment process was problematic even when focusing on the 12 residue
LIR only. The unique Ser-Gly-Gly sequence was easily identified (figure 8.10) as
predicted. However the reminder of the LIR, especially the three consecutive Asp
residues, required a different approach as sequential linking of spin systems was
not possible. The spin systems which had moved in the IH_IsN TROSYs recorded
for the free and MAP-LC3 bound C331S p62 300-440 were noted. These spin
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systems were analysed further in the HNCACB, HN(CO)CACB and HNCA
experiments. These spin systems were considered to be part of the LIR because
they had moved. Using the Ca and C~ shifts from these experiments the amino
acid type for the i and i-I residues could be deduced. Despite this, only half the
LIR was able to be assigned as these were distinctive amino acids (figure 8.11).
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Figure 8.10 - The strips for the Ser-drGly motif in the LIR of the free I3C 15N
C33l S-p62 300-440. The HNCACB (red, green) and HN(CO)CACB (teal,
orange) spectra show the sequential connectivity between Ser332, Gly333 and
Gly334. The HNCACB shows Ca and C~ resonances from residues i and i-I,
whereas the HN(CO)CACB shows only the residues from the i-I residue. Each
strip shows is mapped to the amide IH and side chain I3C frequencies, with the
15N amide frequency displayed at the bottom left. The black arrows indicate
correlating resonances between connected residues.
There are other distinctive residues present in the LIR: a single Thr and another
di-Ser motif. These were logical starting points for this method of assignment.
There are two other di-Ser motifs and several other Thr residues in the C331 S p62
300-440 sequence. However one of the other di-Ser motif is located centrally in
the linker region between the LIR and the UBA it is unlikely to participate in
binding and therefore have spin systems which do not move upon MAP-LC3
binding. The other di-Ser motif (located at the start of the LIR) contains Ser332
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which was previously assigned as part of the unique Ser-diGly motif. Thr339 is
the only Thr residue in the LIR and of the seven Thr residues found in this
construct three are found in the UBA and therefore have known chemical shifts,
two have been previously identified using the unique PSTG and PTG sequences
when attempts were made to assign the p62 341-440 construct282• This leaves just
two unassigned Thr residues in the C331S p62 300-440 construct. The spin
system which was perturbed upon MAP-LC3 binding was likely to be Thr339. To
check this, the Ca and C~ shifts of the preceding residue were checked. Thr339 is
located after Trp338. The spin system assigned to Thr339 showed Ca and C~
which were likely to belong to either a His or Trp residue. The other unassigned
Thr residue, Thr305 is preceded by an Ala residue which has a distinctive C~
shift. Moreover, this residue is located close to the C-terrninus which may prevent
it from being visualised. Therefore Thr339 was assigned to the moving spin
system. Ser331 (the residue preceeding the LIR) was also able to be assigned as it
was connected to the Ser di-Gly motif.
The other residues of the LIR which were attempted to be assigned using the
method of identifying the amino acid type of i and ;-1 residues from perturbed
spin systems were Trp338 and Leu341. Since these residues are not distinctive
like Ser and Thr residues these assignments were tentative at best. The only
residues which were unable to be assigned at all were Asp335, Asp336, Asp337
and His340. If the Asp residues are all located in a fully unstructured region, they
would be expected to be in the same environment and therefore possess the same
Ca and C~ shifts prohibiting their identification from one another. This method
used to assign the LIR is somewhat unusual. It would be preferable to adopt a
classical approach whereby individual spin systems are linked. However, this
would require data which did not have significant overlap of resonances.
In the unbound C331S p62 300-440 construct the UBA domain exhibited
chemical shifts which were very similar to those observed for the unbound
isolated UBA domain. The assignments of 40 resonances were able to be
transferred to the IH_15N TROSY of the C331S p62 300-440. The resonances
which were unable to be assigned were located in the crowded central region of
the spectrum or were at the C-terrninus which exhibits flexibility which can affect
chemical shift. The 3D triple resonance spectra were unable to help overcome this
207
problem as many of the peaks corresponding to the UBA were weak or not
detected at all.
Figure 8.11 - the sequence of the C33l S p62 300-440 construct. The LIR and
UBA are underlined. The residues which were assigned in the free 15N-C33l S p62
300-440 TROSY spectrum are coloured yellow and purple for the LIR and UBA
respectively.
8.2.2.4 Backbone assignment of the C33IS p62 300-440 when bound to MAP-LC3 and
ubiquitin
A 400 J-lM I3CI5N-C331S p62 300-440 saturated with both MAP-LC3 (400 J-lM)
and ubiquitin (1.6 mM) was prepared by dissolving lyophilised protein in 25 mM
potassium phosphate, 25 mM NaCI, pH 7. The concentration of the C331 S p62
300-440 construct was increased in order to detect the resonances corresponding
to the UBA peaks, which were lost at 250 J-lMin the triple resonance experiments.
This was necessary due to differences being observed between the ubiquitin-
bound form for the isolated UBA and the C331 S p62 300-440 construct
(discussed previously). MAP-LC3 had shown to be insoluble above 250 J-lM;
however, gradually adding lyophilised MAP-LC3 to the I3CI5N-C331S p62 300-
440 seemed to prevent this. A IH_15NTROSY showed resonances which overlaid
with a previously recorded spectrum for the MAP-LC3 bound form and confirmed
that the MAP-LC3 bound form had been reached before the addition of ubi quit in.
The same triple resonance experiments were conducted on the bound sample as
the free 13CI5N-C331S p62 300-440, again with the total time for the five
experiments not exceeding 48 hours. BEST pulse sequences were used to keep
data collection times down. Similar to the free form the data produced from the
experiments was difficult to analyse due to significant overlap of resonances,
despite separating into three dimensions.
A full assignment of the p62 LIR in the bound form could not be attained due to
the high degree of overlap of signals. The residues of the LIR that were assigned
confidently in the free form were also able to be assigned in the bound form.
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Ser331 (the residue preceding the LIR), Ser332, Ser342 and Ser343 were all able
to be tracked to the bound form as they were in fast exchange. Gly333, Gly334
and Thr339 were in slow exchange but were able to be assigned from the triple
resonance data using the methodology outlined earlier. This was aided by the
distinctive Ca and C~ shifts for Gly and Thr amino acids. The Ser-diGly motif
also showed spins systems which could be linked sequentially (figure 8.12).
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Figure 8.12 - The trip for the Ser-diGly motif in the LIR of the bound I3C 15N
C331 S-p62 300-440. The HNCACB (deep purple, orange) and HN(CO)CACB
(green, bright purple) pectra show the sequential connectivity between Ser332,
Gly333 and ly334. The HNCACB shows Caand C~ resonances from residues i
and i-i, wh rea the HN( O)CACB shows only the residues from the i-I residue.
Each trip show i mapped to the amide IH and side chain I3C frequencies, with
the 15N amide frequency displayed at the bottom left. The black arrows indicate
correlating re onance between connected residues.
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As previou Iy mentioned, many of the resonances corresponding to the bound
UBA in the 15N_ 331 p62 300-440 construct were not found at the same
chemical hift in the IH_15N TROSY as they were for the isolated domain. These
residue were clu tered in helices 2 and 3 and the C-terminal. Therefore many
peaks in the UBA were unable to be assigned in the ubiquitin bound form.
Increasing the concentration of the J3C 15N C331 S p62 300·440 sample did enable
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the detection of some of the UBA peaks, but not all. Unfortunately the number of
scans could not be increased due to the sensitive nature of this protein. Obviously
residues which did not produce any resonance peaks in the 3D data could not be
assigned. For unassigned residues in the UBA where signals could be detected a
different approach was used to attempt assignment. The I3C chemical shift is not
as sensitive as the 15Nchemical shift. Therefore it is likely that the Ca, C~ and C'
chemical shifts were likely to be similar to those previously reported. Therefore
by using the Ca, Cf and C' chemical shifts which were deposited into the BRMB
for the bound form of the UBA attempts were made to assign the missing UBA
peaks. However, since the Ca and C~ shifts are very similar for most types of
amino acid this was more complicated than anticipated and consequently none of
the missing residues were unable to be unambiguously assigned (figure 8.13).
A
VEGATQSLAEQMRKIALESEGRPEEQMESDNSSGGDDDwrlHLSSKEV
DPSTGELQSLQMPESEGPSSLDPSQEGPTGLKEAALYPHLPPEADPR
B
Figure 8.13 - A) the sequence of the C331 S p62 300-440 construct. The LIR and
UBA are underlined. The residues which were assigned in the bound lSN-C331S
p62 300-440 TROSY spectrum are coloured yellow and purple for the LIR and
UBA respectively. B) a representation of the p62 UBA monomer complexed to
ubiquitin (POB IDs 1UBQ and 2JY8). Unassigned residues of the bound UBA are
coloured grey. Residues which were able to be assigned in the bound UBA are
coloured purple. The majority of the UBA is unassigned in the ubiquitin bound
form. However, loop 1 which contains the conserved MGF motif which binds to
ubiquitin has been assigned highlighting the mechanism of binding has not been
affected.
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8.2.2.5 Assignment summary
Overall the partial assignment of the LIR and UBA in the bound form precludes
the quantitative analysis of the titration data. The distinctive residues of the LIR,
namely Ser332, Gly333, Gly334 and Thr339, Ser343 and Ser343 were assigned in
both the free and bound forms. However, the only residue from the W-X-X-L
motif (which has been previously shown to interact with MAP_LC3)116,275which
was able to be assigned was Thr339. The inability to assign the perturbed residues
observed in the bound form of the UBA prevented any information on the
'alternative bound form' from being gained. Chemical shift perturbation maps,
surface plots and accurate Kd values all could not be completed without a full
assignment.
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Figure 8.14 - A zoom of the Gly region in the free 15N-C331S p62 300-440 (blue)
and the MAP-LC3 bound 15N-C331S p62 300-440 (red). Tyr422, Gly411, Gly425
and Gly405 are part of the UBA. Gly333 and Gly334 were assigned using triple
resonance data reported in this chapter. Gly351 and Gly376 were previously
assigned by Dr Thomas Garner282.
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8.2.2.6IHPN Heteronuclear NOE experiments highlight which parts of the protein
areflexible
During the course of the titrations various IH_1sNheteronuclear NOE spectra were
recorded on the ISN-C33IS p62 300-440 construct. Experiments whereby the p62
construct was saturated with MAP-Le3, saturated with ubiquitin and saturated
with both proteins were recorded (figure 8.15). IH_1sN heteronuc1ear NOE
experiments can reveal flexible regions of the protein. Due to the larger size of the
ternary complex, a TROSY based version of the pulse sequences was applied.
Two interleaved IH_1sNTROSY experiments, one with proton saturation and one
without, were recorded. The spectra are separated and IH_1sNheteronuc1ear NOE
values can be calculated from the ratio of ISNintensities.
The inability to fully assign the LIR and the UBA of the C331 S p62 300-440
construct in the free and bound forms precluded the quantitative analysis of the
spectra. Moreover the extent of degradation was different for each of the spectra
as the data was recorded on different samples at different points in the titrations.
This would cause different peak heights and would consequently cause inaccurate
NOE values to be calculated. However, the observed resonances are a mixture of
positive and negative signals, therefore the regions of the proteins which are
flexible can be observed. Highly flexible regions of proteins produce negative
signals as they relax at a rate which is faster when compared to the overall
tumbling rate of the protein. The negative peaks corresponding to degraded
peptides were ignored for this analysis.
When the MAP-LC3 protein is bound some residues in the LIR and other parts of
the 15N-C331S p62 300-440 construct still exhibit conformational flexibility as
indicated by the negative green peaks (figure 8.15, A). This could reflect the small
number of residues involved in MAP-LC3 binding. The peaks corresponding to
the UBA all show positive signals as they form an ordered domain. The residues
which were able to be assigned to the LIR showed a mixture of positive and
negative signals. Peaks corresponding to Gly333 and Gly334 in the LIR are
negative and therefore flexible; whereas, the peak corresponding to the side chain
of Trp338 in the LIR is positive confirming that this residue is involved directly
with the interaction with MAP-LC3. The mixture of signals exhibited by residues
in the LIR indicates that only the interacting W-X-X-L motif becomes rigid and
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that the other residues remain flexible. The peaks corresponding to the UBA are
all positive since they form a folded domain.
In contrast when ubiquitin is bound less of the molecule is flexible (figure 8.15,
B). Many of the unassigned peaks in the linker which showed negative signals in
the MAP-Le3 bound form are now positive. This is quite surprising as the MAP-
Le3 protein is larger than ubiquitin and the accommodation of a larger protein
would be expected to affect the flexibility of the complex. However, only a small
number of residues are required for interaction the with MAP-Le3 compared to
the folded domain required for ubiquitin binding. As expected, peaks
corresponding to the UBA domain are all positive upon ubiquitin binding
reflecting their highly ordered structure. The assigned peaks the in the LIR exhibit
negative signals indicating that are still flexible despite ubiquitin being pre-bound.
This is easily visualized by the Gly333, Gly334 and the Trp338 side chain (figure
8.15, A).
Unsurprisingly when both proteins are bound nearly all of the peaks are positive
highlighting a ternary complex with limited flexibility (figure 8.15, C). No
substantial differences between the ubiquitin bound form and ternary complex
were observed. This highlights that ubiquitin binding has more of an influence on
the inherent flexibility of the e331 S p62 300-440 construct. The assigned LIR
residues and the UBA all show positive signals highlighting that these regions
become less flexible when bound to their binding partners. The unassigned linker
exhibits positive signals suggesting that the e331 S p62 300-440 is capable of
holding these two proteins in position once they are bound.
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Figure 8.15 - the IH_15Nheteronuclear NOE spectra for the 15N-e331S p62 300-
440 combined with A) MAP-Le3, B) ubiquitin and e) both MAP-Le3 and
ubiquitin as a ternary complex. The Gly region is zoomed for clarity. The
spectrum was recorded in 25 mM potassium phosphate, 25 mM NaCl, pH 7 and
298 K. The blue and green peaks are positive and negative peaks respectively.
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8.2.3 ESI-MS studies on the p62 mediated ternary complex between C331S p62 300-
440, MAP-LC3 and ubiquitin
It was clear from the NMR data that a p62 mediated ternary complex was formed
between the e331S p62 300-440, ubiquitin and MAP-Le3 proteins. The inability
to assign the 'H-'5N TROSY prevented quantitative analysis of all of the NMR
data. In order to obtain quantitative data, attentions were turned to native ESI-MS.
Samples were prepared by dissolving lyophilised protein in 25 mM ammonium
acetate.
8.2.3.1 Native ESI-MS of the e331S p62 300-440 construct
A fresh 5 JlM sample of the e331S p62 300-440 construct was subjected to native
ESI-MS (figure 8.16). Mass ions corresponding to the full length e331 S p62 300-
440 were detected and a mass of 15481 Da. The mass is in excellent agreement
with the predicted mass of 15470 Da. However, the spectrum revealed more
degradation than was previously anticipated. Mass ions corresponding to charge
states +5 to + 13 were visualised, but only the +5 to +8 ions were detected clearly.
The higher charge states were surrounded by ions corresponded to the fragmented
protein.
The amount of degradation is quite surprising as the NMR data had indicated that
the protein was not significantly degraded at the start of an experiment. Although
this was not the same sample that was used for the NMR experiments (it is
unlabelled), the purification protocol used was the same. The level of degradation
would therefore be expected to be similar in each purification. The NMR had
revealed that the e331 S p62 300-440 was unstable with a short lifespan of
approximately 48 hours. ESI-MS was therefore considered to be the ideal
technique to use for this sensitive protein as it uses low sample concentrations and
has extremely quick data collection times. However, the spectrum produced here
indicates the true extent of proteolysis that has occurred during the purification.
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Figure 8.16 - The native ESI-MS spectrum for the C331S p62 300-440 at 5 11M.
Spectra were recorded in 25 mM ammonium acetate, pH 7. A spectrum for a
fragmented protein is visualised. The +5 to +8 charge states which are clear are
labelled although charge states up to + 13 were observed in the spectrum.
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8.2.3.2 Native BSI-MS of the p62 mediated ternary complex
Despite the significant degradation of the C331 S p62 300-440 construct an
experiment whereby the three proteins were mixed together at concentrations of
3:1.5:1.5 and 4:2:2 (p62:ubiquitin:MAP-LC3) was conducted. As expected the
significant degradation of the C33l S p62 300-440 construct prevented a clean
spectrum from being produced and any quantitative analysis being completed.
However some information can be deduced from the spectrum.
Mass ions corresponding to the three individual free proteins, the two binary
complexes and the ternary complex were detected. The spectrum recorded for the
3:1.5:1.5 experiment is shown in figure 8.17. The unbound C331S p62 300-440,
ubiquitin and MAP-LC3 proteins recorded masses of 15481, 8563 and 15141 Da
respectively and were the dominant species in the spectrum. The 1:1 binary
complexes corresponding to the C33l S p62 300-440-MAP-LC3 and C331 S p62
300-440-ubiquitin, recorded masses of 30624 and 24020 Da respectively. The
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binary complexes were detected in vastly different abundances, with much greater
intensity observed for the C331 S p62 300-440- MAP-LC3 than the C331 S p62
300-440-ubiquitin binary complex reflecting the greater affinity p62 has for MAP-
LC3 over ubiquitin and correlates well with the NMR data. Mass ions
corresponding to a I: I: 1 ternary complex (mass of 39182 Da) was also detected,
but in very low abundance. No evidence for a ubiquitin-MAP-LC3 complex was
observed highlighting that the two proteins are unlikely to interact with each other
once bound to the C331 S p62 300-440 construct.
The spectrum recorded in the gas phase is not necessarily a true reflection of the
molecules in solution. Complex formation is low in the gas phase, with many
complexes detected in low abundance (10-20 %). There are several possible
explanations for the low abundance of the ternary complex. The ability to form a
protein complex is attributed partly to the role of the solvent, especially in
hydrophobic interactions which are extremely weak in the gas phase due to the
lack of solvent. The interactions with both MAP-LC3 and ubiquitin are
hydrophobic and the combined effects of two significantly weakened interactions
are likely to reduce the detection of the ternary complex. The data is consistent
with the individual interactions having Kd values in the J..LMrange to produce low
populations of binary and ternary complexes. Noncovalent complexes typically
dissociate when in flight in the mass spectrometer. This tendency might have
resulted in one of the proteins being released from the ternary complex leaving
behind the binary complex, or similarly with the two binary complexes the
individual proteins would left behind. This would explain the dominance of the
individual proteins in the spectrum.
In this particular spectrum it is also possible that binary and ternary complexes are
being formed with the different fragments of the C331 S p62 300-440 complex. It
is clear that the C331 S p62 300-440 is the only one of the three proteins to
degrade, with the degradation likely to occur at multiple sites in the unstructured
region of the protein. It is for this reason that accurate Kdvalues for the binary and
ternary complexes were unable to be calculated from this data.
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Figure 8.17 - The native ESI-MS spectrum of the C331 S p62 300-440, ubiquitin
and MAP-Le3 at concentrations of 3: 1.5: 1.5 respectively. Spectra were recorded
in 25 mM ammonium acetate, pH 7. The degradation is the C331 S p62 300-440 is
clearly visible but the binary complexes and the ternary complex are detected in
the spectrum. Inset a zoom of the m1z region 2950-3300 where the ternary
complex is found .• is the e33lS p62 300-440," is ubiquitin,_ is MAP-Le3,
~ .
• is the e331 S p62 300-440-ubiquitin complex (1: 1), • is the e331 S p62 300-
....
440-MAP-Le3 complex (1:1) and a is the ternary complex (1:1:1).
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8.2.4 Modelling the ternary complex
Since sample degradation was a problem in both the NMR and ESI-MS studies,
attentions were turned to molecular modelling. The structure of MAP-LC3 bound
to the p62 LIR peptide (PDB ID 2K6Q) and ubiquitin bound to the UBA has
already been modeled in HADDOCK (PDB IDs 2JY8 and 1UBQ). Residues
which form the linker between the LIR and UBA were added to the LIR peptide
in the 2K6Q PDB file using Pymol. Residues 387 and 388, both Pros, were added
to the linker region to provide a region of overlap. The two PDB's were
superimposed and one set of the overlapping Pros deleted to create a single PDB.
This file was then energy minimised to produce a model using AMBER (figure
8.18). The energy minimised model revealed a structure that was approximately
0.5 A different to the superimposed PDB file.
The Pro rich PEST domain spans residues 345 - 377 and contains six Pro between
the LIR and the UBA. These Pros cause pronounced kinks in the linker region of
the chain, which are also capable of restricting the rotation in the linker. Flexible
linkers normally allow connecting domains to freely twist and rotate through
space to recruit their binding partners. In this case, the high prevalence of Pro
residues are likely to prevent an interaction between MAP-LC3 and ubiquitin by
restricting rotation whilst maintaining enough flexibility to find their correct
binding partner. Thi is consistent with the results observed by NMR .
•
Figure 8.18 - A model of the p62 mediated ternary complex built from PDBs
2K6Q, 2JY8 and IUBQ using AMBER. Residues 332-436 of the p62 protein are
depicted in this model. A highly kinked linker region separates the two binding
sites on the p62 protein. The kinks are caused by Pro residues which are able to
restrict the rotation of the linker, which potentially prevents an interaction
between MAP-LC3 and ubiquitin once bound to p62.
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8.3 Discussion
The p62 protein's role as a scaffold protein has been clearly established'Y.
Interactions have been observed between domains of the p62 or p62 peptides with
their binding partners27S,140 but structural analysis of the full length p62 with
multiple binding partners is yet to be elucidated. In addition to this, there appears
to be a lack of structural information on multiple interactions of other scaffold
proteins, such as NBRl, highlighting the need to explore this area further.
It is highly likely that the p62 protein will form various multimeric protein
complexes in vivo. The p62 has a central role in the regulation of various
signalling pathways which are activated in response to different stimuli. Different
proteins will therefore be required to bind to the p62 at different times. p62s
ability to bind to multiple proteins has however been investigated biochemically.
The p62 has been shown to form a ternary complex with aPKC ~ and PAR-4 using
coimmunoprecipitation assays. The p62 and PAR-4 proteins are binding partners
of the aPKC ~ protein but in this study contacts between PAR-4 and p62 were
observed. PAR-4 is inactive when bound to aPKC ~. Binding of the aPKC ~ to
p62 enhances the catalytic activity of the aPKC ~ and interaction with p62
reactivates the inactive PAR-4 protein. The interaction with p62 has a clear role in
the regulation of NK-KB activation283• In order to gain a greater insight into the
molecular recognition events utilised by the p62 with both the PAR-4 and aPKC ~
protein, a detailed structural investigation clearly would need to be conducted.
p62 is capable of interpreting molecular signals by binding to different proteins
using distinct binding surfaces. The binding of certain proteins could cause the
p62 to become locked in a certain conformation whereby other proteins which
regulate other pathways are unable to bind. It is currently unknown if protein
recognition sequences found in the unstructured region of the p62 are located
spacially close together. For example, the TRAF-6 recognition sequence which
occupies residues 228-233 is not sequentially close to the LIR (residues 332-345)
but these recognition motifs could be located spaciaUy close together as they are
both found in the flexible linker region. Steric clashes could therefore prevent the
binding of one protein if another protein has already bound. Alternatively, the
flexibility of the linker could be restricted by the presence of a bound protein,
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inducing specific locked conformations. These mechanisms could show a
mechanism of internal regulation of multiple signalling pathways by the p62.
Until recently, autophagy was thought of as a non-selective degradative pathway.
Although the concept of selective autophagy is now generally accepted, very little
is known about the molecular mechanisms that govern the specificity. The
identification of p62 and NBRI as adapter proteins in autophagy provided a
molecular link between the UPS and autophagy. The idea that p62 is able select
certain ubiquitinated proteins and target them to different degradation pathways is
attractive. It is possible that the p62 UBA is able to discriminate between different
levels of ubiquitination on target proteins, with different linkages and lengths
representing distinct molecular signals. Lys48 linked tetraubiquitin has been
shown to be the minimum requirement for degradation by the proteasome, it is
conceivable that an equivalent exists as signal for degradation by selective
autophagy.
With mounting evidence of cross talk between the UPS and autophagy, the human
genome is likely to encode several proteins that possess an LIR and some form of
UBD. Recently a third protein known as NDP52 was shown to bind to
ubiquinated bacteria to target them for autophagic degradatiorr ". NPD52, unlike
p62 and NBRl, contains a UBZ domain and an LIR. Although research is
currently underway into elucidating the exact roles of these adapter proteins in
selective autophagy, the role of ubi quit in binding proteins in autophagy in general
is only beginning to be unravelled.
Overall, the need to explore the full length p62 protein is evident. Understanding
the interplay between the various degradation pathways and the role p62 might
have in them is crucial. Many neurodegenerative diseases such as Alzheimer's
and Parkinson's disease are caused from the defective action of p62. The p62
could therefore potentially represent a therapeutic target in the future treatment of
these diseases.
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8.4 Conclusions
The partial degradation of the e331 S p62 300-440 construct during the
purification has shown to be very problematic during this study. The true extent of
the degradation was not revealed until experiments using ESI-MS were
undertaken. Moreover, the degradation continued once lyophilised protein had
been used to make samples for experiments. The half life of the protein was
shown to be around only around 48 hours, which was problematic for 3D triple
resonance NMR experiments. The binding studies using both NMR and ESI-MS
were therefore only able to be used for qualitative analysis.
However, it was clear from the NMR titration studies that a p62 mediated ternary
complex is formed between the e331 S p62 300-440 construct, MAP-Le3 and
ubiquitin. The binding of the MAP-Le3 protein to the e331S p62 300-440
construct was consistent with the previous study using a peptide corresponding to
the p62 LIR and other protein LIR's. The MAP-Le3 interaction in both cases
showed a high affinity interaction where saturation was observed around 1:1
molar ratio. Moreover, a mixture of slow and fast exchange was observed by both
the p62 and the NBRI LIR during binding to MAP-Le3 indicating a similar
mechanism of binding by both proteins to MAP-Le3. A weak interaction was
observed between the p62 UBA and ubiquitin, which again is consistent with the
previous data. Saturation occurred around 1:4 (UBA:ubiquitin) molar ratio.
Overall the binding of these two proteins to the e331S p62 300-440 is
independent of the occupation of other binding site and an allosteric relationship
is not observed by the two binding proteins.
The NMR data showed no evidence for contacts between ubiquitin and MAP-Le3
once bound to e331 S p62 300-440. esps are only observed for the LIR or the
UBA upon the addition of MAP-Le3 and ubiquitin respectively. This observation
is consistent with the two binding sites functioning as distinct regions on the full
length protein. The IH_1sN heteronuclear NOE data highlighted a structure with
reduced flexibility for the ternary complex. The limited flexibility of the linker
could the prevent associations between the proteins as a 'conformationally locked'
molecule could be formed. It would appear from the hetronuclear NOE data that
binding to ubiquitin has a greater effect on the flexibility of the linker by
restricting free rotation.
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The NMR experiments conducted in this chapter are limited to binding to
monoubiquitin. It is important to consider differences of p62 binding to longer
polyubiquitin chains of different linkages. Longer chains have the potential to
prevent access to the LIR, thereby regulating binding by MAP-LC3 and causing
an allosteric relationship between the two p62 binding proteins. This is something
that should be explored in the future.
Binding experiments using ESI-MS were also able to detect the ternary complex,
as well as the two binary complexes. The ternary complex was detected in a 1:1:1
stoichiometry with very low abundance. This is likely to be the result of the
individual interactions being hydrophobic. Since the mass spectrometer is bias
against hydrophobic interactions it is difficult to maintain and detect intact binary
or ternary complex associated by hydrophobic interactions. The two binary
complexes were both detected in 1:1 stoichiometries. The intensity of the mass
ions corresponding to the C331S p62 300-440-MAP-LC3 binary complex were
much greater than the ions corresponding to the C331 S p62 300-440-ubiquitin
binary complex, reflecting the differences in affinity between the two complexes
as both interactions are hydrophobic. Ions for a complex between MAP-LC3 and
ubiquitin provided further evidence that the two proteins do not contact each other
when bound to p62.
In order to structurally view the ternary complex a model was made based on the
existing structures in the PDB. The model showed a linker region with a large
number of pronounced kinks corresponding to a high prevalence of Pros. The
model showed two structurally distinct binding sites, which were separated by the
linker. The Pro residues were likely to restrict the rotation in the linker to prevent
association of MAP-LC3 and ubiquitin, whilst maintaining enough flexibility to
recruit their correct binding partner.
Overall, the data presented in this chapter demonstrate the difficulties associated
with the study of intrinsically disordered proteins. Many proteins possess folded
domains separated by unstructured linker regions. The linkers enable the domains
to function independently within the protein. Despite the high abundance of
intrinsic disorder in modular proteins very little is known about these regions. The
lack of information is associated with the limited number of techniques available
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which permit the study of these regions; however, NMR is the only technique
capable of probing the structure of such regions. As shown by the NMR
experiments conducted within this chapter, the chemical shifts of residues within
unstructured proteins show a narrow distribution of resonances. Structural
investigations into intrsically disordered protein require new NMR experiments to
reduce the overlap of resonances. Although, such experiments will require a
sample with good stability in order to record high quality data.
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8.5 Future work
This project could prove extremely insightful into determining the role of p62 in
regulating various degradation pathways. If a homogenous sample of the C331 S
p62 300-440 construct or indeed the full length p62 protein were able to be
obtained several extensions to the project could be made. In order to minimise the
degradation a few changes could be made to the purification protocol. All of the
purification could be conducted at 4 ·C, or extra wash steps could be added to the
sepharose column to increase the purity of the thrombin cleaved protein which
would therefore remove the need for the gel filtration column. However, in the
case of the C331 S p62 300-440 construct a methodology of preventing
degradation after purification would also be required. This could potentially be
achieved via mutagenesis of critical amino acids in the unstructured PEST region.
First of all the free and bound forms of the 15N-C33I S p62 300-440 construct
would need to be assigned to produce quantitative information from the titration
and IH_15N heteronuclear NOE data. Multi-dimensional NMR has become the
leading technique to study intrinsically disordered regions of proteins. X-ray
crystallography might be a better technique to examine larger proteins but
problems associated with the disordered regions of proteins occur using this
technique. Disordered regions make proteins hard to crystallize, and if a crystal is
obtained the disordered region is unlikely to be visible on the electron density
map.
Since the 3D triple resonance experiments using IH direct detection for backbone
assignment used in this chapter still produced peaks with significant overlap, more
complex 3D and potentially even 4D NMR experiments would need to be
performed. The development of experiments that exploit l3C direct detection to
improve chemical shift dispersion and non uniform sampling methods to reduce
experiment times have recently been described (reviewed by Felli et aP85).
Moreover, two 40 experiments which also use l3C direct detection known as
HCBCACON and HCBCANCO, were used to assign a 12.8 kDa intrinsically
disordered protein with a high Pro content. The HCBCACON experiment
correlated the resonances of the backbone N of residue; with the Ha, H~, Ca, C~
and C' of residue ;-1; whereas, the HCBCANCO correlates the resonance
frequency of C' in residue ;-1 with the Ha, H~, Ca, C~ and N resonances of
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residue ;286. The obvious limitation to the use of complex NMR experiments is
that they are often time consuming and the IsN-e33IS p62 300-440 construct has
been shown to have a limited life span. Despite the constant improvements in
NMR to decrease experiment times it is unlikely that a full set of experiments
could be completed on a single 13e1SN e331 S p62 300-440 sample. Potentially a
fresh sample would need to be prepared for each individual experiment in order to
collect high quality data.
In order to quantify and confirm that the binding of MAP-Le3 and ubiquitin to
the p62 is independent from each other binding experiments using ITe could be
performed. Although this was observed by NMR in this chapter, accurate Kd
values were unable to be obtained. ITe would be able to produce quantitative
binding affinities which could be complimentary to NMR. ITe unlike ESI-MS is
conducted in solution and would therefore be able to produce more accurate
values of Kd. The MAP-Le3 protein could be titrated into e331 S p62 300-440 in
the presence and absence of ubiquitin, or ubiquitin could be titrated into the
e331 S p62 300-440 construct in the presence and absence of MAP-Le3. If the
affinities produced from the pairs of experiments were comparable the binding is
likely to be independent of the occupation of the other binding site. There are
some things to consider if these experiments are to work successfully. The MAP-
Le3 protein has some solubility problems above 250uM and the p62 UBA dimer
adds complexity. The ITe calorimeter is unable to distinguish heat changes
associated with the dissociation event and the binding event generating inaccurate
binding affinities. Using a UBA mutant which forms a weak dimer such as the
T419K mutant (chapter 6) might help to overcome this problem.
A final extension to the project could be to conduct biochemical assays to
investigate if proteins with different levels of ubiquitination are targeted to
different degradation pathways. Since ubiquitin is used as a signalling molecule it
is likely that the fate of the substrate protein is determined by the type of
ubiquitination that it becomes modified with. Moreover, the ubiquitin signal could
be investigated under proteasome or autophagy inhibited conditions to see if the
substrate protein is still able to be degraded or if it is degraded by a different
pathway.
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9.0 Modelling avidity effects in the binding of oligomeric p62 to
polyubiquitin chains
9.1 Introduction
9.1.1 The avidity effect
The avidity effect, also known as the chelate effect, is the co-operative synergistic
effects of the individual bonds in multivalent interactions. Avidity effects have
been shown to influence the binding of different UBDs to polyubiquitin chains.
The presence of two or more VBDs or the attachment of multiple ubiquitins on
the same substrate can increase binding affinity through avidity effects and
promote ubiquitin-VBD interactions. Avidity might be used by VBDs to filter the
noise from non specific transient ubiquitin-VBD interactions and amplify only the
output of the desired interaction. For example the Rap80 protein which contains
tandem VIM motifs binds to Lys63 polyubiquitin at double stranded DNA breaks
(figure 9.1). The UIMs are spacially positioned for avid binding to Lys63 chains,
their preferred linkage287. In the absence of a binding partner both linear and
Lys63 linked chains exhibit flexible structures in which the individual moieties
can be regarded as independent and unconstrained subunits.
Rap80
Figure 9.1 - The tructure of the tandem Rap80 UIMs in complex with Lys63
diubiquitin (PDB ID 3AIQ).
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9.1.2 Oligomeric p62 and the avidity effect
Different UBDs have the ability to discriminate between polyubiquitin chains of
different linkage. Linkage preference is conferred via a combination of selectivity
and avidity effects to interpret the ubiquitin signal. Avidity effects are thought to
have a role in ubiquitin binding by p62, because it is a highly oligomeric protein.
p62s ability to self-oligomerise via its N-terminal PBI domain is clearly evident
in vivo with p62 found localised in cellular speckles. The individual ubiquitin-
UBA interactions are of low affinity; however, avidity effects are postulated to
raise the overall affinity when present in oligomeric p62. The p62 protein can
therefore present an array of UBAs to long polyubiquitin chains (figure 9.2).
However, the recent discovery of the p62 UBA dimer adds complexity to the
potential role of avidity in ubiquitin binding by the p62 protein as dimerisation
down regulates ubiquitin binding.
Figure 9.2 - A schematic representation of the full length p62 protein when
presented to longer polyubiquitin chains. PB 1 oligomers and the UBA dimer are
shown in the free and bound forms.
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9.1.3 Modelling the full length p62 using GST fusion proteins
To date several studies involving the isolated p62 UBA and its interaction with
different ubiquitin ligands have been conductedl39,140,141. However, GST pull
down studies using the full length protein have revealed the p62 has a preference
for longer polyubiquitin chains 170,171. Moreover, differences in affinity were
observed for the p62 UBA in the full length protein relative to the UBA domain in
isolation 170,171. The p62 has a high tendency to aggregate, a feature which is
mediated by PB I-PB I interactions. The full length p62 protein was therefore
investigated using a model which lacked the PB I domain and replaced it with an
alternative protein oligomer.
The GST protein, present in the pGEX-4T-I plasmid, forms a highly stable dimer
with a Kdim of I nm. When a GST fusion protein is expressed from this plasmid, it
can be used to model the full length p62 protein with the GST component able to
mimic the N-terminal PBI domain (as a dimer). Since the p62 is oligomeric in
vivo and weak binding had been observed by the p62 UBA to monoubiquitin, it is
suspected that avidity effects are used to bind long polyubiquitin chains in order
to raise the overall affinity of the interaction. A study highlighted how using GST
fusion proteins promoted artificial avidity effects by the dimeric GST bringing
together two UBAs in a configuration that favoured simultaneous or avid
binding". Oligomeric p62, like the GST fusions, are likely to spatially position
UBAs in close proximity to each other. It therefore seemed logical to use GST
fusion proteins to model the full length p62 protein. The open conformation of
Lys63 linkage tends to be favoured by avid interactions=", which is consistent
with p62s role in NF-KB signalling.
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Attempts to purify longer p62 constructs lacking the PB I domain had previously
been conducted by the Searle and Layfield groups, as part of a collaborative
project. Therefore some p62 constructs were already cloned and some new
constructs were required to be cloned into pGEX-4T-1 plasmid. By expressing
different length p62 constructs which extend from the C-terminal as GST fusion
proteins, a more realistic model of the full length p62 protein can be created
(figure 9.3). When fused to the GST the molecular weights of the constructs
increases dramatically to sizes which are at the upper end of the spectrum for
proteins which are studied using NMR spectroscopy.
The longer p62 constructs were shown to be susceptible to proteolytic degradation
when expressed as thrombin cleaved proteins. Since the GST is a commonly used
solubility tag, it was predicted that the GST tag would have a protective role by
reducing the susceptibility of the linker region to cleavage.
N
TRAF6 Binding
228-233
LlR
332~343
II I • c
PBl ZZ Zinc Finger PEST UBA
261-387 387-436
261-440 45.9 kDa
GST tag
300-440 41.6 kDaPEST2 UBA
37.1 kDa
GST tag PEST2 UBA
387-436 31.8 kDa
GST tag UBA
Figure 9.3 - A schematic representation of the GST fusion proteins compared to a
schematic repre entation of the full length p62 protein. The molecular weights of
the monomeric GST fu ions are indicated to the right of each construct.
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9.1.4 Summary and aims
The aim of this investigation was to design a model of the full length p62 protein
and investigate the binding affinities associated with monoubiquitin and linear
diubiquitin binding. It was postulated that a stronger interaction would be
observed in the binding of linear diubiquitin compared to monoubiquitin due to
the close positioning of the two UBA monomers, which would favour the avid
binding of linear diubiquitin (figure 9.4). Linear diubiquitin was chosen due to its
structural similarity to Lys63 diubiquitirr", Both linear chains and Lys63 chains
have been implicated in regulating the NF-KB signalling pathway, a pathway in
which the p62 protein has an integral role233• Linear diubiquitin was also easily
prepared as it can be cloned sequentially into a plasmid and does not require
assembly by ubiquitination enzymes. It is important to note that monoubiquitin
from S.Cerevisiae and linear diubiquitin from Homo Sapiens were used to probe
binding. Since ubiquitin is so highly conserved the use of two different ubiquitin
orthologues should not affect the results.
NMR spectroscopy and ESI-MS were used to monitor the binding of the aST
fusion proteins to monoubiquitin and linear diubiquitin. NMR spectroscopy
provides details of the interaction in atomic detail. The results could then be
quantified using binding ESI-MS experiments. ESI-MS was considered to be ideal
as it was able to be conducted at concentrations low enough to minimise the
opposing effects of UBA dimer formation, permitting the calculation of accurate
Kd values for the binding interaction. Both NMR and ESI-MS are techniques
which could highlight differences in affinity between the two ligands, with any
differences likely to be attributed to avidity effects.
The logical approach, given the size of the aST dimer, was to use the smallest
construct which consists of the aST tag, the thrombin cleavage site and the UBA,
termed aST -p62 UBA, to conduct initial suitability studies. The project could
then be extended to studies of the longer constructs in order to build a more
realistic model of the full length protein. The avidity effects are predicted to be
more pronounced in the shorter constructs, since the effective local UBA
concentration is likely to remain high, due to the restricted flexibility in the
shorter linker.
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Figure 9.4 - a chematic representation of the GST fusion proteins used to model
the full length p62 protein when binding to A) monoubiquitin (Ub) and B) linear
diubiquitin (Ub2). The GST-p62 UBA schematic was made from the structures of
the GST dimer (POB ID ]U87) and either the p62 UBA dimer or monomer (PDB
ID's 2KNV and IQ02 respectively). Predictions as to how monoubiquitin (PDB
ID ]UBQ) and linear diubiquitin (2W9N) bind to the GST -p62 UBA are shown.
The p62 UBA dimer (UBA2) dissociates to the biologically active monomer
(UBA) in order to bind to the ubiquitin ligand.
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9.2 Results
9.2.1 Assessing the viability of the model using NMR on the GST-p62 UBA construct
GST fusion proteins were used in this chapter to model of the full length p62
protein. NMR was chosen as the most desirable technique to monitor the binding
of the GST fusion proteins as it provides data in atomic detail. The GST tag used
to mimic the PB 1 domain, exists as a highly stable dimer with a molecular weight
of 52 kDa. Proteins of this size are often unsuitable for NMR studies as they are
quite large. Large proteins tumble slowly in solution producing broad NMR
signals with low resolution. Small proteins or domains of proteins, such as the p62
UBA, tumble rapidly in solution producing sharp signals by NMR which can be
used to determine the structure of the protein and monitor binding interactions
upon the addition of a binding partner. In all of the GST fusion proteins there is a
linker region separating the GST component from the UBA. The linker enables
the GST and the UBA to tumble independently from each other in solution. With
this in mind it was predicted that conducting NMR studies using GST fusion
proteins would be ideal as the peaks corresponding to the UBA domain would be
visible, but those corresponding to the GST, which tumble slowly in solution,
would be undetected. The UBA interaction with ubiquitin could therefore be
easily monitored at atomic level.
The suitability of this model needed to be assessed pnor to any binding
experiments. It was decided that the shortest construct consisting of the GST
fused to the p62 UBA, termed GST -p62 UBA, would be most appropriate to test
the suitability of the model due to its smaller size. In this construct, the C-terminal
end of the GST and the thrombin cleavage site (sequence LVPRGS) are
unstructured forming a linker between the GST and the UBA domain. A IH_15N
TROSY spectrum was recorded on a 500 11M 15N-GST-p62 UBA sample at 298
K. As predicted, resonances were observed for the p62 UBA residues at the same
chemical shifts as those observed for the isolated domain (figure 9.5). This
spectrum confirmed that the UBA dimer was also formed in the GST -p62 UBA
construct. However, some additional resonances were also observed in the
spectrum. These extra resonances were few in number and gave strong signals
consistent with the flexible linker residues at the C-terminus of the GST and the
six residues of the thrombin cleavage site, although this has not been confirmed
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using 3D triple resonance data. Since there were few additional peaks it appeared
that the linker, despite being short, was able to separate the GST -p62 UBA
construct into two separate domains which are capable of tumbling independently
of each other as they would do in a modular protein such as p62. Overall, the
spectrum highlighted the GST -p62 UBA protein as a suitable model of the full
length p62 protein and that binding studies using this construct should be
conducted.
A IH_15N TROSY spectrum of the GST tag alone was recorded as a control. Many
more peaks were visualised in this spectrum than was previously assumed.
Despite the GST protein not being entirely NMR silent, it is clear that when fused
to the p62 UBA domain, nearly all of the sharp resonances correspond to the
UBA. The linker, despite being short, has enabled the two components to tumble
independently of each other, with the signals for the GST broadened to
undetectable levels.
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Figure 9.5 - IH_15N TROSY of the 15N-GST-p62 UBA (black) and isolated 15N_
p62-UBA (red). Both spectra were recorded in 25 mM potassium phosphate, 25
mM NaCI, pH 7 at 298 K.
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9.2.2 Monitoring avidity effects by the GST-p62 UBA using NMR spectroscopy
The preliminary NMR data using the 15N-GST-p62 UBA as a model for the full
length p62 protein showed encouraging results. The GST component is largely
invisible by NMR meaning that the UBA can be clearly monitored in binding
studies with different ubiquitin ligands. The 'NMR silent' GST would allow the
assignments which had been previously determined for the UBA to be transferred
to the GST -p62 UBA construct. NMR titration studies whereby monoubiquitin
and linear diubiquitin were added to 15N_GST-p62 UBA were completed in order
to monitor any avidity effects that might occur. All spectra were recorded in 25
mM potassium phosphate, 25 mM NaCl, pH 7 at 298 K
9.2.2.1 Forwards titrations
The addition of up to 2 mM unlabelled monoubiquitin or ImM unlabelled linear
diubiquitin was added to a 500 IlM 15N-GST-p62 UBA sample (as separate
experiments). Concentration dependent changes in chemical shifts were observed
in both titrations indicative of a binding to both monoubiquitin and linear
diubiquitin (figure 9.6). The changes in chemical shift were consistent with each
other showing the same bound form for the two different ubiquitin ligands.
Moreover, the free and fully bound forms of the ISN-GST-p62 UBA showed near
identical chemical shifts to the free and bound forms of the isolated ISN_p62 UBA
enabling the assignments to be transferred from the 15N_p62UBA to the 15N_GST_
p62 UBA data. Since the chemical shifts for the bound form were so similar to the
isolated domain it is unlikely that the GST also interacts with ubiquitin.
At 250 IlM the free monomer peaks were not visible meaning that only peaks
predominantly in slow exchange were visualised. For resonances in slow
exchange, the intensities of the peaks were concentration dependent consistent
with a monomer-dimer equilibrium. Some resonances, however, did exhibit fast
exchange. These were resonances where the chemical shift for the dimer and
monomer were the same and the residue was involved in binding. This is in
excellent agreement with the previous data recorded for the isolated UBA. A
mixture of slow and fast exchange regimes combined with the near identical
chemical shifts for the free and bound forms highlighted a common mechanism of
binding between the p62 UBA and the GST -p62 UBA, whereby the UBA dimer
must dissociate in order to bind to ubiquitin.
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Figure 9.6 - lH_15N TROSY of the 15N-GST-p62 UBA in the free form (red) and
fully bound to monoubiquitin form (black). The same distribution of chemical
shift wa observed for the bound form when bound to linear diubiquitin
indicating the same mechanism of binding for the two ubiquitin ligands. Both
spectra were recorded in 25 mM potassium phosphate, 25 mM NaCI, pH 7 at 298
K.
By plotting the P for each residue between the free and bound forms, regions
of the protein which are involved in ubiquitin binding can easily be visualised.
The re idue involved in binding are largely confined to the end of helix 1, loop 1
and helix 3, with the overall CSP pattern for binding to monoubiquitin and linear
diubiquitin howing near identical values (figure 9.7). The only difference being
that ly410 was able to be a signed all the way through the titration with linear
diubiquitin. The con i tency in the CSP values for binding to monoubiquitin and
linear diubiquitin indicate that it is unlikely there is a secondary binding site on
the UBA in the pre ence of linear diubiquitin. Since linear diubiquitin adopts an
open conformation, recognition of single ubiquitin moiety in a "beads on a string"
mechanism i likely to occur. The overall CSP pattern is very similar to the CSP
pattern by the i olated p62 UBA and monoubiquitin with values which were
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comparable between the three datasets. The high correlation between the datasets
further confirms that the GST does not interfere with the binding interaction.
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Figure 9.7 - Reside specific CSP for the 15N-GST-p62 UBA and 15N_p62UBA.
Although the CSP values are not exactly the same the general trend correlates
well between the two datasets.
However some differences were observed between the 15N-GST-p62 UBA
construct and the isolated domain as the 15N-GST-p62 UBA construct showed a
higher affinity interaction. The 15N-GST-p62 UBA was saturated at 500 11M
monoubiquitin and 250 11Mlinear diubiquitin, corresponding to a 1: 1 and 1:0.5
(UBA:ubiquitin) molar ratio respectively. The faster saturation is consistent with
there being two binding sites in linear diubiquitin as it takes twice the amount of
monoubiquitin to saturate the 15N-GST-p62 UBA compared to linear diubiquitin.
The isolated domain showed saturation of a 1:4molar ratio. It is possible that the
increased affinity observed by the 15N-GST-p62 UBA construct is the result of a
weaker dimer being formed by the UBA (as shown in chapter 6). The linker
region is potentially too short to permit complete flexibility of the two UBA
domains preventing the formation of a high affinity dimer.
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At high concentrations the effects of both dimer dissociation and ubiquitin
binding of the p62 UBA are observed, therefore an accurate Kd for binding is
unable to be determined, However, by plotting binding isotherms for non-
overlapping residues in the IH_1sN TROSY spectrum, knowledge on the affinity
of an interaction can be gained. Avidity effects are observed by the ISN-GST-p62
UBA when binding to linear diubiquitin as shown by the steeper gradient in figure
9.8. The GST therefore positions the two UBA monomers in close proximity to
one another promoting the formation of the UBA dimer. The UBA dimer then
favours avid binding to linear diubiquitin compared to monoubiquitin. The
increase in affinity for the GST -p62 UBA is not as substantial for linear
diubiquitin compared to monoubiquitin.
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Figure 9.8 - binding isotherms for the isolated p62 UBA and monoubiquitin, the
GST-UBA and monoubiquitin and the GST-UBA and linear diubiquitin. The
curves represent the data averaged for 26 residues.
9.2.2.2 Identifying the binding surface on ubiquitin
Complementary titrations whereby ISN-monoubiquitin and IsN-linear diubiquitin
were titrated into unlabelled GST-p62 UBA (as separate titrations) were also
completed. These titrations would identify if the canonical Ile44Nal70 patch is
still utilised by ubiquitin in binding, despite the UBA existing as part of a GST-
fusion protein. Since the GST-p62 UBA is in excess in these titrations and it is by
far the bigger molecule it would require a large amount of GST -p62 UBA to reach
a 1:4 molar ratio. Therefore a lower molar ratio would be required in order to keep
the GST -p62 UBA soluble in a small volume (600 JlI). A 1:2 molar ratio seemed a
reasonable comprimise given that the forwards titrations showed saturation of 1:1
or 1:0.5 for the monoubiquitin and linear diubuiqitin respectively.
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Figure 9.9 - IH_15N TROSY spectrum forl5N-monoubiquitin (yeast) in the
presence of 0 ~M (red), 250 ~M (blue) and 500 ~M (black) GST -p62 UBA. Inset
a zoom f orne of the residues which perturb upon binding. The spectrum was
recorded in 25 mM pota ium phosphate, 25 mM NaCI, pH 7 at 298 K.
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Up to 500 ~M unlabelled GST -p62 UBA was titrated into 250 ~M 15N_
monoubiquitin (figure 9.9). Concentration dependent changes in chemical shift
were observed consistent with a binding event. Resonances were observed for 72
out of 76 residues. The missing residues corresponded to the two Pro residues in
yeast ubiquitin, Metl and Gly53. Fast exchange was observed for nearly all
residues. However, some peaks broadened during the titration and are therefore in
intermediate exchange. Intermediate exchange was observed for Arg42, Ile44,
Lys48, Leu69 and Leu71. All of these resonances broaden significantly until they
can no longer be detected and never return within the concentration range of this
experiment. Arg42, Lys48 and Leu71 broaden very early in the titration, similar to
the reverse titration between 15N-monoubiquitin and the isolated p62 UBA. Arg42
had broadened to an undetectable level after the addition of 75 ~M GST-p62
UBA; whereas, Lys48 and Leu71 had disappeared by the addition of 1OO~M
GST -p62 UBA. Ile44 and Leu69 broaden later in the titration, after the addition of
175 ~M and 200 ~M GST-p62 UBA respectively. All residues which exhibit
intermediate exchange kinetics are clustered in or around the canonical
I1e44Na170 binding patch. The additional resonances showing intermediate
chemical exchange kinetics is indicative of slower on and off rates for complex
formation and dissociation compared to the interaction between the isolated p62
UBA domain and monoubiquitin. Since fast exchange is often associated with
weak interactions, the presence of a greater number of resonances in intermediate
exchange represents a stronger interaction.
A separate titration was completed by titrating up to 500 ~M GST-p62 UBA into
250 ~M ISN-linear diubiquitin (figure 9.11). Assuming the two subunits of the
diubiquitin moiety are in identical environments resonances in each ubiquitin
moiety will be present at identical chemical shifts. Therefore a spectrum for
monoubiquitin only will be visualised. However many of the peaks had split into
two, highlighting that the two ubiquitin moieties are not in identical environments
(9.10). The regions expected to differ in each of the ubiquitin subunits are the
terminal regions as they are either exposed or connected to the other ubiquitin.
When plotted to the surface of ubiquitin peak splitting was indeed observed for
residues close to the terminals. The extent of peak splitting varied between
residues. Some showed two separate peaks next to each other, whereas others
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such as Ser65 and Ile61, only showed partial splitting. For residues which had
split into two, only one of the peaks was assigned. The observed spectrum for 15N_
linear diubiquitin was slightly different to the spectrum for the free 15N_
monoubiquitin because two different ubiquitin orthologues were used.
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Figure 9.10 - A) The IH-15N HSQC of the free form of linear diubiquitin. Inset a
zoom of re idue er65 and Ile61 which have split into two due do slightly
different chemical environments. These residues are located close to the C-
terminal of each of the ubiquitin subunits. The spectrum was recorded in 25 mM
pota ium pho phate, 25 mM NaCl, pH 7 at 298 K. B) The surface plot of
ubiquitin (I UBQ) with re idues with peaks that had split into two highlighted in
blue.
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Resonances were observed for 70 out of 76 residues. The missing residues
correspond to the three Pro residues in human ubiquitin, Metl, Gly53 and Glu24.
A mixture of fast and intermediate exchange was observed for residues, although
predominantly fast exchange was exhibited. Analogous to the titration between
15N-monoubiq~itin and the GST -p62 UBA peaks corresponding to Arg42, Ile44,
Lys48, Leu69, Leu71 all broaden to undetectable levels during this titration.
Arg42, Lys48 and Leu71 also demonstrate this during the titration between 15N_
ubiquitin and the isolated p62 UBA. Arg42, Lys48 and Ile44 are no longer at
measurable intensity after the addition of 50 11M,75 11Mand 150 11MGST-p62
UBA respectively. Leu69, Leu71 and Arg72 are lost much later in the titration,
after the addition of 250 11MGST -p62 UBA. Arg72 exhibited fast exchange in the
titrations between 15N-monoubiquitin and the GST -p62 UBA and 15N_
monoubiquitin and the isolated p62 UBA. However when titrated with linear
diubiquitin Arg72 changes to intermediate exchange. As well as an additional
peak in intermediate exchange, several peaks which are in fast exchange broaden
significantly but stay at measurable intensity during this titration are also
observed. These peaks correspond to residues Leu8, lIeB, Ala46, Gly47, Leu50
and Val70 and are found either in or around the canonical Ile44Nal70 binding
patch, forming a larger region of the molecule which is affected by binding.
Overall this indicates a stronger binding interaction occurs for linear diubiquitin
when bound to the GST -p62 UBA construct when compared to the interaction
between monoubiquitin and the GST -p62 UBA.
In both of the reverse titrations saturation was not reached. This was confusing
given the rapid saturation points observed in the forwards titrations. A higher
excess of the GST was not attempted to reach saturation as the protein was likely
to precipitate out of solution. Saturation was likely to be restricted by the
competing equilibria in the GST -p62 UBA, although the mechanisms behind this
remain unknown as reverse titrations using the isolated p62 UBA and various
mutants have all managed to reach sautration. Since binding to the GST -p62 UBA
showed more residues which were in intermediate exchange, it is possible that
these residues would return to measurable intensity at saturation. Since saturation
was not reached accurate Kd values could not be determined for the two
interactions.
242
-- f • 105
•
• • • •
.~._~..
110
...., .....:z:
- •
.... 115• • 01
.~.r ~ • .. <,•
• .~'-...; • • 120 '0• "0.-
•
51
• .~.~
.. it ~ • 125•
• • •
130
10.0 1.0 6.5
lH 6 /
lIe31 leu67
!
lys6
!
Ala46 !
lA "_
Y P trum forl5N-Jinear diubiquitin (human) in the
)lM r d , 2 )lM (blu ) and 500 uM (black) GST -p62 UBA. Inset
th r idu which p rturb upon binding. Residues Val70 and
th r idue which broaden significantly during the
rd d in 25 mM potassium phosphate, 25 mM
243
The CSPs were plotted for each of the residues in the two titrations (figure 9.12,
A). The CSP maps identified clusters of large CSPs corresponding to a previously
observed binding epitope on ubiquitin, centred on residues Leu8, Ile44 and Va170.
This signifies that the canonical Ile44Nal70 binding patch is utilised by both
monoubiquitin and linear diubiquitin to bind to the GST -p62 UBA. Smaller CSPs
were also observed relative to the titration between ubiquitin and the isolated p62
UBA domain. Smaller CSP values also indicate that saturation had not been
reached during the titrations. Generally, slightly larger CSPs were observed by
monoubiquitin when compared to linear diubiquitin. This indicates that avidity
effects are responsible for the increase in affinity, as the sum of the two
interactions in diubiquitin raise the overall affinity of the interaction.
Residues with significant CSPs (> 0.05 ppm) were plotted onto the surface of
monoubiquitin (PDB ID 1UBQ) in order to visualise the region of the protein
used to bind to the GST-p62 UBA construct (figure 9.12, B and C). The residues
which were in intermediate exchange were coloured in black; whereas, residues in
fast exchange were coloured in red. The larger CSPs were represented by darker
red colours. A larger region of the molecule is shown to be affected for linear
diubiquitin indicative of a tighter binding interface. The presence of an additional
resonance in intermediate exchange and several residues surrounding the binding
patch which broaden to weak intensities confirm that a larger region is affected,
although only Arg42 was plotted onto the surface of the molecule.
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Figure 9.12 - re idue pecific CSPs of monoubiquitin when bound to the GST-
p62 A (blue) and linear diubiquitin bound to the GST-p62 UBA (red). The
strong c rrelation in the data highlights that the canonical Ile44Nal70 binding
patch i being utili ed to bind the GST-p62 UBA. CSPs plotted onto the surface of
ubiquitin (PO ID 1UBQ) for B) monoubiquitin and C) linear diubiquitin when
bound to the -p 2 UBA. Residues Arg42, Ile44, Lys48, Leu69 and Leu7l,
which broaden to unob ervable levels during the two titrations are coloured black.
Arg72 al 0 exhibit int rrnediate exchange in linear diubiquitin, so is also
coloured black in. P greater than 0.05 ppm are coloured red. The darker the
red, the larger the P. A larger interaction surface is present for the interaction
with linear diubiquitin and GST-p62 UBA.
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9.2.3 Titrations using hHR23A UBA2 as a control
In order to confirm that avid binding effects are observed by the dimeric UBA of
the GST -p62 UBA construct, control titrations using a known monomeric UBA
expressed as a GST fusion protein were also conducted. The hHR23A UBA2
domain was the UBA chosen to act as a control UBA. This UBA has been
previously shown to be structurally very similar to the p62 UBA with no previous
evidence that it exists as a dimer9s,96.Again all spectra were recorded in 25 mM
potassium phosphate, 25 mM NaCl, pH 7 at 298 K.
9.2.3.1 Low concentration NMR of the hHRl3A UBAl domain
The discovery of the UBA dimer in the p62 was initially revealed by low
concentration NMR. In order to confirm that the isolated hHR23A UBA2 exists as
a monomer, a low concentration (10 JlM) IH_1sN HSQC was completed. The
resonances visualised in this spectrum were subsequently compared to the
resonances observed in a high concentration (500 11M) IH_1sN HSQC. At low
concentration the number of peaks in the spectrum doubles for the isolated p62
UBA, with the extra peaks corresponding to a low population of the p62 UBA
monomer. This was not observed for the low concentration spectrum for the
hHR23A UBA2. Peaks at identical chemical shifts but with weaker intensity were
observed at low concentration (figure 9.13), thus confirming the presence of a
monomeric species only. This is consistent with all the previous structural data on
the hHR23A UBA295,96.
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Figure 9.13 - IH_15NHSQC spectrum of the hHR23A UBA2 at 500 11M(black)
and 10 11M(red). Both spectra were recorded in 25 mM potassium phosphate, 25
mM Na I, pH 7 at298 K.
9.2.3.2 GST-hHR23A UDA2 compared to hHR23A UDA
Similar to the ISN_ ST-p62 UBA, the lSN-GST-hHR23A UBA2 produced a IH_
ISN TR Y pectrum with peaks predominantly corresponding to the UBA
domain (figure 9.14). orne additional resonances were also observed highlighting
the G T a not being completely NMR silent in this construct either. Again these
peak are believed to correspond to the unstructured C-terminal of the GST and
thrombin cleavage ite which form the linker between the GST and the UBA. In
addition to thi , the re onances in the spectrum for the free ISN-GST-hHR23A
UBA2 produced slightly broader signals than the spectrum for the 15N-GST-p62
UBA, con i tent with the molecule showing increased flexibility due to the UBAs
not being tethered together a a dimer.
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Figure 9.14 - IH_15N TROSY of the 15N-GST-hHR23A VBA2 (black) and
isolated 15N-hHR23A-UBA2 (red). Both spectra were recorded in 25 mM
potassium phosphate, 25 mM NaCI, pH 7 at 298 K.
9.2.3.3 Titrations using the GST-hHR23A UBA2
The addition of up to 2 mM unlabelled monoubiquitin and 1 mM linear
diubiquitin was added to 500 11M 15N-GST-hHR23A UBA2 (as separate
experiments). Concentration dependent chemical shifts consistent with a binding
event were observed for the addition of both monoubiquitin and linear diubiquitin.
The titration with monoubiquitin showed resonances which were in fast exchange,
indicative of a weak binding event (figure 9.16, C). During the titration with
monoubiquitin saturation was nearly reached by the addition of I mM
monoubiquitin (1:2 molar ratio of GST -hHR23A VBA2:monoubiquitin). This
suggests a weaker binding interaction than observed for the 15N-GST-p62 UBA
with monoubiquitin. The weak interaction is consistent with the weak interaction
for isolated hHR23A VBA2 and monoubiquitin (Kd of 400 ± 100 IlM)54.Both the
free and bound forms of the spectrum exhibited resonances with broad signals,
consistent with the UBA monomers being conformationally flexible in both forms
(figure 9.15, A and B).
248
A~I
c:
/" -105
-
_.
~1l0
•
• 4• ,. • •
-.;,;.1., • • ~~l1S ~Z
~... • . . I 01
..."
q~4II> • 9 - • •~
<,
•
~ ._,.....
~120
"C
~;,. .. "C
.;. .. ~ ;
•
.., .
~12S
• • •...~
~130
c
•
10.0 9.5 9.0
I
8.5 8.0 7.5
1H s / ppm
I
7.0
I
6.5
Figure 9.15 - A schematic diagram of the GST-hHR23A UBA2 in A) the free
form and B) the bound to monoubiquitin form. The black arrows indicate the
flexibility achieved by the linker, which is not restrained by the formation of a
UBA dimer at the C-terminus. This flexibility causes broader peaks to appear in
the spectrum. ) The IH_15NTROSY of the 15N-GST-hHR23A UBA2 in the
pre ence of 0 mM (black), I mM (blue) and 2 mM (red) monoubiquitin. Arrows
are hown for the movement of some of the resonances which had the biggest
perturbation between the free and bound forms. All spectra were recorded in 25
mM potassium pho phate, 25 mM NaCI, pH 7 at 298 K.
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However when linear diubiquitin was titrated in, resonances which were in
intermediate exchange were observed (figure 9.16). After the addition of 50 IlM
linear diubiquitin significant broadening was seen for resonances in the central
region, but these peaks were still able to be detected. Simultaneous to this, the
well dispersed peaks on the outer region of the spectrum, which predominantly
corresponded to the hHR23A UBA2, had broadened to the point where they were
no longer at measurable intensity. The instantaneous broadening of peaks in the
titration with linear diubiquitin precluded the analysis of this data, but does
strongly suggest an interaction with much higher affinity.
The change from fast to intermediate exchange is indicative of a slower on/off
rate between complex formation and dissociation which is associated with a
tighter binding interaction. The hHR23A UBA2 domain is well documented to
have a preference for Lys48 chains. Although linear chains are not the natural
ligand, the data suggests that the GST -fusion has placed the two UBAs in close
proximity to favour avid binding to linear diubiquitin. Avid interactions are highly
sensitive to the orientation of the binding units as well as the flexibility between
the units. The results observed here back up the notion that the linker is not long
enough to permit sufficient flexibility between the subunits.
The avidity effects observed by the GST -hHR23A UBA2 are stronger than for the
GST -p62 UBA as shown by the change in chemical shift regime. This result was
surprising, given that Lys63 and linear chains are favoured by the p62 UBA. On
the other hand the result was not totally unexpected given that the GST -hHR23A
UBA2 does not have UBA dimerisation competing with ubiquitin binding.
Alternatively the length of the polyubiquitin chain could also prove to be
influential on avid binding by the p62 UBA, with longer chains required for
enhanced avidity effects. The idea of spacer ubiquitins in a polyubiquitin chain to
permit the high affinity binding by multiple UBAs is attractive.
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Figure 9.16 - The IH_15N TROSY of the 15N-GST-hHR23A UBA2 in the free
(black) and bound to linear diubiquitin forms (red). Many of the peaks have
broadened ub tantially in the bound form due to the intermediate exchange
regime adopted by the interaction, Both spectra were recorded in 25 mM
pota ium ph phate, 25 mM NaCI, pH 7 at 298 K.
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9.2.4 GST-p61 T419K dilution
Dilution experiments were conducted in order to see if the UBA in the aST fusion
protein was able to dissociate (in the absence of ubiquitin) despite being tethered
to the aST dimer. Since low concentrations, which are not ideally suited to NMR,
are required to shift the equilibrium towards the monomer in the wild type UBA, a
aST-fusion of the weak dimer mutant T419K was used as an alternative. It was
postulated that the UBA dimer would not dissociate at lower concentrations
because the strength of the aST dimer was so high (1 nm interaction).
A IH_15NTROSY was recorded at 50 IlM intervals from 250 IlM to 50 IlM for the
15N-aST-p62 T419K. Similar to the cleaved ISN-T419K spectrum, a complicated
spectrum with evidence for three species in equilibrium was observed at
concentrations greater than 50 JlM (figure 9.17, A). The chemical shifts for the
three species were near identical to those observed in the cleaved T419K. It was
therefore assumed that the ISN-aST-p62 T419K mutation produced the same
effects and was able to form the same alternative dimer species. In agreement with
the wild type aST -p62 UBA and aST -hHR23A UBA2 spectra, some additional
peaks were observed for the 15N-aST-p62 T419K relative to the isolated T419K.
Many of these peaks were located at the same chemical shifts as those for the 15N_
aST -p62 UBA confirming that they belong to the linker between the aST and the
T419K.
During the course of the dilution resonances corresponding to two species (the
two UBA dimers) disappeared leaving a spectrum for a single species, the UBA
monomer (figure 9.17, B). Spectra recorded at 25 JlM and 12.5 JlM showed a
single species, although the resolution at these concentrations was poor suggesting
high protein instability. It was surprising that during the dilution the two dimer
species were lost, as it was suspected that tethering to the aST dimer would be
able to prevent UBA dissociation. The presence of the aST dimer should in
theory maintain the effective local high concentration and thus favour the UBA
dimer. Moreover, the short linker should restrict the flexibility of the UBA, again
favouring the dimeric state. However, dimer dissociation might be permitted in
this case due to the inherently weak dimer formed by the T419K mutant.
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Figure 9.17 - The IH_'5N TROSY spectrum showing the overlay of the 15N_GST_
p62 T419K (black) and cleaved T419K (red) at A) 250 11Mand B) 50 11M.At 250
11M3 pecie are ob erved, whereas at 50 11Mthe T419K monomer is observed
only. Although the G T-p62 T419K is more unstable at lower concentrations as
een by the poor re olution in the 50 11Mspectrum. All spectra were recorded in
25 mM pota ium pho phate, 25 mM NaCI, pH 7 and 298 K.
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9.2.5 Monitoring avidity effects by the GST-p62 UBA using nanospray ESI-MS
In order to confirm the findings of the NMR titrations using the aST -p62 UBA,
attentions were turned to ESI-MS. Several attempts were made to produce an ESI-
MS spectrum; however, signals for the aST -p62 UBA were unable to be detected
in the mass spectrometer. Since large proteins and other macromolecular
complexes are studied using a nanospray source, this was used as an alternative.
Nanospray uses a miniaturized electrospray source and a very low flow rate to
generate droplets in the nanometer range. Nanospray has the advantage of more
readily preserving noncovalent protein complexes compare to standard ESI-MS
methods/'",
Typically higher sample and ammonium acetate concentrations are required for
nanospray ESI-MS 176. Higher ammonium acetate concentrations are able to
reduce the effects of non-volatile adduct ions which might be present in the
sample, permitting better ionisation of the molecule. Both sample and
ammononium acetate concentrations therefore needed to be optimised prior to
data collection.
At both 5 and 10 JIM the spectrum of the aST -p62 UBA showed predominantly
dimer, although a low population of tetramer was also observed. A 1 JIM sample
was also recorded but a high quality spectrum was unable to be produced that this
concentration. The spectrum recorded on a 5 JIM sample in 200 JIM ammonium
acetate was shown to be optimal as it minimised the presence of the tetramer
(figure 9.18). Since the presence of the tetramer decreased with concentration it is
likely that this is a non specific oligomer which is an artefact of the electrospray
process. A mass of 63832.1 Da was observed for the dimer, which was in good
agreement with the predicted mass of 63775.6 Da. Spectra at the aforementioned
concentrations were recorded in both 100 JIM and 200 flM ammonium acetate. A
high quality spectrum was observed in both cases, with no obvious changes
observed between the two concentrations. The higher concentration of 200 flM
was chosen to ensure better ionisation of the protein.
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Figure 9.18 - the nanospray ESI-MS spectrum for a 5 IlM aST-p62 UBA. A
spectrum with predominantly dimer was observed. P:P denotes dimer and P:P:P:P
denotes tetramer. The spectrum was recorded in 200 IlM ammonium acetate, pH
7.
Once the spectrum for the free GST -p62 UBA had been obtained binding
experiments with both monoubiquitin and linear diubiquitin ensued. Experiments
with molar ratios of 1:0.5, I: I and 1:2 (aST -p62 UBA:ubiquitin) were recorded
for both monoubiquitin and linear diubiquitin. In all cases, mass ions were
observed for the aST -p62 UBA and the ubiquitin ligand, but not the protein
complex (figure 9.19). A range of trap and transfers energies were tried, but a
complex was still unable to be detected. Higher voltages are required for bigger
complexes but the risk of dissociation is also greater at higher collision energies,
especially in weak interactions. Moreover, the backing pressure was also adjusted
to see if a higher quality spectrum which contained the complex. All the other
ESI-MS binding experiments detailed in this thesis was able to detect very small
peak corre ponding to the complex. The poor detection in all cases is linked to
the bias of the mass spectrometer against weak hydrophobic interactions. The lack
of a complex could be linked to the increased size of the protein as larger protein
complexes are more fragile and require greater energy for ionisation.
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9.2.6 NMR investigations on the longer GST p62 fusion proteins
9.2.6.1 Degradation is observed in the longer GST p62 fusion proteins
The experiments using the GST p62-UBA construct as a model of the full length
p62 protein showed encouraging results. The next step was to perform similar
experiments on the longer p62 constructs. The longer constructs would improve
the model so that it also contains a long, flexible linker region between the Nand
C terminal domains. However, the addition of a long linker region N-terminal to
the UBA domain has a dramatic effect on the ability to purify a homogenous
sample. The longer GST -p62 constructs, GST -p62 261-440, the GST -p62 300-
440 and the GST -p62 341-440, all showed significant degradation during the
purification protocol when compared to the GST -p62 UBA, even for the GST -p62
341-440 which was the shortest of the longer constructs (figure 9.20). The
degradation could be an intrinsic property of the PEST sequence which the linker
region encodes. PEST sequences are commonly found in proteins with short half
livesI37,J38.
The amount of degradation observed by the longer GST fusions prevented
accurate measurement of concentration, since the degradation could not be
quantified accurately. The presence of the linker in the model produced similar
results to attempts to purify the full length protein with mutations in the PB 1
domain to prevent self oligomerisation. Since the GST protein is used as a
solubility tag it was believed that the GST would have a protective role and help
to prevent protein proteolysis; however, this was shown not to be the case.
30
GST-p62 USA GST-p62341-44O
Figure 9.20 - A comparison of the purification gels (both 20 % acrylamide) for
the GST-p62 UBA construct and the GST-p62 341-440 construct. The addition of
the 41 unstructured residues has a dramatic effect on the amount of degradation
exhibited by the GST -p62 341-440 construct.
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9.2.6.2 NMR titration studies using the longer p62 GSTfusion proteins
The GST -p62 longer constructs were all investigated by NMR despite the
observation of significant degradation. As expected, increasing the length of the
linker between the GST and the UBA resulted in significantly more complicated
spectra. By increasing the unstructured region more sharp peaks become clustered
in the central region producing spectra with a high degree of overlap. Moreover,
all of the longer GST -p62 constructs all exhibit signs of degradation within their
spectra. The spectra produced for all the longer constructs in both the free and
bound forms showed resonances corresponding to residues in the UBA which had
identical chemical shifts to each other but not to the GST -p62 UBA or isolated
p62 UBA. Therefore the GST -p62 261-440 was used as a representative for all the
longer constructs. Since ubiquitin binding is the focus of these experiments only
residues in the UBA were assigned.
The free IH_1sNTROSY spectrum for the 15N-GST-p62 261-440 showed a wide
dispersion of peaks corresponding to the UBA. Most of the resonances for the
UBA in the GST -p62 261-440 were present at very similar chemical shifts to
those previously reported for the isolated domain (figure 9.21). Although some
very slight movement was observed for some resonances. Due to the high
correlation between the free forms of the UBA in the isolated domain and the
GST-p62 261-440 construct, 41 out of 47 residues in the UBA were able to be
assigned based on the previous assignments for the free UBA. The missing
residues, namely Ala390, Asp391, Ser399, Leu416, Lys435 and His436, had
moved significantly. These residues were surrounded by other peaks which
prevented unambiguous assignment. Both Ala390 and As391 are located close to
the N-terminus in the UBA construct; however, these residues form part of the
flexible linker in the long constructs therefore it was expected that these residues
have different chemical shifts as they have changed their chemical environments.
Similarly Lys435 and His436 are located at the C-terminus in the UBA construct,
but the longer constructs are extended by four residues at the C-terminus. The
UBA construct is defined by residues 387-436, but the longer constructs terminate
at the natural C-terminus of residue 440. Again the change in chemical
environments for these residues can be explained.
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Figure 9.21 - A comparison of the free forms for the lon~er GST -p62 constructs
compared to the isolated 15N_p62UBA domain. The IH_I N TROSY for the 15N_
G T-p62 261-440 (blue), '5N-GST-p62 300-440 (red), 15N-GST-p62 341-440
(purple) and 15N_p62 UBA. A zoom of the 'H_'5N TROSY which highlights
re onance which have shifted in the free form for the longer constructs compared
to the i olated domain. All pectra were recorded in 25 mM potassium phosphate,
25 mM Na I, pH 7 at 29 K.
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The movement of resonances was much more pronounced in the bound form of
the GST-p62 261-440 construct (figure 9.22). Therefore many more peaks were
unable to be unambiguously assigned in the bound form compared to the free
form. Only 19 residues were able to be assigned based on the chemical shifts
previously reported for wild type p62 UBA. The assigned residues were not
located in a particular region of the protein, so it is not obvious what has caused
these changes. Of the assigned residues mixed signal intensities were observed,
suggesting that some of these assignments were not correct. This change in
chemical shifts in the longer constructs is consistent with the observation of an
alternative bound form when investigating the p62s ability to form a ternary
complex (chapter 8).
Titrations with monoubiquitin were completed for all the longer GST -p62
constructs despite being unable to assign the bound form. Up to 1 mM unlabelled
ubiquitin was titrated into 250 11Msamples of lSN-GST-p62 longer constructs (as
separate experiments). Since accurate concentrations could not be determined the
titration data could not be examined quantitatively. However, if we assume that
the amount of degradation is the same in all the longer constructs and that the
extent of degradation remains constant throughout the titration, saturation points
can be estimated. Using these assumptions, saturation was observed around 1:2
molar ratio (UBA:ubiquitin). This would imply that the interaction using the
longer p62 constructs is stronger, than the isolated UBA domain but weaker than
the GST -p62 UBA. This result is consistent with differences in affinity being
observed between the isolated UBA and the full length p62 protein using GST
pull down assaysl70,171and with the UBA in the GST-p62 UBA construct forming
a weaker dimer.
Titrations with linear diubiquitin were not completed due to the poor success
shown by the titrations with monoubiqutin. The inability to assign the data
combined with the inability to determine accurate protein concentrations meant
that limited information could be determined from the data.
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Figure ,22 - A compari on of the bound forms for the longer GST -p62
con tructs compared to the isolated 15N_p62UBA domain. The IH_15NTROSY
for the 15N_ T-p62 261-440 (blue), 15N-GST-p62 300-440 (red), 15N-GST-p62
341-440 (purple) and 15N_p62 UBA. A zoom of the IH_15N TROSY which
highlight re nance which have shifted in the bound form for the longer
con truct compared to the isolated domain, There are no obvious peak matches
for Trp4 I2 and lIe395 in the zoom. All spectra were recorded in 25 mM
pota ium pho phate, 25 mM NaCI, pH 7 at 298 K.
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9.3 Discussion
The role of avidity in the binding of polyubiquitin chains to multiple UBDs has
only recently begun to be investigated. A study involving 30 UBA domains was
able to group UBA domains into four categories according to their linkage
preference'", It has since been revealed that the results from this study might be
incorrect due to the promotion of artificial avidity effects using GST fusion
proteins'", Since this discovery, the notion that linkage specificity could arise
from the multivalent arrangement of UBA domains in oligomeric proteins in
nature has begun to be explored.
The p62 protein is capable of self oligomerisation as well as being able to bind to
the structurally similar NBRI protein. The presence of p62 and NBRI in
sequestosomes suggests that multiple UBAs are presented to long polyubiquitin
chains. Since the linker is long in both of these proteins enabling conformational
flexibility in the UBAs. This permits changes in the orientations of the UBA
dependent on the binding partner. Therefore the correct signals are likely to be
amplified using avidity effects, suggesting avidity only plays a part in the binding
of specific polyubiquitin chains. The specificity of the length of the chain as well
as the linkage are likely to be crucial to the high affinity interaction. To date the
concept of spacer molecules in polyubiquitin binding by the p62 has not been
investigated.
Recently a proposed mechanism of binding by the XIAP protein to linear and
Lys63 linked chains was reported using molecular modelling (figure 9.23)236. The
dimerisation of the RING domain of the XIAP protein facilitates the dimerisation
of the XIAP UBA. The XIAP UBA dimer subsequently positions its ubiquitin
binding surfaces in an orientation which can simultaneously recognise separate
ubiquitin moieties in linear or Lys63 linked polyubiquitin chains to achieve a high
affinity interaction. However, the study also revealed that successive ubiquitins
were not recognised by the XIAP UBA and that spacer ubiquitin moieties were
required. The model was consistent with the weak binding of XIAP to linear
linked diubiquitin and the previous report that XIAP requires a tetraubiquitin
chain for a detectable interaction.
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Figure 9.23 -Proposed mechanism of binding by the XIAP UBA dimer to
polyubiquitin chains. The ubiquitins which are cloured in orange are the spacer
ubiquitins which permit avid interactions by linear or Lys63 linked tetraubiquitin.
Taken from Tse et aP36.
The XIAP dimer (Kdim 900 IlM) is weak compared to the p62 UBA dimer (Kdim
4.1 IlM). Ln the ca e of the XIAP, UBA dimerisation is likely to facilitate avid
binding interaction . However, the p62 UBA dimer has an inhibitory role in
ubiquitin binding due to the partial overlapping of the dimerisation and ubiquitin
binding interface . To date no other examples of UBA dimers have been shown to
have partially overlapping dimerisation and ubiqutin binding interfaces. It is quite
clear that the competitive equilibria of the p62 UBA significantly complicates the
avidity the ry f r binding of polyubiquitin chains. Many questions about the role
of the BA dimer in regulating binding affinity remain.
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9.4 Conclusions
The attempts to model the full length p62 protein as a dimer and investigate the
potential avidity effects in ubiquitin binding were not completely successful. The
NMR titration data for the GST -p62 UBA construct showed promising results.
Although a dramatic increase in affinity was observed for the GST -p62 UBA
compared to the isolated domain. This data suggests that the linker region in the
GST -p62 UBA was too short to permit complete flexibility of the UBA,
restricting the formation of a high affinity UBA dimer. An interaction with
increased affinity was observed for binding to linear diubiquitin over
monoubiquitin, suggesting a role for avidity in the binding of oligomeric p62.
However, the observed avidity effects were not substantial, with the increase in
affinity consistent with there being two binding sites in linear diubiquitin.
Although accurate Kd values were unable to be determined from the NMR data at
high concentrations, a change in chemical shift regime was not observed in
binding to linear diubiquitin, consistent with subtle changes in binding affinity.
The limited role of avidity could be caused by the inhibitory role of UBA
dimerisation or the notion that spacer ubiquitin moieties are required for a high
affinity interaction. Avidity effects are highly sensitive to both the orientation of
the UBA as well as the flexibility of the linker between the subunits. In vivo the
fuJI length p62 has a longer linker, which could place the UBA domains further
apart from each other to favour binding to multiple but not consecutive ubiquitin
moieties in a polyubiquitin chain. A greater distance between UBAs is also likely
to have an effect on UBA dimerisation by decreasing the effective local
concentration thereby decreasing dimer formation.
Complementary reverse titrations whereby GST-p62 UBA was titrated into ISN_
monubiquitin and ISN-linear diubiquitin showed confusing results. Saturation was
not reached at a molar ratio of 1:2 (ubiquitin:GST -p62 UBA). This result was
inconsistent with the forwards titrations which saturated at 1:1 and 1:0.5 molar
ratio for monoubiquitin and linear diubiquitin respectively. A higher excess of
GST-p62 UBA could not be used as the protein would precitate out of solution. It
was not particularly obvious why this occurred as reverse titrations with the
isolated UBA and other UBA mutants were able to reach saturation.
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The GST-T419K was diluted from 250 JlM to 12.5 JlM in order to examine if the
UBA domain was able to dissociate at lower concentrations in the absence of
ubiquitin. The GST fusion of the T419K, like the cleaved T419K, showed the
presence of three species at equilibrium. At 50 JlM only a single species was
observed. This was quite unexpected given that the UBA was tethered to the GST
dimer by a short linker. The GST remains dimeric at this concentration and has a
Kdim of I nm. The GST was therefore expected to keep the effective local
concentration high and thus favour dimerisation. The data presented for the
T419K data, contradicts this theory, although the presence of a weak UBA dimer
could affect the results.
Control experiments using a GST fusion of the hHR23A VBA2 protein were also
completed. NMR titrations whereby unlabelled moniubiquitin and linear
diubiquitin were titrated into ISN GST-hHR23A UBA2, with promising data
observed. A weak interaction between the GST -hHR23A VBA2 and
monoubiquitin was observed, similar to the weak interaction observed by the
isolated hllR23A UBA2 domain and monoubiquitin. The results of this
experiment suggest that the increase in affinity observed by the GST -p62 UBA is
likely to be linked to the formation of a weaker VBA dimer in the GST -p62 UBA
construct, rather than an intrinsic property of the GST fusion protein in the model.
The interaction between GST-hHR23A VBA2 and linear diubiquitin showed a
change in the chemical shift regime from fast to intermediate exchange. This
change is associated with a significant increase in affinity due to slower on and off
rates. This data is consistent with previous reports that artificial avidity effects are
promoted by the positioning of the two UBAs in close proximity to each other.
This data would also suggest that the linker region is this construct is too short to
allow total flexibility of the UBA.
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However, problems with the model were exposed when a longer linker was
inserted. The longer GST -p62 constructs showed significant proteolysis which
prevented accurate measurement of protein concentration. The degradation could
be linked to the PEST sequences encoded by the linker region. Moreover a
combination of chemical shift deviations in the free and bound forms and a highly
crowded spectrum prevented the full assignment of the UBA in the bound form.
This result was consistent with the observation of an alternative bound form in the
cleaved C331 S p62 300-440 construct.
The nanospray ESI-MS was unable to detect the complex formed between the
GST-p62 UBA and either of the ubiquitin ligands. Despite experimenting with a
range of molar ratios of UBA:ubiquitin and varying the parameters, the complex
was still not observed. This result was also confusing as nanospray uses more
gentle desolvation conditions to preserve noncovalently bond complexes.
Although, peaks for the complex are not more abundant for the isolated UBA or
any of its mutants, they were able to be detected. It was therefore assumed that the
problems associated with detection of the complex were linked to the increased
size. In order to get the larger complex to ionise larger collision energies are
required but this also increases their fragility as dissociation is more likely to
occur.
Overall we were able to show enhanced binding to linear diubiquitin compared to
monoubiquitin, consistent with avidity effects increasing the affinity of the
interaction. Taken together the data obtained in this chapter showed that in order
to generate a successful model a longer linker is required. However, when
attempts were made to achieve this degradation became a problem. In this case the
degradation could be linked to the fact that PEST signals function as internal
degradation signals. We can also conclude from the data that the dimerisation of
the p62 UBA is also to oppose the avidity effects. However, we are unable to
explore if this inhibitory role is reduced in the full length protein as we were
unable to increase the length of the linker.
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9.S Future work
The future of this project lies with generating the NMR structure of the full length
p62 protein. The full length p62 protein represents a considerable challenge,
considering it contains a large region of unstructured protein. However, recent
advances in NMR spectroscopy, such as "c direct experiments and non uniform
sampling, have the potential to solve the structure of the full length protein. The
ability to obtain large amounts of a homogenous stable sample appear to be the
limiting factor in structural investigation of the full length p62. Since the start of
this project the discovery of mutations which enable p62 PB 1 monomer and
dimers to be formed has been revealed. These mutations were incorporated into
the futJ length protein and attempts to purify it began. However, the purification
was unsuccessful for the full length protein when expressed as both a GST fusion
or cleaved protein. Degradation was also shown to be a problem in the full length
protein. This was combined with a very poor yield, whereby not even 0.5 mg per
Litre of growth was obtained in LB media.
Attempts were also made to make another model of the full length p62 protein
were also made. This model contained the PB I domain mutations and removed a
large segment of the linker between the ZZ domain and the UBA to minimise
degradation. However, the peR deletion to shorten the linker was unsuccessful
despite utilising different conditions and primers. This would not necessarily be
the best model as some of the protein binding sites are removed in this linker.
Assuming a suitable model is used or the full length protein is able to be obtained,
the binding to longer polyubiquitin chains should also be explored. Or
alternatively a molecular model of the full length protein could be used to monitor
binding. As in the case for the XIAP UBA, spacer ubiquitin molecules could be
required to permit a high affinity interaction for the p62 UBA. The isolated p62
UBA has shown a preference for longer polyubiquitin chains, despite UBA
dimerisation opposing the effects of ubiquitin binding. GST pull down assays
conducted on the wild type p62 appear to show a preference for tri and
tetraubiquitin chains or either Lys63 or Lys48 linkage 140, suggesting that one or
two spacer ubiquitins are required to increase the affinity of the interaction. The
avidity effects are likely to be amplified in the binding to the preferred length
chain as well as linkage.
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10 Conclusions
The experiments conducted within this thesis focus on ubiquitin binding by the
p62 UBA. Over 30 different mutations in the p62 UBA have been identified in
patients with PDB. A loss of ubiquitin binding has been previously shown to be
associated with POB, although the exact mechanisms which underlie the decrease
in affinity are currently unknown. A variety of factors including structural
alterations and reduced thermal stability have been shown to influence some
mutations but not others. Other factors are therefore likely to contribute to the
decreased affinity for ubiquitin and subsequently the onset of the disease. We
aimed to investigate the role of other factors in ubiquitin binding by the p62 UBA.
The p62 UBA was recently shown to exist as a highly stable dimer, which is
unusual for a UBA domain. In fact the p62 has been shown to have a novel
mechanism of ubiquitin binding, whereby dimerisation competes with ubiquitin
binding as the two interfaces partially overlap. The p62 UBA dimer dissociates to
facilitate the interaction of the monomer with ubiquitin. The interaction between
the p62 UBA monomer and ubiquitin is weak (40 ± 10 11M). The role of the dimer
in regulating the affinity of ubiquitin was explored using mutations along the
dimerisation interface (chapter 6). A phosphorylation site at Ser403 in the UBA
was also recently identified. The role of phosphorylation in regulating ubiquitin
binding was explored structurally and biophysically using phosphomimetic
mutations (chapter 7). Subtle changes in affinity were observed for the mutants
compared to the wild type p62 UBA by NMR (table 10.1 and 10.2)
In chapter 6 we introduced mutations to solvent exposed residues in helix 2 which
forms the dimcrisation interface. Weaker dimers were formed by the T414A,
T414K and T419K mutants. KJ;", values of 141 ± 111M, 146 ± 1.5 11M and 165 ±
30 11M were calculated from ITC dilution studies for the T414A, T414K and
T419K mutants respectively. The wild type p62 UBA had a Kdi'" of 4.1 ± 0.6 11M,
meaning that the T414A, T414K and T4I9K mutants were an order of magnitude
weaker than the wild type p62 UBA. We were able to show that there is a
relationship between weaker dimers and the affinity of the interaction with
ubiquitin. The weak dimer mutants were shown to have an increased affinity for
ubiquitin.
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The T419K mutant had shifted the equilibrium furthest as the monomeric species
was visible at high concentration (500 flM). This mutation enabled the study of
the monomeric species at low concentration «50 flM). 15Nheteronuclear NOE
experiments revealed an average value of 0.62 indicative of a structure which
exhibits some flexibility. This mutant also reached full saturation before the
T414A and T414K at 1:1 molar ratio. However, when a Kd for binding by the
T419K monomer was calculated the affinity was found to be weaker than the
value previously calculated for wild type. This is likely to be linked to an
inaccurate value for Kdim calculated by a poorly fitted dissociation curve.
In chapter 7 we generated the phosphomimetic mutants S403D and S403E and the
non-phosphorylated mutant S403A. We were able to show a preference for the
phosphomimctic mutants compared to the S403A control. Kd values of 71.4 ± 5.5
flM. 45.5 ± 2.1 flM and 27.8 ± 0.8 flM were calculated for the S403A, S403D and
S403E mutants using ESI-MS. Although these values are likely to be affected by
the bias of the mass spectrometer against hydrophobic interactions. A competitive
binding experiment using ESI-MS also revealed a preference for the
phosphomimctic mutants over the S403A mutant. Reverse NMR titrations
whereby the S403 mutants were titrated into 15N-ubiquitin revealed a larger
binding interface on ubiquitin for the phosphomimetic mutants. Kd'S for the
interaction were calculated at 10J ± 0.5 ~M, 7.1 ± 0.2 flM and 8.7 ± 0.4 flM for
the S403A. S403D and S403E mutants respectively. Consistent with the Kis
calculated by ESI·MS, a preference for the phosphomimetic mutants was
observed. A forward NMR titration for the S4030 mutant produced a Kd of39.1 ±
4.7 flM. which was highly similar to the value reported for wild type p62 UBA.
We were also able to con finn the monomer-dimer equilibrium was not affected by
the S403 mutation. We were able to show that the structural integrity of the dimer
was similar to that of the wild type and therefore changes in affinity could be
attributed to the role of phosphorylation only. Kdim values of 3.5 ± 0.5 flM, 6.7 ±
0.6 flM and 4.2 ± 0.5 flM were calculated for the S403A, S403D and S403E
mutants respectively. Overall the impact of phosphorylation alone on the UBA
was minimal. as shown by the calculated Kdvalues, it was suspected that the small
changes in affinity could be amplified by avidity effects when binding to
oligomeric p62.
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T bI 10 I K fi 62 UBA 1 1a e - d va ues or Pi as ea cu ated from forward NMR titrations.
P62 UBA monomer Kdim Kobs Kd
Wild type 4.1 ± 0.6 741 ± 80 40± 10
T419K 165 ± 30 185.9 ± 8.7 175.1 ± 20.4
S403D 6.7 ±0.6 229 ± 34 39.1 ± 4.7
T bl 102 K fi 62 UBA I 1 d fa e - dva ues or pi asca cu ate rom reverse NMR titrations.
Kdim Kobs Kd
Wild type 4.1 ± 0.6 540 ± 45 47.1 ± 10
S403A 3.5 ± 0.5 373 ± 19 10.3 ± 0.5
S403D 6.7± 0.6 337 ± 11 7.1 ± 0.2
S403E 4.2 ± 0.5 319± 11 8.7 ± 0.4
The role of ubiquitin binding in the context of the full length protein was also
investigated in this thesis. Differences in affinity have been observed between the
isolated UBA domain and the full length protein, suggesting that factors outside
of the UBA are also involved in regulating the binding of the p62 UBA. The
structure of the full length p62 protein has yet to be determined and is considered
to be a long term goal in understanding the role of the p62 as a scaffold protein
which is able to regulate various signalling pathways simultaneously. Chapters 8
and 9 investigated ubiquitin binding in longer constructs of the p62.
In chapter 8 the p62s ability to bind to multiple proteins was explored using a
construct of the p62 which extended back from the e-terminus to residue 300.
This construct encoded both the LlR and UBA of the p62. The p62 has been
shown to target ubiquitinated proteins for degradation by either the UPS or
autophagy. We were able to form a p62 mediated ternary complex with MAP-
Le3 and uhiquitin using NMR. ESt-MS and molecular modelling techniques. An
interaction between the MAP-Le3 and ubiquitin once bound to p62 was not
observed. despite a flexible linker separating the LIR and UBA. A higher affinity
interaction was observed for binding to MAP-Le3 over ubiquitin, consistent with
the previous literature. The binding of both proteins occurred irrelevant of
occupation of the other binding site. We were also unable to observe an allosteric
relationship between MAP-Le3 and ubiquitin in p62 binding. However, the
possibility that allostery could have a role in the binding of longer polyubiquitin
chains can not be excluded, as longer chains could block access to the LlR. One
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particularly unusual observation was that a different ubiquitin bound form was
observed in the C331 S p62 300-440 construct as chemical shift deviations were
observed for residues in the UBA.
The flexibility of the linker was probed using IH_lsN heteronuclear NOE
experiments. With only MAP-LC3 bound to the C331 S p62 300-440 a large
number of negative peaks were observed suggesting the high flexibility in the
linker was maintained despite protein binding. Although when ubiquitin and both
proteins were bound nearly all residues produced positive signals highlighting a
less flexible structure. It would therefore seem that ubiquitin binding has a greater
effect than MAP-LC3 on the flexibility of the p62. The molecular model revelled
that the linker possessed a large number of pronounced kinks due a high
prevalence of Pro residues. These Pro residues also restrict movement of the
linker and are therefore likely to prevent an interaction between the two bound
proteins.
In chapter 9 the role of avidity in raising the affinity of the interaction to a high
affinity interaction were explored using a model of the full length p62 protein.
The model consisted of fragments of the p62 extending back from the C-terminus
expressed as GST fusion proteins. The p62 protein has been shown to be highly
oligomeric due to its ability to self olgiomerise via the N-terminal PB 1 domain. In
vivo the p62 is found in speckles which cause effective local high concentrations.
The p62 is therefore capable of presenting an array ofUBAs to long polyubiquitin
chains. Since the interaction of a single UBA to ubiquitin has been shown to be
weak (40 ± 10 J.lM), it was postulated that the affinity of the interaction could be
levered to a physiologically relevant affinity using avidity effects. NMR
spectroscopy was used as predominantly signals corresponding to the UBA were
visible, with the GST component being largely 'NMR silent'.
The GST -p62 UBA construct bound to ubiquitin much quicker than expected,
suggesting that a weaker dimer was formed UBA. This could have been caused by
the short linker restricting the ability to forma high affinity dimer. Avidity effects
were observed in the binding of the GST -p62 UBA to linear diubiquitin compared
to monoubiquitin. Control experiments using the monomeric hHR23A UBA2
domain were also completed. A higher affinity interaction was observed by the
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GST-hHR23A UBA2 in binding to monoubiquitin, compared to the isolated
domain, suggesting again that the linker was too short to permit total
conformational flexibility. Much stronger avidity effects were observed in the
binding of GST - hHR23A UBA2 to linear diubiquitin than for GST -p62 UBA.
This is consistent with dimerisation not competing with binding and that the short
linker has placed the two UBA monomers close in space to favour avid binding to
linear diubiquitin. It was deduced that the linker was too short in these constructs.
However, when experiments using GST fusions of p62 constructs with longer
linker regions were completed some additional problems with the model were
observed. The predicted protective effect of the GST to prevent degradation in the
linker was not observed. In addition, similar to the cleaved longer C331 S p62
300-440 construct, a different ubiquitin bound form was observed.
Overall it is clear that the differences in affinity are exerted by the full length
protein relative to the isolated UBA domain. In order to fully understand ubiquitin
recognition and binding by the p62, the future should lie with the full length
protein. Thermal stability, small structural perturbations, dimerisation and
phosphorylation have all been shown to have a role in regulating the affinity of
the UilA, although it is clear that other factors which are currently unknown also
have a role in ubiquitin binding. Moreover, how these factors are able to act in
concert to regulate the affinity. It is also unknown if the UBA domain is dimeric
in the full length protein. In vivo the effective local concentration of UBA in
oligomeric p62 can be decreased given that a long linker separates the ZZ domain
and the UilA. Although we have explored ubiquitin binding in the isolated UBA
and in longer p62 constructs, many questions remain about ubiquitin recognition
and regulation of binding by the p62 UBA.
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Appendix A : Primer sequences
T414K
5' GGe GGC TGG CTe AAA AGG CTC CTG CAG ACC 3'
3' GGT eTG CAG GAG CCT TTT GAG CCA GCC GCC 5'
R415K
5' GGC GGC TGG CTe Ace AAA CTC CTG eAG ACC 3'
3' GGT eTG CAG GAG AAA GGT GAG CCA GCC GCC 5'
Q418A
5' GG eTe ACC AGG CTC eTG AAA Ace AAG AAC TAT GAC ATC GG 3'
3' ee GAT GTe ATA GTT CTT GGT TTT CAG GAG CCT GGT GAG CC 5'
T419K
5' e ACC AGG CTC CTG CAG AAA MG AAC TAT GAC ATC G 3'
3' C GAT GTC ATA GTT eTT TTT CTG CAG GAG CCT GGT G 5'
S403A
5' CC CTC TCC CAG ATG eTG GCG ATG GGC TTC TCT GAT GM GGC 3'
3' GCC TTC ATC AGA GM GCC CAT CGC CAG CAT CTG GGA GAG GG 5'
S403D
5' CC CTC TCC eAG ATG CTG GAT ATG GGC TTC TCT GAT GM GGC 3'
3' GCC TTC ATC AGA GM GCC CAT ATC CAG CAT CTG GGA GAG GG 5'
S403E
5' CC CTC Tce eAG ATG CTG GAG ATG GGC TTC TCT GAT GM G 3'
3' C TTC ATC AGA GM GCC CAT CTC CAG CAT CTG GGA GAG GG 5'
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